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ABSTRACT OF THE DISSERTATION 
 
Nickel-Catalyzed Reactions of Amides and  
New Methods for the Synthesis of Nitrogen-Containing Heterocycles 
 
by 
 
Bryan Joseph Simmons 
Doctor of Philosophy in Chemistry 
University of California, Los Angeles, 2019 
Professor Neil K. Garg, Chair 
 
This dissertation is divided into two main themes concerning transition metal-mediated 
methodologies and the synthesis of nitrogen-containing heterocycles. The first part of this 
dissertation focuses on the development of three new reaction pathways utilizing nickel and 
palladium. The impact of transition metals in the field of synthetic organic chemistry cannot be 
overstated, with the 2010 Nobel Prize being awarded for the use of palladium cross-coupling in 
organic synthesis. The second part of this dissertation aims to expand the synthetic toolbox 
towards the generation of nitrogen-containing heterocycles. With over 100 FDA-approved drugs 
containing a nitrogen atom, new methodologies toward these scaffolds remain highly sought 
after. 
 iii 
 
Chapters One, Two, and Three focus on the development of new methodologies utilizing 
nickel and palladium catalysis. Chapters One and Two describe our efforts towards the 
functionalization of the amide moiety. Although amides were once thought to be unreactive due 
to their resonance stabilization, we sought to probe the utility of amides as a functional group 
handle. Chapter One focuses on the alkylation of amides using nickel and an organozinc source 
to generate sp2–sp3 C–C bonds. Chapter Two showcases a methodology to convert secondary 
and tertiary amides to their corresponding amines using a silane reducing agent and nickel 
catalysis. Chapter Three discusses an academic and industrial collaboration towards the synthesis 
of tetra-ortho-substituted biaryls using palladium catalysis. These studies culminated in an 
extensive computational analysis of the reaction mechanism and the synthesis of numerous 
atropisomeric biaryls. 
Chapters Four, Five, and Six detail new methodologies towards the generation of 
nitrogen-containing heterocycles. With the nitrogen atom being prevalent in numerous FDA-
approved drugs, facile routes towards their incorporation remain highly valued. Chapter Four 
illustrates the elusive 3,4-piperidyne’s use in a variety of cycloaddition reactions. This study led 
to the formation of numerous annulated piperidines and exemplifies the utility of our 
methodology. Chapters Five and Six utilize the interrupted Fischer indolization reaction to 
produce an assortment of furanoindoline and pyrrolidinoindoline products. Chapter Five centers 
on the synthesis of the aza-analogues of these products by employing pyridylhydrazines. A 
computational study was undertaken to determine the cause of success or failure in this 
transformation. Chapter Six describes a variation of interrupted Fischer indolization 
methodology performed in a microfluidic device, which should enable its use in medicinal 
chemistry.  
 iv 
 
The dissertation of Bryan Joseph Simmons is approved. 
Yi Tang 
Hosea Martin Nelson 
Kendall N. Houk 
Neil Kamal Garg, Committee Chair 
 
 
 
 
 
 
University of California, Los Angeles 
2019 
  
 v 
 
 
 
 
 
 
 
 
“I’m Uncle Bryan, I do science.” 
– Grace Simmons, Five Years Old 
 
 
 
 
 
For my family 
  
 vi 
 
TABLE OF CONTENTS 
ABSTRACT OF THE DISSERTATION ....................................................................................... ii 
COMMITTEE PAGE .................................................................................................................... iv 
DEDICATION PAGE .................................................................................................................... v 
TABLE OF CONTENTS ............................................................................................................... vi 
LIST OF FIGURES ..................................................................................................................... xiii 
LIST OF SCHEMES ................................................................................................................ xxxii 
LIST OF TABLES ................................................................................................................... xxxiii 
LIST OF ABBREVIATIONS .................................................................................................. xxxvi 
ACKNOWLEDGEMENTS ..................................................................................................... xxxix 
BIOGRAPHICAL SKETCH ........................................................................................................... l 
CHAPTER ONE: Nickel-Catalyzed Alkylation of Amide Derivatives ......................................... 1 
1.1 Abstract ......................................................................................................................... 1 
1.2 Introduction ................................................................................................................... 1 
1.3 Development of the Coupling Using Amides with Various N-Substituents ................. 3 
1.4 Scope of the Coupling with Respect to the Amide Substrate ....................................... 4 
1.5 Scope of the Coupling with Respect to the Organozinc Species .................................. 5 
1.6 Demonstration of the Coupling on Gram-Scale ............................................................ 6 
1.7 Conclusion .................................................................................................................... 7 
 vii 
 
1.8 Experimental Section .................................................................................................... 8 
1.8.1 Materials and Methods ................................................................................... 8 
1.8.2 Experimental Procedures ............................................................................... 9 
1.8.2.1 Syntheses of Amide Substrates ....................................................... 9 
1.8.2.2 Preparation of Organozinc Halides ............................................... 12 
1.8.2.3 Initial Survey of Naphthamide Subsrates with Benzylzinc Bromide
................................................................................................................... 14 
1.8.2.4 Relevant Control Experiments in the Akylation of Amide 1.4e ... 16 
1.8.2.5 Scope of Methodology .................................................................. 17 
1.8.2.6 Gram-Scale Alkylation to Form Ketone 1.21 ............................... 22 
1.9 Spectra Relevant to Chapter one ................................................................................. 24 
1.10 Notes and References ................................................................................................ 37 
CHAPTER TWO: Nickel-Catalyzed Reduction of Secondary and Tertiary Amides .................. 42 
2.1 Abstract ....................................................................................................................... 42 
2.2 Introduction ................................................................................................................. 42 
2.3 Development of the Reduction Using Various Amide Substrates .............................. 44 
2.4 Scope of the Reduction with Respect to the Amide Substrate .................................... 45 
2.5 Scope of the Reduction with Respect to the N-Substituent ........................................ 48 
2.6 Preparation of Cyclic Amines from the Corresponding Lactams ............................... 49 
2.7 Reduction of Amino Acid Derivatives for the Synthesis of α-Deuteroamines .......... 49 
 viii 
 
2.8 Conclusion .................................................................................................................. 51 
2.9 Experimental Section .................................................................................................. 51 
2.9.1 Materials and Methods ............................................................................................. 51 
2.9.2 Experimental Procedure ........................................................................................... 52 
2.9.2.1 Syntheses of Amide Substrates ................................................................. 52 
2.9.2.2 Initial Survey of Amide Substrates with Phenylsilane ............................. 57 
2.9.2.3 Relevant Control Experiments for the Reduction of Amide 2.7 ............... 60 
2.9.2.4 Scope of Methodology .............................................................................. 60 
2.9.2.5 Synthesis of PhSiD3 .................................................................................. 72 
2.9.2.6 Reduction of Amino Acid Derivatives using PhSiD3 ............................... 73 
2.9.2.7 Verification of Enantiopurity – Racemic Compound Synthesis ............... 76 
2.9.2.7.1 Representative Procedure for the Deuterium Reduction of 
Racemic Amino Acid Derivatives ............................................................ 79 
2.9.2.8 Verification of Enantiopurity – er and dr Determination .......................... 81 
2.9.2.9 Procedure for Reduction Performed on 1.0 mmol Scale .......................... 91 
2.10 Spectra Relevant to Chapter Two ............................................................................. 93 
2.11 Notes and References .............................................................................................. 126 
CHAPTER THREE: Computationally Assisted Mechanistic Investigation and Development of 
Pd-Catalyzed Asymmetric Suzuki–Miyaura and Negishi Cross-Coupling Reactions for Tetra-
ortho-Substituted Biaryl Synthesis ............................................................................................. 134 
 ix 
 
3.1 Abstract ..................................................................................................................... 134 
3.2 Introduction ............................................................................................................... 135 
3.3 Ligand Synthesis ....................................................................................................... 143 
3.4 Asymmetric Suzuki–Miyaura Cross-Coupling ......................................................... 145 
3.5 Asymmetric Negishi Cross-Coupling ....................................................................... 150 
3.6 Mechanistic Modeling by DFT Analysis .................................................................. 156 
3.6.1 Negishi Cross-Coupling ............................................................................. 157 
3.6.2 Suzuki–Miyaura Cross-Coupling ............................................................... 160 
3.6.2.1 Oxidative Addition ...................................................................... 163 
3.6.2.2 Transmetalation ........................................................................... 165 
3.6.2.3 Reductive Elimination ................................................................ 167 
3.7 Conclusion ................................................................................................................ 174 
3.8 Experimental Section ................................................................................................ 175 
3.8.1 Materials and Methods ............................................................................... 175 
3.8.2 Experimental Procedures ........................................................................... 177 
3.8.2.1 Synthetic Routes to Ligands ....................................................... 177 
3.8.2.2 Substrate Synthesis ..................................................................... 228 
3.8.2.3 General Procedure for the Asymmetric Suzuki–Miyaura Cross-
Coupling .................................................................................................. 236 
 x 
 
3.8.2.4 General Procedure for the Asymmetric Negishi Cross-Coupling 
................................................................................................................. 236 
3.8.2.5 Analytical Data of Cross-Coupling Products .............................. 237 
3.8.2.5.1 Asymmetric Suzuki–Miyaura Reaction ....................... 237 
3.8.2.5.2 Asymmetric Negishi Reaction ..................................... 241 
3.8.2.6 Details of Computational Studies ............................................... 250 
3.8.2.7 Coordinate and Thermochemical Data for Computed Intermediates 
and Transition States ............................................................................... 251 
3.9 Spectra Relevant to Chapter Three ........................................................................... 252 
3.10 Notes and References .............................................................................................. 335 
CHAPTER FOUR: Generation and Regioselective Trapping of a 3,4-Piperidyne for the 
Synthesis of Functionalized Heterocycles ...................................................................................350 
4.1 Abstract ......................................................................................................................350 
4.2 Introduction ................................................................................................................350 
4.3 Prediction of Regioselectivies Based on the Distortion/Interaction Model ...............352 
4.4 Synthesis of Silyl Triflate Precursor ..........................................................................353 
4.5 Generation & Trapping of 3,4-Piperidyne 4.1a .........................................................354 
4.6 Comparison of Transition States & Distortion Present in 4.1a and 4.3 .....................358 
4.7 Conclusion .................................................................................................................360 
4.8 Experimental Section .................................................................................................361 
 xi 
 
4.8.1 Materials and Methods ................................................................................361 
4.8.2 Experimental Procedures ............................................................................362 
4.8.2.1 Synthesis of 3,4-Piperidyne Precursor .........................................362 
4.8.2.2 Trapping Experiments of 3,4-Piperidyne .....................................364 
4.8.3 Computational Methods ..............................................................................374 
4.8.3.1 Bent’s Rule & Alkyne Distortion Determine Regioselectivity of 
Nucleophilic Addition ............................................................................. 374 
4.8.3.2 n→p* interaction in 3,4-pyridyne ............................................... 375 
4.8.3.3 Energies, Enthalpies, and Free Energies ..................................... 376 
4.8.3.4 Cartesian Coordinates of the Relevant Structures ...................... 376 
4.9 Spectra Relevant to Chapter Four ............................................................................. 377 
4.10 Notes and References .............................................................................................. 393 
CHAPTER FIVE: Understanding and Interrupting the Fischer Azaindolization Reaction ....... 398 
5.1 Abstract ..................................................................................................................... 398 
5.2 Introduction ............................................................................................................... 398 
5.3 Computational Study of the Fischer Azaindolization Reaction ................................ 400 
5.4 Interrupted Fischer Azaindolization Reaction .......................................................... 402 
5.5 Interrupted Fischer Azaindolization Reaction in Bioactive Molecule Synthesis ..... 407 
5.6 Conclusion ................................................................................................................ 408 
5.7 Experimental Section ................................................................................................ 409 
 xii 
 
5.7.1 Materials and Methods ............................................................................... 409 
5.7.2 Experimental Procedure ............................................................................. 410 
5.8 Computational Section .............................................................................................. 432 
5.8.1 Computational Details ............................................................................... 432 
5.8.2 Additional Schemes and Discussion .......................................................... 433 
5.8.3 Origin of Regioselectivity .......................................................................... 439 
5.8.4 Cartesian Coordinates for Reactants and Transition States ....................... 442 
5.9 Spectra Relevant to Chapter Five ............................................................................. 443 
5.10 Notes and References .............................................................................................. 472 
CHAPTER SIX: Synthesis of Fused Indolines by Interrupted Fischer Indolization in a 
Microfluidic Reactor ................................................................................................................... 477 
6.1 Abstract ..................................................................................................................... 477 
6.2 Introduction ............................................................................................................... 477 
6.3 Results and Discussion ............................................................................................. 479 
6.4 Conclusion ................................................................................................................ 484 
6.5 Experimental Section ................................................................................................ 484 
6.5.1 Materials and Methods ............................................................................... 484 
6.5.2 General Information for Flow Reactor Setup ............................................ 485 
6.5.3 General Procedure for Flow Reactor Syntheses and Purification .............. 487 
6.5.4 Optimization of Flow Parameters and Substrate Synthesis ....................... 487 
 xiii 
 
6.6 Spectra Relevant to Chapter Six ............................................................................... 496 
6.7 Note and References ................................................................................................. 505 
 
LIST OF FIGURES 
CHAPTER ONE 
Figure 1.1 Nickel-catalyzed C–C bond forming reactions from amides ........................... 2 
Figure 1.2 1H NMR (500 MHz, CDCl3) of compound 1.4e ............................................ 25 
Figure 1.3 13C NMR (125 MHz, CDCl3) of compound 1.4e ........................................... 25 
Figure 1.4 1H NMR (500 MHz, CDCl3) of compound 1.26 ............................................ 26 
Figure 1.5 13C NMR (125 MHz, CDCl3) of compound 1.26 ........................................... 26 
Figure 1.6 1H NMR (500 MHz, CDCl3) of compound 1.28 ............................................ 27 
Figure 1.7 13C NMR (125 MHz, CDCl3) of compound 1.28 ........................................... 27 
Figure 1.8 1H NMR (500 MHz, CDCl3) of compound 1.30 ............................................ 28 
Figure 1.9 13C NMR (125 MHz, CDCl3) of compound 1.30 ........................................... 28 
Figure 1.10 1H NMR (500 MHz, CDCl3) of compound 1.6 ............................................ 29 
Figure 1.11 1H NMR (500 MHz, CDCl3) of compound 1.7 ............................................ 29 
Figure 1.12 1H NMR (500 MHz, CDCl3) of compound 1.8 ............................................ 30 
Figure 1.13 1H NMR (500 MHz, CDCl3) of compound 1.9 ............................................ 30 
Figure 1.14 1H NMR (500 MHz, CDCl3) of compound 1.10 .......................................... 31 
Figure 1.15 13C NMR (125 MHz, CDCl3) of compound 1.10 ......................................... 31 
Figure 1.16 1H NMR (500 MHz, CDCl3) of compound 1.11 .......................................... 32 
Figure 1.17 1H NMR (500 MHz, CDCl3) of compound 1.12 .......................................... 32 
Figure 1.18 1H NMR (500 MHz, CDCl3) of compound 1.13 .......................................... 33 
 xiv 
 
Figure 1.19 1H NMR (500 MHz, CDCl3) of compound 1.14 .......................................... 33 
Figure 1.20 1H NMR (500 MHz, CDCl3) of compound 1.15 .......................................... 34 
Figure 1.21 1H NMR (500 MHz, CDCl3) of compound 1.16 .......................................... 34 
Figure 1.22 13C NMR (125 MHz, CDCl3) of compound 1.16 ......................................... 35 
Figure 1.23 1H NMR (500 MHz, CDCl3) of compound 1.17 .......................................... 35 
Figure 1.24 1H NMR (500 MHz, CDCl3) of compound 1.18 .......................................... 36 
Figure 1.25 1H NMR (500 MHz, CDCl3) of compound 1.21 .......................................... 36 
 
CHAPTER TWO 
Figure 2.1 Nickel-catalyzed reactions of amide (prior studies) and nickel-catalyzed 
reduction of amides (present study) .................................................................................. 44 
Figure 2.2 1H NMR (500 MHz, CDCl3) of compound 2.47 ............................................ 94 
Figure 2.3 13C NMR (125 MHz, CDCl3) of compound 2.47 ........................................... 94 
Figure 2.4 1H NMR (500 MHz, CDCl3) of compound 2.49 ............................................ 95 
Figure 2.5 13C NMR (125 MHz, CDCl3) of compound 2.49 ........................................... 95 
Figure 2.6 1H NMR (500 MHz, CD2Cl2) of compound 2.52 ........................................... 96 
Figure 2.7 13C NMR (125 MHz, CDCl3) of compound 2.52 ........................................... 96 
Figure 2.8 1H NMR (500 MHz, CDCl3) of compound 2.54 ............................................ 97 
Figure 2.9 13C NMR (125 MHz, CDCl3) of compound 2.54 ........................................... 97 
Figure 2.10 1H NMR (500 MHz, C6D6) of compound 2.56............................................. 98 
Figure 2.11 13C NMR (125 MHz, CDCl3) of compound 2.56 ......................................... 98 
Figure 2.12 1H NMR (500 MHz, CDCl3) of compound 2.58 .......................................... 99 
Figure 2.13 13C NMR (125 MHz, CDCl3) of compound 2.58 ......................................... 99 
 xv 
 
Figure 2.14 1H NMR (500 MHz, CDCl3) of compound 2.8 .......................................... 100 
Figure 2.15 1H NMR (500 MHz, CDCl3) of compound 2.11 ........................................ 100 
Figure 2.16 1H NMR (500 MHz, CDCl3) of compound 2.12 ........................................ 101 
Figure 2.17 1H NMR (500 MHz, CDCl3) of compound 2.13 ........................................ 101 
Figure 2.18 1H NMR (500 MHz, CDCl3) of compound 2.14 ........................................ 102 
Figure 2.19 1H NMR (500 MHz, CDCl3) of compound 2.15 ........................................ 102 
Figure 2.20 13C NMR (125 MHz, CDCl3) of compound 2.15 ....................................... 103 
Figure 2.21 1H NMR (500 MHz, CDCl3) of compound 2.16 ........................................ 103 
Figure 2.22 13C NMR (125 MHz, CDCl3) of compound 2.16 ....................................... 104 
Figure 2.23 1H NMR (500 MHz, CDCl3) of compound 2.17 ........................................ 104 
Figure 2.24 13C NMR (125 MHz, CDCl3) of compound 2.17 ....................................... 105 
Figure 2.25 1H NMR (500 MHz, CDCl3) of compound 2.18 ........................................ 105 
Figure 2.26 1H NMR (500 MHz, CDCl3) of compound 2.19 ........................................ 106 
Figure 2.27 1H NMR (500 MHz, CDCl3) of compound 2.20 ........................................ 106 
Figure 2.28 1H NMR (500 MHz, CDCl3) of compound 2.21 ........................................ 107 
Figure 2.29 1H NMR (500 MHz, CDCl3) of compound 2.22 ........................................ 107 
Figure 2.30 1H NMR (500 MHz, CDCl3) of compound 2.23 ........................................ 108 
Figure 2.31 13C NMR (125 MHz, CDCl3) of compound 2.23 ....................................... 108 
Figure 2.32 1H NMR (500 MHz, CDCl3) of compound 2.24 ........................................ 109 
Figure 2.33 13C NMR (125 MHz, CDCl3) of compound 2.24 ....................................... 109 
Figure 2.34 1H NMR (500 MHz, CDCl3) of compound 2.25 ........................................ 110 
Figure 2.35 13C NMR (125 MHz, CDCl3) of compound 2.25 ....................................... 110 
Figure 2.36 1H NMR (500 MHz, CDCl3) of compound 2.26 ........................................ 111 
 xvi 
 
Figure 2.37 13C NMR (125 MHz, CDCl3) of compound 2.26 ....................................... 111 
Figure 2.38 1H NMR (500 MHz, CDCl3) of compound 2.27 ........................................ 112 
Figure 2.39 13C NMR (125 MHz, CDCl3) of compound 2.27 ....................................... 112 
Figure 2.40 1H NMR (500 MHz, CDCl3) of compound 2.28 ........................................ 113 
Figure 2.41 1H NMR (500 MHz, CDCl3) of compound 2.29 ........................................ 113 
Figure 2.42 1H NMR (500 MHz, CDCl3) of compound 2.30 ........................................ 114 
Figure 2.43 1H NMR (500 MHz, CDCl3) of compound 2.31 ........................................ 114 
Figure 2.44 1H NMR (500 MHz, CDCl3) of compound 2.32 ........................................ 115 
Figure 2.45 1H NMR (500 MHz, CDCl3) of compound 2.33 ........................................ 115 
Figure 2.46 1H NMR (500 MHz, CDCl3) of compound 2.34 ........................................ 116 
Figure 2.47 1H NMR (500 MHz, CDCl3) of compound 2.35 ........................................ 116 
Figure 2.48 1H NMR (500 MHz, CDCl3) of compound 2.36 ........................................ 117 
Figure 2.49 1H NMR (500 MHz, CDCl3) of compound 2.37 ........................................ 117 
Figure 2.50 1H NMR (500 MHz, CDCl3) of compound 2.38 ........................................ 118 
Figure 2.51 1H NMR (500 MHz, CDCl3) of compound 2.39 ........................................ 118 
Figure 2.52 1H NMR (500 MHz, CDCl3) of compound 2.40 ........................................ 119 
Figure 2.53 1H NMR (500 MHz, CDCl3) of compound 2.41 ........................................ 119 
Figure 2.54 13C NMR (125 MHz, CDCl3) of compound 2.41 ....................................... 120 
Figure 2.55 1H NMR (500 MHz, CD2Cl2) of compound 2.42 ....................................... 120 
Figure 2.56 13C NMR (125 MHz, CD2Cl2) of compound 2.42 ...................................... 121 
Figure 2.57 1H NMR (500 MHz, CD2Cl2) of compound 2.43 ....................................... 121 
Figure 2.58 13C NMR (125 MHz, CDCl3) of compound 2.43 ....................................... 122 
Figure 2.59 1H NMR (500 MHz, CDCl3) of compound 2.44 ........................................ 122 
 xvii 
 
Figure 2.60 13C NMR (125 MHz, CDCl3) of compound 2.44 ....................................... 123 
Figure 2.61 1H NMR (500 MHz, CDCl3) of compound 2.45 ........................................ 123 
Figure 2.62 13C NMR (125 MHz, CDCl3) of compound 2.45 ....................................... 124 
Figure 2.63 1H NMR (500 MHz, CDCl3) of compound 2.93 ........................................ 124 
Figure 2.64 13C NMR (125 MHz, CDCl3) of compound 2.93 ....................................... 125 
 
CHAPTER THREE 
Figure 3.1 Natural products and bioactive atropisomeric compounds ........................... 136 
Figure 3.2 Ligands used in this study ............................................................................ 144 
Figure 3.3 Enantioselectivity vs time at 40 and 60 °C ................................................... 154 
Figure 3.4 Stereoselection in Negishi coupling ............................................................. 158 
Figure 3.5 Lowest energy pro-S and pro-R reductive elimination transition states for Me-
BOP ligand 3.L2. Total of 8 transition states were located and analyzed. Free energies 
were computed using M06/6-311+G(d,p)-LANL2DZ(Pd)-SMD-THF//B3LYP/6-31G(d)-
LANL2DZ(Pd); values are in kcal/mol .......................................................................... 158 
Figure 3.6 Efficiency of the chiral Me-BOP ligand vs electron donating property of the 
lower aryl-ring substituent .............................................................................................. 159 
Figure 3.7 Lowest energy pro-S and pro-R reductive elimination transition states for the 
DMM-BOP  ligand (NitinPhos, 3.L7). Total of 32 transition states were located and 
analyzed. Free energies were computed using M06/6-311+G(d,p)-LANL2DZ(Pd)-SMD-
THF//B3LYP/6-31G(d)-LANL2DZ(Pd); values are in kcal/mol ................................... 160 
Figure 3.8 Comparison of the experimental and calculated efficiencies of the ligands in 
the Negishi coupling ....................................................................................................... 160 
 xviii 
 
Figure 3.9 Proposed stereoselection mechanism in Suzuki coupling. Species separted by 
dashed lines cannot equilibrate. Rotation around the bonds marked in red is hindered . 162 
Figure 3.10 Oxidative addition pathways in Suzuki coupling. Intermediates marked in 
red are inert in transmetallation step. Enthalpies and free energies were computed using 
B3LYP-d3/6-31G(d)-lanl2dz(Pd, Br); values are in kcal/mol. Reactions are balanced 
using water as the OH source and HBr as the byproduct of the exchange ..................... 163 
Figure 3.11 Isomeric PdOH intermediates ..................................................................... 164 
Figure 3.12 Energetics and selectivity of the productive oxidative addition pathway in 
Suzuki coupling. Total of 8 oxidative addition transition states were located and 
analyzed. Enthalpies and free energies (in brackets) were computed using B3LYP-d3/6-
31G(d)-LANL2DZ (Pd, Br); values are in kcal/mol. From here on the reactions are 
balanced using KOH as the OH source and KBr as the by-product of PdOH formation 
......................................................................................................................................... 165 
Figure 3.13 Energetics and selectivities of the transmetalation and reductive eliminations 
arising from the major PdOH isomer. Total of 8 transmetalation transition states and 16 
reductive elimination transition states were located and analyzed. Enthalpies and free 
energies (in brackets) were computed using B3LYP-d3/6-31G(d)-LANL2DZ (Pd, Br); 
values are in kcal/mol ..................................................................................................... 166 
Figure 3.14 Energetics and selectivities of the transmetalation and reductive eliminations 
arising from the minor PdOH isomer. Total of 10 transmetalation transition states and 16 
reductive elimination transition states were located and analyzed. Enthalpies and free 
energies (in brackets) were computed using B3LYP-d3/6-31G(d)-lanl2dz (Pd, Br); values 
are in kcal/mol ................................................................................................................. 167 
 xix 
 
Figure 3.15 Lowest energy pro-S and pro-R reductive elimination transition states from 
the major trans and cis isomers of diaryl Pd ................................................................... 168 
Figure 3.16 Simplified energy diagram for Suzuki coupling with DME-BOP (3.L6) 
ligand. Selectivities of each step were calculated based on the Boltzmann distribution of 
the energies of corresponding transition states. (Alternatively, such multi-level processes 
can be analyzed using a system of rate equations, i.e. microkinetic modeling) ............. 170 
Figure 3.17 Simplified energy diagram for Suzuki coupling with DMM-BOP (NitinPhos, 
L7) ligand ........................................................................................................................ 171 
Figure 3.18 Relative energies (in bold), and relative populations of the major branch 
transmetalation transition states for DMM-BOP (NitinPhos, 3.L7) and DME-BOP (3.L6) 
ligands. Green lines represent C–H---O hydrogen bonding interactions. Dashed lines 
indicate additional high-energy conformations that do not significantly contribute to the 
population distribution .................................................................................................... 174 
Figure 3.19 General synthetic route to various ligand scaffolds .................................... 177 
Figure 3.20 1H NMR (500 MHz, CDCl3) of compound 3.31a ...................................... 253 
Figure 3.21 13C NMR (125 MHz, CDCl3) of compound 3.31a ..................................... 253 
Figure 3.22 31P NMR (202 MHz, CDCl3) of compound 3.31a ..................................... 254 
Figure 3.23 1H NMR (400 MHz, CDCl3) of compound 3.L3 ....................................... 254 
Figure 3.24 13C NMR (100 MHz, CDCl3) of compound 3.L3 ...................................... 255 
Figure 3.25 31P NMR (162 MHz, CDCl3) of compound 3.L3 ....................................... 255 
Figure 3.26 1H NMR (500 MHz, CDCl3) of compound 3.31b ...................................... 256 
Figure 3.27 13C NMR (125 MHz, CDCl3) of compound 3.31b ..................................... 256 
Figure 3.28 31P NMR (202 MHz, CDCl3) of compound 3.31b ..................................... 257 
 xx 
 
Figure 3.29 1H NMR (400 MHz, CDCl3) of compound 3.31d ...................................... 257 
Figure 3.30 13C NMR (100 MHz, CDCl3) of compound 3.31d ..................................... 258 
Figure 3.31 31P NMR (162 MHz, CDCl3) of compound 3.31d ..................................... 258 
Figure 3.32 1H NMR (500 MHz, CDCl3) of compound 3.L5 ....................................... 259 
Figure 3.33 13C NMR (125 MHz, CDCl3of compound 3.L5 ......................................... 259 
Figure 3.34 31P NMR (202 MHz, CDCl3) of compound 3.L5 ....................................... 260 
Figure 3.35 1H NMR (400 MHz, CDCl3) of compound 3.31f ....................................... 260 
Figure 3.36 13C NMR (100 MHz, CDCl3) of compound 3.31f ...................................... 261 
Figure 3.37 31P NMR (162 MHz, CDCl3) of compound 3.31f ...................................... 261 
Figure 3.38 1H NMR (500 MHz, CDCl3) of compound 3.L6 ....................................... 262 
Figure 3.39 13C NMR (125 MHz, CDCl3) of compound 3.L6 ...................................... 262 
Figure 3.40 31P NMR (202 MHz, CDCl3) of compound 3.L6 ....................................... 263 
Figure 3.41 1H NMR (500 MHz, CDCl3) of compound 3.31g ...................................... 263 
Figure 3.42 13C NMR (125 MHz, CDCl3) of compound 3.31g ..................................... 264 
Figure 3.43 31P NMR (202 MHz, CDCl3) of compound 3.31g ..................................... 264 
Figure 3.44 1H NMR (500 MHz, CDCl3) of compound 3.31h ...................................... 265 
Figure 3.45 13C NMR (125 MHz, CDCl3) of compound 3.31h ..................................... 265 
Figure 3.46 31P NMR (202 MHz, CDCl3) of compound 3.31h ..................................... 266 
Figure 3.47 1H NMR (400 MHz, CDCl3) of compound 3.L7 ....................................... 266 
Figure 3.48 13C NMR (100 MHz, CDCl3) of compound 3.L7 ...................................... 267 
Figure 3.49 31P NMR (162 MHz, CDCl3) of compound 3.L7 ....................................... 267 
Figure 3.50 1H NMR (400 MHz, CDCl3) of compound 3.31i ....................................... 268 
Figure 3.51 13C NMR (100 MHz, CDCl3) of compound 3.31i ...................................... 268 
 xxi 
 
Figure 3.52 31P NMR (162 MHz, CDCl3) of compound 3.31i ...................................... 269 
Figure 3.53 1H NMR (400 MHz, CDCl3) of compound 3.L8 ....................................... 269 
Figure 3.54 13C NMR (100 MHz, CDCl3) of compound 3.L8 ...................................... 270 
Figure 3.55 31P NMR (162 MHz, CDCl3) of compound 3.L8 ....................................... 270 
Figure 3.56 1H NMR (400 MHz, CDCl3) of compound 3.L11 ..................................... 271 
Figure 3.57 13C NMR (100 MHz, CDCl3) of compound 3.L11 .................................... 271 
Figure 3.58 31P NMR (202 MHz, CDCl3) of compound 3.L11 ..................................... 272 
Figure 3.59 1H NMR (400 MHz, CDCl3) of compound 3.L12 ..................................... 272 
Figure 3.60 13C NMR (100 MHz, CDCl3) of compound 3.L12 .................................... 273 
Figure 3.61 31P NMR (202 MHz, CDCl3) of compound 3.L12 ..................................... 273 
Figure 3.62 1H NMR (400 MHz, CDCl3) of compound 3.31m ..................................... 274 
Figure 3.63 13C NMR (100 MHz, CDCl3) of compound 3.31m .................................... 274 
Figure 3.64 31P NMR (202 MHz, CDCl3) of compound 3.31m .................................... 275 
Figure 3.65 1H NMR (500 MHz, CDCl3) of compound 3.L13 ..................................... 275 
Figure 3.66 13C NMR (100 MHz, CDCl3) of compound 3.L13 .................................... 276 
Figure 3.67 31P NMR (162 MHz, CDCl3) of compound 3.L13 ..................................... 276 
Figure 3.68 1H NMR (400 MHz, CDCl3) of compound 3.L14 ..................................... 277 
Figure 3.69 13C NMR (100 MHz, CDCl3) of compound 3.L14 .................................... 277 
Figure 3.70 31P NMR (202 MHz, CDCl3) of compound 3.L14 ..................................... 278 
Figure 3.71 1H NMR (400 MHz, CDCl3) of compound 3.31o ...................................... 278 
Figure 3.72 13C NMR (100 MHz, CDCl3) of compound 3.31o ..................................... 279 
Figure 3.73 31P NMR (202 MHz, CDCl3) of compound 3.31o ..................................... 279 
Figure 3.74 1H NMR (400 MHz, CDCl3) of compound 3.L15 ..................................... 280 
 xxii 
 
Figure 3.75 13C NMR (100 MHz, CDCl3) of compound 3.L15 .................................... 280 
Figure 3.76 31P NMR (202 MHz, CDCl3) of compound 3.L15 ..................................... 281 
Figure 3.77 1H NMR (400 MHz, CDCl3) of compound 3.31q ...................................... 281 
Figure 3.78 13C NMR (100 MHz, CDCl3) of compound 3.31q ..................................... 282 
Figure 3.79 31P NMR (162 MHz, CDCl3) of compound 3.31q ..................................... 282 
Figure 3.80 1H NMR (400 MHz, CDCl3) of compound 3.L16 ..................................... 283 
Figure 3.81 13C NMR (100 MHz, CDCl3) of compound 3.L16 .................................... 283 
Figure 3.82 31P NMR (162 MHz, CDCl3) of compound 3.L16 ..................................... 284 
Figure 3.83 1H NMR (400 MHz, CDCl3) of compound 3.31s ...................................... 284 
Figure 3.84 13C NMR (100 MHz, CDCl3) of compound 3.31s ..................................... 285 
Figure 3.85 31P NMR (162 MHz, CDCl3) of compound 3.31s ...................................... 285 
Figure 3.86 1H NMR (500 MHz, CDCl3) of compound 3.L17 ..................................... 286 
Figure 3.87 13C NMR (125 MHz, CDCl3) of compound 3.L17 .................................... 286 
Figure 3.88 31P NMR (202 MHz, CDCl3) of compound 3.L17 ..................................... 287 
Figure 3.89 1H NMR (400 MHz, CDCl3) of compound 3.31t ....................................... 287 
Figure 3.90 13C NMR (100 MHz, CDCl3) of compound 3.31t ...................................... 288 
Figure 3.91 31P NMR (162 MHz, CDCl3) of compound 3.31t ...................................... 288 
Figure 3.92 1H NMR (400 MHz, CDCl3) of compound 3.31u ...................................... 289 
Figure 3.93 13C NMR (100 MHz, CDCl3) of compound 3.31u ..................................... 289 
Figure 3.94 31P NMR (162 MHz, CDCl3) of compound 3.31u ..................................... 290 
Figure 3.95 1H NMR (400 MHz, CDCl3) of compound 3.L18 ..................................... 290 
Figure 3.96 13C NMR (100 MHz, CDCl3) of compound 3.L18 .................................... 291 
Figure 3.97 31P NMR (162 MHz, CDCl3) of compound 3.L18 ..................................... 291 
 xxiii 
 
Figure 3.98 1H NMR (500 MHz, CDCl3) of compound 3.35a ...................................... 292 
Figure 3.99 13C NMR (100 MHz, CDCl3) of compound 3.35a ..................................... 292 
Figure 3.100 31P NMR (202 MHz, CDCl3) of compound 3.35a ................................... 293 
Figure 3.101 1H NMR (500 MHz, CDCl3) of compound 3.35b .................................... 293 
Figure 3.102 13C NMR (100 MHz, CDCl3) of compound 3.35b ................................... 294 
Figure 3.103 31P NMR (202 MHz, CDCl3) of compound 3.35b ................................... 294 
Figure 3.104 1H NMR (400 MHz, CDCl3) of compound 3.L21 ................................... 295 
Figure 3.105 13C NMR (100 MHz, CDCl3) of compound 3.L21 .................................. 295 
Figure 3.106 31P NMR (202 MHz, CDCl3) of compound 3.L21 ................................... 296 
Figure 3.107 1H NMR (500 MHz, CDCl3) of compound 3.35c .................................... 296 
Figure 3.108 13C NMR (100 MHz, CDCl3) of compound 3.35c ................................... 297 
Figure 3.109 31P NMR (202 MHz, CDCl3) of compound 3.35c .................................... 297 
Figure 3.110 1H NMR (500 MHz, CDCl3) of compound 3.35d .................................... 298 
Figure 3.111 13C NMR (100 MHz, CDCl3) of compound 3.35d ................................... 298 
Figure 3.112 31P NMR (202 MHz, CDCl3) of compound 3.35d ................................... 299 
Figure 3.113 1H NMR (500 MHz, CDCl3) of compound 3.35e .................................... 299 
Figure 3.114 13C NMR (100 MHz, CDCl3) of compound 3.35e ................................... 300 
Figure 3.115 31P NMR (162 MHz, CDCl3) of compound 3.35e .................................... 300 
Figure 3.116 1H NMR (500 MHz, CDCl3) of compound 3.L22 ................................... 301 
Figure 3.117 13C NMR (100 MHz, CDCl3) of compound 3.L22 .................................. 301 
Figure 3.118 13P NMR (202 MHz, CDCl3) of compound 3.L22 ................................... 302 
Figure 3.119 1H NMR (500 MHz, CDCl3) of compound 3.30a .................................... 302 
Figure 3.120 13C NMR (100 MHz, CDCl3) of compound 3.30a ................................... 303 
 xxiv 
 
Figure 3.121 31P NMR (202 MHz, CDCl3) of compound 3.30a ................................... 303 
Figure 3.122 1H NMR (400 MHz, CDCl3) of compound 3.L24 ................................... 304 
Figure 3.123 13C NMR (100 MHz, CDCl3) of compound 3.L24 .................................. 304 
Figure 3.124 31P NMR (202 MHz, CDCl3) of compound 3.L24 ................................... 305 
Figure 3.125 1H NMR (400 MHz, CDCl3) of compound 3.32a .................................... 305 
Figure 3.126 13C NMR (100 MHz, CDCl3) of compound 3.32a ................................... 306 
Figure 3.127 1H NMR (400 MHz, CDCl3) of compound 3.L25 ................................... 306 
Figure 3.128 13C NMR (100 MHz, CDCl3) of compound 3.L25 .................................. 307 
Figure 3.129 31P NMR (162 MHz, CDCl3) of compound 3.L25 ................................... 307 
Figure 3.130 1H NMR (500 MHz, CDCl3) of compound 3.30c .................................... 308 
Figure 3.131 1H NMR (500 MHz, CDCl3) of compound 3.30d .................................... 308 
Figure 3.132 13C NMR (100 MHz, CDCl3) of compound 3.30d ................................... 309 
Figure 3.133 31P NMR (202 MHz, CDCl3) of compound 3.30d ................................... 309 
Figure 3.134 1H NMR (500 MHz, CDCl3) of compound 3.32b .................................... 310 
Figure 3.135 13C NMR (100 MHz, CDCl3) of compound 3.32b ................................... 310 
Figure 3.136 31P NMR (202 MHz, CDCl3) of compound 3.32b ................................... 311 
Figure 3.137 1H NMR (400 MHz, CDCl3) of compound 3.L26 ................................... 311 
Figure 3.138 13C NMR (100 MHz, CDCl3) of compound 3.L26 .................................. 312 
Figure 3.139 31P NMR (202 MHz, CDCl3) of compound 3.L26 ................................... 312 
Figure 3.140 1H NMR (500 MHz, CDCl3) of compound 3.47 ...................................... 313 
Figure 3.141 13C NMR (125 MHz, CDCl3) of compound 3.47 ..................................... 313 
Figure 3.142 31P NMR (202 MHz, CDCl3) of compound 3.47 ..................................... 314 
Figure 3.143 1H NMR (500 MHz, CDCl3) of compound 3.48 ...................................... 314 
 xxv 
 
Figure 3.144 13C NMR (125 MHz, CDCl3) of compound 3.48 ..................................... 315 
Figure 3.145 31P NMR (202 MHz, CDCl3) of compound 3.48 ..................................... 315 
Figure 3.146 1H NMR (500 MHz, CDCl3) of compound 3.49 ...................................... 316 
Figure 3.147 13C NMR (125 MHz, CDCl3) of compound 3.49 ..................................... 316 
Figure 3.148 1H NMR (500 MHz, CDCl3) of compound 3.50 ...................................... 317 
Figure 3.149 13C NMR (125 MHz, CDCl3) of compound 3.50 ..................................... 317 
Figure 3.150 1H NMR (500 MHz, CDCl3) of compound 3.L27 ................................... 318 
Figure 3.151 13C NMR (125 MHz, CDCl3) of compound 3.L27 .................................. 318 
Figure 3.152 31P NMR (202 MHz, CDCl3) of compound 3.L27 ................................... 319 
Figure 3.153 1H NMR (500 MHz, CDCl3) of compound 3.51 ...................................... 319 
Figure 3.154 13C NMR (125 MHz, CDCl3) of compound 3.51 ..................................... 320 
Figure 3.155 1H NMR (500 MHz, CDCl3) of compound 3.L28 ................................... 320 
Figure 3.156 13C NMR (125 MHz, CDCl3) of compound 3.L28 .................................. 321 
Figure 3.157 31P NMR (202 MHz, CDCl3) of compound 3.L28 ................................... 321 
Figure 3.158 1H NMR (400 MHz, CDCl3) of compound 3.32c .................................... 322 
Figure 3.159 13C NMR (100 MHz, CDCl3) of compound 3.32c ................................... 322 
Figure 3.160 31P NMR (202 MHz, CDCl3) of compound 3.32c .................................... 323 
Figure 3.161 1H NMR (400 MHz, CDCl3) of compound 3.L29 ................................... 323 
Figure 3.162 13C NMR (100 MHz, CDCl3) of compound 3.L29 .................................. 324 
Figure 3.163 31P NMR (162 MHz, CDCl3) of compound 3.L29 ................................... 324 
Figure 3.164 1H NMR (400 MHz, CDCl3) of compound 3.18 ...................................... 325 
Figure 3.165 13C NMR (100 MHz, CDCl3) of compound 3.18 ..................................... 325 
Figure 3.166 1H NMR (500 MHz, CDCl3) of compound 3.18 ...................................... 326 
 xxvi 
 
Figure 3.167 1H NMR (500 MHz, CDCl3) of compound 3.39a .................................... 326 
Figure 3.168 13C NMR (125 MHz, CDCl3) of compound 3.39a ................................... 327 
Figure 3.169 1H NMR (400 MHz, CDCl3) of compound 3.39b .................................... 327 
Figure 3.170 13C NMR (100 MHz, CDCl3) of compound 3.39b ................................... 328 
Figure 3.171 1H NMR (400 MHz, CDCl3) of compound 3.39c .................................... 328 
Figure 3.172 13C NMR (100 MHz, CDCl3) of compound 3.39c ................................... 329 
Figure 3.173 1H NMR (400 MHz, CDCl3) of compound 3.39d .................................... 329 
Figure 3.174 13C NMR (125 MHz, CDCl3) of compound 3.39d ................................... 330 
Figure 3.175 1H NMR (500 MHz, CDCl3) of compound 3.39e .................................... 330 
Figure 3.176 13C NMR (100 MHz, CDCl3) of compound 3.39e ................................... 331 
Figure 3.177 1H NMR (500 MHz, CDCl3) of compound 3.39f ..................................... 331 
Figure 3.178 13C NMR (100 MHz, CDCl3) of compound 3.39f .................................... 332 
Figure 3.179 1H NMR (500 MHz, CDCl3) of compound 3.43b .................................... 332 
Figure 3.180 13C NMR (125 MHz, CDCl3) of compound 3.43b ................................... 333 
Figure 3.181 1H NMR (500 MHz, CDCl3) of compound 3.43c .................................... 333 
Figure 3.182 13C NMR (125 MHz, CDCl3) of compound 3.43c ................................... 334 
 
CHAPTER FOUR 
Figure 4.1 Piperidine-containing drugs, piperidynes 4.1 and 4.2, and pyridines 4.3 and 
4.4.................................................................................................................................... 352 
Figure 4.2 Optimized structures of 4.1a and 4.3 obtained at the B3LYP/6-31G(d) level
......................................................................................................................................... 353 
 xxvii 
 
Figure 4.3 Optimized transition states for nucleophilic addition of morpholine to 4.3 and 
4.1a using B3LYP/6-31G(d). Single-point energies were calculated at the B3LYP-D3/6-
311+G(d,p) level with CPCM solvent model for MeCN. Energies are provided in kcal 
mol–1 ................................................................................................................................ 359 
Figure 4.4 Explanation for differing distortion seen in 4.1a and 4.3 ............................. 360 
Figure 4.5 n→p* interaction in 3,4-pyridyne ................................................................ 376 
Figure 4.6 1H NMR (500 MHz, CDCl3) of compound 4.7 ............................................ 378 
Figure 4.7 13C NMR (125 MHz, CDCl3) of compound 4.7 ........................................... 378 
Figure 4.8 1H NMR (500 MHz, CDCl3) of compound 4.8 ............................................ 379 
Figure 4.9 13C NMR (125 MHz, CDCl3) of compound 4.8 ........................................... 379 
Figure 4.10 1H NMR (500 MHz, C6D6) of compound 4.12........................................... 380 
Figure 4.11 13C NMR (125 MHz, CDCl3) of compound 4.12 ....................................... 380 
Figure 4.12 1H NMR (500 MHz, C6D6) of compound 4.13........................................... 381 
Figure 4.13 13C NMR (125 MHz, CDCl3) of compound 4.13 ....................................... 381 
Figure 4.14 1H NMR (500 MHz, CDCl3) of compound 4.14 ........................................ 382 
Figure 4.15 13C NMR (125 MHz, CDCl3) of compound 4.14 ....................................... 382 
Figure 4.16 1H NMR (500 MHz, CD3CN) of compound 4.15 ...................................... 383 
Figure 4.17 13C NMR (125 MHz, CDCl3) of compound 4.15 ....................................... 383 
Figure 4.18 1H NMR (500 MHz, CD3CN) of compound 4.16 ...................................... 384 
Figure 4.19 13C NMR (125 MHz, CD3CN) of compound 4.16 ..................................... 384 
Figure 4.20 1H NMR (500 MHz, C6D6) of compound 4.17........................................... 385 
Figure 4.21 13C NMR (125 MHz, CD3CN) of compound 4.17 ..................................... 385 
Figure 4.22 1H NMR (500 MHz, CDCl3) of compound 4.19 ........................................ 386 
 xxviii 
 
Figure 4.23 13C NMR (125 MHz, CDCl3) of compound 4.19 ....................................... 386 
Figure 4.24 1H NMR (500 MHz, C6D6) of compound 4.21 and 4.22 ............................ 387 
Figure 4.25 13C NMR (125 MHz, CDCl3) of compound 4.21 and 4.22 ........................ 387 
Figure 4.26 1H NMR (500 MHz, CDCl3) of compound 4.23 ........................................ 388 
Figure 4.27 13C NMR (125 MHz, CDCl3) of compound 4.23 ....................................... 388 
Figure 4.28 1H NMR (500 MHz, CDCl3) of compound 4.24 ........................................ 389 
Figure 4.29 13C NMR (125 MHz, CDCl3) of compound 4.24 ....................................... 389 
Figure 4.30 1H NMR (500 MHz, CDCl3) of compound 4.25 and 4.26 ......................... 390 
Figure 4.31 13C NMR (125 MHz, CDCl3) of compound 4.25 and 4.26 ........................ 390 
Figure 4.32 1H NMR (500 MHz, CD3CN) of compound 4.27 ...................................... 391 
Figure 4.33 13C NMR (125 MHz, CD3CN) of compound 4.27 ..................................... 391 
Figure 4.34 1H NMR (500 MHz, CD3CN) of compound 4.28 ...................................... 392 
Figure 4.35 13C NMR (125 MHz, CD3CN) of compound 4.28 ..................................... 392 
 
CHAPTER FIVE 
Figure 5.1 Zelboraf (5.1), (–)-aspidophylline A (5.2), and interrupted Fischer 
azaindolization reaction .................................................................................................. 400 
Figure 5.2 [3,3]-sigmatropic rearrangement transition states of arylhydrazines ........... 401 
Figure 5.3 Unfavorable equilibrium between 5.10 and 5.11 ......................................... 402 
Figure 5.4 Synthesis of aza-analogues ........................................................................... 408 
Figure 5.5 1H NMR (500 MHz, DMSO-d6) of compound 5.37 .................................... 444 
Figure 5.6 13C NMR (125 MHz, DMSO-d6) of compound 5.37 ................................... 444 
Figure 5.7 1H NMR (500 MHz, DMSO-d6) of compound 5.41 .................................... 445 
 xxix 
 
Figure 5.8 13C NMR (125 MHz, DMSO-d6) of compound 5.41 ................................... 445 
Figure 5.9 1H NMR (500 MHz, DMSO-d6) of compound 5.39 .................................... 446 
Figure 5.10 13C NMR (125 MHz, DMSO-d6) of compound 5.39 ................................. 446 
Figure 5.11 1H NMR (500 MHz, DMSO-d6) of compound 5.33 .................................. 447 
Figure 5.12 13C NMR (125 MHz, DMSO-d6) of compound 5.33 ................................. 447 
Figure 5.13 1H NMR (500 MHz, DMSO-d6) of compound 5.35 .................................. 448 
Figure 5.14 13C NMR (125 MHz, DMSO-d6) of compound 5.35 ................................. 448 
Figure 5.15 1H NMR (500 MHz, DMSO-d6) of compound 5.12 .................................. 449 
Figure 5.16 13C NMR (125 MHz, DMSO-d6) of compound 5.12 ................................. 449 
Figure 5.17 1H NMR (500 MHz, DMSO-d6) of compound 5.29 .................................. 450 
Figure 5.18 13C NMR (125 MHz, DMSO-d6) of compound 5.29 ................................. 450 
Figure 5.19 1H NMR (500 MHz, DMSO-d6) of compound 5.31 .................................. 451 
Figure 5.20 13C NMR (125 MHz, DMSO-d6) of compound 5.31 ................................. 451 
Figure 5.21 1H NMR (500 MHz, DMSO-d6) of compound 5.43 .................................. 452 
Figure 5.22 13C NMR (125 MHz, DMSO-d6) of compound 5.43 ................................. 452 
Figure 5.23 1H NMR (500 MHz, CDCl3) of compound 5.15 ........................................ 453 
Figure 5.24 13C NMR (125 MHz, CDCl3) of compound 5.15 ....................................... 453 
Figure 5.25 1H NMR (500 MHz, CDCl3) of compound 5.17 ........................................ 454 
Figure 5.26 13C NMR (125 MHz, CDCl3) of compound 5.17 ....................................... 454 
Figure 5.27 1H NMR (500 MHz, CDCl3) of compound 5.19 ........................................ 455 
Figure 5.28 13C NMR (125 MHz, CDCl3) of compound 5.19 ....................................... 455 
Figure 5.29 1H NMR (500 MHz, CDCl3) of compound 5.21 ........................................ 456 
Figure 5.30 13C NMR (125 MHz, CDCl3) of compound 5.21 ....................................... 456 
 xxx 
 
Figure 5.31 1H NMR (500 MHz, CDCl3) of compound 5.23 ........................................ 457 
Figure 5.32 13C NMR (125 MHz, CDCl3) of compound 5.23 ....................................... 457 
Figure 5.33 1H NMR (500 MHz, CDCl3) of compound 5.25 ........................................ 458 
Figure 5.34 13C NMR (125 MHz, CDCl3) of compound 5.25 ....................................... 458 
Figure 5.35 1H NMR (500 MHz, CDCl3) of compound 5.27 ........................................ 459 
Figure 5.36 13C NMR (125 MHz, C6D6) of compound 5.27 ......................................... 459 
Figure 5.37 1H NMR (500 MHz, CDCl3) of compound 5.30 ........................................ 460 
Figure 5.38 13C NMR (125 MHz, CDCl3) of compound 5.30 ....................................... 460 
Figure 5.39 1H NMR (500 MHz, CDCl3) of compound 5.32 ........................................ 461 
Figure 5.40 13C NMR (125 MHz, CDCl3) of compound 5.32 ....................................... 461 
Figure 5.41 1H NMR (500 MHz, CDCl3) of compound 5.34 ........................................ 462 
Figure 5.42 13C NMR (125 MHz, CDCl3) of compound 5.34 ....................................... 462 
Figure 5.43 1H NMR (500 MHz, CDCl3) of compound 5.38 ........................................ 463 
Figure 5.44 13C NMR (125 MHz, CDCl3) of compound 5.38 ....................................... 463 
Figure 5.45 1H NMR (500 MHz, CDCl3) of compound 5.40 ........................................ 464 
Figure 5.46 13C NMR (125 MHz, CDCl3) of compound 5.40 ....................................... 464 
Figure 5.47 1H NMR (500 MHz, CDCl3) of compound 5.42 ........................................ 465 
Figure 5.48 13C NMR (125 MHz, CDCl3) of compound 5.42 ....................................... 465 
Figure 5.49 1H NMR (500 MHz, CDCl3) of compound 5.44 ........................................ 466 
Figure 5.50 13C NMR (125 MHz, CDCl3) of compound 5.44 ....................................... 466 
Figure 5.51 1H NMR (500 MHz, CDCl3) of compound 5.64 ........................................ 467 
Figure 5.52 13C NMR (125 MHz, CDCl3) of compound 5.64 ....................................... 467 
Figure 5.53 1H NMR (500 MHz, CDCl3) of compound 5.65 ........................................ 468 
 xxxi 
 
Figure 5.54 13C NMR (125 MHz, CDCl3) of compound 5.65 ....................................... 468 
Figure 5.55 1H NMR (500 MHz, CDCl3) of compound 5.45 ........................................ 469 
Figure 5.56 13C NMR (125 MHz, CDCl3) of compound 5.45 ....................................... 469 
Figure 5.57 1H NMR (500 MHz, CDCl3) of compound 5.47 ........................................ 470 
Figure 5.58 13C NMR (125 MHz, CDCl3) of compound 5.47 ....................................... 470 
Figure 5.59 1H NMR (500 MHz, CDCl3) of compound 5.48 ........................................ 471 
Figure 5.60 13C NMR (125 MHz, CDCl3) of compound 5.48 ....................................... 471 
 
CHAPTER SIX 
Figure 6.1 Example of representative bioactive compounds containing fused indolines
......................................................................................................................................... 478 
Figure 6.2 Flow reactor setup ........................................................................................ 486 
Figure 6.3 1H NMR (400 MHz, CDCl3) of compound 6.6 ............................................ 497 
Figure 6.4 1H NMR (400 MHz, CDCl3) of compound 6.14 .......................................... 497 
Figure 6.5 1H NMR (400 MHz, CDCl3) of compound 6.15 .......................................... 498 
Figure 6.6 1H NMR (400 MHz, CDCl3) of compound 6.16 .......................................... 498 
Figure 6.7 1H NMR (400 MHz, CDCl3) of compound 6.17 .......................................... 499 
Figure 6.8 13C NMR (101 MHz, CDCl3) of compound 6.17 ......................................... 499 
Figure 6.9 19F NMR (376 MHz, CDCl3) of compound 6.17 ......................................... 500 
Figure 6.10 1H NMR (400 MHz, CDCl3) of compound 6.18 ........................................ 500 
Figure 6.11 13C NMR (101 MHz, CDCl3) of compound 6.18 ....................................... 501 
Figure 6.12 1H NMR (400 MHz, CDCl3) of compound 6.19 ........................................ 501 
Figure 6.13 13C NMR (101 MHz, CDCl3) of compound 6.19 ....................................... 502 
 xxxii 
 
Figure 6.14 1H NMR (400 MHz, CDCl3) of compound 6.20 ........................................ 502 
Figure 6.15 1H NMR (400 MHz, CDCl3) of compound 6.24 ........................................ 503 
Figure 6.16 1H NMR (400 MHz, CDCl3) of compound 6.25 ........................................ 503 
Figure 6.17 1H NMR (400 MHz, CDCl3) of compound 6.26 ........................................ 504 
 
LIST OF SCHEMES 
CHAPTER ONE 
Scheme 1.1 Gram-scale coupling to form ketone 1.21 ....................................................... 7 
 
CHAPTER THREE 
Scheme 3.1 Tunable P-chiral phosphine ligands for asymmetric Pd-catalyzed cross-
couplings ......................................................................................................................... 142 
Scheme 3.2 Ligand synthesis .......................................................................................... 143 
 
CHAPTER FOUR 
Scheme 4.1 Synthesis of Silyl Triflate 4.8 ..................................................................... 354 
 
CHAPTER FIVE 
Scheme 5.1 Thermal (unprotected) Fischer indolization reaction of model system ...... 434 
Scheme 5.2 Acid-catalyzed (monoprotonated) Fischer indolization reaction of model 
system ............................................................................................................................. 435 
Scheme 5.3 Reaction pathway for protonated 3-pyridylhydrazine. Free energies in 
kcal/mol ........................................................................................................................... 436 
 xxxiii 
 
Scheme 5.4 Reaction pathway for 3-(1-methylhydrazinyl)pyridine. Free energies in 
kcal/mol ........................................................................................................................... 437 
Scheme 5.5 [3,3]-sigmatropic rearrangement with protonated β-nitrogen of ene-hydrazine
......................................................................................................................................... 440 
 
CHAPTER SIX 
Scheme 6.1 General flow reactor scheme ....................................................................... 479 
Scheme 6.2 Asia flow reactor scheme ............................................................................ 486 
 
LIST OF TABLES 
CHAPTER ONE 
Table 1.1 Survey of amide N-substituents in the coupling of substrates 1.4 with 1.5 ........ 4 
Table 1.2 Scope of the amide substrate .............................................................................. 5 
Table 1.3 Scope of the organozinc coupling partner .......................................................... 6 
Table 1.4 Initial survey of naphthamide substrates with benzylzinc bromide (1.5) ......... 15 
Table 1.5 Relevant control experiments in the alkylation of amide 1.4e ......................... 16 
 
CHAPTER TWO 
Table 2.1 Evaluation of amide substrates ......................................................................... 45 
Table 2.2 Reduction of secondary amides with varying C-substituents ........................... 47 
Table 2.3 Reduction of aliphatic substrates ...................................................................... 48 
Table 2.4 Cyclic amines prepared by reduction of the corresponding lactams ................ 49 
Table 2.5 Reduction of amino acid derivatives for the synthesis of α-deuteroamines .... 50 
 xxxiv 
 
Table 2.6 Initial survey of amide substrates with Phenylsilane ........................................ 59 
Table 2.7 Relevant control experiments in the reduction of amide 2.7 ............................ 60 
 
CHAPTER THREE 
Table 3.1 Asymmetric Suzuki–Miyaura cross-coupling reactions to prepare tri-ortho-
substituted biaryls ........................................................................................................... 139 
Table 3.2 Asymmetric Suzuki–Miyaura cross-coupling reactions to prepare tetra-ortho-
substituted biaryls ........................................................................................................... 141 
Table 3.3 Asymmetric Suzuki–Miyaura cross-coupling reactions to prepare tetra-ortho-
substituted biaryls: base and solvent survey ................................................................... 146 
Table 3.4 Ligand survey in the asymmetric Suzuki–Miyaura cross-coupling towards 
tetra-ortho-substituted biaryls ......................................................................................... 147 
Table 3.5 Effect of Pd-precatalyst and Pd:ligand loading .............................................. 148 
Table 3.6 Effect of boronate coupling partner ................................................................ 149 
Table 3.7 Asymmetric Suzuki–Miyaura cross-coupling reaction scope ........................ 150 
Table 3.8 Ligand survey in the asymmetric Negishi cross-coupling towards tetra-ortho-
substituted biaryls ........................................................................................................... 152 
Table 3.9 Survey of Pd-precatalyst, Pd:3.L13 ratio, Zn-source, and solvent in the Negishi 
cross-coupling reaction ................................................................................................... 153 
Table 3.10 Asymmetric Negishi cross-coupling reaction scope .................................... 156 
 
CHAPTER FOUR 
Table 4.1 Diels–Alder cycloadditions of 3,4-piperidyne 4.1a ........................................ 355 
 xxxv 
 
Table 4.2 Reactions of silyl triflate 4.8 with nucleophiles and cycloaddition partners .. 357 
Table 4.3 Energies, enthalpies, and free energies of the structures calculated at the 
B3LYP-D3/6-311+G(d,p)(CPCMMeCN)//B3LYP/6-31G(d) ........................................... 376 
 
CHAPTER FIVE 
Table 5.1 Scope of the aldehyde surrogate in the interrupted Fischer azaindolization .. 404 
Table 5.2 Scope of hydrazine and correlation to the calculated free energies ............... 406 
Table 5.3 Relative free energies (kcal/mol) for each intermediate or transition state on the 
potential energy pathways of different monoprotonated pyridyl hydrazones formed by 
pyridyl hydrazines and propanal ..................................................................................... 438 
Table 5.4 Relative free energies (kcal/mol, from their respective global minima) and 
NBO charges of the β-protonated ene-hydrazine and transition states, for the various 2- 
substituted 5-pyridylhydrazines ...................................................................................... 441 
 
CHAPTER SIX 
Table 6.1 Optimization of interrupted Fischer indolization in a microfluidic reactor .... 480 
Table 6.2 Hydrazine variants in the microfluidic interrupted Fischer indolization reaction
......................................................................................................................................... 482 
Table 6.3 Variations of the latent aldehyde surrogate in the microfluidic reaction ....... 483 
 
 
 
 
 xxxvi 
 
LIST OF ABBREVIATIONS 
 
α alpha 
[α]D  specific rotation at wavelength of sodium D line 
Å angstrom 
β beta 
c  concentration for specific rotation measurements ! gamma 
m/z  mass to charge ratio 
µ  micro 
π pi 
Ac  acetyl, acetate 
AcOH acetic acid 
AIBN azobisisobutyronitrile 
app.  apparent 
aq.  aqueous 
Boc tert-butoxycarbonyl 
Boc2O di-tert-butyl dicarbonate 
Bn benzyl 
br  broad 
Bu  butyl 
i-Bu isobutyl 
n-Bu butyl (linear) 
t-Bu  tert-butyl 
t-BuOH tert-butyl alcohol 
Bz benzoyl 
°C  degrees Celsius 
calcd calculated 
cat. catalytic 
Cbz carboxybenzyl 
cod 1,5-cyclooctadiene 
d  doublet 
dba dibenzylideneacetone 
dr diastereomeric ratio 
 xxxvii 
 
DCE 1,2-dichloroethane 
Dess–Martin Dess–Martin Periodinane 
DIBAL-H diisobutylaluminium hydride 
DIC N,N′-diisopropylcarbodiimide 
DMA Dimethylacetamide 
DMAP  4-dimethylaminopyridine 
dme dimethoxyethane 
DMF  N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
dppf 1,1′-bis(diphenylphosphino)ferrocene 
ee  enantiomeric excess 
er enantiomeric ratio 
equiv  equivalent 
EDC•HCl 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
Et3N triethylamine 
ESI  electrospray ionization 
Et  ethyl 
g  gram(s) 
h  hour(s) 
HOBt hydroxybenzatriazole 
HRMS high resolution mass spectroscopy 
Hz  hertz 
IBX 2-iodoxybenzoic acid 
IR  infrared (spectroscopy) 
J  coupling constant 
L  liter 
LDA Lithium diisopropylamide 
m  meta 
m  multiplet or milli 
min  minute(s) 
mol  mole(s) 
mp  melting point 
M molecular mass 
Me  methyl 
 xxxviii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MHz  megahertz 
MS  molecular sieves 
NBS N-bromosuccinimide  
NMR  nuclear magnetic resonance 
nM Nanomolar 
Ns nosyl 
[O]  oxidation 
OTf trifluoromethanesulfonate (triflate) 
ppts  para-toluenesulfonic acid 
pH  hydrogen ion concentration in aqueous solution 
PMHS polymethylhydrosiloxane 
ppm  parts per million 
Ph  phenyl 
Piv pivaloyl 
Pr  propyl 
i-Pr isopropyl 
PSI Pounds per square inch 
q  quartet 
quint. quintet 
Rf  retention factor 
s  singlet 
sat. saturated 
sext. sextet 
SFC supercritical fluid chromatography 
SiPr 1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2- ylidene 
t  triplet 
trig trigonal 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMS  trimethylsilyl 
Ts Tosyl 
UV  ultraviolet 
 xxxix 
 
ACKNOWLEDGEMENTS 
 To begin, I would like to thank my advisor Prof. Neil K. Garg. As a kid with limited 
chemical knowledge, coming from a small liberal arts school, Neil took a risk accepting me into 
his lab. I like to believe he saw a potential in me that I had yet to see in myself. When I 
considered joining the lab, the chatter surrounding Neil was about how great of a chemist he was. 
Although true, he was much more than this. Above all else, Neil was everyone’s personal 
advocate. Whether it was an award nomination or trying to acquire an industrial position, Neil 
would be the first one to support you. It was this constant encouragement that I became so 
appreciative of and have tried to emulate throughout my life. I thank him for all the time he’s 
spent on my personal and professional development and for giving me a chance (or two). 
I would also like to acknowledge the rest of my doctoral committee: Professors Ken 
Houk, Yi Tang, and Hosea Nelson. Their guidance and support throughout my graduate career 
has been invaluable and I thank them for serving on my committee. 
 I would also like to thank those who were directly responsible for sparking my love of 
science. Mr. Van Duzee’s molecular biology class was my first exposure to the microscopic 
world and from that first day, when I peered into a microscope, I knew I would never turn back. 
Upon starting at California Lutheran University, I was fortunate to join the research lab of Dr. 
John Tannaci. His infectious love of organic chemistry drove me away from looking at cells and 
I quickly devoted myself to organic synthesis. It was in his lab that I had my first taste of 
research, and although quite bitter at times, his passion for science solidified my idea to be a 
synthetic chemist. I was also fortunate to consider Dr. Tannaci a good friend. Between the bar 
hopping around Thousand Oaks and the late night barbeques and “diet cokes”, I enjoyed the time 
we shared together. Now if only you’d reply to an email! I was also lucky to work alongside a 
 xl 
 
number of incredibly bright chemists during my time there. From my roommates Mike Mayers 
and Scott Lombardi, to the rest of the summer crew, Vanessa Orr and Steven Boggess, my early 
chemistry career would not have been nearly as enjoyable without you. I would also like to 
acknowledge Professors Butcher, Quinlan, and Kingsbury for constantly pushing me to enter into 
graduate school and pursue a doctorate degree. This one’s for you. 
 As I am about to embark on my next chapter as a medicinal chemist at Celgene… BMS? 
no, Celgene, I would like to thank those that helped guide my decision. To everyone at 
Boehringer Ingelheim, especially Drs. Senanayake, Sieber, Patel, and Qu. The conversations we 
shared about life as an industrial chemist and the encouragement to pursue this career proved 
invaluable in my decision to enter into industry. I would also like to thank the entire John lab at 
UCLA for opening the world of medicinal chemistry to me. What started out as a collaboration 
to survey our lab’s compounds turned into a two-year partnership aimed at helping millions of 
patients dealing with Alzheimer’s. Every day on this project gave me the opportunity to learn a 
new skill. Whether it was understanding how high-throughput assays are run from Jesus 
Campagna to methods on delivering your compound to mice with Tina Bilousova, the highly 
multi-disciplinary nature of our collaboration helped me feel secure in my decision to become a 
medicinal chemist.  
 When I joined Neil’s lab, I was fortunate to be a part of 5229. Although I did not know it 
at the time, the individuals I met during my tenure in this room I now consider my family. The 
post-doc at the time, and my direct mentor, was Dr. Travis McMahon. I will never forget the first 
time I met Travis, with his stained t-shirt from high school and haircut out of an early 90’s teen 
drama. His love of diet cokes and muffins was infectious and I still think of him every time I 
purchase one. I want to thank Travis for his patience in training me and for instilling in me the 
 xli 
 
idea that I should always know what every reagent is doing before putting it into my flask. The 
next oldest students in 5229 were Michael Corsello and Jose Medina. Mike bud or Luigi as I 
later called him, played a huge role in my graduate career. Whether it was his boisterous belly 
laugh or the nightly dance sessions to Queen, Mike always knew how to put a smile on my face. 
His chemical knowledge was also second to none. He would be the first one to question me 
about a mechanism or to check in on how my reaction went. I appreciated the time I got to spend 
with him and am looking forward to opening “Bry Guy’s Pizzeria” when we are both old and 
decrepit.  Jose bud or as he was colloquially known, “Bud”, was one of the hardest working 
members of the Garg Lab. If he wasn’t looking at cat videos during his lunch break, Bud was at 
his hood working towards one of his numerous first author publications. He also had exquisite 
taste in music and I was fortunate to accompany him to various concerts throughout LA. With us 
both residing in Southern California, I’m looking forward to continuing our friendship. The next 
oldest student in lab and someone who I was closest with during my time was Elias “Starboy” 
Picazo. Elias has this uncanny ability to see the positives in all aspects of life. When graduate 
school started to beat me down, Eli would be there with some random shower thought from 
Reddit or words of motivation he picked up from a Justin Beiber song. Elias was also one of the 
brightest individuals I have ever met and there is no ceiling to his potential. I thank him for his 
friendship and mentorship throughout the four years I was fortunate enough to work alongside 
him. After getting to spend the better part of a year with these four fine gentlemen, Travis left for 
bigger and better things. In an attempt to replace his prowess in lab, a new French post-doc, Dr. 
Marie Hoffmann, was brought on. Though we questioned whether or not she would be able to fit 
in to our lab culture, Marie did much more than that. Her aggressive but caring nature was a 
perfect fit and she quickly became the fifth “bud” of 5229. It was Marie who instilled in me the 
 xlii 
 
importance of understanding everything about your NMR spectrum and forced me into 
understanding the difference between a doublet of triplets and a doublet of doublet of doublet of 
doublets. I also got to spend numerous late nights with Marie and enjoyed the time we had 
wandering aimlessly (perhaps drunkenly) through the streets of LA.  
 Although I was fortunate to share the glory days of 5229 with the individuals mentioned 
above, numerous other lab members greatly impacted my time in graduate school. When I joined 
the lab, two fifth year graduate students took it upon themselves to get to know me. Joel Smith 
was an absolute wiz when it came to anything synthetic chemistry related and he quizzed me 
often on mechanisms. Noah Fine Nathel had one of the darkest senses of humor of anyone I have 
met but was simultaneously caring and compassionate. When I began to question if I should 
leave the program or not, it was Noah that talked me off the ledge, and for this, I will forever be 
grateful to him. It was this selfless act that has led me to always make time for younger students, 
no matter how busy or stressed I may be. 
 The next youngest class contained two of the happiest-go-luckiest individuals. Tejas Shah 
and Liana Hie were incredibly hardworking and set an example for what a younger student 
should aspire to be. Tejas also was the labs de-facto party planner (even though Jesus would 
invite everyone over without him knowing). I appreciate all their help during the time we spent 
together. True!!! 
 Accompanying Mike and Jose in lab were Nick Weires and Jesus Moreno. Nick was 
someone you could count on to always be chippy and have a pep in his step. Literally, Nick 
walked on his toes and it was impressive.  In one of my first projects, Nick was kind enough to 
join me and help guide me through what it takes to bring a project from infancy to completion. 
As we found out together on this journey, and contrary to popular beliefs, organozincs are hell to 
 xliii 
 
make. I always appreciated his positive attitude and his outlook on life. On the other end of the 
positive attitude spectrum, was Jesus Moreno. Jesus always found something wrong with the 
world, but boy did I love him for that. Jesus was an incredibly bright chemist and an even bigger 
Chivas fan. I’ve lost count how many nights I spent in his apartment watching Liga MX and 
trying to calm him down from throwing his beer through the TV. On a serious note, I consider 
Jesus one of my dearest friends and I am extremely lucky to have gotten to know him. Once he 
no longer has to pay Merck back his signing bonus, you can bet I will be recruiting him to San 
Diego. Who else am I going to go see Tame Impala with?! 
 Having to deal with me for four years, alongside Elias, were Emma Baker and Junyong 
Kim. Like Noah, Emma had a dark sense of humor, and needless to say, we got along very well. 
Her love of cats and Hawaiian shirts have changed my wardrobe for the better (although some 
may say otherwise). I’ve also enjoyed how much closer we have grown after her time in Neil’s 
lab. I now look for her in Trader Joe’s anytime I’m trying to find the perfect potato. Junyong, 
Juny, or June puppy as he is known around certain parts of LA, was notorious for his laugh and 
his impeccable work ethic. On that note, Junyong also taught me it was okay to nap in lab, just so 
long as you have a reaction running in your hood. Like Elias, I can’t wait to see what he does in 
his independent career and any young budding chemist would be fortunate to have him as their 
advisor.  
 I would be remiss to not mention those in my year. Graduate school is definitely a 
journey and I was fortunate to have two amazing people by my side. Joyann Barber is the 
bubbliest and most optimistic person I know. Her positive attitude on life is infectious and I look 
forward to potentially being neighbors down in San Diego! Lucas Morrill, someone who I 
criticized heavily when I first met due to his sandals and tie dye t-shirt, became one of my closest 
 xliv 
 
friends and confidants. If Lucas wasn’t enjoying his 10-lb bar of chocolate, you could find him at 
my hood reminiscing about the old days (mostly us getting yelled at in subgroup). From getting 
beers after work, playing golf on the weekends, or talking about what our futures hold, I’ve 
enjoyed the time we have spent together. I know he’s going to do amazing work at Amgen and I 
am already looking forward to our beer tours in San Diego. 
 At some point in your graduate career you go from being the mentee to being the mentor, 
and I was fortunate enough to mentor and befriend a number of younger students. The class 
below consisted of a number of strong personalities: Jacob Dander, Michael Yamano, Robert 
Susick, and Jordan Dotson. I had the chance to work along side Jacob during my first year and 
lucky enough to do the same during my last. Jacob is the epitome of an intellectual and is the 
resident dictionary of our lab. His quick wit and love for all things political have forced me to 
stay abreast on current affairs. I don’t know where his life will take him, but you can be damn 
sure he has my vote in the future. Dander 2040. Another member of his cohort that I was able to 
get to know during my tenure is Michael Yamano. Although I questioned his choice in music 
(and hockey team) almost daily, his love for science is infectious. If there was ever chemistry to 
try, the odds were that Michael had already tried it. He also had a love for Las Vegas and I 
enjoyed losing all our money playing craps together. Also, since he cannot argue with me in my 
thesis, no Michael, a pop-tart is not a ravioli and how dare you even consider it one. I am also 
thankful for the time I got to spend with Robert Susick. Though quite tall, Robert and I always 
saw eye to eye when it came to music and podcast. His enjoyment (obsession?) of League of 
Legends also found me by his side watching the tournament live. Rob was also a fantastic 
chemist and I was fortunate to get to know him. #TeamMoonPie. Jordan Dotson was the last 
member of this cohort and though I did not get to know him well, as he became a joint student 
 xlv 
 
later in his career, his comments in group meeting could only come from someone well-versed in 
the chemical literature. I wish him the best of luck with his future endeavors. 
 The next class, which consisted of some of the brightest minds in our lab, was Melissa 
Ramirez, Tim Boit, and Sarah Anthony. Melissa joined the craziness of 5229 and became an 
integral part of the lab. Besides being an excellent computational chemist, Melissa had an 
uncanny ability to stay perfectly still. While working in the office, Melissa was so subtle with her 
movements that the lights in the office turned off. Don’t ever change Melissa. Tim, like Joel and 
Mike before him, was an encyclopedia of knowledge when it came to organic chemistry. It has 
been a joy to see him progress as a quiet lost soul, into a budding chemist taking the reigns of the 
lab. I would wish him good luck in his independent career, but there isn’t a person alive that 
doubts him. If there is anyone besides my cohort that understands what five years of graduate 
school is like, it is Sarah Anthony. Having started as an undergraduate shortly after my arrival, 
Sarah has been here since day one. Known for her boisterous personality, Sarah is not one to be 
timid when it comes to how she feels. Besides having a strong personality, Sarah is also 
incredibly strong when it comes to synthetic chemistry. There is not a single reaction that Sarah 
won’t attempt and I know she is going to do amazing work with her remaining time here. I’ve 
also been fortunate to get to know Sarah on a more personal level and I’ve cherished the late 
nights and empty wine bottles we’ve produced. I’m excited to see what the future holds for us. 
 I was fortunate to get to know the following class of Rachel Knapp, Francesca Ippoliti, 
and Jason Chari. Although she would probably deny it, Rachel and I are very much alike. We 
both come from Italian families, we both have a love for classic rock, and we both have had the 
same roommate (she who must not be named). Rachel is also a fantastic chemist and I can’t think 
of anyone I would rather have take over the Alzheimer’s project. Oh, say hi to Shelby for me. 
 xlvi 
 
Francesca, or as I always liked to call her, Franny, is a bright and energetic person, even with her 
Minnesotan accent. Any time I read the label of a wine bottle, I will always do it in her voice. 
You and Josh are always welcome to come visit me in San Diego! Jason Chari has to be the 
nicest person I have ever met. There no doubt you’ll do great things in grad school. 
 As I became a fifth year, I swore I would never spend my time getting to know the first 
years, and although I tried to make that come to fruition, they all became good friends. Katie 
Spence and Milauni (Moana) Mehta, or the dynamic duo, always seemed to be the reason behind 
my headaches. Whether it was the late night texts (please stop texting me) or the new age slang 
(which I still don’t understand and never want to), they were constantly brightening up my day. 
Best of luck over your next five years, you’ll need it. Hey Milauni, you up? The third musketeer 
in that class was Andrew Kelleghan. Though I did not get to know Andrew well, I’ve enjoyed 
the conversations we have had. Good luck with the other two. 
 Last but not least, there is the post-doc Evan Darzi. Sharing a room with you (again) over 
the last year has been a joy. From the constant sports talk to your exquisite taste in music (except 
mouthsounds… never again), I’m glad we’ve gotten to reconnect. You’re an exceptional chemist 
and an even better father. I’ve really enjoyed getting to know you over the last few years and I 
wish you all the best moving forward. 
 From the day I started to when I will be getting hooded, the most constant part of 
graduate school has been my family and friends. To Josh and Danielle, thank you for always 
taking an interest in my rather nerdy endeavor. Your constant questions about anything “science” 
related always put a smile on my face, even if my answer was straight from Wikipedia. You’re 
both amazing people and I’m glad I get to call you my friends. Now hurry up and get married. 
To Chloe Vieira, thank you. No words can really do justice how much you have helped me 
 xlvii 
 
during my time here. From proofreading my applications to grad school, to putting up with me 
for three years, you are a truly exceptional person. I consider you my closest friend and someone 
I have always looked up to. You are going to do amazing things with your life and I’m excited to 
be able to witness all of them. To the friends I’ve made during my time at UCLA, thank you for 
your support. Over the past three years, Margeaux Miller has been my partner in crime when it 
comes to musicals and plays. However, the biggest contributions came from my teachings of 
genres and sub-genres of metal music. She is much better off because of it. For some reason, 
Margeaux also allowed me to be her life coach, not sure how that turned out, but I’m honored to 
have held the title. You’re an amazing person and I’m excited to try all the vegan restaurants in 
San Diego with you. To Dalton Steele, Janice Lin, and Leibniz Hang, thank you for all the fun 
times. Cume prep would not have been the same without you. I would also like to acknowledge 
Mike Jung for allowing me to get my ass kicked in racquetball every week. Although the student 
started to become the master towards the end, our games were always a nice reprieve from lab 
work. Lastly, I would like to thank Ricky Ruiz for all his hard work and dedication to the 
department. I will miss our daily conversations and run-ins at the grocery store. When you strike 
it big at the casino, don’t forget about me. 
Being raised by a small village of Italians, there was never a chance my family wouldn’t 
be involved in every aspect of my life. To my aunts, uncles, and cousins, thank you for 
everything you have done for me. From the persistent love and support, to always being 
confused about what I do, and whether Saturday or Sunday was my day off, you have always 
stood by me. I couldn’t ask for a better family. To my nieces Grace and Olivia, thank you for 
being a little shining glimmer of hope during my time in graduate school. When reactions 
stopped working and the pressure of my surroundings started to cave in, I always had you two. 
 xlviii 
 
The late night video chats where Olivia would just run in circles or where Grace would prop me 
up so I can see her eat dinner, were always the highlight of my day. I know you two will never 
remember what Uncle Bryan went through during this process, but I hope you realize that if I can 
do this, there is nothing you can’t accomplish. I love you two to death and I’m so excited to see 
you grow up and change the world. To my brother Brandon, thank you for always being a role 
model. Through all the adversity you have faced in your life, you’ve always come out stronger. 
Growing up with you has been an experience to say the least, but I’ve enjoyed every minute of it. 
You’re still a jackass, and that will never change, but you’ll always be my brother. Oh, and 
Brandon, can I talk to you now? Lastly, to my parents, Michael and JoAnn, you two have always 
been my biggest supporters. From the times when I thought I couldn’t continue, to the highest 
points in my life, you two were always there for me. You’ve taught me how to be an adult, how 
to put others before myself, and how hard work and dedication will allow you to accomplish 
anything. None of this would have been possible without your countless acts of unselfishness, 
love, and support. Every day I spent here was to make you proud and to show you what kind of 
son you raised. Thank you for everything. I love you both. 
From when I joined the lab to where I sit now writing my thesis, graduate school has 
proven to be many things. For one, graduate school has been an introspective experience. It’s 
forced me to understand my strengths and weakness, my limitations, and my wants. It’s forced 
me to love myself, to truly understand what makes me happy, and what I want out of life. Some 
of the lowest moments of my life have come from this experience, but so have some of the best. 
When I was about to start graduate school, I was told this experience would leave me with 
Stockholm syndrome. The idea that when you are struggling to get through every day, when all 
your reactions are failing and you have deadlines to meet, that you would hate the experience. 
 xlix 
 
When you begin to wrap up though, and have time to reflect on what the experience was like, the 
friends you made, the laughs and tears you shared, you would begin to realize that an opportunity 
like this doesn’t come often. You start to understand how lucky you were to be apart of 
something bigger than yourself. We always ask the question, knowing what we know now, 
would we do graduate school again? For me, the answer is simple. I would.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 l 
 
BIOGRAPHICAL SKETCH 
Education: 
University of California, Los Angeles, CA 
• Ph.D. in Organic Chemistry, anticipated Spring 2019, Advisor: Neil K. Garg 
• NSF Graduate Research Fellowship, 2016–2019 
• UCLA Anderson Business Foundations Certificate, 2018 
 
 California Lutheran University, Thousand Oaks, CA 
• B.S. in Chemistry, Cum Laude, 2014 
 
Professional and Academic Experience: 
Graduate Research Assistant: University of California, Los Angeles, CA 
• July 2014 – present; Advisor: Prof. Neil K. Garg. 
• Advanced material towards the first 3,4-azacyclohexyne and synthesized various 
medicinally privileged piperidine heterocycles. 
• Discovered the nickel-catalyzed alkylation of amides for the formation of alkyl 
ketones. 
• Developed a mild and scalable nickel-catalyzed reduction of amides to furnish 
amines utilizing an air-stable nickel source.  
• Generated complex heterocyclic scaffolds through an interrupted Fischer 
azaindolization cyclization. 
• Discovered novel nSMase2 and AChE inhibitors for the potential treatment of 
neurodegenerative diseases (Collaboration with Prof. Varghese John, UCLA). 
• Aided in the development of an interrupted Fischer indolization methodology using 
a microfluidic reactor (Collaboration with Prof. Varghese John, UCLA). 
Chemical Development Intern: Boehringer Ingelheim, Ridgefield, CT 
• May–August 2017; Advisors: Dr. Joshua Sieber, Dr. Chris Senanayake 
• Expanded the substrate scope for the palladium-catalyzed cross-coupling of tetra-
ortho substituted biaryls. 
Undergraduate Research Assistant: Cal. Lutheran University, Thousand Oaks, CA 
• July 2012 – May 2014; Advisor: Prof. John F. Tannaci 
• Synthesized conjugated polymers for use in organic photovoltaics (collaboration 
with Prof. Barry C. Thompson, USC). 
• Developed palladium-catalyzed C–H activation methodology for small-molecule 
systems. 
 
 li 
 
Honors and Awards: 
• Medicinal and Bioorganic Chemistry Foundation Scholar (2019) 
• Seaborg Symposium Poster Prize, UCLA, (2014, 2017) 
• NSF Graduate Research Fellowship, UCLA, 2016–2019 
• Hanson-Dow Excellence in Teaching Award, UCLA, 2015 
• NSF Graduate Research Fellowship Honorable Mention, UCLA, 2015 
• UCLA University Fellowship, UCLA, 2014 
• Graduation Honors: Cum Laude, Cal. Lutheran University, 2014 
• Swenson Fellowship for Undergraduate Research, Cal. Lutheran University, 2013 
• Cal. Lutheran University Guarantee Scholarship, 2010–2014 
 
Publications 
1. Preparation of Azacyclotridecane via a Nickel-Catalyzed Reduction. Bryan J. 
Simmons, Melissa Ramirez, Neil K. Garg. Org. Synth. (manuscript submitted). 
2. Synthesis of Fused Indolines by Interrupted Fischer Indolization in a Microfluidic 
Reactor. Alexander Tuan-Huy Duong, Bryan J. Simmons, Mohammad Parvez Alam, 
Jesus Campagna, Neil K. Garg, Varghese John. Tetrahedron Lett. 2019, 60, 322–326. 
3.  Computationally Assisted Mechanistic Investigation and Development of Pd-
Catalyzed Asymmetric Suzuki–Miyaura and Negishi Cross-Coupling Reactions for 
Tetra-ortho-Substituted Biaryl Synthesis. Nitinchandra D. Patel, Joshua D. Sieber, 
Sergei Tcyrulnikov, Bryan J. Simmons, et. al. ACS Catal. 2018, 8, 10190–10209. 
4.  Understanding and Interrupting the Fischer Azaindolization Reaction. Bryan J. 
Simmons, Marie Hoffmann, Pier Alexander Champagne, Elias Picazo, Katsuya 
Yamakawa, Lucas A. Morrill, K. N. Houk, and Neil K. Garg. J. Am. Chem. Soc. 2017, 
139, 14833–14836. 
5. Nickel-Catalyzed Reduction of Secondary and Tertiary Amides. Bryan J. Simmons, 
Marie Hoffmann, Jaeyeon Hwang, Mortiz K. Jackl, and Neil K. Garg. Org. Lett. 2017, 
19, 1910–1913. 
6. Nickel-Catalyzed Alkylation of Amide Derivatives. Bryan J. Simmons,† Nicholas A. 
Weires,† Jacob E. Dander, and Neil K. Garg. ACS Catal. 2016, 6, 3176–3179. 
7. Generation and Regioselective Trapping of a 3,4-Piperidyne for the Synthesis of 
Functionalized Heterocycles. Travis C. McMahon,† Jose M. Medina,† Yun-Fang Yang, 
Bryan J. Simmons, K. N. Houk, and Neil K. Garg. J. Am. Chem. Soc. 2015, 137, 4082–
4085. 
Patents: 
1. Inhibitors of nSMase2. Varghese John, Tina Bilousova, Barbara Jagodzinska, Neil K. 
Garg, Bryan J. Simmons, Kanagasabai Vadivel. US Provisional Patent Application No. 
62/746,768. 
 1 
CHAPTER ONE 
 
Nickel-Catalyzed Alkylation of Amide Derivatives 
Bryan J. Simmons†, Nicholas A. Weires†, Jacob E. Dander, and Neil K. Garg. 
ACS Catal. 2016, 6, 3176–3179. 
 
1.1 Abstract 
We report the first catalytic alkylation of amide derivatives, which relies on the use of 
non-precious metal catalysis. Amide derivatives are treated with organozinc reagents utilizing 
nickel catalysis to yield ketone products. The methodology is performed at ambient temperature 
and is tolerant of variation in both coupling partners. A precursor to a nanomolar glucagon 
receptor modulator was synthesized using the methodology, underscoring the mild nature of this 
chemistry and its potential utility in pharmaceutical synthesis. These studies are expected to 
further promote the use of amides as synthetic building blocks. 
 
1.2 Introduction 
The ability to activate traditionally unreactive functional groups as synthons continues to 
be a vital area of research. One particularly stable functionality is the amide.1  The resonance 
stabilization of amides has been well understood for decades;1,2 consequently, the use of amides 
in C–N bond cleavage reactions has remained limited.  Recently, however, there has been much 
interest in breaking amide C–N bonds to forge new C–heteroatom and C–C bonds.3,4,5,6,7 Such 
methodologies provide new tactics to prepare acyl derivatives, but with the key benefit of amide 
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stability. The use of amides in multistep synthesis, followed by selective C–N bond activation 
and coupling, should ultimately prove advantageous in the synthesis of complex molecules. 
The present study focuses on activating and coupling amides to build acyl C–C bonds in 
an intermolecular fashion (Figure 1.1). Such a catalytic methodology would complement 
Weinreb amide chemistry, but without the use of highly basic and pyrophoric organometallic 
reagents.8 Prior contributions in this area include Suzuki–Miyaura couplings (1.1à1.2) reported 
by Zou (Pd),4 Szostak (Pd),5 and our laboratory (Ni).3b In each of these cases, the nucleophilic 
coupling partner was restricted to aryl boronate species, thus limiting the application of this 
methodology. The corresponding alkylative coupling (1.1à1.3) would be highly desirable given 
the prevalence of alkyl ketones in molecules of biological importance and the versatility of alkyl 
ketones as synthetic building blocks. Herein, we report the first alkylative cross-coupling of 
amide derivatives. 
 
 
Figure 1.1. Nickel-catalyzed C–C bond forming reactions from amides. 
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Following unsuccessful attempts to couple amide derivatives with aliphatic boronic acids 
and esters, we opted to pursue the use of organozinc reagents as cross-coupling partners.9 Our 
earlier studies have relied on the use of nickel catalysis for amide C–N bond activation,3 which is 
notable given that nickel is less expensive, more abundant, and displays a lower CO2 footprint 
compared to its precious metal counterpart, palladium.10 Catalytic acyl couplings11 with 
organozinc reagents are well precedented using acid halides (Pd or Ni),12 anhydrides (Pd, Ni, or 
Rh),12a,13 and thioesters (Pd or Ni),12a,b,14 but the corresponding coupling of amides has not been 
reported. 
 
1.3 Development of the Coupling Using Amides with Various N-Substituents 
To initiate our study, we examined the coupling of naphthamides 1.4 with benzylzinc 
bromide (1.5) in the presence of catalytic Ni(cod)2 and the NHC ligand SIPr in THF (Table 1.1). 
Although several amide derivatives failed to undergo the coupling (entries 1–3), we were 
delighted to find that N-alkyl,Boc and N-alkyl,Ts derivatives could be utilized (entries 4–5, 
respectively).15 N-Alkyl,Ts amides (e.g., 1.4e) are well suited for use in multistep synthesis.16  It 
should be noted that the successful reactions of 1.4d and 1.4e proceeded at room temperature, 
which compares favorably to the few existing examples of catalytic amide C–N bond activation 
(ca. 50–160 °C) 3,4,5,6,7 and highlights the mild nature of this coupling. 
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Table 1.1. Survey of amide N-substituents in the coupling of substrates 1.4 with 1.5.a 
 
a Conditions: Ni(cod)2 (10 mol%), SIPr (10 mol%), substrate 1.4 (1.0 equiv), 
benzylzinc bromide (1.5, 1.5 equiv) and THF (1.0 M) at 23 °C for 24 h. b Yields 
determined by 1H NMR analysis using hexamethylbenzene as an internal standard. 
 
1.4 Scope of the Coupling with Respect to the Amide Substrate 
Having found that the alkylative coupling of amide derivatives was indeed possible,17 we 
evaluated the scope of the amide substrate (Table 1.2). The use of the parent naphthyl substrate 
gave 1.6 in 80% isolated yield. Additionally, it was found that the methodology was not 
restricted to extended aromatics. For example, the substrate derived from benzoic acid coupled 
smoothly to furnish 1.7 in 74% yield.  Substrates bearing electron-donating groups could also be 
employed, as demonstrated by the formation of 1.8–1.10. From the latter two cases, it should be 
emphasized that the presence of tertiary amines does not hinder catalysis. As shown by the 
Yield of
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Me
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formation of 1.11 and 1.12, the electron-withdrawing –F and –CF3 substituents were also 
tolerated.18 
 
Table 1.2. Scope of the amide substrate.a 
 a Conditions unless otherwise stated: Ni(cod)2 (10 mol%), SIPr (10 
mol%), substrate (1.0 equiv), benzylzinc bromide (1.5, 1.5 equiv) and 
THF (1.0 M) at 23 °C for 24 h. Yields shown reflect the average of 
two isolation experiments. b The corresponding N-Bn,Boc benzamide 
derivative was used. 
 
1.5 Scope of the Coupling with Respect to the Organozinc Species 
We also examined the scope of the organozinc reagent in this methodology (Table 
1.3).19,20 n-Propylzinc bromide was successfully employed to furnish 1.13 in 80% yield. To 
Ni(cod)2 (10 mol%)
SIPr (10 mol%)
THF, 23 °C, 24 h
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O
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O
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O
F
1.10
78% yield
O
N
O
1.9
87% yield
O
N
Me
Me
1.5
1.12
72% yieldb
O
F3C
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assess the tolerance of the methodology toward β-branching, neopentylzinc iodide, a very 
hindered nucleophile was tested and found to undergo the desired coupling to furnish 1.14. α-
Branched nucleophiles could also be employed, as judged by the formation of 1.15 and 1.16. 
Notably, couplings utilizing secondary organozinc reagents are known to be challenging.21 
Finally, cyclopentyl and cyclohexyl organozinc reagents underwent the desired coupling in good 
yields to deliver products 1.17 and 1.18, respectively. 
 
Table 1.3. Scope of the organozinc coupling partner.a 
 
a Conditions unless otherwise stated: Ni(cod)2 (10 mol%), SIPr (10 
mol%), substrate (1.0 equiv), organozinc reagent (1.5 equiv) and THF 
(1.0 M) at 23 °C for 24 h. Yields shown reflect the average of two 
isolation experiments. 
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1.6 Demonstration of Coupling on Gram-Scale 
 
The alkylative cross-coupling methodology was further probed in a synthetic application 
(Scheme 1.1). On gram-scale, amide derivative 1.19 was coupled with cyclohexylzinc iodide 
(1.20) using our optimal nickel-catalyzed reaction conditions. This transformation provided 
ketone 1.21 in 71% yield without disturbing the ester.22 Ketone 1.21 is an intermediate in 
Pfizer’s synthesis of the glucagon receptor modulator 1.22.23 The cross-coupling route to 1.21 
provides a favorable alternative to the known Weinreb amide displacement chemistry described 
in the literature, which proceeds in 34% yield.23 
 
Scheme 1.1. Gram-scale coupling to form ketone 1.21. 
 
 
1.7 Conclusion 
 
In summary, we have developed the first catalytic alkylation of amide derivatives. The 
transformation involves the coupling of N-alkyl,Ts or N-alkyl,Boc amides with organozinc 
reagents using nickel catalysis. The methodology proceeds at room temperature and is tolerant of 
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variation in both the substrate and nucleophilic coupling partner. The synthesis of 1.21 
underscores the mildness and scalability of this methodology, along with the applicability of this 
technology to pharmaceutical synthesis. As such, we expect these studies will further promote 
the use of amides as synthetic building blocks for use in drug and natural product synthesis. 
 
1.8 Experimental Section 
1.8.1 Materials and Methods 
Unless stated otherwise, reactions were conducted in flame-dried glassware under an 
atmosphere of nitrogen and commercially obtained reagents were used as received. Non-
commercially available substrates were synthesized following protocols specified in Section 
1.8.2.1 in the Experimental Procedures. Prior to use, tetrahydrofuran was purified by distillation 
and taken through five freeze-pump-thaw cycles. Iodine was obtained from Spectrum Chemical. 
Benzyl bromide, 1-bromopropane, 1-iodo-2,2-dimethylpropane, 2-bromopropane, 2-
bromobutane, iodocyclohexane, bromocyclopentane, acid chlorides 1.23, 1.27, and carboxylic 
acid 1.25 were obtained from Sigma–Aldrich and used as received. N,4-
Dimethylbenzenesulfonamide (1.24) and carboxylic acid 1.29 were obtained from Combi-
Blocks. Ni(cod)2, SIPr, and Zn powder (325 mesh, 99.9%) were obtained from Strem Chemicals 
and stored in a glove box. Anhydrous lithium chloride (99%) was obtained from Alfa Aesar and 
stored in a glove box. Chlorotrimethylsilane and 1,2-dibromoethane were obtained from Alfa 
Aesar and Sigma–Aldrich, respectively, and distilled before use. Reaction temperatures were 
controlled using an IKA mag temperature modulator, and unless stated otherwise, reactions were 
performed at room temperature (approximately 23 °C). Thin-layer chromatography (TLC) was 
conducted with EMD gel 60 F254 pre-coated plates (0.25 mm for analytical chromatography and 
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0.50 mm for preparative chromatography) and visualized using a combination of UV, 
anisaldehyde, and potassium permanganate staining techniques. Silicycle Siliaflash P60 (particle 
size 0.040–0.063 mm) was used for flash column chromatography. 1H NMR spectra were 
recorded on Bruker spectrometers (at 300, 400, and 500 MHz) and are reported relative to 
residual solvent signals. Data for 1H NMR spectra are reported as follows: chemical shift (δ 
ppm), multiplicity, coupling constant (Hz), integration. Data for 13C NMR are reported in terms 
of chemical shift (at 75 and 125 MHz). 19F NMR spectra were recorded on Bruker spectrometers 
(at 282 MHz) and reported in terms of chemical shift (δ ppm). IR spectra were recorded on a 
Perkin-Elmer UATR Two FT-IR spectrometer and are reported in terms of frequency absorption 
(cm-1). High-resolution mass spectra were obtained on Thermo Scientific™ Exactive Mass 
Spectrometer with DART ID-CUBE. 
 
1.8.2 Experimental Procedures 
1.8.2.1 Syntheses of Amide Substrates 
Representative Procedure A for the synthesis of amide substrates from Tables 1.1, 1.2, and 
1.3 (synthesis of amide 1.4e is used as an example). 
 
To a solution of sulfonamide 1.24 (3.00 g, 16.2 mmol, 1.0 equiv), DMAP (9.9 mg, 0.081 
mmol, 0.005 equiv), triethylamine (3.40 mL, 24.3 mmol, 1.5 equiv), and i-PrOAc (35.2 mL) at 
55 °C was added dropwise a solution of acid chloride 1.23 (3.41 g, 17.8 mmol, 1.1 equiv) in 
toluene (10.0 mL, 0.46 M in total) over 1 min. The reaction mixture was stirred at 55 °C for 1 h. 
HNMeTs (1.24, 1.0 equiv)
Et3N (1.5 equiv)
DMAP (0.005 equiv)
i-PrOAc / PhMe, 55 °C
(86% yield)
N
O
1.4e
Cl
O
Me
Ts
1.23
(1.1 equiv)
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After cooling the reaction mixture to room temperature, the reaction was quenched by the 
addition of 1.0 M aqueous HCl (10 mL). The resulting biphasic mixture was transferred to a 
separatory funnel with EtOAc (30 mL) and extracted with EtOAc (3 x 30 mL). The organic 
layers were combined, dried over Na2SO4, and the volatiles were removed under reduced 
pressure. The resulting crude residue was purified by flash chromatography (24:1 
Hexanes:EtOAc → 14:1 Hexanes:EtOAc → 9:1 Hexanes:EtOAc) to yield amide 1.4e (5.2 g, 
86% yield) as a white solid. Amide 1.4e: mp: 96–98 ºC; Rf 0.50 (7:3 Hexanes:EtOAc); 1H NMR 
(500 MHz, CDCl3): δ 8.07–8.06 (s, 1H), 7.87–7.84 (m, 5H), 7.62–7.53 (m, 3H), 7.34–7.32 (m, 
2H), 3.34 (s, 3H), 2.44 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 171.9, 145.2, 135.6, 135.1, 
132.5, 132.0, 130.0, 129.9, 129.3, 128.8, 128.5, 128.5, 128.2, 127.3, 124.9, 36.0, 22.0; IR (film): 
3060, 2954, 2922, 1682, 1356 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C19H18NO3S, 
340.10074; found 340.09984. 
 
Representative Procedure B for the synthesis of amide substrates from Tables 1.1, 1.2, and 
1.3 (synthesis of amide 1.26 is used as an example). 
 
To a solution of sulfonamide 1.24 (1.00 g, 5.40 mmol, 1.0 equiv), EDC•HCl (2.48 g, 13.0 
mmol, 2.4 equiv), DMAP (263 mg, 2.16 mmol, 0.4 equiv), triethylamine (2.30 mL, 16.2 mmol, 
3.0 equiv), and CH2Cl2 (15.4 mL, 0.35 M) at 0 °C was added carboxylic acid 1.25 (1.07 g, 6.48 
mmol, 1.2 equiv) as a solid in one portion. The reaction mixture was allowed to come to room 
temperature and then stirred at 40 °C for 16 h. After cooling to room temperature, the reaction 
HNMeTs (1.24, 1.0 equiv)
EDC•HCl (2.4 equiv)
DMAP (0.4 equiv)
Et3N (3.0 equiv)
CH2Cl2, 0 → 40 °C
(83% yield)
N
O
1.26
OH
O
Me
Ts
N
Me
Me
N
Me
Me
1.25
(1.2 equiv)
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mixture was transferred to a separatory funnel with EtOAc (30 mL) and washed with 1.0 M 
aqueous HCl (2 x 10 mL), followed by 1.0 M aqueous NaOH (2 x 10 mL), and deionized water 
(10 mL). The organic layer was dried over Na2SO4, and the volatiles were removed under 
reduced pressure. The resulting crude residue was purified by flash chromatography (20:1 
Benzene:Et2O) to yield amide 1.26 (1.48 g, 83% yield) as an off-white solid. Amide 1.26: mp: 
104–106 ºC; Rf 0.52 (3:2 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.85 (d, J = 8.2, 2H), 
7.65 (d, J = 9.0, 2H), 7.31 (d, J = 8.2, 2H), 6.63 (d, J = 8.9, 2H), 3.20 (s, 3H), 3.05 (s, 6H), 2.43 
(s, 3H); 13C NMR (125 MHz, CDCl3): δ 172.0, 153.7, 144.7, 135.5, 132.3, 129.8, 128.8, 120.5, 
110.8, 40.4, 36.4, 21.9; IR (film): 3060, 2917, 2823, 1672, 1600 cm–1; HRMS-ESI (m/z) [M + 
H]+ calcd for C17H21N2O3S, 333.12729; found 333.12611. 
Note: Supporting information for the syntheses of some amides shown in Tables 1.1, 1.2, 
and 1.3, and Scheme 1.1 have previously been reported: 1.4a,24a 1.4b,24b 1.4c,24c 1.4d,24d 1.19,24d 
1.36,24e 1.37,24f 1.38.24d Syntheses for the remaining substrates shown in Tables 1.1, 1.2, and 1.3 
are as follows: 
Any modifications of the conditions shown in the representative procedures above are 
specified in the following schemes. 
 
 
Amide 1.28. Followed representative procedure A. Purification by flash chromatography (9:1 
Hexanes:EtOAc) generated amide 1.28 (91% yield) as a white solid. Amide 1.28: mp: 80–83 °C; 
Rf 0.54 (7:3 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.3, 2H), 7.62–7.59 
HNMeTs (1.24, 1.0 equiv)
Et3N (1.5 equiv)
DMAP (0.005 equiv)
i-PrOAc / PhMe, 55 °C
(91% yield)
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(m, 2H), 7.33 (d, J = 8.0, 2H), 7.12–7.08 (m, 2H), 3.24 (s, 3H), 2.45 (s, 3H); 13C NMR (125 
MHz, CDCl3): δ 171.0, 165.3 (d, JC–F = 253.9), 145.4, 135.3, 131.7 (d, JC–F = 9.1) 131.1 (d, JC–F 
= 3.3), 130.1, 128.6, 115.8 (d, JC–F = 22.2), 35.8, 22.0; 19F NMR (282 MHz, CDCl3): δ 106.1; IR 
(film): 3074, 2954, 2924, 1683, 1596 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C15H15FNO3S, 
308.07567; found 308.07463. 
 
 
Amide 1.30. Followed representative procedure B. Purification by flash chromatography (1:1 
Hexanes:EtOAc) generated amide 1.30 (93% yield) as a white solid. Amide 1.30: mp: 141–143 
ºC; Rf 0.60 (3:7 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.83 (d, J = 8.3, 2H), 7.63 (d, J 
= 8.8, 2H), 7.32 (d, J = 8.3, 2H), 6.84 (d, J = 8.8, 2H), 3.85 (t, J = 4.8, 4H), 3.29 (t, J = 4.8, 4H), 
3.21 (s, 3H), 2.43 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 171.7, 154.3, 144.9, 135.4, 131.8, 
129.9, 128.8, 124.1, 113.5, 66.9, 47.9, 36.3, 22.0; IR (film): 3049, 2964, 2854, 1673, 1601 cm–1; 
HRMS-ESI (m/z) [M + H]+ calcd for C19H23N2O4S, 375.13785; found 375.13717. 
 
1.8.2.2 Preparation of Organozinc Halides 
  
Following a modification of the procedure reported by Knochel,25 a flame-dried 25 mL round 
bottom flask equipped with a magnetic stir bar and rubber septum was brought into a glove box 
HNMeTs (1.24, 1.0 equiv)
EDC•HCl (2.4 equiv)
DMAP (0.4 equiv)
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CH2Cl2, 0 → 40 °C
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ii. THF (1.0 M), (CH2Br)2 (0.05 equiv), 60 °C
iii. TMSCl (0.01 equiv), I2 (0.005 equiv), 60 °C
iv. Alkyl halide (1.0 equiv), 50 °C, 18 h
AlkylXZnZn powder
(2.0 equiv)
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where Zn powder (650 mg, 10.0 mmol, 2.0 equiv, Strem 325 mesh) and anhydrous LiCl (420 
mg, 10.0 mmol, 2.0 equiv) were added. The flask was then removed from the glove box and 
heated with a heat gun for 10 min under high vacuum, cooled to room temperature, and then 
backfilled with N2. Freshly distilled THF (5.0 mL) and 1,2-dibromoethane (22 µL, 0.25 mmol, 
0.05 equiv) were added via syringe and the reaction mixture was heated at 60 °C for 20 min. 
After cooling to room temperature, freshly distilled TMSCl (6 µL, 0.05 mmol, 0.01 equiv) 
followed by a solution of I2 (6.4 mg, 0.025 mmol, 0.005 equiv) in THF (25 µL, 1.0 M) were 
added via syringe and the reaction mixture was heated again at 60 °C for 20 min. After cooling 
to room temperature, the alkyl halide (5.0 mmol, 1.0 equiv) was added dropwise via syringe over 
1 min. A flame-dried air condenser was attached to the flask under N2 and the reaction vessel 
was heated at 50 °C for 18 h. The reaction mixture was cooled to room temperature and allowed 
to stand for 1 h before the supernatant fluid was transferred to a flame-dried schlenk flask via 
syringe. The concentration of the organozinc halide was determined by iodometric titration using 
Knochel’s procedure.26 
Note: The use of organozinc reagents with lower titers led to lower yields in the subsequent 
coupling reactions. 
 
 
 
 
BrZn
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1.8.2.3 Initial Survey of Naphthamide Substrates with Benzylzinc Bromide (1.5) 
 
Representative Procedure for alkylation reactions of naphthamides from Tables 1.1, 1.2, 
1.4, and 1.5 (coupling of amide 1.4e and benzylzinc bromide (1.5) is used as an example). A 
1-dram vial was charged with a magnetic stir bar and flame-dried under reduced pressure, and 
then allowed to cool under N2. Amide substrate 1.4e (67.8 mg, 0.200 mmol, 1.0 equiv) and 
hexamethylbenzene (3.2 mg, 0.020 mmol, 0.1 equiv) were added, and the vial was flushed with 
N2. The vial was taken into a glove box and charged with Ni(cod)2 (5.5 mg, 0.020 mmol, 10 
mol%) and SIPr (7.8 mg, 0.020 mmol, 10 mol%). Subsequently, THF (0.20 mL, 1.0 M) was 
added, and the vial was removed from the glove box and the reaction was allowed to stir at 23 °C 
for 1 h. Concurrently, the benzylzinc bromide solution (1.5) was heated in a water bath at 50 °C 
for 1 h. A portion of the preheated solution of 1.5 (333 µL, 0.300 mmol, 1.5 equiv, 0.90 M in 
THF) was then added to the reaction mixture dropwise via syringe over 3 sec. The vial was then 
capped with a Teflon-lined screw cap under a flow of N2. The reaction mixture was allowed to 
stir at 23 °C for 24 h. The reaction was quenched by the addition of a saturated aqueous solution 
of NH4Cl (0.5 mL), and the resulting aqueous layer was extracted with EtOAc (3 x 2 mL). The 
combined organics were filtered over a plug of silica gel (10 mL of EtOAc eluent). The volatiles 
were removed under reduced pressure, and the yield was determined by 1H NMR analysis with 
hexamethylbenzene as an internal standard. 
 
N
O
Ts
Me
Ni(cod)2 (10 mol%)
SIPr (10 mol%)
THF, 23 °C
+
1.61.4e (1.5, 1.5 equiv)
O
BrZn
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Any modifications of the conditions shown in the representative procedure  
above are specified below in Tables 1.4 and 1.5. 
 
Table 1.4. Initial survey of naphthamide substrates with benzylzinc bromide (1.5).a 
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1.8.2.4 Relevant Control Experiments in the Alkylation of Amide 1.4e 
 
Table 1.5. Relevant control experiments in the alkylation of amide 1.4e.a 
 
 
 
 
 
 
 
 
 
 
100% 0%
100% 0%
Reaction Conditions
Experimental Results
17% 81%
a Yields were determined by 1H NMR analysis using hexamethylbenzene as an internal standard. 
b Some conversion to the ketone was observed in the absence of SIPr, but in greatly diminished 
yield relative to the experiment run with both Ni(cod)2 and SIPr. Additionally, use of these 
conditions with other substrates was even less successful.
O
N
Ts
Me
O
conditions
Control Experiments:
1.4e 1.6
1.4e 1.6
BnZnBr (1.5 equiv), Ni(cod)2 (10 mol%), SIPr (10 mol%)
THF (1.0 M), 23 °C, 24 h
33% 35%b
BnZnBr (1.5 equiv)
THF (1.0 M), 23 °C, 24 h
BnZnBr (1.5 equiv), SIPr (10 mol%)
THF (1.0 M), 23 °C, 24 h
BnZnBr (1.5 equiv), Ni(cod)2 (10 mol%)
THF (1.0 M), 23 °C, 24 h
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1.8.2.5 Scope of Methodology 
 
Representative Procedure (coupling of amide 1.36 and benzylzinc bromide (1.5) is used as 
an example). Ketone 1.7.  A 1-dram vial was charged with a magnetic stir bar and flame-dried 
under reduced pressure, and then allowed to cool under N2. Amide substrate 1.36 (57.8 mg, 
0.200 mmol, 1.0 equiv) was added, and the vial was flushed with N2. The vial was taken into a 
glove box and charged with Ni(cod)2 (5.5 mg, 0.020 mmol, 10 mol%) and SIPr (7.8 mg, 0.020 
mmol, 10 mol%). Subsequently, THF (0.20 mL, 1.0 M) was added, and the vial was removed 
from the glove box and the reaction was allowed to stir at 23 °C for 1 h. Concurrently, the 
benzylzinc bromide solution (1.5) was heated in a water bath at 50 °C for 1 h. A portion of the 
preheated solution of 1.5 (319 µL, 0.300 mmol, 1.5 equiv, 0.94 M in THF) was then added to the 
reaction mixture dropwise via syringe over 3 sec. The vial was then capped with a Teflon-lined 
screw cap under a flow of N2. The reaction mixture was allowed to stir at 23 °C for 24 h. The 
reaction was quenched by the addition of a saturated aqueous solution of NH4Cl (0.5 mL), and 
the resulting aqueous layer was extracted with EtOAc (3 x 2 mL). The combined organics were 
filtered over a plug of silica gel (10 mL of EtOAc eluent). The volatiles were removed under 
reduced pressure, and the crude residue was purified by preparative thin-layer chromatography 
(5:1 Hexanes:EtOAc) to yield ketone product 1.7 (74% yield, average of two experiments) as a 
white solid. Ketone 1.7: Rf 0.54 (5:1 Hexanes:EtOAc). Spectral data match those previously 
reported.27 
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(74% yield)
+
1.71.36
O
BrZn
(1.5, 1.5 equiv)
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Any modifications of the conditions shown in the representative procedure above are specified in 
the following schemes, which depict all of the results shown in Tables 1.2 and 1.3.  
 
Ketone 1.6. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.6 (80% yield, average of two experiments) as a white solid. Ketone 1.6: Rf 
0.53 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.27 
 
 
Ketone 1.8. Purification by preparative thin-layer chromatography (4:1 Hexanes:EtOAc) 
generated ketone 1.8 (73% yield, average of two experiments) as a white solid. Ketone 1.8: Rf 
0.46 (4:1 Hexanes:EtOAc). Spectral data match those previously reported.28 
 
 
Ketone 1.9. Purification by flash chromatography (8:1:1 PhH:Et2O:CH2Cl2) generated ketone 
1.9 (87% yield, average of two experiments) as a white solid. Ketone 1.9: Rf 0.46 (8:1:1 
PhH:Et2O:CH2Cl2). Spectral data match those previously reported.29 
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(80% yield)
+
1.61.4e
O
BrZn
(1.5, 1.5 equiv)
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(73% yield)
+
1.81.37
O
BrZn
(1.5, 1.5 equiv)
MeO MeO
N
O
Ts
Me Ni(cod)2 (10 mol%) SIPr (10 mol%)
THF (1.0 M), 23 °C
(87% yield)
+
1.91.26
O
BrZn
(1.5, 1.5 equiv)
N N
Me
Me
Me
Me
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Ketone 1.10. Purification by flash chromatography (10:5:1 CHCl3:Hexanes:CH3CN) followed 
by preparative thin-layer chromatography (10:2:1 CHCl3:Hexanes:CH3CN) generated ketone 
1.10 (78% yield, average of two experiments) as a white solid. Ketone 1.10: mp: 138–139 °C; Rf 
0.64 (3:2 Hexanes:EtOAc); 1H NMR (500 MHz, CD3CN): δ 7.94–7.88 (m, 2H), 7.33–7.19 (m, 
5H), 6.95–6.89 (m, 2H), 4.21 (s, 2H), 3.77–3.73 (m, 4H), 3.29–3.24 (m, 4H); 13C NMR (125 
MHz, CD3CN): δ 196.8, 155.5, 137.1, 131.4, 130.6, 129.4, 127.9, 127.4, 114.1, 67.1, 48.1, 45.5; 
IR (film): 3042, 2957, 2857, 2840, 1675, 1595 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for 
C11H8O2, 282.14940; found 282.14800. 
 
 
Ketone 1.11. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.11 (73% yield, average of two experiments) as a white solid. Ketone 1.11: Rf 
0.50 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.27 
 
 
 
N
O
Ts
Me Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(78% yield)
+
1.101.30
O
BrZn
(1.5, 1.5 equiv)
N N
O O
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(73% yield)
+
1.111.28
O
BrZn
(1.5, 1.5 equiv)
F F
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Ketone 1.12. Purification by flash chromatography (100% PhH) generated ketone 1.12 (72% 
yield, average of two experiments) as a white solid. Ketone 1.12: Rf 0.68 (100% PhH). Spectral 
data match those previously reported.30 
  
 
Ketone 1.13. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.13 (80% yield, average of two experiments) as a colorless oil. Ketone 1.13: 
Rf 0.57 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.27 
 
  
Ketone 1.14. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.14 (63% yield, average of two experiments) as a colorless oil. Ketone 1.14: 
Rf 0.63 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.31 
 
 
N
O
Boc
Bn
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(72% yield)
+
1.121.38
O
BrZn
(1.5, 1.5 equiv)
F3C F3C
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(80% yield)
+
1.131.36
O
Me
BrZn
(1.31, 1.5 equiv)
Me
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(63% yield)
+
1.141.4e
O
Me
IZn
(1.32, 1.5 equiv)
Me
Me
Me
Me
Me
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Ketone 1.15. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.15 (72% yield, average of two experiments) as a colorless oil. Ketone 1.15: 
Rf 0.64 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.32 
 
 
Ketone 1.16. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.16 (62% yield, average of two experiments) as a colorless oil. Ketone 1.16: 
Rf 0.44 (10:1 Hexanes:EtOAc); 1H NMR (500 MHz, C6D6): δ 8.35 (br s, 1H), 8.13 (dd, J = 8.6, 
1.6, 1H), 7.63 (d, J = 7.9, 1H), 7.56 (d, J = 8.6, 1H), 7.53 (d, J = 7.9, 1H) 7.27–7.19 (m, 1H), 
3.26–3.18 (m, 1H), 1.93–1.83 (m, 1H), 1.48–1.38 (m, 1H), 1.14 (d, J = 6.9, 3H), 0.83 (t, J = 7.5, 
3H);13C NMR (125 MHz, CD3CN): δ 205.3, 136.4, 135.2, 133.7, 130.7, 130.5, 129.5, 129.4, 
128.6, 127.8, 125.0, 42.7, 27.6, 17.2, 12.0; IR (film): 3060, 2965, 2932, 2875, 1677, 1625 cm–1; 
HRMS-ESI (m/z) [M + H]+ calcd for C11H8O2, 213.12794; found 213.12691. 
 
 
 
 
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(72% yield)
+
1.151.4e
O
MeMeBrZn
(1.33, 1.5 equiv)
Me Me
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(62% yield)
+
1.161.4e
O
BrZn
(1.34, 1.5 equiv)
Me Me
Me Me
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Ketone 1.17. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.17 (81% yield, average of two experiments) as a colorless oil. Ketone 1.17: 
Rf 0.64 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.33 
 
 
Ketone 1.18. Purification by preparative thin-layer chromatography (5:1 Hexanes:EtOAc) 
generated ketone 1.18 (78% yield, average of two experiments) as a colorless oil. Ketone 1.18: 
Rf 0.54 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.34 
 
1.8.2.6 Gram-Scale Alkylation to Form Ketone 1.21 
 
Ketone 1.21. A 20 mL scintillation vial was charged with a magnetic stir bar and flame-
dried under reduced pressure, and then allowed to cool under N2. Amide substrate 1.19 (1.00 g, 
2.71 mmol, 1.0 equiv) was added, and the vial was flushed with N2. The vial was taken into a 
glove box and charged with Ni(cod)2 (74.5 mg, 0.270 mmol, 10 mol%) and SIPr (106 mg, 0.270 
mmol, 10 mol%). Subsequently, THF (2.7 mL, 1.0 M) was added, and the vial was removed 
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(81% yield)
+
1.171.36
O
BrZn
(1.35, 1.5 equiv)
N
O
Ts
Me
Ni(cod)2 (10 mol%)
 SIPr (10 mol%)
THF (1.0 M), 23 °C
(78% yield)
+
1.181.36
O
IZn
(1.20, 1.5 equiv)
N
O
Boc
Bn Ni(cod)2 (10 mol%) SIPr (10 mol%)
THF (1.0 M), 23 °C
(71% yield)
+
1.211.19
O
IZn
(1.20, 1.5 equiv)
MeO
O
MeO
O
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from the glove box and the reaction was allowed to stir at 23 °C for 1 h. Concurrently, the 
cyclohexylzinc iodide solution (1.20) was heated in a water bath at 50 °C for 1 h. A portion of 
the preheated solution of 1.20 (4.32 mL, 4.07 mmol, 1.5 equiv, 0.94 M in THF) was then added 
to the reaction mixture dropwise via syringe over 5 sec. The vial was then capped with a Teflon-
lined screw cap under a flow of N2. The reaction mixture was allowed to stir at 23 °C for 24 h. 
The reaction was quenched by the addition of a saturated aqueous solution of NH4Cl (3 mL), and 
the resulting aqueous layer was extracted with EtOAc (3 x 5 mL). The combined organics were 
filtered over a plug of silica gel (50 mL of EtOAc eluent). The volatiles were removed under 
reduced pressure, and the crude residue was purified by flash chromatography (24:1 
Hexanes:EtOAc) to yield ketone product 1.21 (472 mg, 71% yield) as a pale yellow solid. 
Ketone 1.21: Rf 0.50 (5:1 Hexanes:EtOAc). Spectral data match those previously reported.35 
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1.9 Spectra Relevant to Chapter One: 
 
Nickel-Catalyzed Alkylation of Amide Derivatives 
Bryan J. Simmons†, Nicholas A. Weires†, Jacob E. Dander, and Neil K. Garg. 
ACS Catal. 2016, 6, 3176–3179. 
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Figure 1.2 1H NMR (500 MHz, CDCl3) of compound 1.4e. 
 
Figure 1.3 13C NMR (125 MHz, CDCl3) of compound 1.4e. 
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Figure 1.4 1H NMR (500 MHz, CDCl3) of compound 1.26 
 
Figure 1.5 13C NMR (125 MHz, CDCl3) of compound 1.26. 
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Figure 1.6 1H NMR (500 MHz, CDCl3) of compound 1.28 
 
Figure 1.7 13C NMR (125 MHz, CDCl3) of compound 1.28. 
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Figure 1.8 1H NMR (500 MHz, CDCl3) of compound 1.30. 
 
Figure 1.9 13C NMR (125 MHz, CDCl3) of compound 1.30. 
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Figure 1.10 1H NMR (500 MHz, CDCl3) of compound 1.6. 
 
Figure 1.11 1H NMR (500 MHz, CDCl3) of compound 1.7. 
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Figure 1.12 1H NMR (500 MHz, CDCl3) of compound 1.8. 
 
Figure 1.13 1H NMR (500 MHz, CDCl3) of compound 1.9. 
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Figure 1.14 1H NMR (500 MHz, CDCl3) of compound 1.10. 
 
Figure 1.15 13C NMR (125 MHz, CDCl3) of compound 1.10. 
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Figure 1.16 1H NMR (500 MHz, CDCl3) of compound 1.11. 
 
Figure 1.17 1H NMR (500 MHz, CDCl3) of compound 1.12. 
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Figure 1.18 1H NMR (500 MHz, CDCl3) of compound 1.13. 
 
Figure 1.19 1H NMR (500 MHz, CDCl3) of compound 1.14. 
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Figure 1.20 1H NMR (500 MHz, CDCl3) of compound 1.15. 
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Figure 1.21 1H NMR (500 MHz, CDCl3) of compound 1.16. 
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Figure 1.22 13C NMR (125 MHz, CDCl3) of compound 1.16. 
 
Figure 1.23 1H NMR (500 MHz, CDCl3) of compound 1.17. 
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Figure 1.24 1H NMR (500 MHz, CDCl3) of compound 1.18. 
 
Figure 1.25 1H NMR (500 MHz, CDCl3) of compound 1.21. 
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CHAPTER TWO 
 
Nickel-Catalyzed Reduction of Secondary and Tertiary Amides 
Bryan J. Simmons, Marie Hoffmann, Jaeyeon Hwang, Moritz K. Jackl, and Neil K. Garg. 
Org. Lett. 2017, 19, 1910–1913. 
 
2.1 Abstract 
The nickel-catalyzed reduction of secondary and tertiary amides to give amine products is 
reported. The transformation is tolerant of extensive variation with respect to the amide 
substrate, proceeds in the presence of esters and epimerizable stereocenters, and can be used to 
achieve the reduction of lactams. Moreover, this methodology provides a simple tactic for 
accessing medicinally relevant α-deuterated amines. 
 
2.2 Introduction 
The ability to manipulate amides using nickel catalysis represents a rapidly growing area of 
research.1,2,3,4 Interest in this field has been driven in part by the stability of amides, and their 
consequential promise for applications in multistep synthesis.5,6 The high abundance, low cost, 
and minimal CO2 footprint associated with nickel also render these transformations highly 
attractive.7 In the last year alone, several nickel-catalyzed reactions of amides have been 
developed (Figure 1), including esterification,1a transamidation,1c Suzuki–Miyaura couplings,1b 
Negishi couplings,1d,2c,2d and decarbonylative processes.2a,2b  
 With the aim of expanding the scope of base metal-catalyzed reactions of amides, we 
became interested in the nickel-catalyzed reduction of amides (Figure 2.1, 2.1à2.2). Amide 
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reduction is a powerful synthetic tool and has been the topic of recent investigation,8 with 
notable breakthroughs including contributions by Beller (Fe or Ru, 2° or 3° amides; Zn, 3° 
amides; Cu, 2° amides)8a,8b,8e,8g Nagashima (Pt or Fe, 3° amides),8c,8k and Adolfsson (Mo, 3° 
amides).8d Beller’s Fe-catalyzed amide reduction8a is the most general of those methodologies 
that utilize non-precious metal catalysis, and provides a particularly impressive means to reduce 
tertiary amides.9 Surprisingly, however, only scattered reports of nickel-catalyzed amide 
reduction have been reported over the past century, with no general methodologies having been 
disclosed. Most known examples of nickel-catalyzed amide reduction require the use of Raney 
nickel, high temperatures, and high pressures of H2 gas.10,11 Only one exception exists, which is 
the double reduction of α-ketoanilides to the corresponding α-hydroxylamines.12 A general 
catalytic platform to achieve the Ni-catalyzed reduction of amides has remained elusive.  
Herein, we report a simple catalyst system that enables the reduction of both secondary and 
tertiary amide substrates. The transformation is tolerant of extensive variation with respect to the 
amide C- and N-substituents. Furthermore, the nickel-catalyzed amide reduction can be 
performed in the presence of esters and epimerizable stereocenters. Finally, the methodology 
provides a simple tactic for the synthesis of α-deuterated amines, which are important motifs in 
medicinal chemistry.13 
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Figure 2.1. Nickel-catalyzed reactions of amides (prior studies) 
and nickel-catalyzed reduction of amides (present study). 
 
2.3 Development of the Reduction Using Various Amide Substrates 
To initiate our studies, we examined the nickel-catalyzed reduction of several classes of 
amide substrates (Table 2.1).14 N-Methyl-N-phenylbenzamide (2.3), the substrate used in our 
initial amide coupling studies,1a was tested under a variety of reaction conditions.15 Ultimately, 
we found that 2.3 underwent efficient reduction to amine 2.4 in the presence of PhSiH316 and a 
catalytic amount of the air-stable Ni(II) precatalyst NiCl2(dme) 17 (entry 1). An external ligand 
was not required. With this exciting result in hand, we directed our attention to assessing other 
amide substrate classes, especially those that did not undergo coupling in our prior studies.1 
Amide 2.5, a substrate bearing two aliphatic nitrogen substituents, was reduced to give amine 2.6 
in 92% yield (entry 2).  Moreover, the use of secondary amide 2.7 as a substrate furnished amine 
2.8 in excellent yield (entry 3).  In the final example shown, we evaluated amide 2.9, a substrate 
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derived from an aliphatic carboxylic acid (entry 4).  This reduction delivered amine 2.10 in 93% 
yield. Given that most reported nickel-catalyzed reactions of amides require the use of 
benzamide-type substrates and activating groups on the nitrogen,18 the examples shown in entries 
2–4 were especially encouraging.19  
 
Table 2.1. Evaluation of amide substrates.a 
 
a Conditions unless otherwise stated: NiCl2(dme) (10 mol %), substrate (1.0 
equiv, 0.2 mmol), PhSiH3 (2.0 equiv), and toluene (1.0 M) at 115 °C for 24 h 
in a sealed vial. b Yields determined by 1H NMR analysis using 
hexamethylbenzene as an internal standard. 
 
2.4 Scope of the Reduction with Respect to the Amide Substrate 
 Having identified conditions to effect the nickel-catalyzed reduction of secondary and 
tertiary amides, the scope of this methodology was evaluated.20 We first tested substituent effects 
with regard to the carbon-component of the amide carbonyl using secondary amides derived 
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from benzylamine (Table 2.2). Reduction of the parent benzamide 2.7 gave 2.8 in 94% isolated 
yield. Electron-donating groups on the aromatic ring were tolerated, as exemplified by the 
formation of amines 2.11–2.13 in high yield. From the latter two cases, it should be emphasized 
that a tertiary amine and a phenol, respectively, did not hinder catalytic reduction. As suggested 
by products 2.14 and 2.15, the electron-withdrawing groups –CF3 and –F also withstood the 
reaction conditions. Several heteroaromatic substrates were also examined. To our delight, a free 
indole and a pyrazole were tolerated, as shown by the formation of amines 2.16 and 2.17 in 75 
and 67% yield, respectively. In addition to nitrogen-based heterocycles, sulfur- and oxygen- 
containing heterocycles could be utilized to give thiophene 2.18 and furan 2.19, both in 
synthetically useful yields. 
As noted earlier, one of the key limitations of most nickel-catalyzed reactions of amides 
is the necessity to employ benzamide-type substrates. Thus, we were eager to probe a range of 
amides derived from aliphatic carboxylic acid substrates (Table 2.2). A secondary amide derived 
from decanoic acid underwent reduction to give product 2.20 in 75% isolated yield. α-Branched 
substrates could also be reduced in excellent yields, as shown by products 2.21 and 2.22. It is 
noteworthy that significant steric bulk did not hinder the transformation. Olefin-containing 
compounds were also probed under our reaction conditions. Although all tests were not 
successful, product 2.23 was obtained in high yield, without competitive reduction of the alkene. 
Finally, heterocyclic amides derived from aliphatic carboxylic acids were found to undergo 
smooth reduction, as seen by the formation of 2.24–2.27. The tolerance of this methodology to 
oxygen- and nitrogen-containing heterocycles, including free NHs and carbamates, bodes well 
for future synthetic applications. 
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Table 2.2. Reduction of secondary amides with varying C-substituents.a 
 
a Conditions unless otherwise stated: NiCl2(dme) (10 mol %), substrate (1.0 
equiv, 0.2 mmol), PhSiH3 (2.0 equiv), and toluene (1.0 M) at 115 °C for 24 h 
in a sealed vial. Yields shown reflect the average of two isolation experiments. 
b PhSiH3 (4.0 equiv) was used. c Yields determined by 1H NMR analysis using 
hexamethylbenzene as an internal standard. 
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2.5 Scope of the Reduction with Respect to the N-Substituent 
As shown in Table 2.3, the scope of the methodology is broad with respect to the amide 
nitrogen-substituents. Secondary amides beyond N-Bn,H-amides can be utilized as shown by the 
formation of 2.28 and 2.29.  The latter example also suggests that large groups on the amide 
nitrogen are tolerated. A series of tertiary amides were evaluated, which led to the smooth 
formation of reduced products 2.30–2.36. These results collectively demonstrate that acyclic, 
cyclic, branched, and heterocyclic fragments can be utilized in this methodology.  
 
Table 2.3. Reduction of aliphatic substrates.a 
 
a Conditions unless otherwise stated: NiCl2(dme) (10 mol %), substrate (1.0 
equiv, 0.2 mmol), PhSiH3 (2.0 equiv), and toluene (1.0 M) at 115 °C for 24 h in 
a sealed vial. Yields shown reflect the average of two isolation experiments. b 
Yield determined by 1H NMR analysis using hexamethylbenzene as an internal 
standard. 
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2.6 Preparation of Cyclic Amines from the Corresponding Lactams 
Having demonstrated the broad scope of this methodology for the reduction of acyclic 
amides, we sought to test its applicability to the reduction of lactam substrates. Lactam reduction 
is most often performed using LiAlH4, Red-Al, or two-step protocols.21 As shown in Table 2.4, 
we found that a 4-membered lactam underwent reduction to give azetidine 2.37 in 64% yield. 
Additionally, 6- and 7-membered ring substrates could be reduced to give piperidine (2.38) and 
azepane (2.39), respectively. Finally, reduction of a 13-membered ring substrate delivered 
macrocyclic amine 2.40 in quantitative yield. Thus, our nickel-based approach offers a simple 
and relatively mild alternative to conventional lactam reduction methods and can be used to 
access cyclic amines of varying ring sizes. 
 
Table 2.4. Cyclic amines prepared by reduction of the corresponding lactams.a 
 
 a Conditions unless otherwise stated: NiCl2(dme) (10 mol %), substrate (1.0 
equiv, 0.2 mmol), PhSiH3 (2.0 equiv), and toluene (1.0 M) at 115 °C for 24 h 
in a sealed vial. Yield determined by 1H NMR analysis using 
hexamethylbenzene as an internal standard due to product volatility. b Yield 
shown reflects the average of two isolation experiments. 
 
2.7 Reduction of Amino Acid Derivatives for the Synthesis of α-Deuteroamines 
 As a final test of this methodology, a variety of optically enriched amino acid derivatives 
were reduced using PhSiD3 to give the corresponding α-deuteroamines (Table 2.5).22 α-
Deuteroamines are less prone to undergo metabolism compared to their non-deutero counterparts 
and are therefore sought after in drug discovery.13,23 We found that a valine-derived amide 
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bearing a methyl ester could be reduced to give deuteroamine 2.41.  Similarly, reduction of a 
tyrosine derivative proceeded in the presence of the free alcohol to furnish 2.42. In both cases, 
the ester remained intact and no epimerization was observed.  The same features were noted 
upon reduction of a proline-derived substrate, which gave deuterated aminoester 2.43.  In the last 
two examples, we examined the reduction of two prolinol derivatives, one bearing a free alcohol 
and the other bearing an acetoxy group.  In both cases, reduction proceeded smoothly to give the 
corresponding amines 2.44 and 2.45, respectively. Thus, these results not only underscore the 
utility of our methodology for the preparation of α-deuteroamines, but also re-emphasize the 
relatively mild nature of the reaction conditions. 
 
Table 2.5. Reduction of amino acid derivatives for the synthesis of α-deuteroamines.a 
 
a Conditions unless otherwise stated: NiCl2(dme) (10 mol %), substrate (1.0 
equiv, 0.1 mmol), PhSiD3 (4.0 equiv), and toluene (1.0 M) at 115 °C for 24 h 
in a sealed vial. Yields shown reflect the average of two isolation experiments. 
b PhSiD3 (2.0 equiv) was used. 
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2.8 Conclusion 	 We have developed a facile means to achieve the reduction of secondary and tertiary 
amides using non-precious metal catalysis. The transformation is tolerant of extensive variation 
with respect to the amide substrate, proceeds in the presence of esters and epimerizable 
stereocenters, and can be used to reduce lactams. Moreover, by employing α-deuterated silane as 
the reducing agent, this methodology provides a simple tactic for the synthesis of medicinally 
relevant α-deuterated amines.  Our discovery complements the most general solutions available 
to the problem of amide reduction known to date. 
 
2.9 Experimental Section 
2.9.1 Materials and Methods 
 Unless stated otherwise, reactions were conducted in flame-dried glassware under an 
atmosphere of nitrogen and commercially obtained reagents were used as received. Non-
commercially available substrates were synthesized following protocols specified in Section 
2.9.2.1 of the Experimental Procedures. Prior to use, toluene was purified by distillation and 
taken through five freeze-pump-thaw cycles. NiCl2(dme) and LiAlD4 was obtained from Strem 
Chemicals. Hexamethylbenzene and PhSiH3 were obtained from Alfa Aesar and used as 
received. Carboxylic acids 2.46, 2.48, 2.53, amines 2.51, 2.57, rac-2.51, rac-2.90, rac-2.91, and 
lactam 2.82 were obtained from Combi-Blocks. Carboxylic acid 2.50 was obtained from 
Eastman Organic. Lactams 2.83, 2.84, and PhSiCl3 (2.85) were obtained from Sigma–Aldrich 
and used as received. Benzylamine was obtained from Acros Organics and used as received. 
Reaction temperatures were controlled using an IKAmag temperature modulator, and unless 
stated otherwise, reactions were performed at elevated temperatures (approximately 115 °C). 
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Thin-layer chromatography (TLC) was conducted with EMD gel 60 F254 pre-coated plates (0.25 
mm for analytical chromatography and 0.50 mm for preparative chromatography) and visualized 
using a combination of UV, anisaldehyde, iodine, and potassium permanganate staining 
techniques. Silicycle Siliaflash P60 (particle size 0.040–0.063 mm) was used for flash column 
chromatography. 1H NMR spectra were recorded on Bruker spectrometers (at 300, 400 and 500 
MHz) and are reported relative to residual solvent signals. Data for 1H NMR spectra are reported 
as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz), integration. Data for 2H 
NMR spectra are reported in terms of chemical shift (at 76 MHz). Data for 13C NMR are 
reported in terms of chemical shift (at 75 and 125 MHz). IR spectra were recorded on a Perkin-
Elmer UATR Two FT-IR spectrometer and are reported in terms of frequency absorption (cm-1). 
High-resolution mass spectra were obtained on Thermo Scientific™ Exactive Mass Spectrometer 
with DART ID-CUBE. Determination of enantiopurity was carried out on a Mettler Toledo SFC 
(supercritical fluid chromatography) using a Daicel ChiralPak column. 
 
2.9.2 Experimental Procedures 
2.9.2.1 Syntheses of Amide Substrates 
Representative Procedure A for the synthesis of amide substrates from Table 2.2. (2.47 is 
used as an example). 
 
Amide 2.47. To a solution of carboxylic acid 2.46 (2.00 g, 11.1 mmol, 1.0 equiv), HOBt (1.87 g, 
12.2 mmol, 1.1 equiv), and triethylamine (1.70 mL, 12.2 mmol, 1.1 equiv) in DMF (111.0 mL, 
BnNH2 (1.1 equiv)
EDC•HCl (1.1 equiv)
HOBt (1.1 equiv)
Et3N (1.1 equiv)
DMF, 23 °C
(87% yield)
N
H
O
O
O
2.47
OH
O
O
O
Bn
2.46
(1.0 equiv)
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0.1 M) at 23 °C was added EDC•HCl (1.89 g, 12.2 mmol, 1.1 equiv) followed by benzylamine 
(1.3 mL, 12.2 mmol, 1.1 equiv) dropwise over 1 min under a N2 atmosphere. After stirring at 23 
°C for 18 h, the reaction was diluted with deionized water (100 mL) and transferred to a 
separatory funnel with EtOAc (75 mL). The layers were separated and the aqueous layer was 
extracted with EtOAc (3 x 75 mL). The organic layers were combined and washed with water (3 
x 75 mL), dried over Na2SO4, and the volatiles were removed under reduced pressure. The 
resulting crude residue was purified by flash chromatography (10:1 Hexanes:EtOAc → 2:1 
Hexanes:EtOAc) to yield amide 2.47 (2.6 g, 87% yield) as a white solid. Amide 2.47: mp: 130–
131 ºC; Rf 0.30 (3:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.35–7.27 (m, 3H), 7.25–
7.23 (m, 2H), 6.94–6.85 (m, 5H), 4.75 (dd, J = 7.3, 2.7, 1H), 4.58 (dd, J = 11.4, 2.7, 1H), 4.52 (d, 
J = 6.0, 2H), 4.23 (dd, J = 11.4, 7.3, 1H); 13C NMR (125 MHz, CDCl3): δ 167.3, 143.5, 141.7, 
137.6, 128.9, 127.9, 127.8, 122.6, 122.1, 117.8, 117.3, 73.4, 65.6, 43.3; IR (film): 3029, 2924, 
2876, 1670, 1493 cm-1; HRMS-ESI (m/z) [M + H]+ calcd for C16H16NO3, 270.11247; found 
270.11082. 
 
Representative Procedure B for the synthesis of amide substrates from Table 2.2. (2.49 is 
used as an example). 
 
Amide 2.49. To a solution of carboxylic acid 2.48 (500.0 mg, 3.84 mmol, 1.0 equiv), EDC•HCl 
(1.77 g, 9.22 mmol, 2.4 equiv), and DMAP (188.0 mg, 1.54 mmol, 0.4 equiv) in CH2Cl2 (12 mL, 
0.35 M) was added Et3N (1.6 mL, 11.52 mmol, 3.0 equiv) followed by benzylamine (525.0 µL, 
BnNH2 (1.25 equiv)
EDC•HCl (2.4 equiv)
DMAP (0.4 equiv)
Et3N (3.0 equiv)
CH2Cl2, 23°C
(87% yield)
N
H
O
O
2.49
OH
O
O
Bn
2.48
(1.0 equiv)
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4.80 mmol,1.25 equiv) dropwise over 1 min under a N2 atmosphere. After stirring at 23 °C for 18 
h, the reaction mixture was transferred to a separatory funnel with EtOAc (30 mL) and washed 
with 1.0 M aqueous HCl (2 x 10 mL), followed by 1.0 M aqueous NaOH (2 x 10 mL), and 
deionized water (10 mL). The organic layer was dried over Na2SO4, and the volatiles were 
removed under reduced pressure. The resulting crude residue was purified by flash 
chromatography (1:15 Hexanes:EtOAc) to yield amide 2.49 (775.5 mg, 87% yield) as a white 
solid. Amide 2.49: mp: 116–117 ºC; Rf 0.46 (1:4 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): 
δ 7.35–7.33 (m, 2H), 7.30–7.27 (m, 3H), 5.71 (br. s, 1H), 4.46 (d, J = 5.7, 2H), 4.04–4.00 (m, 
2H), 3.41 (td, J = 11.5, 2.8, 2H), 2.40–2.34 (m, 1H), 1.88–1.82 (m, 2H), 1.81–1.77 (m, 2H); 13C 
NMR (125 MHz, CDCl3): 174.1, 138.3, 128.9, 127.9, 127.8, 67.4, 43.7, 42.4, 29.4; IR (film): 
3064, 2951, 2842, 1635, 1541 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C13H18NO2, 
220.13321; found 220.13214. 
 
Representative Procedure C for the synthesis of amide substrates from Table 2.5. (2.52 is 
used as an example). 
 
Amide 2.52. To a solution of carboxylic acid 2.50 (500.0 mg, 3.33 mmol, 1.0 equiv), HOBt 
(988.9 mg, 7.33 mmol, 2.2 equiv), and EDC•HCl (1.41 g, 7.33 mmol, 2.2 equiv) in DMF (16.6 
mL, 0.2 M) at 23 °C was added amine 2.51 (714.9 mg, 3.66 mmol, 1.1 equiv), followed by 
triethylamine (1.50 mL, 10.9 mmol, 3.3 equiv) under a N2 atmosphere. After stirring at 23 °C for 
EDC•HCl (2.2 equiv)
HOBt (2.2 equiv)
Et3N (3.3 equiv)
DMF, 23 °C
(61% yield)
OH
O
2.50
(1.0 equiv)
N
H
O
OMe
O
OH
2.52
H2N
OMe
O
OH
+
2.51
(1.1 equiv)
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18 h, the reaction was diluted with deionized water (50 mL) and transferred to a separatory 
funnel with EtOAc (40 mL). The layers were separated and the aqueous layer was extracted with 
EtOAc (3 x 40 mL). The organic layers were combined and washed with water (3 x 40 mL), 
dried over Na2SO4, and the volatiles were removed under reduced pressure. The resulting crude 
residue was purified by flash chromatography (3:1 Hexanes:EtOAc → 1:1 Hexanes:EtOAc) to 
yield amide 2.52 (662.1 mg, 61% yield) as a white solid. Amide 2.52: mp: 89–92 ºC; Rf 0.25 (1:1 
Hexanes:EtOAc); 1H NMR (500 MHz, CD2Cl2): δ 7.29–7.26 (m, 2H), 7.20–7.17 (m, 3H), 6.83–
6.82 (m, 2H), 6.71–6.68 (m, 2H), 5.94 (br. d, J = 7.8, 1H), 4.79 (dt, J = 7.8, 5.9, 1H), 3.69 (s, 
3H), 2.99 (dd, J = 13.8, 5.6, 1H), 2.93 (dd, J = 13.8, 5.6, 1H), 2.91–2.88 (m, 2H), 2.53–2.42 (m, 
2H); 13C NMR (125 MHz, CDCl3): δ 172.1, 171.7, 154.9, 140.8, 130.4, 128.6, 128.4, 127.5, 
126.3, 115.5, 53.1, 52.4, 38.2, 37.1, 31.4; IR (film): 3287, 3026, 2951, 1736, 1647 cm-1; HRMS-
ESI (m/z) [M + H]+ calcd for C19H20NO4, 326.13937, found 326.13868. [α] 27.6D +60.00° (c = 
0.10, CH2Cl2). 
Note: Experimental procedures for the syntheses of some amides used in Tables 2.1, 2.2, 
2.3, and 2.4 have previously been reported: 2.7,24 2.59,25 2.60,26 2.61,27 2.62,28 2.63,29 2.64,30 
2.65,25 2.66,26 2.67,31 2.68,24 2.69,32 2.70,33 2.71,33 2.72,34 2.73,35 2.74,36 2.75,37 2.76,38 2.77,39 
2.78,40 2.79,41 2.80,42 2.81,43 2.87,44 2.88,45 2.89.46 Syntheses for the remaining substrates shown 
in Tables 2.2 and 2.5 are as follows: 
Any modifications of the conditions shown in the representative procedures above are 
specified in the following schemes. 
 
BnNH2 (1.25 equiv)
EDC•HCl (2.4 equiv)
DMAP (0.4 equiv)
Et3N (3.0 equiv)
CH2Cl2, 23 °C
(87% yield)
N
H
O
2.54
OH
O
Bn
2.53
(1.0 equiv)
N
N
Me
N
N
Me
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Amide 2.54. Following representative procedure B. Purification by flash chromatography (9:1 
EtOAc:CHCl3) yielded amide 2.54 (810.2 mg, 87% yield) as a white solid. Amide 2.54: mp: 
157–158 °C; Rf 0.27 (1:4 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.83 (s, 1H), 7.70 (s, 
1H), 7.36–7.32 (m, 4H), 7.30–7.27 (m, 1H), 6.06 (s, 1H), 4.59 (d, J = 5.6, 2H), 3.91 (s, 3H); 13C 
NMR (125 MHz, CDCl3): δ 162.4, 138.4, 137.8, 131.9, 128.9, 128.0, 127.7, 118.8, 43.6, 39.4; IR 
(film): 3111, 3064, 2941, 1630, 1566 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C12H14N3O, 
216.11314; found 216.11201. 
 
 
Amide 2.56. Following representative procedure B. Purification by flash chromatography (4:1 
Hexanes:EtOAc) yielded amide 2.56 (230.0 mg, 77% yield) as a white solid. Amide 2.56: mp: 
78–80 °C; Rf 0.32 (3:1 Hexanes:EtOAc); 1H NMR (500 MHz, C6D6): δ 7.13–7.09 (m, 4H), 7.05–
7.02 (m, 1H), 5.62 (br. s, 1H), 4.33 (d, J = 5.9, 2H), 2.99 (s, 2H), 1.69 (t, J = 6.4, 2H), 1.42 (s, 
3H), 1.41–1.38 (m, 2H), 1.31–1.28 (m, 2H), 0.90 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 171.3, 
138.4, 132.9, 132.5, 128.7, 127.5, 127.4, 43.5, 39.4, 36.7, 34.9, 32.6, 28.1, 20.5, 19.1; IR (film): 
3299, 2926, 2865, 1640, 1516 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C18H26NO, 272.19901; 
found 272.20089. 
 
 
 
 
BnNH2 (1.25 equiv)
EDC•HCl (2.4 equiv)
DMAP (0.4 equiv)
Et3N (3.0 equiv)
CH2Cl2, 23 °C
(77% yield)
OH
O
2.55
(1.0 equiv)
Me
MeMe
N
H
O
Me
MeMe
Bn
2.56
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Amide 2.58. Following representative procedure C. Purification by flash chromatography (1:1 
Hexanes:EtOAc) yielded amide 2.58 (234.0 mg, 56% yield) as a colorless oil. Amide 2.58 was 
observed as a 2.9:1 mixture of rotational isomers in CDCl3. Amide 2.58: Rf 0.29 (1:1 
Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3, Major rotational isomer): δ 7.26–7.23 (m, 2H), 
7.20–7.14 (m, 3H), 4.34–4.31 (m, 1H), 4.14 (dd, J = 10.7, 3.8, 1H), 4.06 (dd, J = 10.7, 6.9, 1H), 
3.35–3.31 (m, 1H), 3.28–3.23 (m, 1H), 2.99–2.92 (m, 2H), 2.53 (t, J = 7.7, 2H), 2.01 (s, 3H), 
1.95–1.77 (m, 4H); 1H NMR (500 MHz, CDCl3, Minor rotational isomer): δ 7.26–7.26 (m, 
2H), 7.20–7.14 (m, 3H), 3.94 (dd, J = 10.7, 5.5, 1H), 3.91–3.86 (m, 1H), 3.76 (dd, J = 10.7, 7.4, 
1H), 3.51 (dt, J = 12.3, 8.5, 1H), 3.43–3.38 (m, 1H), 2.99–2.92 (m, 2H), 2.66 (t, J = 7.7, 2H), 
1.99 (s, 3H), 1.95–1.77 (m, 4H); 13C NMR (100 MHz, CDCl3, Major rotational isomer): δ 
171.4, 170.9, 141.5, 128.6, 128.6, 126.2, 64.0, 55.5, 47.2, 36.9, 31.2, 27.4, 24.1, 21.0; 13C NMR 
(100 MHz, CDCl3, Minor rotational isomer): δ 171.6, 170.7, 141.4, 128.6, 128.6, 126.2, 64.7, 
55.8, 45.7, 36.2, 31.8, 28.7, 21.8, 20.9; IR (film): 3474, 2955, 2878, 1737, 1636 cm–1; HRMS-
ESI (m/z) [M + H]+ calcd for C16H22NO3, 276.15906; found 276.15942. [α] 29.6D –29.33° (c = 
0.10, CH2Cl2). 
2.9.2.2 Initial Survey of Amide Substrates with Phenylsilane 
 
EDC HCl (2.2 equiv)
HOBt (2.2 equiv)
Et3N (3.3 equiv)
DMF, 23 °C
(56% yield)
OH
O
2.50
(1.0 equiv)
N
O
2.58
OAc
HN
OAc
2.57
(1.0 equiv)
+
Hexamethylbenzene (0.30 equiv)
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
toluene (1.0 M), 115 °C
2.42.3
N
Me
O
N
Me
HH
Ph Ph
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Representative Procedure for the reduction of amides from Table 2.1 and Table 2.6 
(reduction of amide 2.3 is used as an example). A 1-dram vial was charged with a magnetic 
stir bar, flame-dried under reduced pressure, and allowed to cool under a N2 atmosphere. Amide 
substrate 2.3 (42.3 mg, 0.200 mmol, 1.0 equiv), NiCl2(dme) (4.4 mg, 0.0200 mmol, 10 mol%), 
and hexamethylbenzene (9.7 mg, 0.0600 mmol, 0.30 equiv) were added, and the vial was flushed 
with N2 for 5 min. PhSiH3 (49.4 µL, 0.400 mmol, 2.0 equiv) was added under a N2 atmosphere 
via syringe followed by toluene (200 µL, 1.0 M). The vial was then capped with a Teflon-lined 
screw cap under a flow of N2. The reaction mixture was then placed in a pre-heated aluminum 
block and allowed to stir at 115 °C for 24 h. After cooling to room temperature, the reaction 
mixture was transferred to a separatory funnel with EtOAc (3 mL) and basified with 1.0 M 
aqueous NaOH (4 mL). The layers were separated and the aqueous layer was extracted with 
EtOAc (3 x 5 mL). The combined organic layers were washed with saturated aqueous NaCl (5 
mL). The volatiles were removed under reduced pressure, and the yield was determined by 1H 
NMR analysis with hexamethylbenzene as an internal standard. 
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Table 2.6. Initial survey of amide substrates with Phenylsilane 
 
a Conditions unless otherwise stated: NiCl2(dme) (10 mol%), substrate (1.0 
equiv, 0.2 mmol), PhSiH3 (2.0 equiv), and toluene (1.0 M) at 115 °C for 24 h 
in a sealed vial. b Yields determined by 1H NMR analysis using 
hexamethylbenzene as an internal standard. 
 
 
 
 
 
 
 
 
R
O
N
R'
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
toluene, 115 °C, 24 h R N
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R''
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R''
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N
Bn
HH
92%
Bn Bn
2.3 2.4
2.5 2.6
2.7 2.8
2.9 2.10
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2.9.2.3 Relevant Control Experiments for the Reduction of Amide 2.7 
Table 2.7. Relevant control experiments in the reduction of amide 2.7.a 
 
a Yields were determined by 1H NMR analysis using hexamethylbenzene as an internal 
standard. 
 
2.9.2.4 Scope of Methodology 
 
Representative Procedure (reduction of amide 2.7 is used as an example). Amine 2.8.  A 1-
dram vial was charged with a magnetic stir bar, flame-dried under reduced pressure, and allowed 
to cool under a N2 atmosphere.  Amide substrate 2.7 (42.3 mg, 0.200 mmol, 1.0 equiv) and 
NiCl2(dme) (4.4 mg, 0.0200 mmol, 10 mol%) was added, and the vial was flushed with N2. 
PhSiH3 (49.4 µL, 0.4000 mmol, 2.0 equiv) was added under a N2 atmosphere via syringe 
followed by toluene (200 µL, 1.0 M). The vial was then capped with a Teflon-lined screw cap 
under a flow of N2. The reaction mixture was then placed in a pre-heated aluminum block and 
allowed to stir at 115 °C for 24 h. After cooling to room temperature, the reaction mixture was 
98% 0%
100% 0%
Reaction Conditions
Experimental Results
0% 95%
O
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Control Experiments:
2.7 2.8
2.7 2.8
NiCl2(dme) (10 mol%), PhSiH3 (2.0 equiv),
toluene (1.0 M), 115 °C, 24 h
 PhSiH3 (2.0 equiv),
toluene (1.0 M), 115 °C, 24 h
NiCl2(dme) (10 mol%),
toluene (1.0 M), 115 °C, 24 h
N
H
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H
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transferred to a separatory funnel with EtOAc (3 mL) and basified with 1.0 M aqueous NaOH (4 
mL). The layers were separated and the aqueous layer was extracted with EtOAc (3 x 5 mL). The 
combined organic layers were washed with saturated aqueous NaCl (5 mL). The volatiles were 
removed under reduced pressure, and the crude residue was purified by flash chromatography 
(1:1 Hexanes:EtOAc) to yield amine 2.8 (94% yield, average of two experiments) as a colorless 
oil. Amine 2.8: Rf  0.36 (1:1 Hexanes:EtOAc). Spectral data match those previously reported.47  
 
Any modifications of the conditions shown in the representative procedure above are specified in 
the following schemes, which depict all of the results shown in Tables 2.1, 2.2, and 2.3.  
 
 
Amine 2.11. Purification by flash chromatography (3:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.11 (77% yield, average of two experiments) as a colorless oil. Amine 2.11: Rf 0.41 (4:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.48 
 
 
Amine 2.12. Purification by flash chromatography (1:1 CH2Cl2:CH3CN, 2% Et3N) yielded 
amine 2.12 (70% yield, average of two experiments) as a colorless oil. Amine 2.12: Rf 0.50 (1:1 
CH2Cl2:CH3CN, 2% Et3N). Spectral data match those previously reported.49 
 
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
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(77% yield)
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Amine 2.13. Purification by flash chromatography (EtOAc, 2% Et3N) yielded amine 2.13 (71% 
yield, average of two experiments) as a white solid. Amine 2.13: Rf 0.52 (EtOAc, 2% Et3N). 
Spectral data match those previously reported.50 
 
 
Amine 2.14. Purification by flash chromatography (1:1 Hexanes:EtOAc) yielded amine 2.14 
(80% yield, average of two experiments) as a colorless oil. Amine 2.14: Rf 0.60 (1:1 
Hexanes:EtOAc). Spectral data match those previously reported.51 
 
  
Amine 2.15. Purification by flash chromatography (1:1 Hexanes:EtOAc) yielded amine 2.15 
(78% yield, average of two experiments) as a colorless oil. Amine 2.15: Rf 0.59 (1:1 
Hexanes:EtOAc). 1H NMR (500 MHz, CDCl3): δ 7.35 (d, J = 4.4, 4H), 7.31–7.26 (m, 2H), 7.12–
7.09 (m, 2H), 6.95 (td, J = 8.6, 2.3, 1H), 3.81 (s, 4H), 1.77 (br. s, 1H); 13C NMR (125 MHz, 
CDCl3): δ 164.0, 162.1, 143.0 (d, JC–F = 6.9), 140.1, 129.8 (d, JC–F = 8.1), 128.3 (d, JC–F = 37.6), 
127.1, 123.6 (d, JC–F = 2.9), 114.9 (JC–F = 21.1), 113.8 (JC–F = 21.1), 53.1, 52.6; IR (film): 3064, 
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(71% yield)
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3028, 2831, 1615, 1588 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C14H15FN, 216.11830; found 
216.11803. 
 
 
Amine 2.16. Purification by flash chromatography (4:1 Hexanes:EtOAc, 2% Et3N → 1:1 
Hexanes:EtOAc, 2% Et3N) yielded amine 2.16 (75% yield, average of two experiments) as a 
colorless solid. Amine 2.16: mp: 51–54 °C; Rf 0.36 (1:1 Hexanes:EtOAc, 2% Et3N). 1H NMR 
(500 MHz, CDCl3): δ 8.34 (br. s, 1H), 7.60 (s, 1H), 7.39–7.33 (m, 5H), 7.23–7.26 (m, 1H), 7.21–
7.18 (m, 2H), 6.53 (d, J = 3.1, 1H), 3.93 (s, 2H), 3.85 (s, 2H), 2.44 (br. s, 1H); 13C NMR (125 
MHz, CDCl3): δ 140.0, 135.3, 131.1, 128.5, 128.4, 128.1, 127.1, 124.7, 122.9, 120.5, 111.2, 
102.5, 53.5, 52.9; IR (film): 3410, 3026, 2919, 1623, 1452 cm-1; HRMS-ESI (m/z) [M + H]+ 
calcd for C16H17N, 237.13863; found 237.13806. 
 
 
Amine 2.17. Purification by flash chromatography (EtOAc, 2% Et3N) yielded amine 2.17 (67% 
yield, average of two experiments) as a colorless oil. Amine 2.17: Rf 0.26 (EtOAc, 2% Et3N). 1H 
NMR (500 MHz, CDCl3): δ 7.43 (s, 1H), 7.35–7.32 (m, 4H), 7.31–7.30 (m, 1H), 7.28–7.24 (m, 
2H), 3.87 (s, 3H), 3.81 (s, 2H), 3.69 (s, 2H); 13C NMR (125 MHz, CDCl3): δ 140.3, 138.9, 129.1, 
NiCl2(dme) (10 mol%)
PhSiH3 (4.0 equiv)
toluene (1.0 M), 115 °C
(75% yield)
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128.6, 128.3, 127.1, 120.6, 53.3, 43.3, 39.0; IR (film): 3303, 2936, 2849, 1642, 1453 cm-1; 
HRMS-ESI (m/z) [M + H]+ calcd for C12H16N3, 202.13387; found 202.13355. 
 
 
Amine 2.18. Purification by flash chromatography (10:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.18 (62% yield, average of two experiments) as a colorless oil. Amine 2.18: Rf 0.34 (4:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.49 
 
 
Amine 2.19. Purification by flash chromatography (4:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.19 (96% yield, average of two experiments) as a colorless oil. Amine 2.19: Rf 0.49 (4:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.48 
 
 
Amine 2.20. Purification by flash chromatography (10:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.20 (75% yield, average of two experiments) as a colorless oil. Amine 2.20: Rf 0.38 (10:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.52 
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Amine 2.21. Purification by flash chromatography (10:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.21 (81% yield, average of two experiments) as a colorless oil. Amine 2.21: Rf 0.40 (10:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.53 
 
 
Amine 2.22. Purification by flash chromatography (4:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.22 (91% yield, average of two experiments) as a colorless oil. Amine 2.22: Rf 0.52 (4:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.54 
 
 
Amine 2.23. Purification by preparative thin-layer chromatography (10:1 Hexanes:EtOAc, 2% 
Et3N) yielded amine 2.23 (63% yield, average of two experiments) as a colorless oil. Amine 
2.23: Rf 0.40 (10:1 Hexanes:EtOAc, 2% Et3N). 1H NMR (500 MHz, CDCl3): δ 7.32–7.30 (m, 
4H), 7.27–7.21 (m, 1H), 3.82 (s, 2H), 2.67–2.63 (m, 2H), 2.23 (t, J = 8.5, 2H), 1.89 (t, J = 6.4, 
2H), 1.59 (s, 3H), 1.57–1.53 (m, 2H), 1.41–1.39 (m, 2H), 0.97 (s, 6H); 13C NMR (125 MHz, 
CDCl3): δ 140.7, 134.9, 128.5, 128.4, 128.1, 127.0, 54.1, 49.7, 39.9, 34.9, 32.9, 29.8, 28.9, 20.1, 
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
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(81% yield)
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19.6; IR (film): 3026, 2926, 2864, 1873, 1452 cm-1; HRMS-ESI (m/z) [M + H]+ calcd for 
C18H28N, 258.22074; found 258.22163. 
 
 
Amine 2.24. Purification by flash chromatography (10:1 Hexanes:EtOAc, 2% Et3N → 4:1 
Hexanes:EtOAc, 2% Et3N) yielded amine 2.24 (90% yield, average of two experiments) as a 
colorless oil. Amine 2.24: Rf 0.38 (4:1 Hexanes:EtOAc, 2% Et3N). 1H NMR (500 MHz, CDCl3): 
δ 7.36–7.35 (m, 4H), 7.30–7.27 (m, 1H), 6.90–6.84 (m, 4H), 4.33–4.30 (m, 1H), 4.28 (dd, J = 
11.0, 2.4, 1H), 4.05 (dd, J = 11.0, 7.3, 1H), 3.87 (s, 2H), 2.94 (dd, J = 12.4, 6.6, 1H), 2.88 (dd, J 
= 12.4, 4.6, 1H), 2.00 (br. s, 1H); 13C NMR (125 MHz, CDCl3): δ 143.4, 143.3, 139.9, 128.6, 
128.2, 127.2, 121.6, 121.5, 117.4, 117.2, 72.7, 66.7, 54.0, 49.3; IR (film): 3027, 2919, 2831, 
1592, 1492 cm-1; HRMS-ESI (m/z) [M + H]+ calcd for C16H18NO2, 256.13321; found 256.13258. 
 
 
Amine 2.25. Purification by flash chromatography (1:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.25 (84% yield, average of two experiments) as a colorless oil. Amine 2.25: Rf 0.54 (1:1 
Hexanes:EtOAc, 2% Et3N). 1H NMR (500 MHz, CDCl3): δ 7.43–7.31 (m, 4H), 7.27–7.24 (m, 
1H), 3.97–3.94 (m, 2H), 3.78 (s, 2H), 3.37 (ddd, J = 11.8, 11.8, 1.9, 2H), 2.52 (d, J = 6.6, 2H), 
1.79 (br. s, 1H), 1.72 (ttt, J = 11.8, 6.9, 3.8, 1H), 1.65 (m, 2H), 1.29 (dddd, J = 11.8, 11.8, 11.8, 
NiCl2(dme) (10 mol%)
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toluene (1.0 M), 115 °C
(90% yield)
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4.4, 2H); 13C NMR (125 MHz, CDCl3): δ 140.6, 128.5, 128.1, 127.0, 67.9, 55.6, 54.2, 35.6, 31.4; 
IR (film): 3026, 2916, 2838, 1603, 1453 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C13H20NO, 
206.15394; found 206.15352. 
 
 
Amine 2.26. Purification by flash chromatography (4:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.26 (73% yield, average of two experiments) as an amorphous solid. Amine 2.26: Rf 0.52 
(4:1 Hexanes:EtOAc, 2% Et3N). 1H NMR (500 MHz, CDCl3, 60 °C ): δ 7.32–7.27 (m, 4H), 
7.22–7.18 (m, 1H), 4.03 (d, J =  12.7, 2H), 3.75 (s, 2H), 2.67 (t, J = 12.5, 2H), 2.49 (br. s, 2H) 
1.67 (d, J = 12.4, 2H), 1.61–1.55 (m, 2H) 1.42 (s, 9H), 1.13–1.06 (m, 2H); 13C NMR (125 MHz, 
CDCl3, 60 °C): δ 154.7, 140.5, 128.2, 127.8, 126.7, 78.9, 54.9, 54.0, 43.8, 36.6, 30.3, 28.3; IR 
(film): 2975, 2921, 2849, 1685, 1452 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C18H29N2O2, 
305.22235; found 305.22153. 
 
 
Amine 2.27. 1H NMR analysis of the crude reaction mixture indicated a 73% yield (average of 
two experiments) of amine 2.27 relative to hexamethylbenzene internal standard. Amine 2.27: Rf 
0.11 (CH2Cl2, 2% MeOH). 1H NMR (500 MHz, CDCl3): δ 7.33–7.29 (m, 4H), 7.25–7.22 (m, 
1H), 3.77 (s, 2H), 3.05 (ddd, J = 12.1, 2.7, 2.7, 2H), 2.58 (ddd, J = 12.1, 12.1, 2.4, 2H), 2.49 (d, J 
= 6.7, 2H), 1.77 (br. s, 1H), 1.72–1.69 (m, 2H), 1.59 (ttt, J = 12.1, 6.8, 2.5, 1H), 1.11 (dddd, J = 
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12.1, 12.1, 12.1, 3.9, 2H); 13C NMR (125 MHz, CDCl3): δ 140.6, 128.5, 128.2, 126.9, 55.9, 54.3, 
46.6, 36.8, 31.9; IR (film): 3308, 3026, 2921, 1633, 1542 cm–1; HRMS-ESI (m/z) [M + H]+ calcd 
for C13H21N2, 205.16993; found 205.16948. 
 
 
Amine 2.28. Purification by preparative thin-layer chromatography (EtOAc, 2% Et3N) yielded 
amine 2.28 (86% yield, average of two experiments) as a colorless oil. Amine 2.28: Rf 0.25 
(EtOAc, 2% Et3N). Spectral data match those previously reported.55 
 
 
Amine 2.29. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc, 2% 
Et3N) yielded amine 2.29 (83% yield, average of two experiments) as a colorless oil. Amine 
2.29: Rf 0.34 (1:1 Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.55 
 
 
Amine 2.30. Purification by flash chromatography (20:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.30 (77% yield, average of two experiments) as a colorless oil. Amine 2.30: Rf 0.57 (10:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.56 
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
toluene (1.0 M), 115 °C
(86% yield)
2.72
N
H
n-Octyl
O
2.28
N
H
n-Octyl
HH
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
toluene (1.0 M), 115 °C
(83% yield)
2.292.73
N
H
HH
N
H
O
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
toluene (1.0 M), 115 °C
(77% yield)
2.74
N
Ph
O
Me
2.30
N
Ph
Me
HH
 69 
 
 
Amine 2.31. Purification by flash chromatography (20:1 Hexanes:EtOAc, 2% Et3N) yielded 
amine 2.31 (82% yield, average of two experiments) as a colorless oil. Amine 2.31: Rf 0.63 (10:1 
Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.57 
  
 
Amine 2.32. Purification by flash chromatography (7:3 Hexanes:EtOAc, 2% Et3N) followed by  
preparative thin-layer chromatography (7:3 Hexanes:EtOAc, 2% Et3N) yielded amine 2.32 (74% 
yield, average of two experiments) as a colorless oil. Amine 2.32: Rf 0.35 (7:3 Hexanes:EtOAc, 
2% Et3N). Spectral data match those previously reported.58 
 
 
Amine 2.33. 1H NMR analysis of the crude reaction mixture indicated a 77% yield (average of 
two experiments) of amine 2.33 relative to hexamethylbenzene internal standard. Amine 2.33: Rf 
0.23 (3:1 Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.58 
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Amine 2.34. Purification by preparative thin-layer chromatography (1:4 Hexanes:EtOAc, 2% 
Et3N) yielded amine 2.34 (67% yield, average of two experiments) as a colorless oil. Amine 
2.34: Rf 0.23 (1:4 Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.59 
 
 
Amine 2.35. Purification by preparative thin-layer chromatography (1:4 Hexanes:EtOAc, 2% 
Et3N) yielded amine 2.35 (83% yield, average of two experiments) as a colorless oil. Amine 
2.35: Rf 0.26 (1:4 Hexanes:EtOAc, 2% Et3N). Spectral data match those previously reported.60 
 
 
Amine 2.36. Purification by flash chromatography (9:1 Hexanes:EtOAc) yielded amine 2.36 
(86% yield, average of two experiments) as a colorless oil. Amine 2.36: Rf 0.55 (4:1 
Hexanes:EtOAc). Spectral data match those previously reported.61 
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Amine 2.37. Purification by flash chromatography (39:1 Pentane:Et2O) yielded amine 2.37 (64% 
yield, average of two experiments) as a colorless oil. Amine 2.37: Rf 0.23 (39:1 Pentane:Et2O). 
Spectral data match those previously reported.43 
 
 
Amine 2.38. 1H NMR analysis of the crude reaction mixture indicated a 58% yield (average of 
two experiments) of amine 2.38 relative to hexamethylbenzene internal standard. Spectral data 
match those previously reported.62 
 
 
Amine 2.39. 1H NMR analysis of the crude reaction mixture indicated an 83% yield (average of 
two experiments) of amine 2.39 relative to hexamethylbenzene internal standard. Spectral data 
match those previously reported.62 
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Amine 2.40. 1H NMR analysis of the crude reaction mixture indicated a 99% yield (average of 
two experiments) of amine 2.40 relative to hexamethylbenzene internal standard. Amine 2.40: Rf 
0.39 (Hexanes). Spectral data match those previously reported.63 
 
2.9.2.5 Synthesis of PhSiD3 
 
A round bottom flask equipped with a reflux condenser and a magnetic stir bar was flame-dried 
under reduced pressure, and then cooled under a N2 atmosphere. LiAlD4 (1.14 g, 27.21 mmol, 2 
equiv) was added, and the flask was flushed with N2 for 10 min. After cooling to 0 °C, Et2O (90 
mL) was added, followed by PhSiCl3  (2.85) (2.18 mL, 13.61 mmol, 1 equiv) dropwise over 2 
min. The resulting grey suspension was refluxed for 14 h. After cooling to room temperature, the 
resulting suspension was filtered through celite and cooled to 0 °C. The filtrate was then 
quenched by the dropwise addition of chilled H2O (50 mL, 0 °C) with vigorous stirring. The 
reaction mixture was transferred to a separatory funnel and the aqueous layer was extracted with 
Et2O (2 x 30 mL). The organic layers were combined, dried over MgSO4, and filtered. Using a 
rotary evaporator, with a bath cooled to 0 °C, the solution was evaporated at 220 mbar for 2 h 
until minimal solvent remained. MgSO4 was added and the mixture was filtered through cotton. 
Using a rotary evaporator, with a bath cooled to 0 °C, the solution was evaporated at 130 mbar 
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for 1 h, and then warmed to 23 °C and evaporated at 20 mbar for 10 min. Desired compound 
2.86 (1.02 g, 67% yield) was obtained as a colorless oil. Spectral data match those previously 
reported.64 
 
2.9.2.6 Reduction of Amino Acid Derivatives using PhSiD3 
 
Representative Procedure (reduction of amide 2.87 is used as an example). Amine 2.41.  A 
1-dram vial was charged with a magnetic stir bar, flame-dried under reduced pressure, and 
allowed to cool under a N2 atmosphere. Amide substrate 2.87 (26.3 mg, 0.100 mmol, 1.0 equiv) 
and NiCl2(dme) (2.2 mg, 0.0100 mmol, 10 mol%) were added, and the vial was flushed with N2 
for 5 min. PhSiD3 (49.4 µL, 0.4000 mmol, 4.0 equiv) was added under a N2 atmosphere via 
syringe followed by toluene (100 µL, 1.0 M). The vial was then capped with a Teflon-lined 
screw cap under a flow of N2. The reaction mixture was then placed in a pre-heated aluminum 
block and allowed to stir at 115 °C for 24 h. After cooling to room temperature, the reaction 
mixture was transferred to a separatory funnel with EtOAc (3 mL) and basified with 1.0 M 
aqueous NaOH (4 mL). The layers were separated and the aqueous layer was extracted with 
EtOAc (3 x 5mL). The combined organic layers were washed with saturated aqueous NaCl (5 
mL). The volatiles were removed under reduced pressure, and the crude residue was purified by 
preparative thin-layer chromatography (4:1 Hexanes:EtOAc) to yield amine 2.41 (65% yield, 
average of two experiments) as a colorless oil. Amine 2.41: Rf  0.52 (4:1 Hexanes:EtOAc). 1H 
NMR (500 MHz, CDCl3): δ 7.28–7.26 (m, 2H), 7.18–7.16 (m, 3H), 3.71 (s, 3H), 2.97 (d, J = 6.2, 
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1H), 2.70–2.59 (m, 2H), 1.88 (dsept, J = 6.8, 6.8, 1H), 1.81–1.71 (m, 2H), 0.95 (d, J = 6.8, 3H), 
0.93 (d, J = 6.8, 3H); 2H NMR (76 MHz, CDCl3): δ 2.6, 2.4; 13C NMR (125 MHz, CDCl3): δ 
176.0, 142.4, 128.6, 128.4, 125.8, 67.5, 51.5, 47.42 (m), 33.5, 31.8, 31.7, 19.4, 18.9; IR (film): 
3336, 3026, 2927, 1732, 1453 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C15H22D2NO2, 
252.19235; found 252.19381; [α] 30.4D –7.33° (c = 0.10, CH2Cl2). 
Any modifications of the conditions shown in the representative procedure above are specified in 
the following schemes, which depict all of the results shown in Table 2.5.  
 
 
Amine 2.42. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded amine 2.42 (53% yield, average of two experiments) as a colorless oil. Amine 2.42: Rf 
0.39 (1:1 Hexanes:EtOAc). 1H NMR (500 MHz, CD2Cl2): δ 7.25 (t, J = 7.4, 2H), 7.17–7.12 (m, 
3H), 7.02 (d, J = 8.4, 2H), 6.72 (d, J = 8.4, 2H), 3.62 (s, 3H), 3.44 (t, J = 6.6, 1H), 2.89–2.82 (m, 
2H), 2.60–2.57 (m, 2H), 1.77–1.67 (m, 2H); 2H NMR (76 MHz, CD2Cl2): δ 2.59, 2.45; 13C NMR 
(125 MHz, CD2Cl2): (14 of 15 signals observed) δ 175.2, 155.0, 142.6, 130.8, 129.8, 128.8, 
128.6, 126.1, 115.5, 63.4, 51.9, 38.9, 35.6, 31.8; IR (film): 3291, 3025, 2927, 1734, 1515 cm–1; 
HRMS-ESI (m/z) [M + H]+ calcd for C19H22D2NO3, 316.18762; found 316.18708; [α] 29.7D 
+5.33° (c = 0.10, CH2Cl2). 
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Amine 2.43. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded amine 2.43 (58% yield, average of two experiments) as a colorless oil. Amine 2.43: Rf 
0.52 (1:1 Hexanes:EtOAc). 1H NMR (500 MHz, CD2Cl2): δ 7.27–7.25 (m, 2H), 7.20 –7.14 (m, 
3H), 3.65 (s, 3H), 3.16–3.09 (m, 2H), 2.68–2.57 (m, 2H), 2.37–2.32 (m, 1H), 2.10–2.01 (m, 1H), 
1.91–1.84 (m, 2H), 1.82–1.74 (m, 3H); 2H NMR (76 MHz, CDCl3): δ 2.68, 2.39; 13C NMR (125 
MHz, CDCl3): δ 174.9, 142.2, 128.5, 128.4, 125.9, 66.2, 54.0 (m), 53.6, 52.0, 33.8, 30.1, 29.5, 
23.3; IR (film): 3059, 2947, 2860, 1731, 1453 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C15-
H20D2NO2, 250.17587; found 250.17816;  [α] 30.8D –57.33° (c = 0.10, CH2Cl2).  
 
 
Amine 2.44. Purification by preparative thin-layer chromatography (EtOAc, 2% Et3N) yielded 
amine 2.44 (64% yield, average of two experiments) as a colorless oil. Amine 2.44: Rf 0.45 
(EtOAc. 2% Et3N). 1H NMR (500 MHz, CDCl3): δ 7.29–7.26 (m, 2H), 7.19–7.17 (m, 3H), 3.59 
(dd, J = 10.6, 3.9, 1H), 3.37 (dd, J = 10.6, 2.2, 1H), 3.20–3.16 (m, 1H), 2.73–2.67 (m, 1H), 2.61–
2.54 (m, 2H), 2.27–2.21 (m, 1H), 1.90–1.69 (m, 6H); 2H NMR (76 MHz, CDCl3): δ 2.73, 2.29; 
13C NMR (125 MHz, CDCl3): δ 142.3, 128.5, 128.4, 125.9, 64.9, 61.9, 54.2, 53.5 (m), 33.7, 30.5, 
27.8, 23.8; IR (film): 3362, 3084, 2936, 2800, 1602 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for 
C14H20D2NO, 222.18170; found 222.18214; [α] 31.0D –44.66° (c = 0.10, CH2Cl2). 
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Amine 2.45. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc, 2% 
Et3N) yielded amine 2.45 (79% yield, average of two experiments) as a colorless oil. Amine 
2.45: Rf 0.35 (1:1 Hexanes:EtOAc, 2% Et3N). 1H NMR (500 MHz, CDCl3): δ 7.28–7.26 (m, 
2H), 7.19–7.16 (m, 3H), 4.04 (dd, J = 10.9, 5.1, 1H), 3.92 (dd, J = 10.9, 6.1, 1H), 3.15–3.12 (m, 
1H), 2.70–2.57 (m, 3H), 2.23–2.18 (m, 1H), 2.01 (s, 3H), 1.92–1.86 (m, 1H), 1.85–1.79 (m, 2H), 
1.78–1.71 (m, 2H), 1.62–1.56 (m, 1H); 2H NMR (76 MHz, CDCl3): δ 2.79, 2.33; 13C NMR (125 
MHz, CDCl3): δ 171.3, 142.4, 128.5, 128.4, 125.8, 67.4, 62.4, 54.8 (m), 54.4, 33.8, 30.3, 28.4, 
23.2, 21.1; IR (film): 3062, 2940, 2785, 1738, 1603 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for 
C16H22D2NO2, 264.19221; found 264.19271;  [α] 29.9D –54.66° (c = 0.10, CH2Cl2). 
 
2.9.2.7 Verification of Enantiopurity – Racemic Compound Synthesis 
 
Representative Procedure for the synthesis of racemic amide substrates (synthesis of amide 
rac-2.87 is used as an example). Amide rac-2.87. To a solution of carboxylic acid 2.50 (300.0 
mg, 1.99 mmol, 1.0 equiv), HOBt (594.0 mg, 4.39 mmol, 2.2 equiv), and EDC•HCl (848.0 mg, 
4.39 mmol, 2.2 equiv) in DMF (10.0 mL, 0.2 M) at 23 °C was added amine rac-2.90 (376.0 mg, 
2.19 mmol, 1.1 equiv) followed by triethylamine (0.92 mL, 6.59 mmol, 1.1 equiv) under a N2 
atmosphere. The reaction mixture stirred at 23 °C for 18 h. The reaction was diluted with 
NiCl2(dme) (10 mol%)
PhSiD3 (2.0 equiv)
toluene (1.0 M), 115 °C
(79% yield)2.58
O
N
2.45
N
OAcDDOAc
EDC•HCl (2.2 equiv)
HOBt (2.2 equiv)
Et3N (3.3 equiv)
DMF, 23 °C
(96% yield)
OH
O
2.50
(1.0 equiv)
N
H
O
OMe
O
Me
rac-2.87
H2N
OMe
O
Me
+
rac-2.90
(1.1 equiv)
Me Me
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deionized water (50 mL) and transferred to a separatory funnel with EtOAc (40 mL). The layers 
were separated and the aqueous layer was extracted with EtOAc (3 x 40 mL). The organic layers 
were combined and washed with water (3 x 40 mL), dried over Na2SO4, and the volatiles were 
removed under reduced pressure. The resulting crude residue was purified by flash 
chromatography (3:1 Hexanes:EtOAc) to yield amide rac-2.87 (506.0 mg, 96% yield) as an off-
white solid.  
 
 
Amide rac-2.52. Following representative procedure. Purification by flash chromatography (3:1 
Hexanes:EtOAc → 1:1 Hexanes:EtOAc) to yield amide rac-2.52 (269.3 mg, 50% yield) as a 
white solid. 
 
Amide rac-2.88. Following representative procedure. Purification by flash chromatography (1:1 
Hexanes:EtOAc → 1:3 Hexanes:EtOAc) to yield amide rac-2.88 (221.1 mg, 77% yield) as a 
colorless oil. 
 
 
EDC•HCl (2.2 equiv)
HOBt (2.2 equiv)
Et3N (3.3 equiv)
DMF, 23 °C
(50% yield)
OH
O
2.50
(1.0 equiv)
N
H
O
OMe
O
OH
rac-2.52
H2N
OMe
O
OH
+
rac-2.51
(1.1 equiv)
EDC•HCl (2.2 equiv)
HOBt (2.2 equiv)
Et3N (3.3 equiv)
DMF, 23 °C
(77% yield)
OH
O
2.50
(1.0 equiv)
N
O
rac-2.88
HN
OMe
rac-2.91
(1.0 equiv)
+
O OMeO
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Amide rac-2.89. To a solution of amide rac-2.88 (100.0 mg, 0.383 mmol, 1 equiv) in THF (8.0 
mL, 0.05 M) at 0 °C under a N2 atmosphere, was added LiBH4 (25.0 mg, 1.15 mmol, 3 equiv) in 
one portion. The vial was then capped with a Teflon-lined screw cap under a flow of N2 and 
placed in a pre-heated aluminum block and allowed to stir at 45 °C for 15 h. After cooling to 
room temperature, deionized H2O was added (2 mL) and the reaction mixture was transferred to 
a separatory funnel with CH2Cl2 (3 mL) and extracted with CH2Cl2 (3 x 3mL). The combined 
organic layers were washed with saturated aqueous NaCl (5 mL). The volatiles were removed 
under reduced pressure, and the resulting crude residue was purified by flash chromatography 
(1:3 Hexanes:EtOAc → EtOAc) to yield amide rac-2.89 (72.0 mg, 81% yield) as a colorless oil. 
 
 
Amide rac-2.58. A 1-dram vial was charged with a magnetic stir bar, flame-dried under reduced 
pressure, and allowed to cool under a N2 atmosphere. Amide substrate rac-2.89 (25.6 mg, 0.110 
mmol, 1 equiv) and DMAP (1.3 mg, 0.010 mmol, 0.1 equiv) were added and the vial flushed 
with N2 for 5 min. CH2Cl2 (2.0 mL, 0.05 M), AcCl (9.4 µL, 0.132 mmol, 1.2 equiv), and Et3N 
(18.3 µL, 0.132 mmol, 1.2 equiv) were added under a N2 atmosphere and the reaction was left to 
stir for 3 h at 23 °C. NH4Cl (2 mL) was added and the reaction mixture was transferred to 
separatory funnel with CH2Cl2 (3 mL). The layers were separated and the aqueous layer was 
LiBH4 (3.0 equiv)
THF 0 to 45 °C
(81% yield)
N
O
rac-2.88
OMeO
N
O
rac-2.89
OH
AcCl (1.2 equiv)
DMAP (0.1 equiv)
Et3N (1.2 equiv)
CH2Cl2, 23 °C
(60% yield)
N
O
rac-2.89
OH
N
O
rac-2.58
OAc
 79 
extracted with CH2Cl2 (3 x 3 mL). The combined organic layers were washed with saturated 
aqueous NaCl (5 mL). The volatiles were removed under reduced pressure, and the resulting 
crude residue was purified by preparative thin-layer chromatography (1:3 Hexanes:EtOAc → 
EtOAc) to yield amide rac-2.58 (16.0 mg, 60% yield) as a colorless oil. 
 
2.9.2.7.1 Representative Procedure for the Deuterium Reduction of Racemic Amino Acid 
Derivatives 
 
Representative Procedure (reduction of amide rac-2.87 is used as an example). Amine rac-
2.41. A 1-dram vial was charged with a magnetic stir bar, flame-dried under reduced pressure, 
and allowed to cool under a N2 atmosphere. Amide substrate rac-2.87 (26.3 mg, 0.100 mmol, 1.0 
equiv) and NiCl2(dme) (2.2 mg, 0.0100 mmol, 10 mol%) was added, and the vial was flushed 
with N2. PhSiD3 (49.4 µL, 0.4000 mmol, 4.0 equiv) was added under a N2 atmosphere via syringe 
followed by toluene (100 µL, 1.0 M). The vial was then capped with a Teflon-lined screw cap 
under a flow of N2. The reaction mixture was then placed in a pre-heated aluminum block and 
allowed to stir at 115 °C for 24 h. After cooling to room temperature, the reaction mixture was 
transferred to a separatory funnel with EtOAc (3 mL) and basified with 1.0 M aqueous NaOH (4 
mL). The layers were separated and the aqueous layer was extracted with EtOAc (3 x 5mL). The 
combined organics were washed with saturated aqueous NaCl (5 mL). The volatiles were 
removed under reduced pressure, and the crude residue was purified by preparative thin-layer 
NiCl2(dme) (10 mol%)
PhSiD3 (4.0 equiv)
toluene (1.0 M), 115 °C
(60% yield)
rac-2.87
O
N
H
OMe
O
MeMe
rac-2.41
N
H
OMe
O
MeMe
DD
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chromatography (4:1 Hexanes:EtOAc) to yield amine rac-2.41 (15.0 mg, 60% yield) as a 
colorless oil. 
 
 
Amine rac-2.42. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded amine rac-2.42 (15.0 mg, 48% yield) as a colorless oil.  
 
 
Amine rac-2.43. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded amine rac-2.43 (15.2 mg, 61% yield) as a colorless oil.  
 
 
Amine rac-2.44. Purification by preparative thin-layer chromatography (EtOAc, 2% Et3N) 
yielded amine rac-2.44 (14.1 mg, 64% yield) as a colorless oil.  
 
 
NiCl2(dme) (10 mol%)
PhSiD3 (4.0 equiv)
toluene (1.0 M), 115 °C
(48% yield)
rac-2.52
O
N
H
OMe
O
OH
rac-2.42
N
H
OMe
O
OH
DD
NiCl2(dme) (10 mol%)
PhSiD3 (4.0 equiv)
toluene (1.0 M), 115 °C
(61% yield)rac-2.88
O
N
O OMe
rac-2.43
N
O OMeDD
NiCl2(dme) (10 mol%)
PhSiD3 (4.0 equiv)
toluene (1.0 M), 115 °C
(64% yield)rac-2.89
O
N
OH
rac-2.44
N
OHDD
NiCl2(dme) (10 mol%)
PhSiD3 (2.0 equiv)
toluene (1.0 M), 115 °C
(87% yield)rac-2.58
O
N
OAc
rac-2.45
N
OAcDD
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Amine rac-2.45. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc, 
2% Et3N) yielded amine rac-2.45 (22.2 mg, 87% yield) as a colorless oil. 
 
2.9.2.8 Verification of Enantiopurity – er and dr Determination 
The enantiomeric ratio of 2.41 was determined by chiral SFC analysis. 
 
Compound
Method
Column
/Temp
Polar
Cosolvent
Method
Flow
Rate
Retention
Times
Enantiomeric
Ratio
(er)
Daicel
ChiralPak
OB-H / 35 °C
Daicel
ChiralPak
OB-H / 35 °C
1% iPrOH
1% iPrOH
0.60
mL/min
0.60
mL/min
16.36/21.20
min
14.34/17.31
min
0:100
51:49
rac-2.41
2.41
N
H
OMe
O
MeMe
DD
N
H
OMe
O
MeMe
DD
17.42/21.53
min
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 83 
 
 
Chiral SFC analysis of rac-2.42 did not lead to separation of the enantiomers. The 
diastereomeric ratio of 2.42 was then determined by coupling with enantiopure carboxylic acid 
2.92. 
 
EDC•HCl (2.2 equiv)
HOBt (2.2 equiv)
Et3N (2.2 equiv)
DMF, 23 °C
(67% yield)
> 20:1 dr
2.92
(1.0 equiv)
HN+
2.42
(1.1 equiv)
O
OH D
D
N D
D
O
OMe
O
OH
O
OMe
OH
2.93
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Amide 2.93. To a solution of carboxylic acid 2.92 (7.3 mg, 0.058 mmol, 1.0 equiv), HOBt (17.3 
mg, 0.128 mmol, 2.2 equiv), and EDC•HCl (24.5 mg, 0.128 mmol, 2.2 equiv) in DMF (582 µL, 
0.1 M) at 23 °C was added amine 2.42 (20.2 mg, 0.064 mmol, 1.1 equiv), followed by 
triethylamine (17.8 µL, 0.128 mmol, 2.2 equiv) under a N2 atmosphere. The reaction mixture 
stirred at 23 °C for 18 h. The reaction was diluted with deionized water (2 mL) and transferred to 
a separatory funnel with EtOAc (3 mL). The layers were separated and the aqueous layer was 
extracted with EtOAc (3 x 3 mL). The organic layers were combined and washed with water (3 x 
3 mL), dried over Na2SO4, and the volatiles were removed under reduced pressure. The resulting 
crude residue was purified by preparative thin-layer chromatography (3:1 Hexanes:EtOAc) to 
yield amide 2.93 (16.6 mg, 67% yield, > 20:1 dr) as a colorless oil. Amide 2.93: Rf 0.50 (2:1 
Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.27–7.24 (m, 2H), 7.19–7.17 (m, 3H), 7.14–
7.12 (m, 2H), 7.00–6.99 (m, 2H), 5.74–5.73 (m, 2H), 3.63 (s, 3H), 3.47 (t, J = 6.9, 1H), 2.92 (d, J 
= 6.9, 2H), 2.83–2.78 (m, 1H), 2.59 (t, J = 7.7, 2H), 2.40–2.38 (m, 2H), 2.19–2.14 (m, 3H), 
1.87–1.81 (m, 1H), 1.80–1.70 (m, 2H); 2H NMR (76 MHz, CD2Cl2): δ 2.61, 2.45; 13C NMR (125 
MHz, CDCl3): δ 175.2, 174.5, 149.8, 142.1, 134.9, 130.2, 128.5, 128.4, 126.9, 125.9, 125.1, 
121.6, 63.1, 51.8, 47.3 (m), 39.5, 39.3, 33.4, 31.5, 27.5, 25.2, 24.5 IR (film): 3331, 3025, 2925, 
1752, 1507 cm-1; HRMS-ESI (m/z) [M + H]+ calcd for C26H30D2NO4, 424.24514; found 
424.24403; [α] 31.3D –34.00° (c = 0.10, CH2Cl2). 
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The enantiomeric ratio of 2.43 was determined by chiral SFC analysis. 
 
 
Compound
Method
Column
/Temp
Polar
Cosolvent
Method
Flow
Rate
Retention
Times
Enantiomeric
Ratio
(er)
Daicel
ChiralPak
OB-H / 35 °C
Daicel
ChiralPak
OB-H / 35 °C
3% iPrOH
3% iPrOH
3.00
mL/min
3.00
mL/min
4.50/5.10
min
3.92/4.43
min
0:100
50:50
2.43
N
O OMeDD
rac-2.43
N
O OMeDD
4.44/5.06
min
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The enantiomeric ratio of 2.44 was determined by chiral SFC analysis. 
 
Compound
Method
Column
/Temp
Polar
Cosolvent
Method
Flow
Rate
Retention
Times
Enantiomeric
Ratio
(er)
Daicel
ChiralPak
OD-H / 35 °C
Daicel
ChiralPak
OD-H / 35 °C
15% MeOH,
2.00 min
10%/min, 
25% MeOH
4.00
mL/min
4.00
mL/min
2.09/2.65
min
1.78/2.03
min
0:100
43:57
2.44
N
OHDD
rac-2.44
N
OHDD 15% MeOH,
2.00 min
10%/min, 
25% MeOH 2.10/2.56min
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 88 
 
 
Chiral SFC analysis of rac-2.45 did not lead to separation of the enantiomers. For this reason, 
acetate 2.45 was converted to alcohol 2.44 and the enantiomeric ratio was determined by chiral 
SFC analysis in comparison to rac-2.44. 
 
 
Amine 2.44. To a solution of amine 2.45 (20.0 mg, 0.073 mmol, 1 equiv) in MeOH (726 µL, 0.1 
M) at 23 °C was added K2CO3 (50.2 mg, 0.363 mmol, 5 equiv) in one portion. The reaction was 
K2CO3 (5.0 equiv)
MeOH, 23 °C
(10% yield)
2.45
N
2.44
N
OHDDOAcDD
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stirred vigorously for 1 h. The reaction mixture was diluted with EtOAc (10 mL) and transferred 
to a seperatory funnel. Deionized H2O (10 mL) was added, the layers separated, and the aqueous 
layer was extracted with EtOAc (3 x 10 mL). The combined organics were washed with 
saturated aqueous NaCl (5 mL) and dried over Na2SO4. The volatiles were removed under 
reduced pressure, and the resulting crude residue was purified by preparative thin-layer 
chromotagraphy (EtOAc, 2% Et3N) to yield amine 2.44 (1.6 mg, 10% yield) as a colorless oil. 
 
Compound
Method
Column
/Temp
Polar
Cosolvent
Method
Flow
Rate
Retention
Times
Enantiomeric
Ratio
(er)
Daicel
ChiralPak
OD-H / 35 °C
Daicel
ChiralPak
OD-H / 35 °C
15% MeOH,
2.00 min
10%/min, 
25% MeOH
4.00
mL/min
4.00
mL/min
2.10/2.76
min
1.78/2.03
min
0:100
43:57
2.44
N
OHDD
rac-2.44
N
OHDD 15% MeOH,
2.00 min
10%/min, 
25% MeOH 2.10/2.56
min
 90 
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2.9.2.9 Procedure for Reduction Performed on 1.0 mmol Scale 
 
Representative procedure for the 1.0 mmol scale reduction of amide 2.69. Amine 2.22. A 
20-scintillation vial was charged with a magnetic stir bar, flame-dried under reduced pressure, 
and allowed to cool under a N2 atmosphere. Amide substrate 2.69 (269.2 mg, 1.000 mmol, 1.0 
equiv) and NiCl2(dme) (21.9 mg, 0.1000 mmol, 10 mol %) was added, and the vial was flushed 
with N2 for 10 min. PhSiH3 (246.7 µL, 2.000 mmol, 2.0 equiv) was added under a N2 atmosphere 
NiCl2(dme) (10 mol%)
PhSiH3 (2.0 equiv)
toluene (1.0 M), 115 °C
(92% yield)
2.222.69
N
H
Bn
HH
N
H
Bn
O
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via syringe followed by toluene (1.0 mL, 1.0 M). The vial was then capped with a Teflon-lined 
screw cap under a flow of N2. The reaction mixture was then placed in a pre-heated aluminum 
block and allowed to stir at 115 °C for 24 h. After cooling to room temperature, the reaction 
mixture was transferred to a separatory funnel with EtOAc (10 mL) and basified with 1.0 M 
aqueous NaOH (10 mL). The layers were separated and the aqueous layer was extracted with 
EtOAc (3 x 30 mL). The combined organic layers were washed with saturated aqueous NaCl (45 
mL). The volatiles were removed under reduced pressure, and the crude residue was purified by 
flash chromatography (4:1 Hexanes:EtOAc, 2% Et3N) to yield amine 2.22 (92% yield) as a 
colorless oil. Amine 2.22: Rf  0.52 (4:1 Hexanes:EtOAc, 2% Et3N). Spectral data match those 
previously reported.54  
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2.10 Spectra Relevant to Chapter Two 
 
Nickel-Catalyzed Reduction of Secondary and Tertiary Amides 
Bryan J. Simmons, Marie Hoffmann, Jaeyeon Hwang, Moritz K. Jackl, and Neil K. Garg. 
Org. Lett. 2017, 19, 1910–1913. 
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Figure 2.2 1H NMR (500 MHz, CDCl3) of compound 2.47. 
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Figure 2.3 13C NMR (125 MHz, CDCl3) of compound 2.47. 
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Figure 2.4 1H NMR (500 MHz, CDCl3) of compound 2.49. 
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Figure 2.5 13C NMR (125 MHz, CDCl3) of compound 2.49. 
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Current Data Parameters
NAME     BJS-3-254-PROTON3
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161023
Time              10.14 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT          CD2Cl2
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300194 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.6 1H NMR (500 MHz, CD2Cl2) of compound 2.52. 
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Current Data Parameters
NAME     BJS-3-255-COLUMNCARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160925
Time              11.14 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                14.67
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577892 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.7 13C NMR (125 MHz, CDCl3) of compound 2.52. 
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Current Data Parameters
NAME     BJS-3-PYRAZOLESM
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160622
Time              16.36 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                23.34
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.8 1H NMR (500 MHz, CDCl3) of compound 2.54. 
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PROCNO                1
F2 - Acquisition Parameters
Date_          20160622
Time              16.41 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                13.13
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                 9.63 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577730 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.9 13C NMR (125 MHz, CDCl3) of compound 2.54. 
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NAME     BJS-3-220-BENZENE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160913
Time              16.07 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT            C6D6
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1299959 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.10 1H NMR (500 MHz, C6D6) of compound 2.56. 
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NAME     BJS-3-220-COLUMN-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160718
Time              16.07 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   24
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                13.13
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577892 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.11 13C NMR (125 MHz, CDCl3) of compound 2.56. 
 
 99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1.
77
0
1.
77
5
1.
78
0
1.
78
4
1.
79
4
1.
79
8
1.
80
2
1.
80
4
1.
81
9
1.
82
6
1.
83
2
1.
83
6
1.
83
9
1.
84
5
1.
84
8
1.
99
4
2.
00
6
2.
51
5
2.
53
0
2.
53
4
2.
54
6
2.
66
0
2.
67
6
2.
92
0
2.
93
5
2.
95
1
2.
95
6
2.
97
2
3.
26
7
3.
32
3
3.
33
0
4.
04
9
4.
06
3
4.
07
1
4.
08
4
4.
13
1
4.
13
9
4.
15
3
4.
16
1
4.
32
6
7.
14
2
7.
15
7
7.
17
1
7.
17
9
7.
18
8
7.
19
3
7.
19
5
7.
20
1
7.
23
1
7.
23
4
7.
24
5
7.
25
4
7.
25
7
7.
26
0
5.
47
4
1.
09
6
2.
80
2
1.
96
1
0.
70
1
2.
66
3
0.
99
1
0.
99
0
0.
35
2
0.
34
3
0.
34
3
0.
34
1
0.
34
5
1.
00
0
0.
97
7
0.
96
8
3.
98
9
2.
66
2
Current Data Parameters
NAME     MH-2-222-PROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161019
Time              18.44 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300146 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.12 1H NMR (500 MHz, CDCl3) of compound 2.58. 
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NAME      MH-2-222-pbis
EXPNO               191
PROCNO                1
F2 - Acquisition Parameters
Date_          20160927
Time              14.51
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  360
DS                    0
SWH           25252.525 Hz
FIDRES         0.385323 Hz
AQ            1.2976128 sec
RG               189.85
DW               19.800 usec
DE                 6.50 usec
TE                299.6 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        100.6243395 MHz
NUC1                13C
P1                10.00 usec
PLW1        52.00000000 W
======== CHANNEL f2 ========
SFO2        400.1324008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             90.00 usec
PLW2        13.00000000 W
PLW12        0.36111000 W
PLW13        0.29249999 W
F2 - Processing parameters
SI                65536
SF          100.6127613 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.13 13C NMR (125 MHz, CDCl3) of compound 2.58. 
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Current Data Parameters
NAME     BJS-3-093-PLUG
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160407
Time               9.21
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                203.2
DW               50.000 usec
DE                 6.00 usec
TE                297.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300221 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.14 1H NMR (500 MHz, CDCl3) of compound 2.8. 
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Current Data Parameters
NAME     BJS-3-098-PLUG2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160412
Time              18.48
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                   64
DW               50.000 usec
DE                 6.00 usec
TE                297.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300215 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.15 1H NMR (500 MHz, CDCl3) of compound 2.11. 
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EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
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Time               9.48
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D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300215 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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NAME     BJS-3-096-PURE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160412
Time              18.41
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                101.6
DW               50.000 usec
DE                 6.00 usec
TE                297.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300217 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.16 1H NMR (500 MHz, CDCl3) of compound 2.12. 
 
Figure 2.17 1H NMR (500 MHz, CDCl3) of compound 2.13. 
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NAME          MOJ-1-179
EXPNO                 2
PROCNO                1
F2 - Acquisition Parameters
Date_          20160329
Time               9.37 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
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DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300123 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME          MOJ-1-182
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160330
Time              14.05
INSTRUM           av300
PROBHD   5 mm PABBO BB-
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH            5995.204 Hz
FIDRES         0.091480 Hz
AQ            5.4657025 sec
RG                  256
DW               83.400 usec
DE                 6.00 usec
TE                297.7 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                14.75 usec
PL1      0 dB
PL1W         9.31909847 W
SFO1        300.1318008 MHz
F2 - Processing parameters
SI                65536
SF          300.1300121 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.40
Figure 2.18 1H NMR (500 MHz, CDCl3) of compound 2.14. 
 
Figure 2.19 1H NMR (500 MHz, CDCl3) of compound 2.15. 
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Current Data Parameters
NAME          MOJ-1-179
EXPNO                 3
PROCNO                1
F2 - Acquisition Parameters
Date_          20160329
Time               9.48 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  120
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG               204.54
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                 9.63 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577892 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.20 13C NMR (125 MHz, CDCl3) of compound 2.15. 
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Current Data Parameters
NAME     BJS-3-144-PREP3
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160518
Time               9.06
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                101.6
DW               50.000 usec
DE                 6.00 usec
TE                300.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300219 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.21 1H NMR (500 MHz, CDCl3) of compound 2.16. 
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Current Data Parameters
NAME     BJS-3-144-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160617
Time              17.00
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  160
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                298.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080716 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.22 13C NMR (125 MHz, CDCl3) of compound 2.16. 
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Current Data Parameters
NAME      BJS-3-PYRAZ-3
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160616
Time               9.21
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                  181
DW               50.000 usec
DE                 6.00 usec
TE                297.3 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300221 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.23 1H NMR (500 MHz, CDCl3) of compound 2.17. 
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Current Data Parameters
NAME     BJS-3-PYRAZ-CARBON2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160617
Time              16.27
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  160
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                298.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080642 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.24 13C NMR (125 MHz, CDCl3) of compound 2.17. 
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Current Data Parameters
NAME     BJS-3-141-COLUMN
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160515
Time               9.16 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.25 1H NMR (500 MHz, CDCl3) of compound 2.18. 
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Current Data Parameters
NAME     BJS-3-109-COLUMN
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160422
Time               8.55 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.27 1H NMR (500 MHz, CDCl3) of compound 2.20. 
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Current Data Parameters
NAME     BJS-3-139-COLUMN2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160512
Time               9.52
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                 80.6
DW               50.000 usec
DE                 6.00 usec
TE                297.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300222 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.26 1H NMR (500 MHz, CDCl3) of compound 2.19. 
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Current Data Parameters
NAME     BJS-3-105-COLUMN
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160420
Time               9.14 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-3-126-COLUMN
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160502
Time              18.47
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                   57
DW               50.000 usec
DE                 6.00 usec
TE                297.5 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300216 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.28 1H NMR (500 MHz, CDCl3) of compound 2.21. 
 
Figure 2.29 1H NMR (500 MHz, CDCl3) of compound 2.22. 
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Current Data Parameters
NAME     BJS-3-232-PREP
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160802
Time               8.57 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300121 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.30 1H NMR (500 MHz, CDCl3) of compound 2.23. 
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Current Data Parameters
NAME     BJS-3-232-PREPCARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160802
Time               9.03 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                14.67
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577741 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.31 13C NMR (125 MHz, CDCl3) of compound 2.23. 
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Current Data Parameters
NAME     BJS-3-147-COLUMN
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160518
Time              17.59
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                   57
DW               50.000 usec
DE                 6.00 usec
TE                297.2 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300221 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.32 1H NMR (500 MHz, CDCl3) of compound 2.24. 
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Current Data Parameters
NAME     BJS-3-146-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160617
Time              16.50
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  160
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                298.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080712 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.33 13C NMR (125 MHz, CDCl3) of compound 2.24. 
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Current Data Parameters
NAME     BJS-3-119-COLUMN
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160501
Time               9.22
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                   57
DW               50.000 usec
DE                 6.00 usec
TE                297.3 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300220 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.34 1H NMR (500 MHz, CDCl3) of compound 2.25. 
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Current Data Parameters
NAME     BJS-3-119-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160617
Time              16.38
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  160
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                298.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080701 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.35 13C NMR (125 MHz, CDCl3) of compound 2.25. 
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Current Data Parameters
NAME     BJS-3-184-BOC2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160701
Time               9.35
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                 45.3
DW               50.000 usec
DE                 6.00 usec
TE                333.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300416 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.36 1H NMR (500 MHz, CDCl3) of compound 2.26. 
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Current Data Parameters
NAME     BJS-3-184-BOC-CARBON2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160701
Time               9.41
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG              11585.2
DW               15.300 usec
DE                 6.00 usec
TE                333.1 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080969 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.37 13C NMR (125 MHz, CDCl3) of compound 2.26. 
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Current Data Parameters
NAME     BJS-3-214-PURE2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160711
Time              16.44 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300124 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.38 1H NMR (500 MHz, CDCl3) of compound 2.27. 
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Current Data Parameters
NAME     BJS-3-214-PURE-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160711
Time              16.49 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                10.71
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                 9.63 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577760 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.39 13C NMR (125 MHz, CDCl3) of compound 2.27. 
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Current Data Parameters
NAME        MH-2-086A-p
EXPNO               210
PROCNO                1
F2 - Acquisition Parameters
Date_          20160606
Time              13.35
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               189.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300178 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.40 1H NMR (500 MHz, CDCl3) of compound 2.28. 
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Current Data Parameters
NAME         MH-2-110-p
EXPNO               340
PROCNO                1
F2 - Acquisition Parameters
Date_          20160620
Time              18.22
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300184 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.41 1H NMR (500 MHz, CDCl3) of compound 2.29. 
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Current Data Parameters
NAME        MH-2-050B-p
EXPNO               550
PROCNO                1
F2 - Acquisition Parameters
Date_          20160510
Time              18.31 h
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.303045 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300176 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.42 1H NMR (500 MHz, CDCl3) of compound 2.30. 
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Current Data Parameters
NAME        MH-2-053B-p
EXPNO               110
PROCNO                1
F2 - Acquisition Parameters
Date_          20160513
Time              11.22
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300178 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.43 1H NMR (500 MHz, CDCl3) of compound 2.31. 
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Current Data Parameters
NAME       MH-2-118-p-1
EXPNO               480
PROCNO                1
F2 - Acquisition Parameters
Date_          20160627
Time              18.25
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300176 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.44 1H NMR (500 MHz, CDCl3) of compound 2.32. 
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Current Data Parameters
NAME         MH-2-148-1
EXPNO                30
PROCNO                1
F2 - Acquisition Parameters
Date_          20160717
Time              13.45
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300179 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.45 1H NMR (500 MHz, CDCl3) of compound 2.33. 
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Current Data Parameters
NAME        MH-2-059A-p
EXPNO               460
PROCNO                1
F2 - Acquisition Parameters
Date_          20160516
Time              20.32
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300178 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.46 1H NMR (500 MHz, CDCl3) of compound 2.34. 
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Current Data Parameters
NAME        MH-2-065C-p
EXPNO               380
PROCNO                1
F2 - Acquisition Parameters
Date_          20160524
Time              18.35
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300175 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.47 1H NMR (500 MHz, CDCl3) of compound 2.35. 
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Current Data Parameters
NAME         MH-2-111-p
EXPNO               520
PROCNO                1
F2 - Acquisition Parameters
Date_          20160621
Time              19.46
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               189.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300175 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.48 1H NMR (500 MHz, CDCl3) of compound 2.36. 
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Current Data Parameters
NAME       MH-2-155-bis
EXPNO                90
PROCNO                1
F2 - Acquisition Parameters
Date_          20160722
Time               9.32
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               189.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300178 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.49 1H NMR (500 MHz, CDCl3) of compound 2.37. 
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Current Data Parameters
NAME     BJS-3-205-CRUDE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160707
Time              15.18 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Hexamethylbenzene  
Figure 2.50 1H NMR (500 MHz, CDCl3) of compound 2.38. 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1.
60
4
2.
82
6
2.
83
8
2.
84
8
8.
17
2
4.
00
0
Current Data Parameters
NAME     BJS-3-207-CRUDE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160707
Time              17.41
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                  181
DW               50.000 usec
DE                 6.00 usec
TE                300.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300222 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.51 1H NMR (500 MHz, CDCl3) of compound 2.39. 
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Current Data Parameters
NAME     BJS-3-192-PURE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20160710
Time              14.57 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                 7.89
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300125 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.52 1H NMR (500 MHz, CDCl3) of compound 2.40. 
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Current Data Parameters
NAME     BJS-3-263-PROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161019
Time              18.37 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300121 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.53 1H NMR (500 MHz, CDCl3) of compound 2.41. 
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NAME     BJS-3-267-PROTON2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161023
Time              10.50 h
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PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300193 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-3-263-CARBON3
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161027
Time              13.36 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  240
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                17.16
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577727 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.54 13C NMR (125 MHz, CDCl3) of compound 2.41. 
 
Figure 2.55 1H NMR (500 MHz, CD2Cl2) of compound 2.42. 
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F2 - Processing parameters
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Current Data Parameters
NAME     MH-2-247-PROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161024
Time               9.02 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT          CD2Cl2
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300194 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.57 1H NMR (500 MHz, CD2Cl2) of compound 2.43. 
 
Figure 2.56 13C NMR (125 MHz, CD2Cl2) of compound 2.42. 
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F2 - Acquisition Parameters
Date_          20161025
Time               9.18 h
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P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577738 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.58 13C NMR (125 MHz, CDCl3) of compound 2.43. 
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Current Data Parameters
NAME     BJS-3-274-PREP
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161012
Time               9.15 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300125 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.59 1H NMR (500 MHz, CDCl3) of compound 2.44. 
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F2 - Acquisition Parameters
Date_          20161023
Time              13.43 h
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TE                298.0 K
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TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577737 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.60 13C NMR (125 MHz, CDCl3) of compound 2.44. 
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Current Data Parameters
NAME     MH-2-233-PREP1
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161021
Time              16.06 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300139 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
Figure 2.61 1H NMR (500 MHz, CDCl3) of compound 2.45. 
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F2 - Acquisition Parameters
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CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
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F2 - Processing parameters
SI               131072
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SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 2.62 13C NMR (125 MHz, CDCl3) of compound 2.45. 
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Figure 2.63 1H NMR (500 MHz, CDCl3) of compound 2.93. 
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Figure 2.64 13C NMR (125 MHz, CDCl3) of compound 2.93. 
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CHAPTER THREE 
 
Computationally Assisted Mechanistic Investigation and Development of Pd-Catalyzed 
Asymmetric Suzuki–Miyaura and Negishi Cross-Coupling Reactions for Tetra-ortho-
Substituted Biaryl Synthesis 
Nitinchandra Dahyabhai Patel, Joshua D. Sieber, Sergei Tcyrulnikov, Bryan J. Simmons, Daniel 
Rivalti, Krishnaja Duvvuri, Yongda Zhang, Donghong A. Gao, Keith R. Fandrick, Nizar Haddad, 
Kendricks So Lao, Hari Prasad Reddy Mangunuru, Soumik Biswas, Bo Qu, Nelu Grinberg, Scott 
Pennino, Heewon Lee, Jinhua J. Song, B. Frank Gupton, Neil K. Garg, Marisa C. Kozlowski, and 
Chris H. Senanayake 
ACS Catal. 2018, 8, 10190–10209. 
 
3.1 Abstract 
Metal-catalyzed cross-coupling reactions are extensively employed in both academia and 
industry for the synthesis of biaryl derivatives for applications to both medicine and material 
science. Application of these methods to prepare tetra-ortho-substituted biaryls leads to chiral 
atropisomeric products that introduces the opportunity to use catalyst-control to develop 
asymmetric cross-coupling procedures to access these important compounds. Asymmetric Pd-
catalyzed Suzuki–Miyaura and Negishi cross-coupling reactions to form tetra-ortho-substituted 
biaryls were studied employing a collection of P-chiral dihydrobenzooxaphosphole (BOP) and 
dihydrobenzoazaphosphole (BAP) ligands. Enantioselectivities of up to 95:5 and 85:15 er were 
identified for the Suzuki–Miyaura and Negishi cross-coupling reactions, respectively. Unique 
ligands for the Suzuki–Miyaura reaction and the Negishi reaction were identified. A 
computational study on these Suzuki–Miyaura and Negishi cross-coupling reactions enabled an 
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understanding of the differences between the enantiodiscriminating events between these two 
cross-coupling reactions. These results support that enantioselectivity in the Negishi reaction 
results from the reductive elimination step, whereas all steps in the Suzuki–Miyaura catalytic 
cycle contribute to the overall enantioselection with transmetalation and reductive elimination 
providing the most contribution to the observed selectivities.   
 
3.2 Introduction 
Transition metal catalyzed sp2–sp2 cross-coupling is one of the most powerful and 
extensively utilized reactions in organic synthesis and materials science to access biaryl 
compounds.1 Of these methods, the Pd-catalyzed Suzuki–Miyaura2 and Negishi3 cross-coupling 
have received considerable development over the past 40 years.1,4 Significant advances in the 
development of highly active Pd-catalysts5 to achieve efficient processes have even allowed for 
these reactions to be employed on industrial scale.6 In general, bulky electron-rich phosphines7 
and N-heterocyclic carbenes8,9 have been the ligands of choice to enable these cross-coupling 
reactions. Despite these advances, cross-coupling catalysts for the formation of sterically 
demanding biaryls, such as tetra-ortho-substituted systems, remains limited.9 Additionally, 
because appropriately substituted tri- and tetra-ortho-substituted biaryls exist as chiral 
atropisomers about the biaryl axis, methods to forge this bond in an enantioselective fashion are 
important since many biologically active natural products10 and potential pharmaceuticals11 
contain single atropisomeric biaryl groups within their structure (Figure 3.1). Therefore, one 
desirable strategy to access the biaryl functionality in these compounds is to utilize a catalyst-
controlled asymmetric Suzuki–Miyaura or Negishi sp2–sp2 cross-coupling.12 While transition 
metal catalyzed asymmetric Suzuki–Miyaura13 and Negishi14 sp2–sp2 cross-coupling reactions 
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have been developed, significantly fewer methods are available for the asymmetric construction 
of tetra-ortho-substituted biaryls.13c,d,p-t,14,15  
 
 
Figure 3.1 Natural products and bioactive atropisomeric compounds 
 
The first highly enantioselective sp2–sp2 cross-coupling reaction was reported in 1988 by 
Hayashi and coworkers15 to afford atopisomeric binaphthalenes in up to 95% ee using a 
Kumada–Corriu16 coupling. It was not until the year 2000 that the first reports of Pd-catalyzed 
asymmetric Suzuki–Miyaura cross-coupling reactions were disclosed by the groups of 
Cammidge13c,d and Buchwald.13a,b Cammidge applied Hayashi’s15 chiral ferrocene ligand 
(PFNMe) to access tri-ortho-substituted biaryl 3.8a with modest enantioselection (82:18 er, 
Table 3.1). At the same time, Buchwald discovered that KenPhos could be employed as the 
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chiral ligand affording high enantioselectivities in the cross-coupling if the R-substituent of the 
aryl halide coupling partner contained a Lewis basic donating group at the ortho-position (3.8b-
d). Mechanistic studies on this class of cross-coupling by Buchwald13b and others11b,13n,x typically 
consider reductive elimination as the enantiodetermining event in the catalytic cycle and have 
shown that these Lewis basic ortho-substituents aid in the stabilization of the dominating 
transition state. However, restricted rotation of the intermediate Pd-complexes as a function of 
the ortho-substitution pattern of the aryl halide coupling partner can lead to scenarios where  
oxidative addition13f and transmetalation13d,f may be involved in enantioselection.17 After these 
initial reports, intense research into the area of catalyst-controlled asymmetric biaryl synthesis by 
a variety of groups has led to the introduction of multiple chiral ligands that affect  this 
transformation (Table 3.1).11,13 The majority of these studies have focused on the investigation of 
the formation of tri-ortho-substituted binaphthalene derivatives.11,13a,b,e-o,u-bb Of these, 
asymmetric synthesis of the aryl phosphonate products (3.8b–3.8d) by asymmetric cross-
coupling have been one of the more common systems studied between different chiral catalysts 
with variable results. 13a,b,j,n,u-y For example, our group11,13n,o introduced the P-chiral 
dihydrobenzooxaphosphole (BOP) class of ligands (BIDIME, 3.9, 3.10) that are effective in 
asymmetric cross-coupling reactions and are highly tunable to enable ligand modification for 
enhancement of stereoselectivities. Suzuki–Miyaura cross-coupling to afford 3.8c employing 
BOP ligand 3.9b13n gave improved enantioselectivity to that of KenPhos;13a however, in the 
coupling to produce 3.8b, KenPhos resulted in improved selectivity over ligand 3.9b. These 
results highlight the fact that asymmetric cross-coupling reactions are typically very substrate 
dependent. Synthesis of 3.8b–3.8d has also been acheived by asymmetric cross-coupling 
employing the atropisomeric, hemi-labile ligands Cy-MOP,13w 3.11,13u,x and 3.12,13v and using a 
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helically-chiral polymeric phosphine ligand (PQXPhos). 13i Other ligand classes including chiral 
dienes (3.13),13h bis(hydrazones) (3.14),13f and a resin-supported chiral ligand (3.15)13p have all 
been shown to afford high enantioselectivities in certain asymmetric Suzuki–Miyaura cross-
coupling reactions. Despite these significant advances in asymmetric cross-coupling 
methodologies, a general catalyst for a wide-array of substitution patterns is still an unsolved 
problem. However, these technologies have found utility in natural product13k,o and API 
synthesis (e.g. 3.5 via 3.8).11   
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Table 3.1 Asymmetric Suzuki–Miyaura cross-coupling reactions to prepare  
tri-ortho-substituted biaryls. 
 
R'
3.8
(R or R' = H)
tri-ortho-substituted biaryls
R
X
B(OR)2
R'
R cat. Pd/L*
+
3.6
Me
(S,R)-PFNMe: 82:18 er
3.13:   5:95 er
3.14:   5:95 er
Me
3.8e
(S)-KenPhos: 97:3 er
3.8c
P(O)(OR)2
N
H
O
Ph
Me Me
NMe2
(R)-KenPhos
PCy2
(S,R)-PFNMe
3.7
X = Cl, Br, I
Me
Me
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MeH
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Me
3.8f
3.13: 92:8 er
3.15: 96:4 er
Me
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Me Me
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O
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OMeMeO
R
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O NMe2
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While asymmetric Suzuki–Miyaura cross-coupling to generate tri-ortho-substituted 
biaryls (Table 3.1) has been successful with a variety of chiral ligand types, 13a,b,e-o,u-bb the 
synthesis of tetra-ortho-substituted biaryls by the same means has proven more difficult. 13c,d,p-t 
Tetra-ortho-substituted biaryl product 3.18 (Table 3.2)13c,d,p-q has typically been the standard 
cross-coupling reaction analyzed when developing new catalysts for this challenging coupling.12c 
While the Ni-catalyzed Kumada–Corriu16 coupling to prepare 3.18 was reported by Hayashi15 
with good enantioselectivity, the analogous Suzuki–Miyaura coupling has proven more 
challenging.13c,d,p-t Cammidge’s initial report13c,d demonstrated that the PFNMe ligand gave good 
enantioselectivity (93:7 er) in this reaction; however, long reaction time (6 days) was required 
affording only modest yield (Table 3.2). Espinet13r was able to optimize this result to reduce the 
reaction time to 3 days at 5 mol % Pd loading by using Pd2(dba)3•CHCl3 as the Pd-source in the 
presence of excess ligand (20 mol %) to improve the yield to 85%. The catalyst loading could be 
reduced to employ 3 mol % Pd and 12 mol % ligand by utilizing Pd(MeCN)4(BF4)2 in place of 
Pd2(dba)3•CHCl3 as the precatalyst with an improvement in enantioselectivity of up to 95:5 er. 
However, only 55% yield was obtained after 4 day reaction time. While these conditions can be 
applied to the synthesis of 3.18, reaction times are still quite long (days), and the scope of the 
reaction to other substrates is limited or has not been further investigated. Of the catalytic 
systems reported for the synthesis of 3.16 by Suzuki–Miyaura cross-coupling, Uozumi’s13p 
conditions employing resin-supported phosphine ligand 3.15 are performed in water under 
heterogeneous conditions that allow for recycling of the catalyst and show the most generality in 
terms of reaction scope and enantioselectivity; however, only simple substituted naphthalenes 
have been disclosed in the coupling. Recently there has been increased focus on the development 
of Suzuki–Miyaura cross-coupling reactions performed using water18,19 as the solvent due to the 
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potential “greenness” of replacing typical organic solvents by water.20,21 However, none of these 
methods have been extended to enantioselective cross-coupling. Uozumi’s13p report represents 
the only known catalytic asymmetric cross-coupling carried out in neat water.22 Future studies 
are needed in this area to determine if improvements in catalytic asymmetric coupling reactions 
can be achieved using water as solvent.   
 
Table 3.2 Asymmetric Suzuki–Miyaura cross-coupling reactions to prepare tetra-ortho-
substituted biaryls. 
 
As noted above (Table 3.1), previous work in our laboratories identified the P-chiral 
dihydrobenzooxaphosphole (BOP) ligand class (BIDIME, 3.9, 3.10) as a highly tunable scaffold 
for applications in many different types of asymmetric transformations by modulating the 
substituents of ligand structure 3.23 (Scheme 3.1). By variation of the oxaphosphole C-2 R-
substituent and the bis(alkoxy)phenyl aryl-group of ligand 3.23, catalysts for Suzuki–Miyaura7p-
t,9a,19a,23 and asymmetric Suzuki–Miyaura11,13n-o cross-coupling, Buchwald–Hartwig amination,24 
borylation,25 asymmetric propargylation of aldehydes26 and imines,27 asymmetric conjugate 
addition,28 asymmetric addition of boronic acids to imines,29 asymmetric allenylation of imines,30 
Me
3.18
Me
X
BR2
Me
Me cat. Pd/L*
+
3.16a:  R = OH
3.16b:  R = glycol
3.17a:  X = I
3.17b:  X = Br
(S,R)-PFNMe (20 mol %)
2.5 mol % Pd2(dba)3-CHCl3
3.16a, 3.17b, 65 oC, 3 days
85% yield, 93:7 er
(S,R)-PFNMe (6 mol %)
3 mol % PdCl2
3.16b, 3.17a, 65 oC, 6 days
60% yield, 93:7 er
Cy2P
1-naphthyl
Fe
3.19 (5 mol %)
1 mol % Pd2(dba)3
3.16a, 3.17b, 75 oC, 24 h
65% yield, 23:77 er
3.15 (10 mol % P)
10 mol % Pd(OAc)2
3.16a, 3.17b, 80 oC, 24 h
90% yield, 94:6 er
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asymmetric hydrogenation of polar31 and unfunctionalized32 alkenes, asymmetric hydrogenation 
of heterocycles,33 asymmetric hydroformylation,34 and asymmetric hydrogenation of ketones35 
have all been developed. Due to the lack of a general solution for the asymmetric synthesis of 
tetra-ortho-substituted biaryls using the Suzuki–Miyaura cross-coupling reaction, we sought to 
investigate application of ligand family 3.23 as a potential solution to this problem because of the 
modular nature of 3.23 and because of its good activity in the asymmetric cross-coupling to 
furnish tri-ortho-substituted biaryls.11,13n,o We disclose our studies towards the application of the 
dihydrobenzooxaphosphole (3.23, X = O, BOP) and dihydrobenzoazaphosphole (3.23, X = NR, 
BAP) ligand scaffold for both the asymmetric Pd-catalyzed Suzuki–Miyaura and Negishi cross-
coupling reaction to form tetra-ortho-substituted biaryls (Scheme 3.1). The differences in the 
enantiodiscrimination mechanism between these two processes were probed computationally and 
are also disclosed herein.  
 
Scheme 3.1 Tunable P-chiral phosphine ligands for asymmetric Pd-catalyzed cross-couplings. 
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3.3 Ligand Synthesis 
The ligands employed in the current study were prepared by the general strategy outlined 
in Scheme 3.2. Starting from the known P-chiral triflates (3.26, 3.27),13n,35b Negishi7t or Suzuki–
Miyaura cross-coupling was used to install the lower aryl ring of the ligand biaryl axis affording 
oxides 3.29 or 3.30. Deprotonation of 3.29 or 3.30 with LDA followed by electrophilic trapping 
allowed for substitution of the C-2 position of the oxaphosphole or azaphosphole ring providing 
3.31 or 3.32, respectively. Oxide reduction then provided the final BOP (X = O) or BAP (X = 
NR) ligands (3.33). Additionally, the 3,5-positions of the lower aryl ring of the biaryl group of 
3.34 can be functionalized by bromination11b to afford 3.35 followed by cross-coupling and 
alkylation to afford ligand family 3.36. These procedures have enabled the synthesis of a tunable 
family of P-chiral phosphine ligands. The ligands prepared and used in this study are shown in 
Figure 3.2. 
 
Scheme 3.2 Ligand synthesis. 
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Figure 3.2 Ligands used in this study. 
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3.4 Asymmetric Suzuki–Miyaura Cross-Coupling 
To investigate the Suzuki–Miyaura cross-coupling to prepare tetra-ortho-substituted 
biaryls, we initially examined the “benchmark”12c cross-coupling reaction to form tetra-ortho-
substituted biaryl compound 3.18 (Table 3.3) employing 1-bromo-2-methylnaphthalene (3.17b) 
and (2-methylnaphthalen-1-yl)boronic acid (3.16a) as the coupling partners. Initial experiments 
probed conditions that previously were shown to be suitable for hindered cross-coupling 
reactions (Entries 1 – 3). These consisted of the use of K3PO4 as base and employing BIDIME 
(3.L1), AntPhos, or C2-i-Pr-BIDIME (3.L4) as the ligand. Gratifyingly, under these conditions, 
product 3.18 was observed. While almost no enantioinduction was observed using BIDIME 
(3.L1) or AntPhos, which lack substitution at the C-2 position of the oxaphosphole ring (entries 
1 and 2), C2-i-Pr-BIDIME (3.L4) afforded modest enantioselectivity and yield in the reaction 
(entry 3). As has been previously noted for reactions forming tetra-ortho-substituted biaryls,13d,r 
protodeboronation was a significant side-reaction that prevented the coupling from proceeding to 
full conversion. To circumvent this issue, alternate bases were examined in an effort to reduce 
protodeboronation; however, no improvements over the use of K3PO4 were identified (entries 3 – 
8). Additionally, solvents such as toluene and 1,4-dioxane were found to be equally effective in 
the coupling and did not improve enantioselectivity or yield (entries 9 and 10). Finally, to 
achieve full reaction conversion, the effect of catalyst loading was examined (entries 11 – 14). 
Use of 5 mol% Pd was needed to achieve full conversion and allowed for high yield in the 
desired reaction (entry 13). Addition of water as a co-solvent to these reactions when employing 
THF or n-BuOH as solvent afforded < 10% yield of product due to significant amounts of 
protodeboronation (data not shown) that is not uncommon considering that the addition of excess 
water is often avoided in sterically demanding and asymmetric cross-coupling reactions.9,13 
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Table 3.3 Asymmetric Suzuki–Miyaura cross-coupling towards tetra-ortho-substituted biaryls: 
base and solvent survey. 
 
aIsolated yield. bDetermined by chiral HPLC analysis with Chiralpak OD-H column. 
 
With moderate conditions in hand for the Suzuki–Miyaura cross-coupling reaction (Table 
3.3, entry 13), we next attempted to modify the ligand structure to improve enantioselection 
(Table 3.4). The substitution at the C-2 position of the oxaphosphole ring of the ligand was first 
examined (entries 1–6). This enabled the identification of a ligand that provided 
enantioselectivities of up to 95:5 er when a dimethylmethoxy (DMM) substituent was at the C-2 
position of the oxaphosphole ring (3.L7, NitinPhos, entry 4). Furthermore, it was critical that the 
ligand contained a dimethoxyphenyl ring as part of the biaryl axis of the ligand. When this group 
was replaced with phenyl, anthracene, or methoxy, inferior yields and selectivities were obtained 
(entry 4 vs entries 9–11). The importance of the lower dimethoxyphenyl ring in enhancing 
Br
Me
MeMe
Pd(OAc)2
Ligand
Base
Solvent, Temp., 24 h
Me
B(OH)2
3.17b 3.16a
(2 equiv)
+
3.18
P
O
t-Bu
(R)-AntPhos
Entry Mol % Pd Ligand (mol%) Base 
(3 equiv) 
Solvent %Yielda erb 
1 1 3.L1 (2) K3PO4 THF 40 55:44 
2 1 (R)-AntPhos (2) K3PO4 THF 30 50:50 
3 1 3.L4 (2) K3PO4 THF 50 86:14 
4 1 3.L4 (2) CsF THF 18 ND 
5 1 3.L4 (2) KF THF < 5 ND 
6 1 3.L4 (2) K2CO3 THF 9 ND 
7 1 3.L4 (2) Na2CO3 THF < 2 ND 
8 1 3.L4 (2) NaOt-Bu THF < 3 ND 
9 1 3.L4 (2) K3PO4 Toluene 48 85:15 
10 1 3.L4 (2) K3PO4 1,4-dioxane 50 85.5: 14.5 
11 3 3.L4 (6) K3PO4 THF 64 86:14 
12 3 3.L4 (6) K3PO4 Toluene 56 85:15 
13 5 3.L4 (10) K3PO4 THF 90 86:14 
14 5 3.L4 (10) K3PO4 Toluene 85 85:15 
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enantioselectivities through an interaction between one methoxy-group and Pd has been 
postulated previously,11b,13n and is further supported by DFT modeling of this system (vide 
infra). Replacement of the methoxy-groups on this lower aryl ring with iso-propoxy groups 
afforded no improvement (entry 1 vs entries 7–8).  
 
Table 3.4 Ligand survey in the asymmetric Suzuki–Miyaura cross-coupling towards tetra-ortho-
substituted biaryls. 
 
 
 
 
 
 
 
 
 
aIsolated yield. bDetermined by chiral HPLC 
analysis with Chiralpak OD-H column. 
 
The effect of Pd-precatalyst and Pd:ligand loading was next examined (Table 3.5). The 
use of excess ligand enabled the highest reaction yield (entry 1 vs 2). Additionally, Pd(OAc)2 
gave less side-product formation than compared to the use of Pd2(dba)3 or [PdCl(allyl)]2 (entry 2 
vs entries 3–4).  
 
 
Br
Me
MeMe
Pd(OAc)2 5 mol%
Ligand 10 mol%
K3PO4 (5 equiv)
THF, 65 oC, 24h
Me
B(OH)2
3.17b 3.16a
+
3.18
(5 equiv)
Entry Ligand % yielda erb 
1 3.L4 92 86:14 
2 3.L5 80 90:10 
3 3.L6 75 86:14 
4 3.L7 97 94.5:5.5 
5 3.L8 45 81.5:18.5 
6 3.L10 91 83:17 
7 3.L13 73 84.5:15.5 
8 3.L14 75 83:17 
9 3.L16 75 73:27 
10 3.L17 35 88:12 
11 3.L18 50 64:36 
12 3.L20 89 78:22 
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Table 3.5 Effect of Pd-precatalyst and Pd:ligand loading. 
 
 
 
 
 
aIsolated yield. bDetermined by chiral HPLC analysis with 
Chiralpak OD-H column. c1-2% side products were observed 
with 23 % of bromide substrate remaining,  d5-7% side 
products were observed with 29% of bromide substrate, e8-9% 
side products were observed with 35% of bromide substrate. 
 
In an effort to further reduce the loading of the boron coupling partner, we next examined 
other boron derivatives in the coupling reaction in an effort to reduce protodeboronation side-
reactions (Table 3.6). Use of the glycol ester (3.16b) that was optimal in Cammidge’s system13d 
and has been recently shown to give improved transmetalation rates in Suzuki–Miyaura cross-
coupling reactions30 gave similar enantioselectivities as that observed with boronic acid 3.16a but 
did not afford full conversion in the reaction, even at prolonged reaction times. Use of the 
pinacol ester 3.16c allowed for reduction of the boron coupling partner to 2 equiv; however, long 
reaction times were required and a slight loss in enantiopurity was obtained. The change in 
enantioselectivity based off of the nature of the boronate36 employed has been observed 
previously13d and hints that the transmetalation step in the catalytic cycle for this reaction may be 
involved in the enantiodeterming event (vide infra). Finally, use of the potassium trifluoroborate 
salt (3.16d), which are known for their resistance to protodeboronation,37 was not effective in the 
cross-coupling reaction. 
Br
Me
MeMe
Pd
NitinPhos (3.L7)
K3PO4 (3 equiv)
THF, 65 oC, 24h
Me
B(OH)2
3.17b 3.16a
(5 equiv)
+
3.18
Entry Pd Source (mol %) Mol % L7 % yielda erb 
1 Pd(OAc)2 (5) 10 97% 94.5:5.5 
2 Pd(OAc)2 (5) 5 75%c 94.5:5.5 
3 Pd2(dba)3 (2.5) 5 64%d 94:6 
4 [PdCl(allyl)]2 (5) 5 55%e 93.7:6.3 
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Table 3.6 Effect of boronate coupling partner. 
 
 
With identification of a reactive catalytic system to form tetra-ortho-substituted biaryl 
product 3.18 with good enantioselectivities, the scope of this catalytic system was then briefly 
examined (Table 3.7). Unfortunately, it was quickly determined that the present system did not 
show good generality, as has been a common problem in asymmetric Pd-catalyzed Suzuki–
Miyaura reactions providing tetra-ortho-substituted biaryls. Even subtle modification to the 
coupling partners led to decreased reaction efficiency due to increased amounts of 
protodeboronation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
B
Me
B
Me
B
Me
OOOO
Me
Me
Me
Me
3.16a
(5 equiv)
97% yield
(18h)
94.5: 5.5 er
3.16c
(2 equiv)
90% yield
(>40h)
92.3: 7.7 er
3.16b
(2 equiv)
43% yield
(24h)
94:6 er
BF3K
Me
3.16d
(2 equiv)
no reaction
Br
Me
MeMe
5 mol % Pd(OAc)2
10 mol % 3.L7
3.17b
3.16
K3PO4 (3 equiv)
THF, 65 oC
3.18
OHHO
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Table 3.7 Asymmetric Suzuki–Miyaura cross-coupling reaction scope. 
 
 
3.5 Asymmetric Negishi Cross-Coupling 
Because of the issues identified with the Suzuki–Miyaura cross-coupling reaction (poor 
generality, high boronate loading), we decided to investigate the analogous reaction employing 
Negishi cross-coupling with aryl-zinc reagent 3.40 prepared by lithium-halogen exchange of 
3.17b with t-BuLi followed by addition of a THF solution of anhydrous ZnBr2. ZnBr2 was our 
preferred choice over ZnCl2 due to its higher solubility in THF. Towards this end, we surveyed 
our family of P-chiral oxaphosphole and azaphosphole ligands in the Negishi cross-coupling 
reaction (Table 3.8). The highest yield and selectivity was obtained with 3.L13 having iso-
propoxy groups on the lower aryl-ring of the ligand biaryl axis (entry 10). Surprisingly, the 
optimal ligand for the asymmetric Suzuki–Miyaura reaction (NitinPhos, 3.L7, entry 5) gave poor 
3.18
97%
94.5:5.5 er
Me
Me
3.39b
26%
88.6:11.4 er
OMe
OMe
Br
R
RR
Pd(OAc)2 (5 mol%)
3.L7 (10 mol%)
K3PO4 
THF, 65 oC, 24h
R
B(OR'')2
3.37
3.38
3.39
3.39c
0%
Me
Me
Me
Me
R'
R' R'
R'
3.39a
27%
88.0:12.0 er
Et
Et
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yield and selectivity in the Negishi coupling considering that the presumed enantiodetermining 
step of reductive elimination should be identical for the Negishi and Suzuki–Miyaura reactions. 
This difference in selectivity was something we wanted to understand further (vide infra). In 
general, C2-substituion on the oxaphosphole or azaphosphole ring of the ligand was required for 
good selectivity (entry 1 vs entries 2–10, and entries 15–16 vs entries 17–21). Further increasing 
the steric bulk at this C2-position by introducing a second methyl group enabled similar 
selectivities but led to a reduction in yield (entries 8 & 12). Additionally, a trend was observed 
where increasing the electron-donating ability of the lower aryl-ring bearing the alkoxy-
substituents led to improved enantioselection (compare entries 2, 9, and 10). Lastly, the 
azaphosphole series of ligands were extremely efficient in terms of reaction yield; however, 
enantioselectivities were lower with this series (entries 15, 17, 18, 19). 
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Table 3.8 Ligand survey in the asymmetric Negishi cross-coupling towards tetra-ortho- 
substituted biaryls. 
 
 
 
 
 
 
aIsolated yield. bDetermined by chiral HPLC 
analysis with Chiralpak OD-H column. 
 
With identification of 3.L13 as the best ligand out of the ligand survey in Table 3.8, we 
further optimized parameters for the Negishi coupling reaction with ligand 3.L13 in an effort to 
improve enantioselection (Table 3.9). The Pd-precatalyst, metal-ligand ratio, Zn-source, and 
solvent were examined in the reaction (Table 3.9). The choice of Pd-precatalyst had little impact 
on the reaction enantioselectivity, but the yield varied from 70–80% (entries 1, 4, 5, 7). The 
Br
1.5 equiv
Me
MeMe
Pd2(dba)3 (2.5 mol%)
ligand (10 mol%)
THF, 60 °C
Me
ZnBr
3.17b 3.40
+
3.18
Entry Ligand % yielda erb 
1 3.L1 69 52.5:47.5 
2 3.L2 49 78.5:21.5 
3 3.L3 ND 81.5:18.5 
4 3.L4 38 82.5:17.5 
5 3.L7 44 72.5:27.5 
6 3.L9 82 76.5:23.5 
7 3.L10 89 83.0:17.0 
8 3.L11 69 85.5:14.5 
9 3.L12 81 71.3:28.7 
10 3.L13 93 85.0:15.0 
11 3.L14 45 82.0:18.0 
12 3.L15 24 83.0:17.0 
13 3.L21 67 77.0:23.0 
14 3.L22 36 65.0:35.0 
15 3.L23 91 60.5:39.5 
16 3.L24 68 61.0:39.0 
17 3.L25 96 82.5:17.5 
18 3.L26 89 79.0:21.0 
19 3.L27 99 53.0:47.0 
20 3.L28 76 60.0:40.0 
21 3.L29 82 78.0:22.0 
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metal-ligand ratio also had no impact on selectivity; however, the yield improved if a 1:1.5 
Pd:3.L13 ratio was employed (entries 8–10). Finally, use of other Zn-salt precursors or other 
solvents did not lead to improvements in reaction efficiency (entries 2, 3, 6, 7).  
 
Table 3.9 Survey of Pd-precatalyst, Pd:3.L13 ratio, Zn-source, and solvent in the Negishi cross-
coupling reaction. 
 
aIsolated yield. bDetermined by chiral HPLC. cThe zinc reagent was prepared from the 
Grignard according to Knochel’s protocol (ref 38a). 
 
To determine if enantioselection in the reaction was variable with reaction progress, the 
enantioselectivity was monitored over time at both 40 and 60 oC (Figure 3.3). Enantioselection 
Br
Me
MeMe
Pd (2.5 mol%)
3.L13 (10 mol%)
solvent, 60 °C
Me
ZnX
3.17b 3.41
+
3.18
3.17b
t-BuLi
THF, –78 oC
then ZnX2
Entry Pd Metal:3.L13 
ratio 
ZnX2 Solvent Yield 
%a 
erb 
1 Pd(OAc) 2 1:2 ZnBr2 THF 81 85.0:15.0 
2 Pd2(dba)3 1:2 ZnBr2 Toluene 80 85.0:15.0 
3 Pd2(dba)3 1:2 ZnBr2 Dioxane 90 85.0:15.0 
4 PdCl2(PhCN)2 1:2 ZnBr2 THF 71 82.0:18.0 
5 [crotylPdCl]2 1:2 ZnBr2 THF 73 83.0:17.0 
6 Pd2(dba)3 1:2 Zn(OAc)2 THF 56 78.0:22.0 
7c Pd2(dba)3 1:2 Zn(OPiv)2 THF 77 84.0:16.0 
8 Pd2(dba)3 1:2 ZnBr2 THF 80 85.0:15.0 
9 Pd2(dba)3 1:1.5 ZnBr2 THF 93 85.0:15.0 
10 Pd2(dba)3 1:1 ZnBr2 THF 76 85.0:15.0 
 154 
was independent of conversion implying that the active catalyst was not changing over time. 
Reduction of the reaction temperature led to slight improvements in enantioselectivity, but 
incomplete conversion was obtained at 40 oC. 
 
 
(a) 60	°C	
 
(b) 40 °C 
 
Figure 3.3 Enantioselectivity vs time at 40 and 60 °C 
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The most efficient catalyst conditions identified in our studies (Table 3.9, entry 9) were 
next utilized to examine the scope of the Negishi cross-coupling to afford other tetra-ortho-
substitued biaryls (Table 3.10). Notably, the Negishi reaction showed much better scope in terms 
of reaction yield relative to the Suzuki–Miyaura reaction albeit with lower enantioselection. For 
the first time, a variety of R-alkyl substituents other than R = Me or OMe have been analyzed in 
an asymmetric cross-coupling reaction to provide tetra-ortho-substituted products (3.39d-f). In 
general, the cross-coupling employing 3.35 with R = n-alkyl afforded comparable results (3.18, 
3.39a,c-f). Methoxy-substitution (3.39b) was not well tolerated and afforded reduced yield due 
to significant amounts of reduction of the aryl bromide as a byproduct. Adding an additional 
methyl-substituent on the naphthalene ring also led to decreased reaction efficiency and 
enantioselectivity (3.39c); however, product formation was observed whereas the corresponding 
Suzuki–Miyaura coupling afforded no reaction with this substrate class (Table 3.7). Finally, the 
present system was specific to coupling naphthalene derivatives. Cross-coupling to afford 3.43 
proceeded in moderate to good yields, but almost no enantioselection was observed despite the 
nature of the alkoxy-substituent.   
 
 
 
 
 
 
 
 
 156 
Table 3.10 Asymmetric Negishi cross-coupling reaction scope. 
 
3.6 Mechanistic Modeling by DFT Analysis. 
The results of our combined studies of the asymmetric Suzuki–Miyaura and Negishi 
cross-coupling reactions employing ligand series 3.33 and 3.36 prompted us to investigate the 
mechanistic differences between these two reactions in terms of the enantiodiscrimination steps. 
Specifically, these ligands gave very different results in the coupling reaction when employed in 
a Suzuki–Miyaura vs a Negishi type protocol, yet mechanistically, the final step in the catalytic 
Pd2(dba)3 (2.5 mol%)
3.L13 (7.5 mol%)
Br
R
RR
R
ZnBr
3.37
(1.0 equiv)
3.42
+
3.37
(1.5 equiv)
t-BuLi
THF, –78 oC
then ZnBr2
THF, 60 oC
14 h
3.18
93%; 85:15 er
3.39a
80%; 75:25 er
3.39d
79% 80:20 er
Me
Me
Et
Et
3.39c
29%; 67:33 er
Me
Me
Me
Me
3.39b
31%; 75:25 er
OMe
OMe
3.43a:  R = Me
 52%; 58:42 er
3.43b:  R = i-Pr
81%; 60:40 er
3.43c:  R = t-Bu
67%; 54:46 er
Me
ORMe
RO
3.39e
81%; 83:17 er
3.39f
61%; 81:19 er
O
O
Ph
Ph
BnO
BnO
R'
R'
R'
R'
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cycle for both processes would presumably proceed through the same reductive elimination 
intermediate (vide supra). To help understand these differences and to aid in the development of 
new ligand structures to improve enantioselectivity, we modeled the cross-coupling process 
using density functional theory (DFT) calculations.39 
 
3.6.1 Negishi Cross-Coupling 
 Most analyses of the stereoselectivity in cross-couplings regard the final step as 
stereodetermining.11b,13b,n,x Such an approach assumes equal accessibility to all of the different 
conformers of the transition state precursors. The percentage of product that forms via each of 
the possible reductive elimination transitions states can then be determined by Boltzmann 
analysis of their relative energies. 
For the system in question here, a defining feature of the Pd biaryl intermediates 
preceding reductive elimination is the hindered rotation along the aryl-Pd bonds due to the large 
size of the aryl groups employed. As such, direct interconversion13f,15a of the different 
conformations of these intermediates does not occur. However, we hypothesize that all the 
conformers will be equally accessible due to the reversibility of transmetalation and oxidative 
addition in the Negishi coupling.40 In such a scenario, a classical analysis of just the reductive 
elimination transition states pertains. Thus, all four of the possible biaryl palladium isomers need 
to be considered, each giving rise to two reductive elimination transition states, pro-S and pro-R 
(Figure 3.4).  
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Figure 3.4. Stereoselection in Negishi coupling 
 
Analyzing reductive eliminations for the Me-BOP ligand 3.L2 in such a fashion, we 
found that there is one dominant transition state for each of pro-S and pro-R sets, controlling the 
overall selectivity (Figure 3.5). 
 
 
Figure 3.5 Lowest energy pro-S and pro-R reductive elimination transition states for Me-BOP 
ligand 3.L2. Total of 8 transition states were located and analyzed. Free energies were 
computed using M06/6-311+G(d,p)-LANL2DZ(Pd)-SMD-THF//B3LYP/6-31G(d)-
LANL2DZ(Pd); values are in kcal/mol. 
 
Coordination of Pd to the methoxy-group of the lower aryl ring of the Me-BOP ligand 
provides extra stabilization for the pro-S transition state, resulting in highly S-selective reaction. 
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For the pro-R transition state, such an arrangement is not favorable due to the steric interactions 
with the ligand. A correlation between the electron-donating properties of the lower ring 
substituent (sp) and the experimental er of the product supports the contribution of this specific 
substituent to the enantioselection mechanism (Figure 3.6).   
 
 
Figure 3.6 Efficiency of the chiral Me-BOP ligand vs electron donating property of the lower 
aryl-ring substituent 
 
When the Negishi coupling is performed with the alternate DMM-substituted BOP ligand 
(NitinPhos, 3.L7), enantioselectivity drops. This result can be rationalized using the same 
approach. Analysis of the selectivity-determining transition states revealed that the additional 
coordinating group of the DMM-substituent of NitinPhos ligand 3.L7 allows selective 
stabilization of the higher energy pro-R transition state (Figure 3.7), which diminishes the pro-R 
– pro-S energy gap and hence the selectivity of the overall process. 
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Figure 3.7 Lowest energy pro-S and pro-R reductive elimination transition states for the DMM-
BOP  ligand (NitinPhos, 3.L7). Total of 32 transition states were located and analyzed. Free 
energies were computed using M06/6-311+G(d,p)-LANL2DZ(Pd)-SMD-THF//B3LYP/6-
31G(d)-LANL2DZ(Pd); values are in kcal/mol.  
 
This analysis of the reductive elimination transition states for the Negishi reaction 
rationalizes the experimentally observed enantioselectivities and highlights the key interactions 
(Figure 3.8). 
 
 
Figure 3.8 Comparison of the experimental and calculated efficiencies of the ligands in the 
Negishi coupling.  
 
3.6.2 Suzuki–Miyaura Cross-Coupling 
The different performance of the DMM-BOP ligand (NitinPhos, 3.L7) in the Suzuki–
Miyaura coupling requires a different enantioselection mechanism. Irreversible transmetalation41 
in Suzuki–Miyaura coupling would prevent pre-equilibration of pre-reductive elimination Pd(II) 
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species. As such, enantioselectivity of the overall process would be determined not only by the 
energetics of reductive elimination, but also by the relative population of the pre-reductive 
elimination Pd(II) intermediates. Thus, it is necessary to consider the relative rates of formation 
of corresponding species by modeling the transmetalation step. Based on the proposed structures 
of the pre-transmetalation intermediates,42 the same hindered rotation issues are expected as for 
the pre-reductive elimination intermediates. Therefore, pre-transmetalation intermediates 
partition into two groups that react via independent pathways. In turn, the population of the pre-
transmetalation intermediates is controlled by the energetics of oxidative addition. Therefore, all 
three major steps of the cross-coupling mechanism contribute to the overall selectivity of the 
reaction (Figure 3.9). Earlier computational studies of the stereoselectivity in Suzuki–Miyaura 
cross-coupling suggest that oxidative addition is the stereodetermining step.43 We further 
develop this idea of early enantioinduction by employing the experimental findings of 
Denmark,42a,b Hartwig, 42c and others42d,e that point to the mechanism of the transmetalation step 
proceeding through a Pd-OH complex.17 The exact mechanism for the transmetalation step in 
Suzuki–Miyaura cross-coupling is still somewhat controversial39 as there are some reports44 that 
support the alternate “boronate”-transmetalation pathway.45 The studies reported herein are 
calculated using the Pd-OH transmetalation pathway;42 however, we would like to stress that the 
model proposed herein is also compatible with the “boronate”-transmetalation44,45 mechanism:  
both possibilities ultimately lead to the same transmetalation transition states. The nature of the 
incoming boron species (boronate vs boronic acid) is not crucial for the selection of the 
productive oxidative addition step (discussed later) as the same steric interactions are present. 
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Figure 3.9 Proposed stereoselection mechanism in Suzuki coupling. Species separated by dashed 
lines cannot equilibrate. Rotation around the bonds marked in red is hindered.  
 
Hence, detailed computational analysis of all the steps of the coupling is required. The 
resultant three-layer selectivity mechanism is shown in Figure 3.9. This important difference 
between the Suzuki–Miyaura and Negishi couplings is the result of the irreversible nature of 
transmetalation in Suzuki–Miyaura coupling. As such, the difference in the energetics of 
transmetalation significantly complicates the stereoselection process, which explains the well-
known challenges in the design of stereoselective Suzuki–Miyaura couplings.  
This analysis of the Suzuki–Miyaura coupling focuses two very similar ligands, DMM- 
and DME-BOP (3.L7 vs 3.L6, respectively). Despite minor differences in structure, these ligands 
provide substantially different selectivity levels. The following study rationalizes these 
selectivity differences within the proposed multi-level selectivity framework. To begin, a 
detailed analysis of the DME-BOP (3.L6) ligand is outlined.  
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3.6.2.1 Oxidative Addition 
Oxidative addition to Pd(0) can occur via two pathways, A and B (Figure 3.10). 
Exchange of the bromide ultimately leads to several isomers of the PdOH species (Figure 3.11). 
 
 
Figure 3.10 Oxidative addition pathways in Suzuki coupling. Intermediates marked in red are 
inert in transmetallation step. Enthalpies and free energies (in brackets) were computed using 
B3LYP-d3/6-31G(d)-lanl2dz(Pd, Br); values are in kcal/mol. Reactions are balanced using water 
as the OH source and HBr as the by-product of the exchange. 
 
In considering the PdOH isomers (Figure 3.11), only iso1 is ultimately relevant to the 
next step, transmetalation.  For transmetalation to take place, the hydroxyl group and the vacant 
orbital in PdOH species must be positioned cis on the metal center, which rules out iso2 and 
iso3. Isomers iso4 and iso5 gave severe destabilizing steric interactions between ligand and the 
naphthyl group, making them unlikely to be formed.  Furthermore, iso6 is not active in 
transmetalation as the vacant orbital is blocked by the ligand, so the approach of incoming 
boronic acid is problematic. As a consequence, only iso1, which arises from oxidative addition 
pathway A, needs to be analyzed. Given the activity of iso1 PdOH in transmetalation, we 
theorize that the other species may eventually convert to iso1.  
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Figure 3.11 Isomeric PdOH intermediates. 
 
Pathway A oxidative addition can occur via two conformations, corresponding to 
different orientations of the aryl group (‘up’ and ‘down’, see Figure 3.12).  The relative energies 
of these conformations ultimately translate to the ratio of the PdOH species after exchange of the 
bromide. Based on the energies of oxidative addition transition states, 85% of the formed PdOH 
arises from OA A1 where the methyl of the naphthyl unit is pointing ‘away’. This selectivity is 
attributed to an unfavorable methyl-ligand interaction in the transition state OA A2 (red arrow, 
Figure 3.12 insert). This differentiation sets up the first layer in the enantioselection mechanism. 
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Figure 3.12 Energetics and selectivity of the productive oxidative addition pathway in Suzuki 
coupling. Total of 8 oxidative addition transition states were located and analyzed. Enthalpies 
and free energies (in brackets) were computed using B3LYP-d3/6-31G(d)-LANL2DZ (Pd, Br); 
values are in kcal/mol. From here on the reactions are balanced using KOH as the OH source and 
KBr as the by-product of PdOH formation. 
 
3.6.2.2 Transmetalation 
The resultant PdOH intermediates form a pre-transmetalation complex with the boronic 
acid (preTM, insert in Figure 3.13). The incoming boronic acid can coordinate such that the 
methyl substituents on the naphthyl rings are cis or trans. Starting from the major PdOH adduct 
(PdOH_iso 1_a, Figure 3.12), the trans adduct is more favorable due to the lack of Me-Me 
repulsion. This interaction also controls the energies of the concomitant transmetalation 
transition states (TM TS cis and trans, Figure 3.13). The energy gap between transition states 
results in 85% of the pre-RE-trans product vs 15% of the pre-RE-cis product. For the minor 
PdOH adduct (PdOH_iso 1_b, Figure 3.12), these trends are reversed (see Figure 3.14) due to 
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3.14) predomominates over the trans (pre-RE-trans, Figure 3.14) adduct (76% vs 24%). During 
the transmetalation process, an equivalent of boronic acid is released that exists as the borate 
under the basic reaction conditions.46  
 
 
Figure 3.13 Energetics and selectivities of the transmetalation and reductive eliminations arising 
from the major PdOH isomer. Total of 8 transmetalation transition states and 16 reductive 
elimination transition states were located and analyzed. Enthalpies and free energies (in brackets) 
were computed using B3LYP-d3/6-31G(d)-LANL2DZ (Pd, Br); values are in kcal/mol. 
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Figure 3.14 Energetics and selectivities of the transmetalation and reductive eliminations arising 
from the minor PdOH isomer. Total of 10 transmetalation transition states and 16 reductive 
elimination transition states were located and analyzed. Enthalpies and free energies (in brackets) 
were computed using B3LYP-d3/6-31G(d)-lanl2dz (Pd, Br); values are in kcal/mol. 
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pre-reductive elimination intermediate affords the R-isomer with excellent selectivity, while the 
trans isomer furnishes exclusively the S-product (reductive eliminations, Figure 3.13).  
The extremely high selectivity of the individual reductive eliminations is due to the 
compact nature of the transition states. Even minor deviations from the optimal arrangement 
result in significant energetic penalties. For example, the reductive elimination transition states 
from the major PdOH isomer depicted in Figure 3.13, illustrate these phenomena (Figure 3.15). 
For the pre-RE-trans isomer, tr S transition state (100%) is much more favorable than tr R, in 
which interactions of the methyl of the upper naphthyl unit (arising from the aryl bromide) and 
the back side of the ligand destabilize the structure. Similarly, cis R (100%) is more stable than 
cis S for the pre-RE-cis isomer. 
 
 
Figure 3.15 Lowest energy pro-S and pro-R reductive elimination transition states from the 
major trans and cis isomers of diaryl Pd. 
 
As the orientation of the naphthyl fragment is important for the high stereoselectivity of 
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from the minor PdOH isomer (Figure 3.14), where the upper naphthyl unit is rotated in the 
opposite direction. Indeed, the pre-RE-cis is only moderately selective towards reductive 
elimination vs cis R (65%). Reductive elimination from pre-RE-trans remains highly selective 
(100% tr R) because the methyl group on the lower ring is pointing toward a sterically crowded 
portion of the transition state.  
However, the relative energies of the reductive elimination transition states do not tell the 
whole story as the intermediates needed for this step form at different rates with both oxidative 
addition and transmetalation contributing to the partitioning. Figure 3.16 illustrates a simplified 
version where different conformational isomers are not shown for each of the branches. 
Oxidative addition leads to two branches (left = minor, right = major), which again bifurcate at 
transmetalation and reductive elimination. The pathway highlighted with blue arrows is the only 
S-selective channel on the diagram. Even though there are more pathways to the R-enantiomer, 
the S-selective channel is lower in energy and is the main route responsible for formation of the 
product.  
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Figure 3.16 Simplified energy diagram for Suzuki coupling with DME-BOP (3.L6) ligand. 
Selectivities of each step were calculated based on the Boltzmann distribution of the energies of 
corresponding transition states. (Alternatively, such multi-level processes can be analyzed using 
a system of rate equations, i.e. microkinetic modeling.47) 
 
Analysis of the DMM-BOP (NitinPhos, 3.L7) ligand generates a similar outcome (Figure 
3.17). The entire transformation is still S-selective and just like in a previous case, there is only 
one pathway responsible for the production of the major product. However, this pathway is more 
favorable than it is in the DME-BOP (3.L6) case. For the DMM ligand (NitinPhos, 3.L7) 
transmetalation selectivity in the ‘major branch’ (Figure 3.17) is 90:10, whereas for the DME 
ligand it is at a slightly smaller 85:15. This difference causes selectivity levels to be higher for 
DMM (NitinPhos, 3.L7).  
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Figure 3.17 Simplified energy diagram for Suzuki coupling with DMM-BOP (NitinPhos, L7) 
ligand. 
 
If one assumes that the entire reaction is controlled only by the selectivity of the major 
branch, then the difference in the transmetalation energetics would predict the experimentally 
observed selectivities with improved accuracy (see ‘major branch’ selectivities on each of the 
diagrams). Thus, our model would predict 85% S selectivity for DME-BOP (3.L6) ligand vs 86% 
experimental and 90% S selectivity for DMM-BOP (NitinPhos, 3.L7) ligand vs 94% 
experimental. Given the complex nature of the selectivity mechanism and the large number of 
transition states that contribute to the finalized percentages (26 transition states conformers were 
analyzed and utilized in Boltzmann distributions), this result may indicate that the major branch 
is indeed the only controlling channel. Such a situation would occur if our estimates of the pre-
transmetalation intermediates are not entirely accurate. In our work we tested five computational 
methods (different combinations of various optimization and single-point calculations) with 36-
56 transition state conformations depending on the method. These analyses did not improve the 
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quality of the predictions. This high sensitivity of the selectivity estimates to the type of method 
used may indicate that our method of choice is not optimal and leads to incorrect estimates of the 
energetics of major/minor branch splitting. It might also point to the existence of other 
selectivity-contributing steps (for example, Br exchange) that were not considered. 
Since the transmetalation selectivity in the major branch seems to account for the 
observed difference in the performance of the ligands, we undertook further study of the 
transmetalation step. As discussed earlier, each of the energy levels shown on the diagrams 
represents only the lowest energy structure out of a set of calculated conformational isomers. 
Importantly, molecules traversing the reaction coordinate proceed through a distribution of 
available conformational transition states rather than through the single lowest energy pathway;48 
therefore, the calculated selectivities given in this study were determined using the energies of all 
the available conformations identified by calculation. This consideration accounts for the 
computationally observed different transmetalation selectivities of the DMM-BOP (NitinPhos, 
3.L7) and DME-BOP (3.L6) ligands (Figure 3.18). For the DMM-BOP (NitinPhos, 3.L7) ligand, 
the transmetalation pathways leading to S-selective reductive elimination are more populated 
than that for the DME (3.L6) ligand (90% vs 85%), while the other pathways are less populated 
(10% vs 15%). This result arises from the greater partitioning to the S-selective transition states 
for the DMM-BOP ligand which are clustered close together relative to those for the DME-BOP 
ligand which cover a larger range and are less populated overall relative to the R-selective 
transition state.  This phenomenon accounts for the improved transmetalation selectivity obtained 
with the DMM-BOP ligand (3.L7) vs the DME-BOP ligand (3.L6), and can be explained 
structurally by the presence of hydrogen bonding interactions between weak C–H hydrogen bond 
donors of the methylnaphthalene coupling partners with the methoxy-group of the DMM-BOP 
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ligand that is not possible in the DME-BOP ligand case (i.e. 3.42 vs 3.45). Hydrogen bond 
contacts between the methoxy-group of NitinPhos (3.L7) and C–H bonds of the 
methylnaphthalene coupling partners are present in transmetalation transition states (3.42, 3.43). 
The bond distances for these O–H interactions are within the distance and angles typical of weak 
C–H–O hydrogen bonds (2.2–2.8 A; 3.42: Csp2–H–O = 119o, Csp3–H–O = 157o; 3.43:  Csp3–H–O 
= 158o, 135o).13b,49 These stabilizing interactions cause fewer accessible low-energy 
transmetalation transition state conformations to be available in the DMM-BOP ligand case 
because rotation of the DMM-group results in loss of these interactions which creates a higher 
energy gap between these conformations such that they cannot contribute to product formation. 
In contrast, the DME-BOP ligand does not have these interactions, and therefore, the energy 
splitting between conformers is less severe and leads to several accessible pathways of various 
energy levels with slight differences in steric interactions due to the orientation of the ethyl-
group of the DME-substituent. Finally, it is worth noting that direct coordination of the methoxy-
substituent of the DMM-BOP ligand (3.L7) to the metal center was not found in any of the 
relevant transition states. 
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Figure 3.18 Relative energies (in bold), and relative populations of the major branch 
transmetalation transition states for DMM-BOP (NitinPhos, 3.L7) and DME-BOP (3.L6) 
ligands. Green lines represent C–H---O hydrogen bonding interactions. Dashed lines indicate 
additional high-energy conformations that do not significantly contribute to the population 
distribution. 
 
This DFT study of the stereoselectivity of Suzuki–Miyaura coupling allowed us to 
propose a multi-step stereoselection framework. This mechanism is likely to operate in the 
coupling of sterically hindered substrates, where isomeric organometallic intermediates do not 
readily interconvert.  
 
3.7 Conclusion 
In conclusion, Pd-catalyzed asymmetric Suzuki–Miyaura and Negishi cross-coupling 
reactions to form tetra-ortho-substituted biaryls were developed. Higher enantioselectivities were 
obtained for the Suzuki–Miyaura reaction; however, better substrate generality was obtained for 
the Negishi coupling. For each coupling reaction, a unique ligand was identified to be optimal 
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for the Suzuki–Miyaura vs the Negishi reaction in terms of providing maximum enantioselection. 
Detailed DFT calculations of these two processes offered an explanation for the differences in 
the enantiodiscrimination mechanism between the Suzuki–Miyaura and Negishi cross-coupling 
reactions that likely proceed through the same Pd-intermediate for reductive elimination.  
Analysis of only the reductive elimination step in the Negishi cross-coupling reaction by 
DFT provided good correlation with the experimental enantioselectivity, implying that reductive 
elimination was enantiodetermining. In contrast, this same analysis for the Suzuki–Miyaura 
coupling did not accurately predict the observed experimental selectivities. A complete analysis 
of the oxidative addition, transmetalation, and reductive elimination steps in the Suzuki–Miyaura 
reaction using DFT revealed that the selectivity in the Suzuki–Miyaura reaction was influenced 
by all three steps in the catalytic cycle. The delicate interplay of oxidative addition, 
transmetalation, and reductive elimination calculated for stereocontrol in the Suzuki–Miyaura 
cross-coupling reaction for the formation of tetra-ortho-substituted biaryls may be the reason 
why the Suzuki–Miyaura reaction was less tolerant to substrate modifications relative to the 
analogous Negishi reaction. These findings may aid in the design and development of new 
catalysts to improve reactivity and selectivity in asymmetric cross-coupling reactions to furnish 
tetra-ortho-substituted biaryls.  
 
3.8 Experimental Section 
3.8.1 Materials and Methods 
1H NMR spectra were recorded on Bruker 400 MHz or 500 MHz spectrometers. 
Chemical shifts are reported in ppm from tetramethylsilane with the solvent resonance as an 
internal standard (CDCl3: 7.26 ppm, CD2Cl2:  5.32 ppm). Data are reported as follows: chemical 
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shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, h = 
hextet, hept = heptet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR was 
recorded on a Bruker 500 MHz (125 MHz) or 400 MHz (100 MHz) instrument with complete 
proton decoupling. Chemical shifts are reported in ppm from tetramethylsilane with the solvent 
as the internal standard (CDCl3: 77.0 ppm, CD2Cl2:  54 ppm). 31P shifts were referenced to 85% 
H3PO4 in D2O at 0.0 ppm as external standard and obtained with 1H decoupling. Liquid 
chromatography was performed using forced flow (flash chromatography) on silica gel using a 
Biotage system. Thin layer chromatography (TLC) was performed on EMD silica gel F254 
2.5x7.5 cm plates. Visualization was achieved using UV light or potassium permanganate in 
water followed by heating. HRMS was collected using Thermo LTQ FT Ultra mass spectrometer 
at 100,000 resolving power using DART source ionization. All reactions were conducted in oven 
or flame dried glassware under an inert atmosphere of nitrogen or argon with magnetic stirring 
unless otherwise noted. THF (<0.02% water content), CH2Cl2, EtOH, EtOAc, IPAc, Diglyme, 
MeOH, DMF, hexane and toluene were purchased from Sigma Aldrich and used directly without 
further purifications. PMHS (polymethylhydrosiloxane) and TMDS (1,1,3,3-
tetramethyldisiloxane) were purchased from Aldrich and used without further purifications. 
Solvents were degassed by Ar sparge. Ligand 3.L1,13n 3.L2,13n,24 3.L4,13o 3.L9,29 3.L10,23 
3.L19,24 3.L20,11b and 3.L237v,35b were prepared according to our previously published 
procedures. 1-Bromo-2-ethylnaphthalene and 1-bromo-2,3-dimethylnaphthalene were prepared 
according to the literature.9 All other reagents were purchased from either Fisher or Aldrich 
Chemical Companies and used directly. 
 
 
 177 
3.8.2 Experimental Procedures 
3.8.2.1 Synthetic Route to Ligands 
 
Figure 3.19 General synthetic route to various ligand scaffolds. 
 
 
To a solution of 3.84 g (11.1 mmol) of BIDIME oxide (3.29a) in 20 mL of THF at –78 
°C was slowly added a solution of LDA in THF (2M, 20 mL, 40 mmol). The mixture was 
allowed to sitr at –78 °C for 1 h. Iodoethane (3.26 mL, 40.5 mmol) was then added dropwise at –
78 °C. The resultant mixture was allowed to stir at –78 °C for 2 h and then allowed to warm to 
23 °C overnight. Water was then added, and the mixture was extracted with CH2Cl2. The 
combined organic layers were washed with brine, dried with anhydrous Na2SO4, and 
concentrated in vacuo. The crude residue was purified by flash chromatography (gradient, 20 – 
70% EtOAc/hexanes) to afford 2.3 g (55%) of oxide 3.31a as a white solid. [α]D22 = – 20.4 (c 
0.69, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.47 (t, J = 7.9 Hz, 1H), 7.29 (t, J = 8.4 Hz, 1H), 
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6.87–6.89 (m, 2H), 6.64 (d, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4, 1H), 4.28–4.31 (m, 1H), 3.77 (s, 
3H), 3.72 (s, 3H), 1.97 (q, J = 7.5 Hz, 2H), 1.16 (t, J = 7.4, 3H), 0.84 (d, J = 16, 9H); 
31P{1H}NMR (162 MHz, CDCl3): δ 59 ppm; 13C{1H}NMR (100 MHz, CDCl3):  δ 163.9 (d, JCP 
= 19 Hz), 158.8, 157.3, 138.4 (d, JCP = 5.0 Hz), 133.9 (d, JCP = 1.7 Hz), 129.8, 124.7 (d, JCP = 
8.2 Hz), 117.5, 114.4 (d, JCP = 90 Hz), 112.2 (d, JCP = 5.5 Hz), 104.5, 103.0, 75.1 (d, JCP = 62 
Hz), 56.1, 55.4, 33.3 (d, JCP = 71 Hz), 23.7, 23.4, 10.4 (d, JCP = 7.3 Hz); HRMS (DART) m/z 
calculated for C21H28O4P [M + H]+:  375.1720; found:  375.1722. 
 To a 200 mL two-neck round bottom flask with magnetic stir-bar was charged 2.0 g (5.3 
mmol) of oxide 3.31a. A reflux condenser was added, and the reaction was inerted with Ar using 
vacuum-purge cycles (3x). Toluene (25 mL) was charged followed by triethylamine (3.44 mL, 
25 mmol) and HSiCl3 (1.88 mL, 18.8 mmol). The mixture was then immersed in an oil bath at 
65 °C and monitored by 31P NMR spectroscopy. After 12 h, the reaction was cooled to 23 °C and 
quenched with 20 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed 
to vigorously stir at 23 °C for 1 h. The flask was transferred in the glove box. The aqueous layer 
was removed and subsequently extracted with MTBE (2 × 15 mL). The combined organics were 
dried with Na2SO4, filtered quickly through a pad of basic alumina, and immediately 
concentrated in vacuo to afford 1.7 g (92%) of 3.L3 as a white solid. [α]D22 = – 125 (c 0.51, 
CHCl3); 1H NMR (400 MHz, CDCl3): δ 7.26–7.32 (m, 2H), 6.82–6.86 (m, 2H), 6.64 (d, J = 8.3, 
1H), 6.58 (d, J = 8.3 Hz, 1H), 4.76 (t, J = 6.8, 1H), 3.73 (s, 3H), 3.71 (s, 3H), 1.69–1.82 (m, 2H), 
1.01 (t, J = 7.2, 3H), 0.73 (d, J = 12, 9H); 31P{1H}NMR (202 MHz, CDCl3): δ 3.9 ppm; 
13C{1H}NMR (100 MHz, CDCl3):  δ 163.2, 157.8, 157.1, 138.5 (d, JCP = 17 Hz), 130.4, 128.9, 
124.3 (d, JC-P = 13 Hz), 123.4 (d, JC-P = 4.0 Hz), 119.8, 109.4, 104.4, 103.6, 84.7 (d, JC-P = 22 
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Hz), 55.8, 55.4, 30.8 (d, JC-P = 18 Hz), 28.5 (d, JCP = 26 Hz), 26.7 (d, JCP = 14 Hz), 10.2 (d, JCP = 
13 Hz); HRMS (DART) m/z calculated for C21H28O3P [M + H]+:  359.1771; found:  359.1770. 
 
 
To a solution of BIDIME oxide (3.29a, 6.0 g, 17.5  mmol, 1 equiv) in THF (60 mL) at –
78 °C was added LDA (10.5 mL, 2.0 M in heptane/THF/chlorobenzene, 21.0 mmol, 1.2 equiv). 
The mixture was stirred at –78 °C for 30 min before dropwise addition of 2-methyl-1-nitroprop-
1-ene (2.05g, 19.2 mmol, 1.1 equiv, 95% purity). The resulting mixture was kept at –78 °C for 1 
h before it was warmed to 23 °C over 1 h. After stirring at 23 °C for 1h, saturated aqueous 
NH4Cl and EtOAc were added to the mixture. The aqueous layer was further extracted with 
EtOAc. The combined EtOAc solution was washed with brine, dried over MgSO4, concentrated 
to give the crude product (3.31b, 2.34 g, crude product was used in the next step without any 
purification). 1H NMR (500 MHz, CDCl3): δ  7.51 (t, J = 8.0 Hz, 1H), 7.29 (t, J = 8.4 Hz, 1H), 
6.94 (ddd, J = 13.0, 7.3, 3.5 Hz, 2H), 6.62 (d, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 1H), 4.85 (d, J 
= 11.3 Hz, 1H), 4.56 (d, J = 11.3 Hz, 1H), 4.42 (d, J = 2 Hz, 1H), 3.72 (d, J = 1 Hz, 6H), 1.33 (s, 
3H), 1.32 (s, 3H), 0.9 (d, J = 15.8 Hz, 9H); 31P NMR (202 MHz, CDCl3): δ 61.18 ppm; 13C NMR 
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(125 MHz, CDCl3): δ 163.4 (d, J = 19.2 Hz), 158.5, 157.1, 138.6 (d, J = 5.3 Hz), 134.5 (d, J = 
2.0 Hz), 129.9, 125.4 (d, J = 8.6 Hz), 116.3 (d, J = 2.2 Hz), 113.1 (d, J = 92.0 Hz), 111.5 (d, J = 
5.8 Hz), 104.0, 103.0, 82.2 (d, J = 4.4 Hz), 75.5 (d, J = 57.0 Hz), 55.5, 55.3, 40.6 (d, J = 1.0 Hz), 
34.2 (d, J = 71.0 Hz), 23.1 (d, J = 1.0 Hz), 21.2 (dd, J = 10.4, 3.7 Hz). HRMS (DART) m/z 
calculated for C23H31O6NP [M+H]+:  448.1884; found:  448.1885. 
To a solution of 3.31b (0.3 g, 0.67 mmol, 1 equiv) in methanol (5 mL) was charged a 
mixture of 0.5M disodium phosphate, Na2HPO4 (12.07 mL, 6.03 mmol, 9.0 equiv) and 1M 
sodium hydroxide, NaOH (12.07 mL, 12.07 mmol, 18.0 equiv) and stirred for 1 h. To the 
resulting suspension was charged a solution of Oxone (1.23g, 2.01 mmol, 3.0 equiv) in water 
(2.0 mL) and stirred at 23 °C for 24h. Upon reaction completion by HPLC, the reaction mixture 
was acidified with 4N aqueous HCl (3.0 mL, 12.07 mmol, 18.0 equiv) to maintain pH ~ 1-2. The 
mixture was extracted with isopropyl acetate, IpOAc (2 x 5 mL). The combined organic layer 
was washed with water, brine and then dried over sodium sulfate before solvent evaporation to 
afford the desired carboxylic acid product (0.261 g) that was used directly in the next step.  
To a solution of the carboxylic acid (0.261 g, 0.604 mmol, 1 equiv) in THF (5 mL) at 0 
°C was charged 1 M solution of BH3•THF (1.21 mL, 1.21 mmol, 2 equiv) under nitrogen 
atmosphere. The resulting mixture was allowed to warm to 23 °C and stirred overnight. Upon 
reaction completion (HPLC), the reaction mixture was quenched with methanol (0.5 mL) and 
water (0.5 mL) and stirred for 30 min. The volatiles (THF, MeOH) were removed by Rotavap 
and the residue was diluted with EtOAc (5 mL) and washed with water (2 mL). The organics 
were concentrated to afford desired primary alcohol product (0.253 g) that was used directly in 
the next step.  
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To the solution of the primary alcohol (0.250 g, 0.6 mmol, 1 equiv) was charged dry 
pyridine (1.25 mL) and p-toluenesulfonyl chloride (0.24 g, 1.26 mmol, 2.1 equiv) under nitrogen. 
The resulting mixture was stirred at 23 °C for 24 h, after which the reaction mixture was diluted 
with EtOAc (5 mL) and sat. ammonium chloride (3 mL). The top organic layer was concentrated 
to afford the desired tosylate product (0.37 g) that was used directly in the next step without any 
purification.   
To a solution of the tosylate (200 mg, 0.28 mmol, ~ 1 equiv) in 2-MeTHF (4 mL) was 
charged anhydrous lithium iodide (510 mg, 3.81 mmol, 13.7 equiv) under nitrogen, heated to 80 
°C (reflux) and stirred for 15 h and cooled to 23 °C The reaction mixture was quenched with 
10% sodium thiosulfate solution (0.5 mL) and water (1 mL) and extracted with EtOAc (2 x 2 
mL). The organics were combined and concentrated under reduced pressure to give crude residue 
which was then purified using silica gel chromatography (0-100% EtOAc) to afford the desired 
iodide product (3.31c, 152 mg, 0.264 mmol, 95% crude yield with 92 area% purity) as an oily 
residue.  
To the solution of iodide 3.31c (153 mg, 1 equiv) in toluene (5 mL) were charged 
tributyltin hydride (180 mg, 0.612 mmol, 2.10 equiv) and AIBN (28.0 mg, 0.18 mmol, 60 mol%) 
under nitrogen and then heated to 80 °C for 2 h. The reaction mixture was cooled to 23 °C and 
quenched with methanol (2 mL) and sat. ammonium chloride (4 mL). The resulting mixture was 
extracted with toluene (5 mL). The organic layer was dried over sodium sulfate and concentrated 
under reduced pressure to afford crude residue, which was purified using silica gel 
chromatography (Rf: 0.52 in 1:1 EtOAc in hexanes) using 0-90% EtOAc in hexanes to afford 
3.31d (104 mg, 89%) as a white solid. 1H NMR (400 MHz, CDCl3): δ 7.47 (t, J = 8.0 Hz, 1H), 
7.27 (t, J = 8.4 Hz, 1H), 6.89–6.85 (m, 2H), 6.63 (d, J = 8.3 Hz, 1H), 6.55 (d, J = 8.3 Hz, 1H), 
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3.99 (d, J = 3.0 Hz, 1H), 3.74 (s, 3H), 3.72 (s, 3H), 1.17 (s, 9H), 0.89 (d, J = 15.4 Hz, 9H); 31P 
NMR (162 MHz, CDCl3): δ 59.80 ppm; 13C NMR (100 MHz, CDCl3): δ 163.9 (d, J = 20.0 Hz), 
158.7, 157.1, 138.5 (d, J = 5.0 Hz), 134.0 (d, J = 1.7 Hz), 129.6, 124.6 (d, J = 8.4 Hz), 116.7 (d, 
J = 2.0 Hz), 114.0 (d, J = 91.0 Hz), 111.4 (d, J = 5.6 Hz), 104.0, 102.8, 80.4 (d, J = 59.3 Hz), 
55.6, 55.3, 36.4, 33.9 (d, J = 71.5 Hz), 25.9 (d, J = 3.8 Hz), 23.2. HRMS (DART) m/z calculated 
for C23H32O4P [M+H]+: 403.2033; found: 403.2033. 
To a solution of 3.31d (61 mg, 0.151 mmol, 1.0 equiv) in THF (2.3 mL) at 23 °C was 
added PMHS (0.15 g) and Ti(Oi-Pr)4 (0.150 mL, 0.52 mmol, 3.4 equiv). The mixture was stirred 
at reflux for 12 h, and then concentrated under vacuum to remove most THF. 30% aqueous 
NaOH solution (3 mL) was carefully added to the residue. Gas was generated during addition. 
The resulting mixture was further stirred at 60 °C for 0.5 h. To the mixture at 23 °C was added 
MTBE (5 mL). The MTBE layer was separated and the aqueous layer was washed with MTBE 
(2 x 5 mL) under nitrogen. The MTBE solution was dried, concentrated, and purified by passing 
through a neutral alumina plug to afford 3.L5 (20 mg, 35%) as a white crystalline solid. 1H NMR 
(400 MHz, CDCl3): δ 7.23–7.18 (m, 2H), 6.77 (d, J = 8.09 Hz, 1H), 6.71 (dd, J = 7.3, 3.0 Hz, 
1H), 6.56 (d, J = 8.5 Hz, 1H),  6.50 (d, J = 8.3 Hz, 1H), 4.38 (s, 1H), 3.65 (s, 3H), 3.64 (s, 3H), 
0.93 (s, 3H), 0.65 (d, J = 12.0, 9H); 31P NMR (202 MHz, CDCl3): δ -3.36 ppm; 13C NMR (100 
MHz, CDCl3): δ 163.6, 156.8, 156.0, 137.0 (d, J = 17.8 Hz), 129.2, 127.8, 123.3 (d, J = 14.2 Hz), 
122.2 (d, J = 4.1 Hz), 118.7, 107.6, 103.2, 102.5, 92.0 (d, J = 30.5 Hz), 54.6, 54.4, 35.1 (d, J = 
16.4 Hz), 29.7 (d, J = 18.0 Hz), 25.5 (d, J = 14.5 Hz), 25.1 (d, J = 8.6 Hz). HRMS (DART) m/z 
calculated for C23H32O3P [M+H]+:  387.2084; found:  387.2083. 
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To a solution of 3.31b (0.7 g, 1.56 mmol, 1.0 equiv) in THF (8.0 mL) was added 2.0 M 
LDA/THF/EtPh/heptane (2.4 mL, 4.7 mmol, 3.0 equiv) at –78 °C under argon atmosphere. The 
resulting mixture was aged at –78 oC for additional 30 min before it was warmed to –30 °C for a 
brief hold of 30 min and then was cooled back to –78 °C using a dry ice/acetone bath. To the 
resulting solution, was charged iodomethane (1.1 g, 7.82 mmol, 5.0 equiv) and then allowed to 
age for 12 h while warming up to 23 °C. The reaction mixture was quenched with saturated 
ammonium chloride (5 mL) and extracted with EtOAc (2 x 20 mL). The organics were combined 
and washed with water (15 mL). The resulting organics were dried over magnesium sulfate and 
concentrated under reduced pressure to afford oily residue. The crude residue was purified by 
silica gel column chromatography using 0-60% EtOAc in hexanes to afford 0.68 g of crude 31e 
as a foam in a 2:1 diastereromeric mixture (from methylation) along with the unreacted starting 
material in 25-30 area%. Rf 0.256 (30% EtOAc in hexanes). This crude mixture was used 
directly in the next step. HRMS (DART) m/z calculated for C24H33O6NP [M+H]+:  462.2040; 
found:  462.2042. 
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To the solution of 3.31e (0.68 g, 1.06 mmol, 1.0 equiv, 70% purity) in degassed toluene 
(13 mL) were charged tributyltin hydride (3.09 g, 10.6 mmol, 10.0 equiv) and AIBN (2,2’-
Azobis(2-methylpropionitrile) (122 mg, 0.74 mmol, 0.75 equiv) under argon. The resulting 
mixture was heated to 110 °C (reflux) for 12 h and then cooled to 0 °C using an ice/salt bath. The 
reaction mixture was quenched with 1M NaOH (10.6 mL, 10.6 mmol, 10.0 equiv) and stirred for 
additional 2 h at 23 °C. The resulting milky white biphasic layers were passed through a short 
Celite pad and the filtrate was diluted with water (5 mL). The layers were separated and an 
aqueous layer was extracted with toluene (15 mL). The organics were combined and washed 
with saturated ammonium chloride (10 mL). The resulting organics were dried over magnesium 
sulfate and concentrated to afford crude product, which was purified using silica gel column 
chromatography using 0-100% EtOAc in hexanes to afford 0.260 g of 3.31f as an off-white solid 
(59%). Rf = 0.38 in 30% EtOAc in hexanes. 1H NMR (400 MHz, CDCl3): δ 7.48-7.45 (m, 1H), 
7.26 (t, J = 8.4 Hz, 1H), 6.89–6.83 (m, 1H), 6.62 (d, J = 8.3 Hz, 1H), 6.53 (d, J = 8.3 Hz, 1H), 
4.07 (d, J = 2.5 Hz, 1H), 3.73 (s, 3H), 3.71 (s, 3H), 1.73–1.52 (m, 2H), 1.11 (s, 6H), 0.94–0.87 
(m, 3H), 0.87 (d, J = 15.3 Hz, 9H); 31P NMR (162 MHz, CDCl3): δ 60.08 ppm; 13C NMR (100 
MHz, CDCl3): δ 163.9 (d, J = 20.0 Hz), 158.8, 157.1, 138.4 (d, J = 5.0 Hz), 133.9 (d, J = 1.7 
Hz), 129.6, 124.5 (d, J = 8.4 Hz), 116.7 (d, J = 2.0 Hz), 113.7 (d, J = 91.0 Hz), 111.3 (d, J = 5.6 
Hz), 104.0, 102.8, 79.4 (d, J = 59.2 Hz), 55.6, 55.3, 39.1, 34.0 (d, J = 71.0 Hz), 30.9 (d, J = 4.7 
Hz), 23.2, 22.4 (d, J = 3.9 Hz), 21.6 (d, J = 2.7 Hz), 7.97. HRMS (DART) m/z calculated for 
C24H34O4P [M+H]+:  417.2189; found:  417.2193. Note: Isolated solids of 3.31f were 
contaminated with ~5-10% of the tributyltin byproducts.    
To a solution of 3.31f (0.2 g, 0.48 mmol, 1.0 equiv) in THF (3.0 mL) at 23 °C was added 
PMHS (0.3 g) and Ti(OiPr)4 (0.36 mL, 1.2 mmol, 2.5 equiv). The mixture was stirred at reflux 
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for 12 h, and then concentrated under vacuum to remove most THF. 30% aqueous NaOH 
solution (4 mL) was carefully added to the residue. Gas was generated during addition. The 
resulting mixture was further stirred at 60 °C for 0.5 h. To the mixture at 23 °C was added 
MTBE (5 mL). The MTBE layer was separated and the aqueous layer was washed with MTBE 
(2 x 8 mL) under nitrogen. The MTBE solution was dried, concentrated, and purified by passing 
through a neutral alumina plug affording the desired product (2S,3S)-3-(tert-butyl)-4-(2,6-
dimethoxyphenyl)-2-(tert-pentyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole (3.L6) as white solid 
(164 mg, 85%). 1H NMR (500 MHz, CDCl3): δ 7.21–7.18 (m, 2H), 6.77 (d, J = 7.9 Hz, 1H), 6.71 
(dd, J = 7.5, 3.2 Hz, 1H), 6.56 (d, J = 8.3 Hz, 1H), 6.50 (d, J = 8.4 Hz, 1H), 4.47 (s, 1H), 3.65 (s, 
3H), 3.64 (s, 3H), 1.46–1.30 (m, 2H), 0.85 (d, J = 2.5 Hz, 6H), 0.81 (t, J = 7.5 Hz, 3H), 0.66 (d, J 
= 12.0, 9H); 31P NMR (202 MHz, CDCl3): δ -3.83 ppm; 13C NMR (125 MHz, CDCl3): δ 163.7, 
156.7, 156.0, 137.0 (d, J = 17.4 Hz), 129.2 (d, J = 0.7 Hz), 127.8, 123.4 (d, J = 14.0 Hz), 122.2 
(d, J = 4.2 Hz), 118.7 (d, J = 1.2 Hz), 107.6 (d, J = 0.8 Hz), 103.1, 102.5, 91.1 (d, J = 30.6 Hz), 
54.6 (d, J = 1.2 Hz), 54.4, 37.7 (d, J = 14.7 Hz), 29.8 (d, J = 7.6 Hz), 29.6, 25.6 (d, J = 14.5 Hz), 
21.7 (d, J = 8.4 Hz), 21.5 (d, J = 9.7 Hz), 7.2 (d, J = 0.7 Hz). HRMS (DART) m/z calculated for 
C24H34O3P [M+H]+:  401.2240; found:  401.2243. 
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To a solution of BIDIME oxide (3.29a, 0.50 g, 1.444  mmol, 1 equiv) in THF (5 mL) at –
78 oC was added LDA (0.938 mL, 2.0 M in heptane/THF/chlorobenzene, 1.877 mmol, 1.3 
equiv). The mixture was stirred at –78 °C for 30 min before addition of dry acetone (0.4 mL, 5.5 
mmol, 3.8 equiv). The resulting mixture was kept at –78 °C for 2 h before it was warmed to 23 
°C over 1 h. After stirring at 23 °C overnight, saturated aqueous NH4Cl and EtOAc were added 
to the mixture. The aqueous layer was further extracted with EtOAc. The combined EtOAc 
solution was washed with brine, dried over magnesium sulfate and concentrated to afford 0.565 g 
(97%) of 3.31g as an off-white solid that was used without further purification. 1H NMR (500 
MHz, CDCl3): δ 7.50 (t, J = 7.9 Hz, 1H), 7.29 (t, J = 8.4 Hz, 1H), 6.90 (ddd, J = 10.8, 7.0, 3.0 
Hz, 2H), 6.63 (d, J = 8.4 Hz, 1H), 6.55 (d, J = 8.3 Hz, 1H), 4.38 (s, 1H), 4.18 (d, J = 2.5 Hz, 1H), 
3.73 (s, 6H), 1.43 (s, 3H), 1.40 (s, 3H), 0.91 (d, J = 16 Hz, 9H); 31P NMR (202 MHz, CDCl3): δ 
65.7 ppm; 13C NMR (125 MHz, CDCl3): δ 164.3 (d, J = 20.0 Hz), 158.5 (d, J = 164.0 Hz), 138.4 
(d, J = 5.2 Hz), 134.5 (d, J = 2H), 130.0, 125.1 (d, J = 8.4 Hz), 116.6 (d, J = 2.0 Hz), 113.5 (d, J 
= 91.0 Hz), 111.9 (d, J = 5.8 Hz), 103. 9 (d, J = 124.2 Hz), 77.7 (d, J = 60.7 Hz), 73.4 (d, J = 2.0 
Hz), 55.5 (d, J = 17.1 Hz), 34.2 (d, J = 71.0 Hz), 28.5 (d, J = 6.6 Hz), 24.4 (d, J = 2.5 Hz), 23.1 
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(d, J = 1 Hz). HRMS (DART) m/z calculated for C22H30O5P [M+H]+:  405.1825; found:  
405.1824. 
To a solution of 3.31g (0.50 g, 1.24 mmol, 1 equiv) in THF (5 mL) at 0 °C was added 
NaH (0.34 g, 60% dispersion in mineral oil, 1.5 mmol, 1.2 equiv). The mixture was stirred at 10 
°C for 2 h before addition of iodomethane (0.38 g, 2.64 mmol, 2.1 equiv). The resulting mixture 
was warmed to 23 °C over 1 h. After stirring at 23 °C overnight, saturated aqueous NH4Cl and 
EtOAc were added to the mixture. The aqueous layer was further extracted with EtOAc. The 
combined organic solution was washed with brine, dried over magnesium sulfate, concentrated, 
and purified by silica gel column chromatography (0-100% EtOAc in hexanes) to afford 0.50 g 
(97%) of 3.31h as a white solid. Rf = 0.45 in 100% EtOAc. 1H NMR (500 MHz, CDCl3): δ 7.49 
(t, J = 8.0 Hz, 1 H), 7.28 (t, J = 8.3 Hz, 1H), 6.99 (dd, J = 8.3, 3.5 Hz, 1H), 6.91 (dd, J = 7.3, 3.2 
Hz, 1H), 6.62 (d, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 1H), 4.39 (s, 1H), 3.72 (d, J = 6.4 Hz, 6H), 
3.36 (s, 3H), 1.43 (s, 3H), 1.36 (s, 3H), 0.88 (d, J = 15.6 Hz, 9H); 31P NMR (202 MHz, CDCl3): 
δ 58.8 ppm; 13C NMR (125 MHz, CDCl3): δ 163.8 (d, J = 19.5 Hz), 158.8, 157.2, 138.5 (d, J = 
5.5 Hz), 134.2 (d, J = 1.9 Hz), 129.7, 124.9 (d, J = 8.6 Hz), 116.7 (d, J = 2.2 Hz), 113.6, 112.8, 
111.8 (d, J = 5.8 Hz), 104.0, 102.9, 77.5, 77.2 (d, J = 3.0 Hz), 55.5 (d, J = 35.0 Hz), 49.3 (d, J = 
1.0 Hz), 34.1 (d, J = 72.7 Hz), 23.3 (d, J = 1.0 Hz), 20.3, 19.9 (d, J = 1.6 Hz). HRMS (DART) 
m/z calculated for C23H32O5P [M+H]+:  419.1982; found:  419.1984. 
To a solution of 3.31h (0.44 g, 1.04 mmol) in THF (7 mL) at 23 °C was added PMHS 
(0.45 g) and Ti(Oi-Pr)4 (0.62 mL, 2.08 mmol, 2.0 equiv). The mixture was stirred at reflux for 12 
h, and then concentrated under vacuum to remove most THF. 30% aqueous NaOH solution (5 
mL) was carefully added to the residue. Gas was generated during addition. The resulting 
mixture was further stirred at 60 °C for 0.5 h. To the mixture at 23 °C was added MTBE (5 mL). 
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The MTBE layer was separated and the aqueous layer was washed with MTBE under nitrogen. 
The MTBE solution was dried, concentrated, and purified by passing through a neutral alumina 
plug to afford 0.416 g (99%) of 3.L7 as a white crystalline solid. 1H NMR (400 MHz, CDCl3) δ 
7.31–7.26 (m, 2H), 6.91 (d, J = 7.9 Hz, 1H), 6.80 (d, J = 4.6 Hz), 6.60 (dd, J = 19.8, 8.2 Hz, 2H),  
4.77 (s, 1H), 3.72 (d, J = 3.0 Hz, 6H), 3.34 (s, 3H), 1.22 (s, 3H), 1.18 (s, 3H), 0.74 (d, J = 12.0, 
9H); 31P NMR (162 MHz, CDCl3) δ 1.8 ppm; 13C NMR (100 MHz, CDCl3) δ 164.6, 157.4 (d, J 
= 85.0 Hz), 138.0 (d, J = 17.7 Hz), 130.4, 128.9, 124.2 (d, J = 14.0 Hz), 123.5 (d, J = 4.0 Hz), 
119.6, 109.1, 103.9 (d, J = 57.6 Hz), 89.1 (d, J = 31.0 Hz), 77.8 (d, J = 19.0 Hz), 55.5 (d, J = 
18.6 Hz), 49.9, 31.1 (d, J = 18.2 Hz), 26.6 (d, J = 14.5 Hz), 21.3 (d, J = 11.9 Hz), 20.8 (d, J = 5.0 
Hz). HRMS (DART) m/z calculated for C23H32O4P [M+H]+:  403.2033; found:  403.2037.     
 
 
Synthesis of 3.31i was performed using a modification of our literature procedure.11o To a 
solution of oxide 3.31g (0.5 g, 1.23 mmol, 1.0 equiv) in fluorobenzene (12.5 mL) was charged a 
premixed catalyst solution prepared in the glovebox of 1,1,1-trifluoro-N-
phenylmethanesulfonamide (18.2 mg, 0.062 mmol,  5 mol%) and 2,6-lutidine (66.2 mg, 0.618 
mmol, 50 mol%). To the resulting mixture was added tert-butyl 2,2,2-trichloroacetimidate (4.05 
g, 18.55 mmo, 15.0 equiv), and the mixture was allowed to stir at 23 °C for 24 h (Note: white 
slurry was formed gradually). The reaction mixture was concentrated under reduced pressure and 
diluted with hexanes (20 mL). The insoluble solids of 2,2,2-trichloroacetamide were collected by 
filtration, and the resulting filtrate was concentrated under reduced pressure and purified using 
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silica gel column chromatography (0-100% EtOAc in hexanes) to afford 0.55 g (97%) of oxide 
3.31i as a glossy solid. Rf = 0.68 in 1:1 EtOAc/hexanes.  1H NMR (400 MHz, CDCl3) δ 7.48–
7.45 (m, 1 H), 7.28 (t, J = 8.4 Hz, 1H), 6.90 (ddd, J = 8.3, 3.4, 1.0 Hz, 1H), 6.86 (ddd, J = 7.4, 
3.3, 1.0 Hz, 1H), 6.62 (d, J = 8.0 Hz, 1H), 6.54 (d, J = 8.3 Hz, 1H), 4.13 (d, J = 3.0 Hz, 1H), 3.72 
(s, 3H), 3.71  (s, 3H), 1.52 (s, 3H), 1.48 (s, 3H), 1.32 (s, 9H), 0.88 (d, J = 15.4 Hz, 9H); 31P NMR 
(162 MHz, CDCl3) δ 58.65 ppm; 13C NMR (100 MHz, CDCl3) δ 163.8 (d, J = 20.0 Hz), 158.7, 
157.2, 138.5 (d, J = 5.3 Hz), 133.9 (d, J = 1.6 Hz), 129.6, 124.6 (d, J = 8.4 Hz), 116.9 (d, J = 2.0 
Hz), 113.7 (d, J = 92.0 Hz), 111.6 (d, J = 5.6 Hz), 104.0, 102.9, 79.3 (d, J = 59.6 Hz), 78.0, 75.2, 
55.6, 55.3, 34.0 (d, J = 73.2 Hz), 31.7, 26.2 (d, J = 4.0 Hz), 23.8, 23.3. HRMS (DART) m/z 
calculated for C26H38O5P [M+H]+:  461.2451; found:  461.2449.     
To a solution of 3.31i (0.117 g, 0.253 mmol) in THF (2 mL) at 23 °C was added PMHS 
(0.121 g) and Ti(Oi-Pr)4 (0.15 mL, 0.51 mmol, 2.0 equiv). The mixture was stirred at reflux for 
12 h, and then concentrated under vacuum to remove most THF. 30% aqueous NaOH solution (5 
mL) was carefully added to the residue. Gas was generated during addition. The resulting 
mixture was further stirred at 60 °C for 0.5 h. To the mixture at 23 °C was added MTBE (5 mL). 
The MTBE layer was separated and the aqueous layer was washed with MTBE (5 mL x 3) under 
nitrogen. The MTBE solution was dried, concentrated, and purified by passing through a neutral 
alumina plug to afford 95 mg (85%) of 3.L8 as a thick pale orange oil. 1H NMR (400 MHz, 
CD2Cl2) δ 7.18 (t, J = 8.4 Hz, 1H), 7.12 (t, J = 7.9 Hz, 1H), 6.70 (d, J = 8.0 Hz, 1H), 6.62 (dd, J 
= 7.5, 3.2 Hz, 1H), 6.54 (dd, J = 15.1, 8.4 Hz, 2H), 4.37 (s, 1H), 3.61 (d, J = 2.0 Hz, 6H), 1.28 (s, 
3H), 1.19 (s, 9H), 1.16 (s, 3H), 0.60 (d, J = 11.8, 9H). 31P NMR (162 MHz, CD2Cl2) δ 1.25 ppm; 
13C NMR (100 MHz, CD2Cl2) δ 164.8, 157.9, 156.9, 138.3 (d, J = 17.5 Hz), 129.7, 128.8, 125.3 
(d, J = 16.8 Hz), 123.4 (d, J = 3.8 Hz), 119.6, 103.8 (d, J = 25.5 Hz), 91.7 (d, J = 29.1 Hz), 77.6 
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(d, J = 15.2 Hz), 74.6, 55.4, 55.3, 31.3, 26.6 (d, J = 3.7 Hz), 26.4 (d, J = 14.8 Hz), 23.3 (d, J = 
11.4 Hz). HRMS (DART) m/z calculated for C26H38O4P [M+H]+:  445.2502; found:  445.2501. 
 
 
To a solution of oxide 3.31j (400 mg, 1.11 mmol, 1.0 eq) in THF (8 mL) cooled to –78 
°C was added a 2.55M solution of n-BuLi (520 µL, 1.33 mmol, 1.2 eq). The dark red solution 
was allowed to stir for 1 hour at –78 °C. Methyl iodide (100 µL, 1.67 mmol, 1.5 eq) was then 
added dropwise and the reaction mixture was stirred at –78 oC for 30 min then slowly warmed to 
23 °C. After 30 min, the reaction was quenched with sat NH4Cl, and extracted with CH2Cl2 (3x). 
The combined organic layers were washed with water, then brine, dried with MgSO4, and 
concentrated in vacuo. The crude residue was purified by flash chromatography (0.5% to 7% 
MeOH in CH2Cl2) to afford 3.31k as a white solid (260 mg) in 63% yield. 1HNMR (400 MHz, 
CDCl3): δ 7.45 (td, J = 7.9 Hz, J = 0.7 Hz, 1H), 7.28 (t, J = 8.4 Hz, 1H), 6.93 (ddd, J = 7.5 Hz, J 
= 3.0 Hz, J = 0.8 Hz, 1H), 6.79 (ddd, J = 8.2 Hz, J = 3.8 Hz, J = 0.8 Hz, 1H), 6.63 (d, J = 8.4 Hz, 
1H), 6.55 (d, J = 8.1 Hz, 1H), 3.77 (s, 3H), 3.73 (s, 3H), 1.75 (d, J = 11 Hz, 3H), 1.61 (d, J = 10 
Hz, 3H), 0.96 (d, J = 15 Hz, 9H); 31P{1H}NMR (162 MHz, CDCl3): δ 62 ppm; 13C{1H}NMR 
(100 MHz, CDCl3):  δ 161.8 (d, JC-P = 17 Hz), 158.7, 157.0, 139.0 (d, JC-P = 3.8 Hz), 133.4 (d, 
JC-P = 1.6 Hz), 129.7, 125.3 (d, JCP = 7.9 Hz), 116.6 (d, JCP = 2.0 Hz), 115.7 (d, JCP = 88 Hz), 
112.4 (d, JCP = 4.9 Hz), 104.2, 102.9, 81.8 (d, JC-P = 67 Hz), 55.9, 55.3, 34.8 (d, JC-P = 65 Hz), 
24.3 (d, JC-P = 3.4 Hz), 24.0, 22.2 (d, JC-P = 4.2 Hz); HRMS (DART) m/z calculated for 
C21H28O4P [M + H]+:  375.1720; found:  375.1720. 
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To a 10 mL Schlenk flask with magnetic stir bar was charged oxide 3.31k (206 mg, 0.55 
mmol, 1.0 eq). A reflux condenser was added, and the reaction was inerted with Ar using 
vacuum-purge cycles. PhMe (2.0 mL) was as added followed by triethylamine (155 µL, 1.10 
mmol, 2.0 eq) and HSiCl3 (83 µL, 0.83 mmol, 1.5 eq). The mixture was then immersed in an oil 
bath at 60 °C and monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 23 
°C and quenched with 10 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then 
allowed to vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently 
extracted under Ar with MTBE (3 × 5 mL). The combined organics were dried with MgSO4, 
filtered quickly through a pad of Celite, and immediately concentrated in vacuo. The crude 
residue was chromatographed on the bench by dissolving the crude solid in CH2Cl2 and loading 
the mixture onto a short pad of silica gel and eluting with degassed (Ar sparge) 20% EtOAc in 
hexanes using Ar to pressurize the flash column. The product fractions were immediately 
collected and concentrated in vacuo to afford 98.2 mg (50%) of 3.L11 as a white solid. [α]D25 = 
– 160 (c 0.32, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.23–7.17 (m, 2H), 6.79–6.75 (m, 2H), 
6.55 (d, J = 8.4, 1H), 6.51 (d, J = 8.4 Hz, 1H), 3.65 (d, J = 2.9 Hz, 6H), 1.73 (d, J = 7.25 Hz, 
3H), 1.35 (d, J = 16.2 Hz, 3H), 0.72 (d, J = 11.6Hz, 9H); 31P{1 H}NMR (202 MHz, CDCl3) δ 
12.5 ppm; 13C{1H}NMR (100 MHz, CDCl3) δ 161.4 (d, JC−P = 0.8 Hz), 156.5, 156.0, 137.8 (d, 
JC−P = 16.2 Hz), 129.0 (d, JC−P = 1.0 Hz), 127.9, 126.4 (d, JC−P = 13.4 Hz), 122.7 (d, JC−P = 4.3 
Hz), 118.8 (d, JC−P = 1.35 Hz), 108.9 (d, JC−P = 1.0 Hz), 103.4, 102.6, 87.2 (d, JC−P = 26.6 Hz), 
54.7 (d, JC−P = 1.7 Hz), 54.4, 31.3 (d, JC−P = 22.3 Hz), 28.1 (d, JC−P = 32.2 Hz), 26.1 (d, JC−P = 
14.1 Hz), 22.7 (d, JC−P = 4.2 Hz). HRMS (DART) m/z calculated for C21H28O3P [M + H]+: 
359.1771; found:  359.1770. 
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To a solution oxide 3.29b (0.289 g, 0.614 mmol) in THF (1 mL) cooled to –78 °C was 
added a freshly prepared solution of LDA in THF (0.48 mL (1.2 mmol, 2.0 eq) of 2.55 M 
solution of n-BuLi was added to a solution of di-isopropylamine (180 µL, 1.29 mmol, 2.1 eq) in 
THF (2 mL) at –78 °C and stirred for 25 min before use). The dark red solution was allowed to 
stir for 1 h at –78 °C. Dimethyl sulfate (0.87 mL, 0.92 mol) was then added dropwise, and the 
reaction mixture was stirred at –78 °C for 30 min and then slowly warmed to 23 °C. After 30 
min, the reaction was quenched with sat NH4Cl, and extracted with CH2Cl2 (3x). The combined 
organic layers were washed with water, then brine, dried with MgSO4, and concentrated in 
vacuo. The crude residue was purified by flash chromatography (20% to 80% EtOAc in hexanes) 
to afford 3.31l as a white solid (214 mg) in 72% yield. 1H NMR (400 MHz, CDCl3) δ 7.38 (t, J = 
8.1 Hz, 1H), 7.29–7.36 (m, 6H), 7.07–7.15 (m, 3H), 6.98 (d, J = 7.6 Hz, 2H), 6.93 (dd, J = 7.1 
Hz, J = 2.7 Hz 1H), 6.86 (dd, J = 8.2 Hz, J = 3.4 Hz, 1H), 6.51 (d, J = 8.2 Hz, 1H), 6.41 (d, J = 
8.4 Hz, 1H), 4.58 (p, J = 6.4 Hz, 1H), 1.62 (dd, J = 12 Hz, J = 7.1 Hz, 3H), 1.06 (d, J = 16 Hz, 
9H); 31P{1H}NMR (162 MHz, CDCl3) δ 60 ppm; 13C{1H}NMR (100 MHz, CDCl3) δ 163.9 (d, 
JC−P = 18 Hz), 158.6, 156.6, 155.8, 155.5, 137.2 (d, JCP = 5.0 Hz), 134.0 (d, JCP = 1.6 Hz), 129.8, 
129.6, 129.4, 124.6, 124.5, 124.4, 123.6, 122.2, 119.4, 114.7 (d, JCP = 88 Hz), 113.0 (d, JCP = 5.3 
Hz), 110.4, 109.5, 70.5 (d, JCP = 6.3 Hz), 33.3 (d, JCP = 7.1 Hz), 24.2, 15.1. HRMS (DART) m/z 
calculated for C30H30O4P [M + H]+:  485.1876; found:  485.1880. 
To a Schlenk flask with magnetic stir bar was charged oxide 3.31l (205 mg, 0.423 mmol, 
1.0 eq). A reflux condenser was added, and the reaction was inerted with Ar using vacuum-purge 
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cycles. PhMe (2.0 mL) was as added followed by triethylamine (120 µL, 0.846 mmol, 2.0 eq) 
and HSiCl3 (65 µL, 0.635 mmol, 1.5 eq). The mixture was then immersed in an oil bath at 60 °C 
and monitored by 31P NMR spectroscopy. After 3.5 h, the reaction was cooled to 23 °C and 
quenched with 8 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed to 
vigorously stir at  for 1 h. The aqueous layer was removed and subsequently extracted under Ar 
with MTBE (3 × 6 mL). The combined organics were dried with MgSO4, filtered quickly 
through a pad of Celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude solid in CH2Cl2 and loading the mixture 
onto a short pad of silica gel and eluting with degassed (Ar sparge) 20% EtOAc in hexanes using 
Ar to pressurize the flash column. The product fractions were immediately collected and 
concentrated in vacuo to afford 186 mg (93%) of 3.L12 as a white solid. [α]D25 = + 50.8 (c 0.19, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.37–7.33 (m, 2H), 7.25–7.21 (m, 2H), 7.18–7.11 (m, 
3H), 7.04–6.98 (m, 5H), 6.87–6.84 (m, 1H), 6.80 (dd, J = 8.0 Hz, J = 0.8 Hz, 1H), 6.67 (dd, J = 
8.3 Hz, J = 0.9 Hz, 1H), 6.58 (dd, J = 8.3 Hz, J = 0.9 Hz, 1H), 5.02 (m, 1H), 1.40 (dd, J = 16.4 
Hz, J = 7.12 Hz, 3H), 0.88 (d, J = 12.0 Hz, 9H); 31P{1H}NMR (202 MHz, CDCl3) δ 8.8 ppm; 
13C{1H}NMR (100 MHz, CDCl3) δ 162.6, 156.8, 156.6, 156.4, 155.2, 137.4 (d, JCP = 16.9 Hz), 
130.5, 129.8, 129.3, 128.8, 123.7, 123.4, 123.3, 123.0, 119.8, 119.2, 119.2, 122.9, 111.7, 110.2, 
78.9 (d, JCP = 23.9 Hz), 31.1 (d, JCP = 17.9 Hz), 27.0 (d, JCP = 14.2 Hz), 21.3 (d, JCP = 28.9 Hz). 
HRMS (DART m/z calculated for C30H30O3P [M + H]+:  469.1927; found:  469.1926. 
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To a solution oxide 3.29c (1.2 g, 2.98 mmol, 1.0 eq) in THF (5 mL) cooled to –78 °C was 
added a freshly prepared solution of LDA in THF (2.28 mL (5.82 mmol, 1.95 eq) of 2.55M 
solution of n-BuLi was added to a solution of diisopropylamine (890 µL, 6.26 mmol, 2.1 eq) in 
THF (2 mL) at –78 °C and stirred for 25 min before use). The dark red solution was allowed to 
stir for 1 hour at –78 °C. Dimethyl sulfate was then added dropwise and the reaction mixture was 
stirred at –78 °C for 30 min then slowly warmed to 23 °C. After 30 min, the reaction was 
quenched with sat NH4Cl, and extracted with CH2Cl2 (3x). The combined organic layers were 
washed with water, then brine, dried with MgSO4, and concentrated in vacuo. The crude residue 
was purified by flash chromatography (0% to 8% MeOH in CH2Cl2) to afford 3.31m as a semi-
solid (1.12 g) in 90% yield. [α]D22 = – 82.1 (c 0.33, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.43 
(t, J = 7.7 Hz, 1H), 7.21 (t, J = 8.4 Hz, 1H), 6.83–6.79 (m, 2H), 6.54 (d, J = 8.4 Hz, 1H), 6.46 (d, 
J = 8.4 Hz, 1H), 4.54–4.44 (m, 3H), 1.54 (dd, J = 11.6 Hz, J = 7.2 Hz, 3H), 1.31 (d, J = 6.0 Hz, 
3H), 1.22 (d, J = 6.0 Hz, 3H), 1.17 (d, J = 3.6 Hz, 3H), 1.15 (d, J = 3.6 Hz, 3H), 1.31 (d, J = 6.0 
Hz, 3H), 0.87 (d, J = 15.4 Hz, 9H); 31P{1 H}NMR (202 MHz, CDCl3) δ 59.5 ppm; 13C{1 
H}NMR (100 MHz, CDCl3) δ 162.1 (d, JC−P = 19.2 Hz), 157.7, 155.9, 139.7 (d, JC−P = 5.34 Hz), 
133.5 (d, JC−P = 1.7 Hz), 129.2(d, JC−P = 12.2 Hz), 125.1 (d, JC−P = 8.4 Hz), 118.4 (d, JC−P = 2.0 
Hz), 114.5, 113.6, 111.6 (d, JC−P = 5.6 Hz), 104.9, 103.6, 70.5, 70.3, 69.6, 69.3, 33.7, 32.9, 24.3, 
23.8, 22.3, 22.1, 22.0, 21.9, 15.5. HRMS (DART) m/z calculated for C24H34O4P [M + H]+:  
417.2189; found:  417.2188.  
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 To a 10 mL Schlenk flask with magnetic stir bar was charged oxide 3.31m (0.99 g, 2.38 
mmol, 1.0 eq). A reflux condenser was added, and the reaction was inerted with Ar using 
vacuum-purge cycles. PhMe (8.0 mL) was added followed by triethylamine (0.67 mL, 4.76 
mmol, 2.0 eq) and HSiCl3 (0.36 mL, 3.6 mmol, 1.5 eq). The mixture was then immersed in an oil 
bath at 60 °C and monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 23 
°C and quenched with 10 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then 
allowed to vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently 
extracted under Ar with MTBE (3 × 10 mL). The combined organics were dried with MgSO4, 
filtered quickly through a pad of Celite, and immediately concentrated in vacuo. The crude 
residue was chromatographed on the bench by dissolving the crude solid in CH2Cl2 and loading 
the mixture onto a short pad of silica gel and eluting with degassed (Ar sparge) 20% EtOAc in 
hexanes using Ar to pressurize the flash column. The product fractions were immediately 
collected and concentrated in vacuo to afford 865 mg (91%) of 3.L13 as a white solid. [α]D22 = – 
111 (c 0.28, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.24 (t, J = 7.8 Hz, 1H), 7.18 (t, J = 8.3 Hz, 
1H), 6.82 (d, J = 8.0 Hz, 1H), 6.77 (dd, J = 7.5 Hz, J = 3.1Hz, 1H), 6.60 (d, J = 8.25 Hz, 1H), 
6.52 (d, J = 8.35 Hz, 1H), 4.98 (q, J = 7.1 Hz, 1H), 4.47 (p, J = 6.1 Hz, 1H), 4.29 (p, J = 6.1 Hz, 
1H), 1.44 (dd, J = 12.1 Hz, J = 7.2 Hz, 3H), 1.26 (d, J = 6.0 Hz, 3H), 1.24 (d, J = 6.0 Hz, 3H), 
1.14 (d, J = 6.1 Hz, 3H), 1.00 (d, J = 6.1 Hz, 3H), 0.74 (d, J = 11.9 Hz, 3H); 31P{1 H}NMR (202 
MHz, CDCl3) δ 9.6 ppm; 13C{1 H}NMR (100 MHz, CDCl3) δ 162.3, 156.4, 155.7, 139.5 (d, JC−P 
= 13.5 Hz), 129.7 (d, JC−P = 0.7 Hz), 128.4, 124.3, 124.2 (d, JC−P = 3.4 Hz), 122.4 (d, JC−P = 0.9 
Hz), 109.1 (d, JC−P = 0.7 Hz), 108.3, 104.9, 78.8, 78.6, 71.5, 69.1, 31.0 (d, JC−P = 14.7 Hz), 26.9 
(d, JC−P = 11.4 Hz), 22.5 (d, JC−P = 2.1 Hz), 22.2, 22.1, 22.0, 21.8, 21.6. HRMS (DART) m/z 
calculated for C24H34O3P [M + H]+:  401.2240; found:  401.2242. 
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To a solution oxide 3.29c (1.00 g, 2.48 mmol) in THF (3 mL) cooled to –78 °C was 
added a freshly prepared solution of LDA in THF (1.95 mL (4.97 mmol, 2.0 eq) of 2.55 M 
solution of n-BuLi was added to a solution of di-isopropylamine (730 µL, 5.21 mmol, 2.1 eq) in 
THF (8 mL) at –78 °C and stirred for 30 min before use). The dark red solution was allowed to 
stir for 1 h at –78 °C. 2-Iodopropane (0.57 mL, 3.7 mol) was then added dropwise, and the 
reaction mixture was stirred at –78 °C for 30 min and then slowly warmed to 23 °C. After 30 
min, the reaction was quenched with sat NH4Cl, and extracted with CH2Cl2 (3x). The combined 
organic layers were washed with water, then brine, dried with MgSO4, and concentrated in 
vacuo. The crude residue was purified by flash chromatography (20% to 70% EtOAc in hexanes) 
to afford 3.31n as a white solid (852 mg) in 78% yield. 1H NMR (400 MHz, CDCl3) δ 7.40 (td, J 
= 7.8 Hz, J = 0.7 Hz, 1H), 7.18 (t, J = 8.4 Hz, 1H), 6.82 (d, J = 8.2 Hz, J = 3.5 Hz, 1H), 6.77 
(ddd, J = 7.4 Hz, J = 3.2 Hz, J = 0.6 Hz, 1H), 6.53 (d, J = 8.4 Hz, 1H), 6.46 (d, J = 8.3 Hz, 1H), 
4.40–4.55 (m, 2H), 4.10 (dd, J = 6.2 Hz, J = 3.5 Hz, 1H), 2.25–2.41 (m, 1H), 1.30 (d, J = 6.1 Hz, 
3H), 1.21 (d, J = 6.0 Hz, 3H), 1.16 (d, J = 6.4 Hz, 6H), 1.12 (d, J = 6.0 Hz, 3H), 1.11 (d, J = 6.7 
Hz, 3H), 0.90 (d, J = 16 Hz, 9H); 31P{1H}NMR (162 MHz, CDCl3) δ 59 ppm; 13C{1H}NMR 
(100 MHz, CDCl3) δ 163.7 (d, JCP = 20 Hz), 157.6, 156.0, 139.5 (d, JCP = 5.1 Hz), 133.4 (d, JCP 
= 1.7 Hz), 129.1, 124.9 (d, JCP = 8.4 Hz), 118.5 (d, JCP = 2.1 Hz), 114.3 (d, JCP = 90 Hz), 111.1 
(d, JCP = 5.6 Hz), 105.0, 103.6, 78.0 (d, JCP = 61 Hz), 70.3, 69.3, 33.6 (d, JCP = 71 Hz), 29.8, 
23.6, 22.3, 22.1, 22.0, 21.9, 19.7 (d, JCP = 5.2 Hz), 18.1 (d, JCP = 4.6 Hz). HRMS (DART) m/z 
calculated for C26H38O4P [M + H]+:  445.2502; found:  445.2503. 
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To a Schlenk flask with magnetic stir bar was charged oxide 3.31n (806 mg, 1.81 mmol, 
1.0 eq). A reflux condenser was added, and the reaction was inerted with Ar using vacuum-purge 
cycles. PhMe (8.0 mL) was added followed by triethylamine (504 µL, 3.63 mmol, 2.0 eq) and 
HSiCl3 (275 µL, 2.72 mmol, 1.5 eq). The mixture was then immersed in an oil bath at 60 °C and 
monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 23 °C and quenched 
with 10 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed to 
vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently extracted 
under Ar with MTBE (3 × 12 mL). The combined organics were dried with MgSO4, filtered 
quickly through a pad of Celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude solid in CH2Cl2 and loading the mixture 
onto a short pad of silica gel and eluting with degassed (Ar sparge) 20% EtOAc in hexanes using 
Ar to pressurize the flash column. The product fractions were immediately collected and 
concentrated in vacuo to afford 659 mg (85%) of 3.L14 as a white solid. [a]D25 = – 94.8 (c 0.33, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.22–7.15 (m, 2H), 6.80 (dd, J = 8.0 Hz, J = 0.8 Hz, 1H), 
6.80–6.70 (m, 1H), 6.60 (d, J = 8.2 Hz, 1H), 6.51 (d, J = 8.2 Hz, 1H), 4.54 (d, J = 7.2 Hz, 1H), 
4.46 (p, J = 6.0 Hz, 1H), 4.33 (p, J = 6.0 Hz, 1H), 2.00–1.93 (m, 1H), 1.25 (t, J = 6.6 Hz, 3H), 
1.44 (d, J = 16.0 Hz, 3H), 1.28 (d, J = 6.0 Hz, 3H), 1.25 (d, J = 6.0 Hz, 3H), 1.14 (d, J = 6.0 Hz, 
6H), 1.14 (d, J = 6.1 Hz, 3H), 1.03 (d, J = 6.1 Hz, 3H), 1.00 (d, J = 6.1 Hz, 3H), 0.97 (d, J = 6.1 
Hz, 3H), 0.76 (d, J = 11.9 Hz, 9H); 31P{1 H}NMR (202 MHz, CDCl3) δ –0.2 ppm; 13C{1 
H}NMR (100 MHz, CDCl3) δ 163.7, 156.5, 155.9, 139.1 (d, JC−P = 17.4 Hz), 129.5, 128.4, 124.0 
(d, JC−P = 4.3 Hz), 108.3, 107.9, 104.8, 89.3 (d, JC−P = 27.9 Hz), 71.5, 69.1, 33.1 (d, JC−P = 21.6 
Hz), 30.7 (d, JC−P = 18.4 Hz), 26.9 (d, JC−P = 14.4 Hz), 22.3 (d, JC−P = 2.1 Hz), 22.2, 22.1, 21.9, 
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19.2, 19.1, 19.0, 18.9. HRMS (DART) m/z calculated for C26H38O3P [M + H]+:  429.2553; 
found:  429.2552.  
 
To a solution of oxide 3.31m (840 mg, 2.01 mmol, 1.0 eq) in THF (12 mL) cooled to –78 
°C was added a 2.55M solution of n-BuLi (960 µL, 2.42 mmol, 1.2 eq). The dark red solution 
was allowed to stir for 45 minutes at –78 °C. Methyl iodide (200 µL, 3.02 mmol, 1.5 eq) was 
then added dropwise and the reaction mixture was stirred at –78 °C for 30 min then slowly 
warmed to 23 °C. After 30 min, the reaction was quenched with sat NH4Cl, and extracted with 
CH2Cl2 (3x). The combined organic layers were washed with water, then brine, dried with 
MgSO4, and concentrated in vacuo. The crude residue was purified by flash chromatography 
(0% to 8% MeOH in CH2Cl2) to afford 3.31o as a white solid (489 mg) in 52% yield. [a]D25 = – 
54.0 (c 0.19, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.38 (t, J = 8.1 Hz, 1H), 7.19 (t, J = 8.4 Hz, 
1H), 6.83–6.73 (m, 2H), 6.53 (d, J = 8.3 Hz, 1H), 6.44 (d, J = 8.3 Hz, 1H), 4.51–4.44 (m, 2H), 
1.74 (d, J = 10.7 Hz, 3H), 1.60 (d, J = 10.0 Hz, 3H), 1.35 (d, J = 6.0 Hz, 3H), 1.24 (d, J = 6.0 Hz, 
3H), 1.15 (d, J = 6.0 Hz, 3H), 1.11 (d, J = 6.0 Hz, 3H), 1.00 (d, J = 14.8 Hz, 9H); 31P{1 H}NMR 
(202 MHz, CDCl3) δ 61.6 ppm; 13C{1 H}NMR (100 MHz, CDCl3) δ 161.7 (d, JC−P = 16.9 Hz), 
157.4, 155.8, 140.1 (d, JC−P = 4.0Hz), 132.8 (d, JC−P = 1.5 Hz), 129.1 (d, JC−P = 5.0 Hz), 125.9 (d, 
JC−P = 8.1 Hz), 117.9, 116.3, 115.4, 111.8 (d, JC−P = 4.9 Hz), 104.7, 103.3, 81.9. 81.2, 35.2, 34.6, 
25.1 (d, JC−P = 3.5 Hz), 24.3, 22.7 (d, JC−P = 4.2 Hz), 22.2 (d, JC−P = 13.8 Hz), 22.0 (d, JC−P = 
13.8 Hz). HRMS (DART) m/z calculated for C25H36O4P [M + H]+:  431.2346; found:  431.2344. 
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 To a Schlenk flask with magnetic stir bar was charged oxide 3.31o (448 mg, 1.04 mmol, 
1.0 eq). A reflux condenser was added, and the reaction was inerted with Ar using vacuum-purge 
cycles. PhMe (4.0 mL) was added followed by triethylamine (290 µL, 2.08 mmol, 2.0 eq) and 
HSiCl3 (160 µL, 1.56 mmol, 1.5 eq). The mixture was then immersed in an oil bath at 60 °C and 
monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 23 °C and quenched 
with 8 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed to 
vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently extracted 
under Ar with MTBE (3 × 8 mL). The combined organics were dried with MgSO4, filtered 
quickly through a pad of Celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude solid in CH2Cl2 and loading the mixture 
onto a short pad of silica gel and eluting with degassed (Ar sparge) 20% EtOAc in hexanes using 
Ar to pressurize the flash column. The product fractions were immediately collected and 
concentrated in vacuo to afford 865 mg (91%) of 3.L15 as a white solid. [a]D25 = – 104 (c 0.36, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.24–7.16 (m, 3H), 6.81–6.76 (m, 2H), 6.61 (d, J = 8.1 
Hz, 1H), 6.50 (d, J = 8.2 Hz, 1H), 4.45 (p, J = 6.1 Hz, 1H), 4.36 (p, J = 6.1 Hz, 1H), 1.79 (d, J = 
7.8 Hz, 3H), 1.44 (d, J = 16.0 Hz, 3H), 1.28 (d, J = 6.0 Hz, 3H), 1.25 (d, J = 6.0 Hz, 3H), 1.14 (d, 
J = 6.0 Hz, 3H), 0.96 (d, J = 6.0 Hz, 3H), 0.81 (d, J = 11.5 Hz, 9H); 31P{1 H}NMR (202 MHz, 
CDCl3) δ 12.6 ppm; 13C{1 H}NMR (100 MHz, CDCl3) δ 162.2, 156.2, 155.8, 139.7 (d, JC−P = 
16.4 Hz), 129.3, 128.4, 124.5 (d, JC−P = 4.4 Hz), 109.3, 108.1, 104.6, 88.3, 88.0, 71.5, 69.1, 32.5 
(d, JC−P = 22.7 Hz), 29.7 (d, JC−P = 32.2 Hz), 27.4 (d, JC−P = 14.1 Hz), 24.1 (d, JC−P = 3.9 Hz), 
22.6 (d, JC−P = 1.9 Hz), 22.1 (d, JC−P = 7.2 Hz). HRMS (DART) m/z calculated for C25H36O3P [M 
+ H]+:  415.2397; found:  415.2397. 
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To a solution of oxide 3.29d (1.0 g, 3.5 mmol, 1 equiv) in THF (13 mL) at –78 °C was 
added LDA (2.27 mL, 2.0 M in heptane/THF/chlorobenzene, 4.54 mmol, 1.3 equiv). The 
mixture was stirred at –78 °C for 30 min before addition of dry acetone (3.5 mL, 47.7 mmol, 
13.7 equiv). The resulting mixture was kept at –78 °C for 2 h before it was warmed to 23 °C over 
1 h. After stirring at 23 °C overnight, saturated aqueous NH4Cl and EtOAc were added to the 
mixture. The aqueous layer was further extracted with EtOAc. The combined EtOAc solution 
was washed with brine, dried over magnesium sulfate, concentrated to give 1.13 g (94%) of 
3.31p as a beige solid that was used directly in the next step without further purification. HRMS 
(DART) m/z calculated for C20H26O3P [M+H]+:  345.1614; found:  345.1614.     
To a solution of oxide 3.31p (1.0 g, ~2.90 mmol, 1 equiv) in THF (10 mL) at 0 oC was 
added NaH (1.0 g, 60% dispersion in mineral oil, 4.4 mmol, 1.5 equiv). The mixture was stirred 
at 10 °C for 2 h before addition of iodomethane (1.5 g, 10.6 mmol, 3.65 equiv). The resulting 
mixture was warmed to 23 °C over 1 h. After stirring at 23 °C overnight, saturated aqueous 
NH4Cl and EtOAc were added to the mixture. The aqueous layer was further extracted with 
EtOAc. The combined organic solution was washed with brine, dried over magnesium sulfate, 
concentrated, and purified by silica gel column chromatography (0-100% EtOAc in hexanes) to 
give afford 0.78 g (75%) of 3.31q as a white solid. Rf = 0.45 100% EtOAc. 1H NMR (400 MHz, 
CDCl3): δ 7.76–7.74 (m, 2H), 7.52–7.48 (m, 1H), 7.44–7.40 (m, 2H), 7.37–7.33 (m, 1H), 7.02 
(dddd, J = 13.8, 7.5, 3.8, 0.8 Hz, 2H), 4.4 (d, J = 1.3 Hz, 1H), 3.36 (s, 3H), 1.49 (s, 3H), 1.44 (s, 
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3H), 0.77 (d, J = 15.8 Hz, 9H); 31P NMR (162 MHz, CDCl3): δ 60.41 ppm; 13C NMR (100 MHz, 
CDCl3): δ 164.4 (d, J = 18.8 Hz), 146.8 (d, 5.9 Hz), 140.3 (d, J = 2.0 Hz), 134.8 (d, J = 1.7 Hz), 
130.0, 128.3, 128.2, 123.4 (d, J = 8.2 Hz), 112.2 (d, J = 5.5 Hz), 111.9 (d, J = 89.0 Hz), 77.4, 
76.8, 49.4, 34.4 (d, J = 72.0 Hz), 23.8, 20.3, 20.1 (d, J = 1.4 Hz). HRMS (DART) m/z calculated 
for C21H28O3P [M+H]+:  359.1771; found:  359.1771.     
To a solution of oxide 3.31q (0.2 g, 0.56 mmol) in THF (3.5 mL) at 23 °C was added 
PMHS (0.40 g) and Ti(Oi-Pr)4 (0.33 mL, 1.12 mmol, 2.0 equiv). The mixture was stirred at 
reflux for 12 h, and then concentrated under vacuum to remove most THF. 30% aqueous NaOH 
solution (3 mL) was carefully added to the residue. Gas was generated during addition. The 
resulting mixture was further stirred at 60 °C for 0.5 h. To the mixture at 23 °C was added 
MTBE (5 mL). The MTBE layer was separated and the aqueous layer was washed with MTBE 
(5 mL x 2) under nitrogen. The MTBE solution was dried, concentrated, and purified by passing 
through a neutral alumina plug to afford 0.185 g (97%) of 3.L16 as a white crystalline solid. 1H 
NMR (400 MHz, CDCl3): δ  7.60–7.58 (m, 2H), 7.34–7.30 (m, 2H), 7.25–7.21 (m, 2H), 6.88–
6.84 (m, 2H), 4.68 (d, J = 1.5 Hz, 1H), 3.27 (s, 1H), 1.21 (s, 3H), 1.18 (s, 3H), 0.58 (d, J = 12.0 
Hz, 9H); 31P NMR (162 MHz, CDCl3): δ -2.31 ppm; 13C NMR (100 MHz, CDCl3): δ 165.1, 
145.5 (d, J = 13.3 Hz), 142.5, 131.2, 129.1 (d, J = 5.2 Hz), 128.3, 127.3, 121.7 (d, J = 3.0 Hz), 
121.2 (d, J = 18.1 Hz), 109.6, 89.0 (d, J = 30.6 Hz), 77.5 (d, J = 18.1 Hz), 49.9, 31.8 (d, J = 19.6 
Hz), 26.7 (d, J = 13.4 Hz), 21.3, 21.1 (d, J = 15.0 Hz). HRMS (DART) m/z calculated for 
C21H28O2P [M+H]+:  343.1821; found:  343.1821.    
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To a solution of oxide 3.29e (0.22 g, 0.57 mmol, 1 equiv) in THF (2.5 mL) at –78 °C was 
added LDA (0.37 mL, 2.0 M in heptane/THF/chlorobenzene, 0.74 mmol, 1.3 equiv). The 
mixture was stirred at –78 °C for 30 min before addition of dry acetone (1.0 mL, 13.6 mmol, 24 
equiv). The resulting mixture was kept at –78 °C for 1 h before it was warmed to 23 °C over 1 h. 
After stirring at 23 °C overnight, saturated aqueous NH4Cl and EtOAc were added to the 
mixture. The aqueous layer was further extracted with EtOAc. The combined EtOAc solution 
was washed with brine, dried over magnesium sulfate, concentrated to give 0.266 g) of oxide 
3.31r that was used directly in the next step without further purification.      
To a solution of oxide 3.31r (0.266 g, 0.598 mmol, 1 equiv) in THF (2.5 mL) at 0 °C was 
added NaH (0.165 g, 60% dispersion in mineral oil, 0.72 mmol, 1.2 equiv). The mixture was 
stirred at 10 °C for 2 h before addition of iodomethane (0.2 g, 1.40 mmol, 2.35 equiv). The 
resulting mixture was warmed to 23 °C over 1 h. After stirring at 23 °C overnight, saturated 
aqueous NH4Cl and EtOAc were added to the mixture. The aqueous layer was further extracted 
with EtOAc. The combined organic solution was washed with brine, dried over magnesium 
sulfate, concentrated, and purified by silica gel column chromatography (0–50% EtOAc in 
hexanes) to afford 0.270 g (98%) of oxide 3.31s as an off-white solid. Rf: 0.8 in 1:1 EtOAc in 
hexanes. 1H NMR (400 MHz, CDCl3): δ 8.48 (s, 1H), 7.99 (dd, J = 24.0, 8.5 Hz, 2H), 7.66–7.62 
(m, 3H), 7.46–7.32 (m, 4H), 7.24 (ddd, J = 9.0, 3.8, 0.7 Hz, 1H), 7.07 (ddd, J = 8.0, 4.1, 0.7 Hz, 
1H),  4.41 (d, J = 2.2 Hz, 1H), 3.37 (s, 3H), 1.46 (s, 3H), 1.37 (s, 3H), 0.52 (d, J = 15.8 Hz, 9H); 
31P NMR (162 MHz, CDCl3): δ 58.3 ppm; 13C NMR (100 MHz, CDCl3): δ 164.6 (d, J = 19.0 
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Hz), 142.2 (d, J = 6.1 Hz), 134.5 (d, J = 1.6 Hz), 133.5 (d, J = 1.9 Hz), 131.1, 131.0, 130.7, 
130.4, 128.8, 128.2, 127.6, 127.5, 126.2, 126.0, 125.9, 125.6, 124.9, 124.6, 115.2 (d, J = 90.0 
Hz), 112.9 (d, J = 5.3 Hz), 78.0 (d, J = 56.1 Hz), 77.4 (d, J = 2.7 Hz), 49.3, 33.8 (d, J = 72.3 Hz), 
23.4, 20.4, 19.9.   
To a solution of 3.31s (0.270 g, 0.589 mmol) in THF (0.6 mL) at 23 °C was added 
1,1,3,3-tetramethyldisiloxane (TMDS, 0.158 g, 1.18 mmol, 2 equiv) and Ti(Oi-Pr)4 (0.227 mL, 
0.765 mmol, 1,3 equiv). The mixture was stirred at reflux for 12 h, and then concentrated under 
vacuum to remove most THF. 30% aqueous NaOH solution (3 mL) was carefully added to the 
residue. Gas was generated during addition. The resulting mixture was further stirred at 60 °C for 
0.5 h. To the mixture at 23 °C was added MTBE (5 mL). The MTBE layer was separated and the 
aqueous layer was washed with MTBE (3 mL x 3) under nitrogen. The MTBE solution was 
dried, concentrated, and purified by passing through a neutral alumina plug to afford 0.173 g 
(67%) of 3.L17 as a beige solid. 1H NMR (500 MHz, CDCl3): δ 8.47 (s, 1H), 8.01 (t, J = 7.2 Hz, 
2H), 7.89 (d, J = 8.7 Hz, 1H), 7.66 (d, J = 8.8 Hz, 1H), 7.47–7.42 (m, 3H), 7.39–7.32 (m, 2H), 
7.12 (d, J = 8.0 Hz, 1H), 6.98 (dd, J = 7.3, 3.2 Hz, 1H), 4.75 (s, 1H), 3.33 (s, 3H), 1.27 (s, 3H), 
1.25 (s, 3H), 0.45 (d, J = 12.2 Hz, 9H); 31P NMR (202 MHz, CDCl3): δ 0.138 ppm; 13C NMR 
(125 MHz, CDCl3): δ 165.3, 141.7 (d, J = 17.1 Hz), 136.4, 131.4 (d, J = 12.5 Hz), 130.8 (d, J = 
5.9 Hz), 129.0, 128.5, 128.3, 127.4 (d, J = 3.6 Hz), 127.0 (d, J = 10.7 Hz), 125.4, 125.2 (d, J = 
9.8 Hz), 124.8, 124.7 (d, J = 3.8 Hz), 110.0, 89.8 (d, J = 30.9 Hz), 77.8 (d, J = 18.6 Hz), 49.9 (d, 
J = 0.9 Hz), 30.7 (d, J = 19.6 Hz), 26.9 (d, J = 14.5 Hz), 21.0 (d, J = 3.8 Hz), 20.9 (d, J = 1.1 
Hz). HRMS (DART) m/z calculated for C29H32O2P [M+H]+:  443.2134; found:  443.2133. 
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To a solution of oxide 3.29f (3.0 g, 12.5  mmol, 1 equiv) in THF (30.0 mL) at –78 °C was 
added LDA (8.2 mL, 2.0 M in heptane/THF/chlorobenzene, 16.2 mmol, 1.3 equiv). The mixture 
was stirred at –78 °C for 30 min before addition of dry acetone (3.7 mL, 50.0 mmol, 4 equiv). 
The resulting mixture was kept at –78 °C for 1 h before it was warmed to 23 °C over 1 h. After 
stirring at 23 °C overnight, saturated aqueous NH4Cl and EtOAc were added to the mixture. The 
aqueous layer was further extracted with EtOAc. The combined EtOAc solution was washed 
with brine, dried over MgSO4, concentrated and purified using silica gel column chromatography 
(0-70% EtOAc in hexanes) to afford 2.7 g (73%) of oxide 3.31t as an off-white solid. 1H NMR 
(400 MHz, CDCl3): δ 7.38 (t, J = 8.3 Hz, 1H), 6.53 (dd, J = 8.0, 3.0 Hz, 1H), 6.45 (dd, J = 8.1 
Hz, 4.2 Hz, 1H), 4.19 (d, J = 3.7 Hz, 1H), 3.85 (s, 3H), 1.44 (s, 3H), 1.37 (s, 3H), 1.23 (d, J = 
16.3 Hz, 9H); 31P NMR (162 MHz, CDCl3): δ 66.5 ppm; 13C NMR (100 MHz, CDCl3): δ 165.8 
(d, J = 16.7 Hz), 161.3 (d, J = 1.8 Hz), 136.7, 106.0 (d, J = 5.4 Hz), 103.1 (d, J = 5.7 Hz), 101.8 
(d, J = 91.3 Hz), 78.8 (d, J = 59.4 Hz), 73.2 (d, J  = 2.0 Hz), 55.6, 34.0 (d, J = 72.6 Hz), 28.5 (d, 
J = 5.6 Hz), 24.7 (d, J = 2.8 Hz), 24.3.  
To a solution of oxide 3.31t (1.9 g, 6.4 mmol, 1 equiv) in THF (15 mL) at 0 °C was 
added NaH (0.73 g, 60% dispersion in mineral oil, 18.3 mmol, 2.8 equiv). The mixture was 
stirred at 10 °C for 2 h before addition of iodomethane (1.81 g, 12.74 mmol, 2.0 equiv). The 
resulting mixture was warmed to 23 °C over 1 h. After stirring at 23 °C overnight, saturated 
aqueous NH4Cl and EtOAc were added to the mixture. The aqueous layer was further extracted 
with EtOAc. The combined organic solution was washed with brine, dried over magnesium 
sulfate, concentrated, and purified by silica gel column chromatography (0-100% EtOAc in 
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hexanes) to afford 1.8 g (91%) of oxide 3.31u as a clear oil. Rf: 0.42 (100% EtOAc).  1H NMR 
(400 MHz, CDCl3): δ  7.38 (t, J = 8.3 Hz, 1H), 6.60 (dd, J = 8.2, 3.0 Hz, 1H), 6.45 (dd, J = 8.2 
Hz, 4.2 Hz, 1H), 4.38 (d, J = 3.0 Hz, 1H), 3.86 (s, 3H), 3.33 (s, 3H), 1.46 (s, 3H), 1.35 (s, 3H), 
1.23 (d, J = 16.0 Hz, 9H); 31P NMR (162 MHz, CDCl3): δ 60.74 ppm; 13C NMR (100 MHz, 
CDCl3): δ 165.2 (d, J = 16.5 Hz), 161.4 (d, J = 1.9 Hz), 136.4, 105.9 (d, J = 5.4 Hz), 102.9 (d, J 
= 5.7 Hz), 102.2 (d, J = 92.6 Hz), 78.6 (d, J = 55.3 Hz), 77.2 (d, J = 2.0 Hz), 55.5, 49.3, 34.2 (d, 
J = 74.6 Hz), 24.6, 20.4, 20.2 (d, J = 1.8 Hz). 
 To a solution of oxide 3.31u (0.78 g, 2.5 mmol) in THF (1.2 mL) at 23 °C was added 
1,1,3,3-tetramethyldisiloxane (TMDS, 0.67 g, 5.0 mmol, 2.0 equiv) and Ti(Oi-Pr)4 (0.96 mL, 3.3 
mmol, 1.3 equiv). The mixture was stirred at reflux for 12 h, and then concentrated under 
vacuum to remove most THF. 30% aqueous NaOH solution (8 mL) was carefully added to the 
residue. Gas was generated during addition. The resulting mixture was further stirred at 60 °C for 
0.5 h. To the mixture at 23 °C was added MTBE (5 mL). The MTBE layer was separated and the 
aqueous layer was washed with MTBE (3 mL x 3) under nitrogen. The MTBE solution was 
dried, concentrated, and purified by passing through a neutral alumina plug to afford 0.700 g 
(95%) of 3.L18  as a thick light yellow oil. 1H NMR (400 MHz, CDCl3): δ  7.13 (t, J = 8.1 Hz, 
1H), 6.53 (dd, J = 8.0, 0.5 Hz, 1H), 6.34 (dd, J = 8.0 Hz, 3.8 Hz, 1H), 4.74 (d, J = 1.8 Hz, 1H), 
3.75 (s, 3H), 3.23 (s, 3H), 1.17 (s, 3H), 1.04 (s, 3H), 0.93 (d, J = 12.4 Hz, 9H); 31P NMR (162 
MHz, CDCl3): δ -3.55 ppm; 13C NMR (100 MHz, CDCl3): δ 166.0,  161.4 (d, J = 12.2 Hz), 
132.1, 109.8 (d, J = 12.5 Hz), 104.0, 102.3 (d, J = 2.0 Hz), 89.8 (d, J = 30.0 Hz), 77.7 (d, J = 
19.3 Hz), 55.3, 49.9 (d, J = 1.0 Hz), 31.5 (d, J = 18.8 Hz), 27.1 (d, J = 14.0 Hz), 21.0 (d, J = 11.0 
Hz), 20.5 (d, J = 6.0 Hz). HRMS (DART) m/z calculated for C16H26O3P [M+H]+:  297.1614; 
found:  297.1614. 
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To a solution of oxide 3.31m (544 mg, 1.31 mmol) in 2.0 mL of MeCN was charged 581 
mg (3.27 mmol) of NBS in three portions over 5 min. The resultant mixture was then stirred at 
23 °C for 6 h. Water (5 mL) and EtOAc (10 mL) was then charged, and the mixture agitated for 
10 min. The layers were then separated, and the aqueous layer was extracted 1x with 10 mL of 
EtOAc. The combined organics were washed with 10 mL of 1 M HCl, dried with anhydrous 
Na2SO4, and concentrated in vacuo. The crude residue was purified by flash chromatography 
(gradient, 20–50% EtOAc/hexanes) to afford 732 mg of 3.35a as a white solid that was 
contaminated with a small amount of NBS and succinimide. Purity assay of this material by 
quantitative 1HNMR spectroscopy using dimethylfumarate as the standard showed the material 
was 95 wt% purity (93% yield). This material was used directly in the next step.  1H NMR (500 
MHz, CDCl3): δ 7.77 (s, 1H), 7.46 (t, J = 7.8 Hz, 1H), 6.96 (dd, J = 8.3 Hz, J = 3.1 Hz, 1H), 6.91 
(dd, J = 7.5 Hz, J = 3.1 Hz, 1H), 4.67 (p, J = 6.8 Hz, 1H), 4.38 (sept, J = 6.1 Hz, 1H), 4.36 (sept, 
J = 6.1 Hz, 1H), 1.47 (dd, J = 12 Hz, J = 7.2 Hz, 3H), 1.16 (d, J = 6.1 Hz, 3H), 1.14 (d, J = 6.1 
Hz, 3H), 1.13 (d, J = 16 Hz, 9H), 0.91 (d, J = 6.1 Hz, 3H), 0.82 (d, J = 6.1 Hz, 3H); 
31P{1H}NMR (202 MHz, CDCl3): δ 62 ppm; 13C{1H}NMR (100 MHz, CDCl3):  δ 164.3 (d, JCP 
= 18 Hz), 154.2, 152.7, 138.2 (d, JCP = 4.9 Hz), 136.0, 133.4 (d, JCP = 1.7 Hz), 132.0, 125.5 (d, 
JCP = 7.7 Hz), 115.5 (d, JCP = 85 Hz), 114.1 (d, JCP = 5.1 Hz), 113.5, 112.2, 77.8, 76.5, 71.3 (d, 
JCP = 62 Hz), 33.8 (d, JCP = 70 Hz), 23.8, 23.0, 22.7, 22.5, 15.4; HRMS (DART) m/z calculated 
for C24H32O4Br2P [M + H]+:  573.0399; found:  573.0400. 
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 To a crimp-cap vial was charged 82.3 mg (0.112 mmol) of (dppf)PdCl2 and 680 mg (95 
wt%, 1.13 mmol) of oxide 3.35a. The vial was sealed and inerted with Ar using vac-purge cycles 
(3x). 2-MeTHF (1.9 mL) was then charged and the resultant mixture was stirred at 23 °C for 5 
min. A THF solution of MeZnCl (2.0 M, 1.7 mL, 3.4 mmol) was then charged, and the mixture 
was allowed to stir for 10 min (gas evolution). The mixture was then heated at 65 °C in an oil 
bath for 22 h. The reaction was cooled to 23 °C and quenched with 10 mL of 1 M HCl. The 
mixture was then extracted with CH2Cl2 (3x), and the combined organics were washed with 5% 
citric acid (2 x 10mL), dried with anhydrous Na2SO4, and concentrated in vacuo. The crude 
residue was purified by flash chromatography (gradient, 20–60% EtOAc/hexanes) to afford an 
orange solid that was further purified by preparatory reverse phase HPLC (Agilent Prep-C18 
column, 0.1% formic acid/MeCN, 68% MeCN) to afford 311 mg (58%) of pure 3.35b as a white 
solid. [a]D24 = + 29.5 (c 0.27, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.43 (t, J = 7.9 Hz, 1H), 
6.97 (dd, J = 7.2 Hz, J = 3.3 Hz, 1H), 6.96 (s, 1H), 6.91 (dd, J = 8.3 Hz, J = 3.3 Hz, 1H), 4.62 (p, 
J = 6.8 Hz, 1H), 4.18 (sept, J = 6.2 Hz, 1H), 4.00 (sept, J = 6.2 Hz, 1H), 2.24 (s, 3H), 2.17 (s, 
3H), 1.48 (dd, J = 12 Hz, J = 7.1 Hz, 3H), 1.09 (d, J = 16 Hz, 9H), 1.07 (d, J = 6.2 Hz, 3H), 1.00 
(d, J = 6.2 Hz, 3H), 0.84 (d, J = 6.2 Hz, 3H), 0.78 (d, J = 6.2 Hz, 3H); 31P{1H}NMR (202 MHz, 
CDCl3): δ 62 ppm; 13C{1H}NMR (100 MHz, CDCl3):  δ 164.1 (d, JC-P = 19 Hz), 153.5, 152.2, 
140.7 (d, JC-P = 5.2 Hz), 133.0 (d, JC-P = 1.7 Hz), 132.4, 128.7 (d, JC-P = 1.9 Hz), 126.7, 125.9 (d, 
JC-P = 8.0 Hz), 125.8, 115.6 (d, JC-P = 86 Hz), 112.9 (d, JC-P = 5.2 Hz), 75.25 (d, JC-P = 71 Hz), 
71.30, 70.67, 33.64 (d, JC-P = 70 Hz), 23.78, 22.77, 22.66, 22.51, 22.40, 16.89, 16.86, 15.39; 
HRMS (DART) m/z calculated for C26H38O4P [M + H]+:  445.2502; found:  445.2501. 
 To a 25 mL Schlenk flask with magnetic stir bar was charged 289 mg (0.650 mmol) of 
oxide 3.35b. A reflux condenser was added, and the reaction was inerted with Ar using vacuum-
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purge cycles. Toluene (3.0 mL) was charged followed by triethylamine (0.27 mL, 2.0 mmol) and 
HSiCl3 (0.16 mL, 1.6 mmol). The mixture was then immersed in an oil bath at 60 °C and 
monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 23 °C and quenched 
with 3 mL of degassed (Ar sparge) 30% NaOH (aq.) at 0 °C. The mixture was then allowed to 
vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently extracted 
under Ar with MTBE (3 x 3 mL). The combined organics were dried with MgSO4, filtered 
quickly through a pad of celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude in hexanes and loading the mixture onto a 
short pad of silica gel and eluting with degassed (Ar sparge) hexanes/EtOAc (gradient, neat 
hexanes to 10% EtOAc/hexanes) using Ar to pressurize the flash column. The product fractions 
were immediately collected and concentrated in vacuo to afford 251 mg (90%) of 3.L21 as a 
white solid. [a]D25 = – 198 (c 0.46, CHCl3);  1H NMR (400 MHz, CDCl3): δ 7.28 (t, J = 7.8 Hz, 
1H), 7.10 (ddd, J = 7.6 Hz, J = 4.0 Hz, J = 0.9 Hz, 1H), 6.95 (s, 1H), 6.87 (dd, J = 8.0 Hz, J = 
0.9 Hz, 1H), 5.01 (q, J = 7.0 Hz, 1H), 3.86 (sept, J = 6.0 Hz, 1H), 3.70 (sept, J = 6.1 Hz, 1H), 
2.26 (s, 3H), 2.20 (s, 3H), 1.48 (dd, J = 16 Hz, J = 7.1 Hz, 3H), 1.04 (d, J = 6.1 Hz, 3H), 1.00 (d, 
J = 6.0 Hz, 3H), 0.98 (d, J = 6.1 Hz, 3H), 0.84 (d, J = 6.0 Hz, 3H), 0.77 (d, J = 12 Hz, 9H); 
31P{1H}NMR (202 MHz, CDCl3): δ 14 ppm; 13C{1H}NMR (100 MHz, CDCl3):  δ 163.2, 152.2, 
151.7, 140.5 (d, JCP = 16 Hz), 131.9, 130.0, 129.4, 127.3, 126.6, 124.5 (d, JC-P = 4.1 Hz), 124.0 
(d, JC-P = 21 Hz), 110.2, 78.5 (d, JC-P = 23 Hz), 75.0, 73.8, 31.1 (d, JCP = 20 Hz), 27.1 (d, JCP = 
14 Hz), 22.7, 22.4, 22.2 (d, JCP = 31 Hz), 22.1, 17.2, 16.9; HRMS (DART) m/z calculated for 
C26H38O3P [M + H]+:  429.2553; found:  429.2553. 
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To a solution of oxide 3.29c (871 mg, 2.16 mmol) in 4.0 mL of MeCN was charged 963 
mg (5.41 mmol) of NBS in three portions over 5 min. The resultant mixture was then stirred at 
23 °C. After 4 h, a slurry had formed, and an additional 2 mL of MeCN was charged. The slurry 
was stirred for an additional 4 h, and then the solid was isolated by filtration to afford 740 mg 
(61%) of 3.35c as a white solid. 1H NMR (500 MHz, CDCl3): δ 7.78 (s, 1H), 7.49 (t, J = 7.8 Hz, 
1H), 7.00 (dd, J = 8.4 Hz, J = 3.1 Hz, 1H), 6.95 (dd, J = 7.3 Hz, J = 3.3 Hz, 1H), 4.59 (dd, J = 14 
Hz, J = 2.8 Hz, 1H), 4.40 (sept, J = 6.2 Hz, 1H), 4.28 – 4.36 (m, 2H), 1.16 (d, J = 5.5 Hz, 3H), 
1.15 (d, J = 17 Hz, 9H), 1.14 (d, J = 5.2 Hz, 3H), 0.92 (d, J = 6.2 Hz, 3H), 0.86 (d, J = 6.2 Hz, 
3H); 31P{1H}NMR (202 MHz, CDCl3): δ 63 ppm; 13C{1H}NMR (100 MHz, CDCl3):  δ 165.8 (d, 
JCP = 19 Hz), 154.2, 152.7, 137.7 (d, JCP = 5.6 Hz), 136.1, 133.5 (d, JCP = 1.6 Hz), 131.9 (d, JCP 
= 2.0 Hz), 125.7 (d, JCP = 7.8 Hz), 116.0 (d, JCP = 87 Hz), 113.9 (d, JCP = 5.1 Hz), 113.6, 112.2, 
77.9, 76.6, 66.5 (d, JCP = 60 Hz), 34.2 (d, JCP = 70 Hz), 23.9, 22.9, 22.6, 22.48, 22.47; HRMS 
(DART) m/z calculated for C23H30O4Br2P [M + H]+:  559.0243; found:  559.0246. 
P
O
Oi-Pri-PrO
t-Bu
3.35c
Br Br
O
P
O
Oi-Pri-PrO
t-Bu
Me
3.L22OMe
MeO OMe
OMe
P
O
Oi-Pri-PrO
t-Bu
3.35dOMe
MeO OMe
OMe
P
O
Oi-Pri-PrO
t-Bu
Me
3.35eOMe
MeO OMe
OMe
O
O
Pd(OAc)2
BIDIME
Na2CO3
OMe
MeO B(OH)2
P
O
Oi-Pri-PrO
t-Bu
3.29c
O
NBS
MeCN
LDA
Me2SO4
HSiCl3
Et3N
 210 
 To a crimp-cap vial was charged 8.7 mg (0.039 mmol) of Pd(OAc)2, 12.8 mg (0.0387 
mmol) of rac-BIDIME, 410 mg (3.87 mmol) of Na2CO3, 587 mg (3.23 mmol) of 
dimethoxyphenyl boronic acid, and 723 mg (1.29 mmol) of oxide 3.35c. The vial was sealed and 
inerted with Ar using vac-purge cycles (3x). 2-MeTHF (3.2 mL) and water (1.1 mL) was then 
charged and the resultant mixture was heated at 70 °C in an oil bath for 18 h. The reaction was 
cooled to 23 °C and water was added. The layers were separated, and the aqueous layer was then 
extracted with EtOAc (1x). The combined organics were washed with water (1x), dried with 
anhydrous Na2SO4, and concentrated in vacuo. The crude residue was purified by flash 
chromatography (gradient, 50–100% EtOAc/hexanes) to afford 852 mg (97%) of 3.35d as a tan 
solid. [a]D25 = + 43.2 (c 0.30, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.47 (t, J = 7.9 Hz, 1H), 
7.31 (s, 1H), 6.98 (dd, J = 7.4 Hz, J = 3.3 Hz, 1H), 6.96 (dd, J = 8.3 Hz, J = 3.3 Hz, 1H), 6.87 (d, 
J = 2.2 Hz, 2H), 6.68 (d, J = 2.2 Hz, 2H), 6.43 (t, J = 2.2 Hz, 1H), 6.40 (t, J = 2.2 Hz, 1H), 4.56 
(dd, J = 14 Hz, J = 2.1 Hz, 1H), 4.37 (dd, J = 14 Hz, J = 11 Hz, 1H), 4.03 (sept, J = 6.1 Hz, 1H), 
3.94 (sept, J = 6.1 Hz, 1H), 3.82 (s, 6H), 3.81 (s, 6H), 1.19 (d, J = 16 Hz, 9H), 0.87 (d, J = 6.1 
Hz, 3H), 0.81 (d, J = 6.1 Hz, 3H), 0.69 (d, J = 6.1 Hz, 3H), 0.66 (d, J = 6.1 Hz, 3H); 
31P{1H}NMR (202 MHz, CDCl3): δ 62 ppm; 13C{1H}NMR (100 MHz, CDCl3):  δ 165.4 (d, JCP 
= 19 Hz), 160.5, 160.3, 154.4, 152.2, 141.8, 141.4, 139.8 (d, JCP = 5.6 Hz), 133.1, 133.0 (d, JCP = 
1.4 Hz), 131.4, 130.1 (d, JCP = 2.0 Hz), 129.7, 126.0 (d, JCP = 8.2 Hz), 116.0 (d, JCP = 89 Hz), 
112.7 (d, JCP = 5.3 Hz), 107.7, 106.9, 99.4, 99.3, 76.0, 74.2, 66.0 (d, JCP = 61 Hz), 55.5, 55.4, 
34.0 (d, JCP = 71 Hz), 24.2, 22.52, 22.50, 22.4, 22.2. HRMS (DART) m/z calculated for 
C39H48O8P [M + H]+:  675.3081; found:  675.3083. 
 To a solution of oxide 3.35d (0.500 g, 0.741 mmol) in 2.3 mL of THF at –78 °C was 
slowly charged a freshly prepared solution of LDA in THF (LDA prep: dropwise addition of 
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0.40 mL, 0.89 mmol of 2.2 M n-BuLi in hexanes to 0.14 mL, 0.96 mmol of di-iso-propylamine 
in 0.55 mL of THF at 0 °C followed by stirring at 0 °C for 20 min) by canula. The resultant red-
orange solution was stirred at –78 °C for 40 min. Dimethyl sulfate (0.091 mL, 0.96 mmol) was 
then charged by syringe, and the mixture was stirred at –78 °C for 30 min. The reaction was then 
quenched by the addition of 3 mL of 10% aqueous NH4Cl. The mixture was warmed to 23 °C, 
extracted with CH2Cl2, and the combined organic layers were dried with anhydrous Na2SO4 and 
concentrated in vacuo. The crude residue was then purified by flash chromatography (gradient, 
50–80% EtOAc/hexanes) to afford 418 mg (82%) of 3.35e as a white solid. [a]D25 = + 81.8 (c 
0.14, CHCl3); 1H NMR (500 MHz, CDCl3): δ 7.46 (t, J = 7.9 Hz, 1H), 7.31 (s, 1H), 6.96 (dd, J = 
7.3 Hz, J = 3.3 Hz, 1H), 6.92 (dd, J = 8.2 Hz, J = 3.3 Hz, 1H), 6.87 (d, J = 2.2 Hz, 2H), 6.68 (d, J 
= 2.2 Hz, 2H), 6.43 (t, J = 2.2 Hz, 1H), 6.40 (t, J = 2.2 Hz, 1H), 4.63 (dq, J = 6.0 Hz, J = 7.0 Hz, 
1H), 4.06 (sept, J = 6.1 Hz, 1H), 3.93 (sept, J = 6.1 Hz, 1H), 3.81 (s, 6H), 3.80 (s, 6H), 1.54 (dd, 
J = 12 Hz, J = 7.2 Hz, 3H), 1.19 (d, J = 16 Hz, 9H), 0.86 (d, J = 6.1 Hz, 3H), 0.81 (d, J = 6.1 Hz, 
3H), 0.67 (d, J = 6.1 Hz, 3H), 0.63 (d, J = 6.1 Hz, 3H); 31P{1H}NMR (162 MHz, CDCl3): δ 61 
ppm; 13C{1H}NMR (100 MHz, CDCl3):  δ 163.7 (d, JCP = 19 Hz), 160.5, 160.2, 154.4, 152.2, 
141.8, 141.4, 140.4 (d, JCP = 5.0 Hz), 133.0 (d, JC-P = 1.7 Hz), 132.9, 131.4, 130.1 (d, JCP = 1.9 
Hz), 129.6, 126.0 (d, JCP = 8.0 Hz), 115.5 (d, JCP = 87 Hz), 112.8 (d, JCP = 5.3 Hz), 107.9, 106.8, 
99.4, 99.3, 75.9, 74.3, 70.8 (d, JCP = 63 Hz), 55.5, 55.4, 33.6 (d, JCP = 70 Hz), 21.1, 22.6, 22.5, 
22.4, 22.1, 15.2; HRMS (DART) m/z calculated for C40H50O8P [M + H]+:  689.3238; found:  
689.3241. 
 To a 25 mL Schlenk flask with magnetic stir-bar was charged 382 mg (0.555 mmol) of 
oxide 3.35e. A reflux condenser was added, and the reaction was inerted with Ar using vacuum-
purge cycles. Toluene (2.5 mL) was charged followed by triethylamine (0.23 mL, 1.7 mmol) and 
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HSiCl3 (0.14 mL, 1.4 mmol). The mixture was then immersed in an oil bath at 60 °C and 
monitored by 31P NMR spectroscopy. After 5 h, the reaction was cooled to 23 °C and quenched 
with 3 mL of degassed (Ar sparge) 30% NaOH (aq.) at 0 °C. The mixture was then allowed to 
vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently extracted 
under Ar with MTBE (3x3 mL). The combined organics were dried with MgSO4, filtered quickly 
through a pad of celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude in hexanes and loading the mixture onto a 
short pad of silica gel and eluting with degassed (Ar sparge) hexanes/EtOAc (gradient, neat 
hexanes to 30% EtOAc/hexanes) using Ar to pressurize the flash column. The product fractions 
were immediately collected and concentrated in vacuo to afford 283 mg (76%) of 3.L22 as a 
white solid. [a]D25 = – 65.4 (c 0.66, CHCl3);  1H NMR (500 MHz, CDCl3): δ 7.288 (s, 1H), 7.287 
(t, J = 7.9 Hz, 1H), 7.04 (dd, J = 7.9 Hz, J = 3.4 Hz, 1H), 6.89 (d, J = 2.3 Hz, 2H), 6.87 – 6.91 
(m, 1H), 6.68 (d, J = 2.3 Hz, 2H), 6.42 (t, J = 2.2 Hz, 2H), 5.03 (q, J = 7.2 Hz, 1H), 3.94 (sept, J 
= 6.1 Hz, 1H), 3.83 (s, 6H), 3.80 (s, 3H), 3.65 (sept, J = 6.1 Hz, 1H), 1.43 (dd, J = 16 Hz, J = 7.1 
Hz, 3H), 0.90 (d, J = 6.1 Hz, 3H), 0.89 (d, J = 6.1 Hz, 3H), 0.87 (d, J = 12 Hz, 9H), 0.71 (d, J = 
6.1 Hz, 3H), 0.61 (d, J = 6.1 Hz, 3H); 31P{1H}NMR (202 MHz, CDCl3): δ 12.1 ppm; 
13C{1H}NMR (100 MHz, CDCl3):  δ 162.7, 160.4, 160.2, 152.9, 152.6, 142.2, 141.5, 140.6, 
140.4, 131.9, 131.2, 130.5, 129.6, 125.6 (d, JCP = 19 Hz), 124.0 (d, JCP = 3.8 Hz), 110.0, 107.6, 
107.2, 99.2, 99.1, 79.1 (d, JCP = 25 Hz), 75.5, 73.8, 55.4, 30.9 (d, JCP = 20 Hz), 27.2 (d, JCP = 15 
Hz), 22.5, 22.4, 22.2, 22.1, 21.6 (d, JCP = 30 Hz); HRMS (DART) m/z calculated for C40H50O7P 
[M + H]+:  673.3289; found:  673.3290. 
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A crimp-cap vial with a magnetic stir bar was sealed with a crimp-cap septum and inerted 
with Ar using vacuum-purge cycles. To the vial was charged 1,3-diisopropoxybenzene (0.62 mL, 
3.07 mmol, 2.2 eq) followed by hexanes (1.5 mL). A 2.55 M solution of n-BuLi (1.1 mL. 2.75 
mmol, 2.0 eq) was charged dropwise. The mixture was then stirred at 70 °C for 2 h. In a second 
crimp-cap vial was prepared a slurry of ZnBr2 (754 mg, 3.34 mmol, 2.38 eq) in THF (2.2 mL). 
To the ZnBr2 mixture cooled in an ice-bath was charged the aryllithium solution by syringe. The 
resulting mixture was then warmed to 23 °C and allowed to stir for 15 min before use. In a third 
crimp-cap vial with stir bar were charged triflate 3.278 (835 mg, 1.40 mmol, 1 eq), Pd(OAc)2 (9.4 
mg, 0.042 mmol, 3 mol%), and BI-DIME (21 mg, 0.063 mmol, 4.5 mol%). The mixture was 
inerted with Ar using vacuum-purge cycles. THF (2 mL) was then added, and the mixture was 
allowed to stir for 10 min. The zincate solution was then transferred to the catalyst/triflate 
solution by syringe. The final mixture was then immersed in an oil bath at 70 °C. After 12 h, the 
reaction was cooled to 23 °C and quenched with 2 M HCl (10 mL). CH2Cl2 (80 mL) was then 
added. The layers were separated, and the aqueous phase was extracted with CH2Cl2 (1 x 50 
mL). Combined organics were washed with 20% citric acid (50 mL), dried with MgSO4, and 
concentrated in vacuo. Purification of the crude mixture by flash chromatography (gradient, 40-
100% EtOAc in hexanes then 0-5% MeOH in CH2Cl2) afforded 602 mg (89%) of 3.30a as a 
white solid. 1H NMR (500 MHz, CDCl3) δ 8.18 (dd, J = 8.5 Hz, J = 3.2 Hz, 1H), 7.48 (t, J = 7.5 
Hz, 1H), 7.21 (t, J = 8.4 Hz, 1H), 6.97–6.94 (m, 1H), 6.55 (d, J = 8.4 Hz, 1H), 6.46 (d, J = 8.4 
Hz, 1H), 4.48 (sext, J = 6.0 Hz, 1H), 4.34 (dd, J = 13.5 Hz, J = 7.6 Hz, 1H), 3.93 (t, J = 13.9 Hz, 
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1H), 1.44 (s, 9H), 1.28 (d, J = 6.0 Hz, 3H), 1.21 (d, J = 6.0 Hz, 3H), 1.17–1.14 (m, 6H), 0.94 (d, 
J = 15.6 Hz, 9H); 31P{1 H}NMR (202 MHz, CDCl3) δ 56.96 ppm; 13C NMR (100 MHz, CDCl3) 
δ 176.9 (d, JC−P = 3.5 Hz), 157.8, 156.1, 148.8 (d, JC−P = 15.6 Hz), 139.3 (d, JC−P = 5.0 Hz), 
132.5 (d, JC−P = 1.9 Hz), 128.2 (d, JC−P = 9.3 Hz),119.3, 119.0 (d, JC−P = 8.7 Hz), 118.5, 118.0, 
117.9, 104.9, 103.7, 70.6, 69.4, 46.6, 46.0, 41.0, 34.3, 33.6, 28.3, 23.9, 22.4, 23.6, 22.1, 21.9. 
HRMS (DART) m/z calculated for C28H41O4NP [M + H]+:  486.2768; found:  486.2766. 
 To a Schlenk flask with magnetic stir bar was charged 3.30a (362 mg, 0.754 mmol, 1.0 
eq). A reflux condenser was added, and the reaction was inerted with Ar using vacuum-purge 
cycles. PhMe (3.0 mL) was as added followed by triethylamine (1.2 mL, 9.05 mmol, 12.0 eq) 
and HSiCl3 (600 µL, 5.96 mmol, 8.0 eq). The mixture was then immersed in an oil bath at 107 
°C and monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 23 °C and 
quenched with 10 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed 
to vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently extracted 
under Ar with MTBE (3 × 10 mL). The combined organics were dried with MgSO4, filtered 
quickly through a pad of Celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude solid in CH2Cl2 and loading the mixture 
onto a short pad of silica gel and eluting with degassed (Ar sparge) 20% EtOAc in hexanes using 
Ar to pressurize the flash column. The product fractions were immediately collected and 
concentrated in vacuo to afford 257 mg (74%) of 3.L24 as a white solid. [a]D25 = – 155 (c 0.28, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.09 (dd, J = 8.32 Hz, J = 0.88 Hz, 1H), 7.32 (t, J = 8.08 
Hz, 1H), 7.19 (t, J = 8.32 Hz, 1H), 6.95–6.92 (m, 1H), 6.58 (d, J = 8.04 Hz, 1H), 6.53 (d, J = 
8.24 Hz, 1H), 4.47 (p, J = 6.1 Hz, 1H), 4.41–4.37 (m, 1H), 4.22 (p, J = 6.12 Hz, 1H), 3.93–3.85 
(m, 1H), 1.45 (s, 9H), 1.26 (d, J = 6.0 Hz, 3H), 1.20 (d, J = 6.0 Hz, 3H), 1.12 (d, J = 6.0 Hz, 3H), 
 215 
0.99 (d, J = 6.0 Hz, 3H), 0.75 (d, J = 12.0 Hz, 9H); 31P{1H}NMR (202 MHz, CDCl3) δ  – 11.1 
ppm; 13C NMR (100 MHz, CDCl3) δ 176.6, 156.6, 155.8, 148.5, 138.8 (d, JC−P = 19.8 Hz), 
129.1, 128.6, 127.3, 127.2, 122.0, 118.4, 108.2, 104.9, 71.6, 69.2, 46.9, 46.7, 40.7, 31.4, 31.2, 
27.0 (d, JC−P = 14.7 Hz), 22.4, 22.2, 22.1, 21.9. HRMS (DART) m/z calculated for C28H41O3NP 
[M + H]+:  470.2819; found:  470.2818. 
 
 
To a solution of oxide 3.30b7,8 (0.400 g, 0.949 mmol) in 10 mL of THF at –78 °C was 
charged a solution of LDA in THF (2.0 M, 1.42 mL, 2.8 mmol). The mixture was stirred for 5 
min and then dimethyl sulfate (0.13 mL, 1.4 mmol) was charged dropwise. The mixture was 
stirred at –78 °C for 1 h and then quenched by the addition of 10% NH4Cl. The mixture was 
warmed to 23 °C and extracted with EtOAc. The combined organics were dried with anhydrous 
Na2SO4 and concentrated in vacuo. The crude residue was purified by flash chromatography 
(gradient, 25 to 100% EtOAc in hexanes) to afford 343 mg (83%) of oxide 3.32a as a light 
brown solid. 1HNMR (400 MHz, CDCl3) δ 7.40 (t, J = 8.2 Hz, 2H), 7.25–7.33 (m, 4H), 7.19 (t, J 
= 7.3 Hz, 1H), 6.72 (dd, J = 8.3 Hz, J = 3.5 Hz, 1H), 6.68 (dd, J = 7.34 Hz, J = 3.5 Hz, 1H), 6.66 
(d, J = 8.0 Hz, 1H), 6.57 (d, J = 8.2 Hz, 1H), 3.83 (s, 3H), 3.77–3.85 (m, 1H), 3.74 (m, 3H), 1.48 
(dd, J = 12 Hz, J = 7.0 Hz, 3H), 0.89 (d, J = 15 Hz, 9H); 31P{1H}NMR (162 MHz, CDCl3) δ 59 
ppm; 13CNMR (100 MHz, CDCl3) δ 159.0, 157.4, 152.8 (d, JCP = 16 Hz), 142.7 (d, JCP = 6.5 
Hz), 139.1 (d, JCP = 4.4 Hz), 133.0 (d, JCP = 1.7 Hz), 129.64, 129.57, 125.0, 124.6, 122.4 (d, JCP 
= 9.1 Hz), 117.9 (d, JCP = 2.7 Hz), 114.5 (d, JCP = 87 Hz), 110.6 (d, JCP = 8.1 Hz), 104.5, 103.0, 
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56.1, 55.4, 52.9 (d, JCP = 67 Hz), 33.4 (d, JCP = 70 Hz), 23.9, 14.1 (d, JCP = 2.0 Hz). HRMS 
(DART) m/z calculated for C26H31O3NP [M + H]+:  436.2036; found:  436.2038. 
 To a Schlenk flask with magnetic stir bar was charged 3.32a (250 mg, 0.574 mmol). A 
reflux condenser was added, and the reaction was inerted with Ar using vacuum-purge cycles. 
PhMe (6.0 mL) was as added followed by triethylamine (0.23 mL, 1.7 mmol) and HSiCl3 (144 
µL, 1.44 mmol). The mixture was then immersed in an oil bath at 65 °C and monitored by 31P 
NMR spectroscopy. After 3 h, the reaction was cooled to 23 °C and quenched with 15 mL of 
degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed to vigorously stir at 23 °C 
for 1 h. The aqueous layer was removed and subsequently extracted under Ar with MTBE (3 × 
10 mL). The combined organics were dried with MgSO4, filtered quickly through a pad of Celite, 
and immediately concentrated in vacuo. The crude residue was chromatographed on the bench 
by dissolving the crude in 10% EtOAc in hexanes and loading the mixture onto a short pad of 
silica gel and eluting with degassed (Ar sparge) hexanes/EtOAc (gradient, neat hexanes to 15% 
EtOAc/hexanes) using Ar to pressurize the flash column. The product fractions were 
immediately collected and concentrated in vacuo to afford 149 mg (62%) of 3.L25 as a white 
solid that was contaminated with a small amount of impurities that could not be removed by 
further purification and therefore was used directly in subsequent experiments. We cannot rule 
out that low enantioselectivity in the subsequent cross-coupling reactions using this ligand was a 
result of the present impurities. [a]D25 = – 108 (c 0.65, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.14–7.30 (m, 6H), 6.98 (dd, J = 8.1 Hz, J = 0.8 Hz, 1H), 6.90 (tt, J = 7.1 Hz, J = 1.2 Hz, 1H), 
6.66 (dd, J = 3.2 Hz, J = 0.8 Hz, 1H), 6.58 (d, J = 8.2 Hz, 1H), 6.52 (d, J = 8.3 Hz, 1H), 3.99 (q, 
J = 7.0 Hz, 1H), 3.70 (s, 3H), 3.67 (s, 3H), 1.38 (dd, J = 17 Hz, J = 7.0 Hz, 3H), 0.64 (d, J = 12 
Hz, 9H); 31P{1H}NMR (162 MHz, CDCl3) δ 7.6 ppm; 13C NMR (100 MHz, CDCl3) δ 157.9, 
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157.1, 149.1, 144.7, 139.8 (d, JCP = 18 Hz), 129.6, 129.2, 128.8, 122.3 (d, JCP = 4.4 Hz), 121.5, 
119.9, 119.1, 112.7, 111.3, 104.4, 103.6, 58.5 (d, JCP = 18 Hz), 55.8 (d, JCP = 1.8 Hz), 55.4, 30.5 
(d, JCP = 19 Hz), 26.9 (d, JCP = 14 Hz), 20.8 (d, JCP = 33 Hz). HRMS (DART) m/z calculated for 
C26H31O2NP [M + H]+:  420.2087; found:  420.2089. 
 
 
A crimp-cap vial with a magnetic stir bar was charged oxide 3.30a (1.27 g, 2.62 mmol, 
1.0 eq) followed by methanol (13 mL). A 1.0 M solution of NaOH (3.9 mL, 3.93 mmol, 1.5 eq) 
was charged. The mixture was then stirred at 50 °C for 1 h. The reaction mixture was cooled to 
23 °C then concentrated in vacuo. Purification of the crude mixture by flash chromatography 
(gradient, 50–100% EtOAc in hexanes then 0–10% MeOH in CH2Cl2) afforded 1.04 g (99%) of 
3.30c as a white semi-solid. 1H NMR (500 MHz, CDCl3) δ 7.29–7.26 (m, 1H), 7.17 (t, J = 8.4 
Hz, 1H), 6.63–6.58 (m, 2H), 6.55 (t, J = 8.4 Hz, 1H), 6.46 (t, J = 8.3 Hz, 1H), 4.51–4.41 (m, 2H), 
3.61–3.48 (m, 2H), 1.30–1.14 (m, 12H), 0.92 (d, J = 15.6 Hz, 9H); 31P{1H}NMR (202 MHz, 
CDCl3) δ 64.95 ppm. 
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A crimp-cap vial with a magnetic stir bar was charged with Pd2(dba)3 (48 mg, 0.052 
mmol, 2 mol%), RuPhos (70 mg, 0.157 mmol, 6 mol%), NaOt-Bu (302 mg, 3.14 mmol, 1.2 eq) 
and the reaction vessel was inerted with Ar using vacuum-purge cycles. A solution of oxide 
3.30c (1.04 g, 2.62 mmol, 1.0 eq) in THF (10 mL) was added followed by PhBr (414 µL, 3.93, 
1.5 eq). The mixture was then stirred at 70 °C for 4.5 h. The reaction was cooled to 23 °C, 
quenched with 1M HCl, and extracted with CH2Cl2, washed with water and brine, dried with 
MgSO4, filtered and concentrated in vacuo. Purification of the crude mixture by flash 
chromatography (gradient, 40–100% EtOAc in hexanes) afforded 791 mg (63% - over 2 steps) of 
3.30d as a white solid. 1H NMR (500 MHz, CDCl3) δ 7.38 (t, J = 7.3 Hz, 2H), 7.31–7.10 (m, 
4H), 6.91 (dd, J = 8.3 Hz, J = 3.6 Hz, 1H), 6.63 (dd, J = 8.2 Hz, J = 2.8 Hz, 1H), 6.57 (d, J = 8.4 
Hz, 1H), 6.47 (d, J = 8.4 Hz, 1H), 4.53–4.48 (m, 2H), 4.00 (t, J = 13.6 Hz, 1H), 3.76 (dd, J = 
13.5 Hz, J = 6.1 Hz, 1H), 1.35 (d, J = 6.0 Hz, 3H), 1.26–1.19 (m, 9H), 0.96 (d, J = 15.4 Hz, 9H); 
31P{1H}NMR (202 MHz, CDCl3) δ 57.98. ppm; 13C NMR (100 MHz, CDCl3) δ 158.0, 156.0, 
152.8 (d, JC-P = 15.5 Hz), 144.2 (d, JC-P = 6.5 Hz), 140.2 (d, JC-P = 4.8 Hz), 132.4 (d, JC-P = 1.8 
Hz), 129.5, 129.2, 123.9, 123.3, 123.2, 122.4, 118.8, 116.4, 115.5, 109.4 (d, JC-P = 8.3 Hz), 
105.2, 103.7, 70.8, 69.3, 50.4, 49.8, 34.2, 33.5, 23.1 (d, JC-P = 27.6 Hz) 22.4, 22.1, 21.9. 
A crimp-cap vial with a magnetic stir-bar was charged oxide 3.30d (450 mg, 0.943 mmol, 
1.0 eq) followed by dimethyl sulfate (135 µL, 1.42 mmol, 1.5 eq) and the reaction vessel was 
inerted with Ar using vacuum-purge cycles. THF (5 mL) was charged and the reaction mixture 
was cooled to –78 °C. A 1.0 M solution of freshly made LDA (1.91 mL, 1.88 mmol, 2.0 eq) was 
charged dropwise. The mixture was then stirred at –78 °C for 30 min and then allowed to reach 
23 °C. The reaction mixture quenched with sat NH4Cl, and extracted with CH2Cl2, washed with 
water and brine, dried with MgSO4, filtered and concentrated in vacuo. Purification of the crude 
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mixture by flash chromatography (gradient, 40-100% EtOAc in hexanes) afforded 453 mg (98%) 
of 3.32b as a white solid. 1H NMR (500 MHz, CDCl3) δ 7.40–7.30 (m, 4H), 7.26–7.13 (m, 4H), 
6.76–6.73 (m, 1H), 6.63–6.61 (m, 1H), 6.55 (d, J = 8.4 Hz, 1H), 6.46 (d, J = 8.3 Hz, 1H), 4.53–
4.47 (m, 2H), 3.84–3.78 (m, 1H), 1.51–1.46 (m, 3H), 1.37 (d, J = 6.1 Hz, 3H), 1.25–1.19 (m, 
9H), 0.93 (d, J = 15.0 Hz, 9H); 31P{1H}NMR (202 MHz, CDCl3) δ 59.5 ppm; 13C NMR (100 
MHz, CDCl3) δ 157.9, 156.0, 151.7 (d, JC-P = 16.4 Hz), 143.4 (d, JC-P = 6.2 Hz), 140.4 (d, JC-P = 
4.5 Hz), 132.3 (d, JC-P = 1.8 Hz), 129.5, 129.0, 124.4, 123.6, 123.2, 123.1, 118.7 (d, JC-P = 2.9 
Hz), 115.3, 114.4, 110.2 (d, JC-P = 8.2 Hz), 104.9, 103.6, 70.5, 69.2, 53.5, 52.8, 33.9, 33.2, 23.9, 
22.4, 22.3, 22.1, 22.0, 14.8 (d, JC-P = 1.5 Hz). HRMS (DART) m/z calculated for C30H39O3NP [M 
+ H]+:  492.2662; found:  492.2660. 
To a Schlenk flask with magnetic stir bar was charged azaphosphole 3.32b (360 mg, 
0.727 mmol, 1.0 eq). A reflux condenser was added, and the reaction was inerted with Ar using 
vacuum-purge cycles. PhMe (3.0 mL) was as added followed by triethylamine (1.2 mL, 8.72 
mmol, 12.0 eq) and HSiCl3 (590 µL, 5.82 mmol, 8.0 eq). The mixture was then immersed in an 
oil bath at 107 °C and monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 
23 °C and quenched with 10 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was 
then allowed to vigorously stir at 23 °C for 1 h. The aqueous layer was removed and 
subsequently extracted under Ar with MTBE (3 × 10 mL). The combined organics were dried 
with MgSO4, filtered quickly through a pad of Celite, and immediately concentrated in vacuo. 
The crude residue was chromatographed on the bench by dissolving the crude solid in CH2Cl2 
and loading the mixture onto a short pad of silica gel and eluting with degassed (Ar sparge) 10% 
EtOAc in hexanes using Ar to pressurize the flash column. The product fractions were 
immediately collected and concentrated in vacuo to afford 304 mg (88%) of 3.L26 as a white 
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solid. [α]D25 = – 107 (c 0.24, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.37-7.27 (m, 4H), 7.20-
7.15 (m, 2H), 7.03-7.00 (m, 1H), 6.97-6.93 (m, 1H), 6.67-6.64 (m, 1H), 6.62 (d, J = 8.1 Hz, 1H), 
6.53 (d, J = 8.3 Hz, 1H), 4.49 (p, J = 6.0 Hz, 1H), 4.31 (p, J = 6.0 Hz, 1H), 4.06 (q, J = 7.0 Hz, 
1H), 1.51-1.44 (m, 3H), 1.29-1.24 (m, 9H), 1.18 (d, J = 6.1 Hz, 3H), 1.00 (d, J = 6.1 Hz, 3H), 
0.71 (d, J = 11.7 Hz, 9H); 31P{1H}NMR (202 MHz, CDCl3) δ 7.5 ppm; 13C NMR (100 MHz, 
CDCl3) δ 156.7, 155.7, 148.8, 145.1 (d, JC−P = 1.5 Hz), 140.5 (d, JC−P = 18.6 Hz), 129.1, 128.7, 
128.2, 123.2 (d, JC−P = 4.6 Hz), 121.3, 119.0, 110.8, 108.7, 105.0, 71.7, 69.2, 58.6 (d, JC−P = 18.6 
Hz), 30.7, 30.5, 29.7, 27.3 (d, JC−P = 14.5 Hz), 22.5 (d, JC−P = 2.0 Hz), 22.2, 22.1, 22.0. HRMS 
(DART) m/z calculated for C30H39O2NP [M + H]+:  476.2713; found:  476.2714. 
 
 
To a slurry of phenol 3.468 (8.00 g, 25.9 mmol) and 3.88 g (64.7 mmol) of K2CO3 in 16 
mL of DMF and 80 mL of 2-MeTHF was charged 4.0 mL (65 mmol) of iodomethane, and the 
resultant mixture was allowed to stir at 23 °C for 15 h. Water was then charged, and the layers 
were separated. The aqueous layer was extracted with 2-MeTHF (2x10 mL), and the combined 
organic layers were washed with brine, dried with anhydrous Na2SO4, and concentrated in vacuo 
to afford 7.42 g (89%) of 3.47 as a white solid that was used directly in the next step without 
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further purification. [α]D25 = – 44.0 (c 0.42, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.88 (dd, J = 
8.5 Hz, J = 2.8 Hz, 1H), 7.45 (t, J = 8.4 Hz, 1H), 6.65 (dd, J = 8.2 Hz, J = 4.4 Hz, 1H), 4.29 (dd, 
J = 14 Hz, J = 6.3 Hz, 1H), 4.08 (dd, J = 15 Hz, J = 14 Hz, 1H), 3.90 (s, 3H),1.41 (s, 9H), 1.24 
(d, J = 16 Hz, 9H); 13C NMR (125 MHz, CDCl3) δ 177.3 (d, JCP = 4.1 Hz), 161.0 (d, JCP = 1.2 
Hz), 151.0 (d, JCP = 12 Hz), 135.7 (d, JCP = 1.4 Hz), 113.5 (d, JCP = 0.7 Hz), 106.3 (d, JCP = 88 
Hz), 106.0 (d, JCP = 6.1 Hz), 55.62, 46.47 (d, JCP = 62 Hz), 41.11, 34.05 (d, JCP = 73 Hz), 28.24, 
24.46 (d, JCP = 1.1 Hz); 31P NMR (202 MHz, CDCl3) δ 59. HRMS (DART) m/z calculated for 
C17H27O3NP [M + H]+:  324.1723; found:  324.1723. 
A mixture of 3.47 (7.00 g, 21.6 mmol), 32 mL of 1M NaOH (32 mmol), and 70 mL of 
MeOH was agitated at 50 °C for 22 h. The reaction was then cooled to 23 °C and concentrated in 
vacuo to crystallize a white solid. The resultant slurry was agitated at 23 °C for 1 h, and the solid 
was then isolated by filtration and washed with water. The solid was dried in vacuo overnight to 
provide 4.01 g (77%) of 3.48 as a white solid. [α]D25 = + 9.5 (c 0.38, CHCl3); 1H NMR (500 
MHz, CDCl3) δ 7.24 (t, J = 8.1 Hz, 1H), 6.28 (dd, J = 8.1 Hz, J = 3.1 Hz, 1H), 6.24 (dd, J = 8.1 
Hz, J = 4.5 Hz, 1H), 4.19 (d, J = 19 Hz, 1H), 3.85 (s, 3H), 3.60 (d, J = 3.7 Hz, 1H), 3.58 (ddd, J 
= 19 Hz, J = 14 Hz, J = 3.7 Hz, 1H), 1.24 (d, J = 16 Hz, 9H); 13C NMR (125 MHz, CDCl3) δ 
161.9 (d, JCP = 1.9 Hz), 157.5 (d, JCP = 17 Hz), 135.9 (d, JCP = 1.3 Hz), 105.1 (d, JCP = 7.3 Hz), 
101.2 (d, JCP = 91 Hz), 100.2 (d, JCP = 5.9 Hz), 55.26, 43.45 (d, JCP = 64 Hz), 33.95 (d, JCP = 74 
Hz), 24.42; 31P NMR (202 MHz, CDCl3) δ 67; HRMS (DART) m/z calculated for C12H19O2NP 
[M + H]+:  240.1148; found:  240.1149. 
Oxide 3.48 (1.00 g, 4.18 mmol), Pd2(dba)3 (0.0962 g, 0.105 mmol), RuPhos (0.1951 g, 
0.418 mmol), and sodium tert-butoxide (0.482 g, 5.01 mmol) were added to a flask under N2. 
The flask was backfilled with N2 three times. Phenyl bromide (0.51 mL, 5.0 mmol) and THF (10 
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mL) were added, followed by backfilling with N2 three times. The reaction mixture was stirred at 
23 °C for 5 min and heated at 67 °C overnight. The reaction mixture was passed through a pad of 
celite, which was then washed with THF (3 × 50 mL). The crude product was concentrated and 
purified by column chromatography on silica gel (CH2Cl2/MeOH, 94:6) to obtain 3.49 as a 
yellow solid (1.29 g, 98% yield). [α]D25 = + 68.9 (c 0.52, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.41−7.35 (m, 2H), 7.27−7.14 (m, 4H), 6.48 (dd, J = 8.3, 3.0 Hz, 1H), 6.29 (dd, J = 8.1, 4.5 Hz, 
1H), 4.03 (t, J = 14.5 Hz, 1H), 3.88 (s, 3H), 3.85 (dd, J = 14.0, 4.27 Hz, 1H), 1.29 (d, J = 16.0 
Hz, 9H); 13C NMR (100 MHz, CDCl3) δ 143.6, 135.7, 129.659, 125.0, 123.4, 104.3, 104.2, 
100.7, 100.6, 55.4, 50.8, 50.1, 34.4, 33.6, 24.5; 31P NMR (162 MHz, CDCl3) δ 60.37. HRMS 
(DART) m/z calculated for C18H23O2NP [M + H]+:  316.1461; found:  316.1462.  
To a solution of 3.49 (0.400 g, 1.27 mmol) in 4 mL of THF under Ar was charged 2-
iodopropane (0.32 g, 1.9 mmol), and the mixture was cooled to –78 °C. A solution of LDA (2.0 
M in THF/heptane/ethylbenzene, 1.6 mL, 3.2 mmol) was charged dropwise. The mixture was 
agitated at –78 °C for 10 min and then allowed to warm to 23 °C and stirred an additional 15 
min. Aqueous HCl (2.0 M, 10 mL) was then charged, and volatile organics were removed in 
vacuo. The aqueous residue was then extracted with CH2Cl2 (3 x 10mL). The combined organics 
were dried with anhydrous Na2SO4 and concentrated in vacuo. The crude residue was then 
purified by flash chromatography (gradient, 0 to 5% MeOH in CH2Cl2) to afford 304 mg (70%) 
of 3.50 as a yellow solid. 1H NMR (500 MHz, CDCl3) δ 7.41 (t, J = 7.8 Hz, 2H), 7.28 (d, J = 7.9 
Hz, 2H), 7.24 (t, J = 7.4 Hz, 1H), 7.15 (t, J = 8.2 Hz, 1H), 6.18 – 6.24 (m, 2H), 3.84 (s, 3H),  
3.75 (dd, J = 5.5 Hz, J = 3.7 Hz, 1H), 2.13 – 2.29 (m, 1H), 1.24 (d, J = 15 Hz, 9H), 1.20 (d, J = 
7.1 Hz, 3H), 1.11 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 162.3 (d, JCP = 0.7 Hz), 
155.3 (d, JCP = 14 Hz), 142.2 (d, JCP = 6.7 Hz), 135.5 (d, JCP = 1.2 Hz), 129.7, 126.4, 126.1, 
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103.1 (d, JCP = 8.2 Hz), 101.3 (d, JCP = 88 Hz), 100.0 (d, JCP = 6.1 Hz), 61.0 (d, JCP = 63 Hz), 
55.2, 34.7 (d, JCP = 73 Hz), 30.4 (d, JCP = 2.3 Hz), 24.5 (d, JCP = 0.7 Hz), 18.5 (d, JCP = 0.7 Hz), 
17.8 (d, JCP = 5.1 Hz); 31P NMR (162 MHz, CDCl3) δ 61; HRMS (DART) m/z calculated for 
C21H29O2NP [M + H]+:  358.1930; found:  358.1931. 
To a 10 mL Schlenk flask with magnetic stir bar was charged 3.50 (260 mg, 0.727 mmol, 
1.0 eq). A reflux condenser was added, and the reaction was inerted with Ar using vacuum-purge 
cycles. PhMe (2.0 mL) was as added followed by triethylamine (210 µL, 1.45 mmol, 2.0 eq) and 
HSiCl3 (110 µL, 1.09 mmol, 1.5 eq). The mixture was then immersed in an oil bath at 60 °C and 
monitored by 31P NMR spectroscopy. After 3.5 h, the reaction was cooled to 23 °C and quenched 
with 3 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed to 
vigorously stir at 23 °C for 1 h. The aqueous layer was removed and subsequently extracted 
under Ar with MTBE (3 × 5 mL). The combined organics were dried with MgSO4, filtered 
quickly through a pad of Celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude solid in CH2Cl2 and loading the mixture 
onto a short pad of silica gel and eluting with degassed (Ar sparge) 25% EtOAc in hexanes using 
Ar to pressurize the flash column. The product fractions were immediately collected and 
concentrated in vacuo to afford 130 mg (52%) of 3.L27 as a white solid that was contaminated 
with a small impurity (93/7 by 31PNMR spectroscopy). This material was used without further 
purification. We cannot rule out that low enantioselectivity in the subsequent cross-coupling 
reactions using this ligand was a result of the present impurities.  [α]D25 = + 57.5 (c 0.43, 
CHCl3);  1H NMR (500 MHz, CDCl3) δ 7.29–7.37 (m, 4H), 7.08 (t, J = 7.9 Hz, 2H), 6.46 (d, J = 
8.2 Hz, 1H), 6.28 (dd, J = 8.1 Hz, J = 2.6 Hz, 1H), 4.08 (t, J = 3.5 Hz, 1H), 3.83 (s, 3H), 2.10–
2.22 (m, 1H), 1.00 (d, J = 6.7 Hz, 3H), 0.99 (d, J = 12 Hz, 9H), 0.81 (d, J = 6.7 Hz, 3H); 13C 
 224 
NMR (125 MHz, CDCl3) δ 161.8 (d, JCP = 12 Hz), 154.4 (d, JCP = 1.0 Hz), 144.5 (d, JCP = 1.4 
Hz), 131.3, 129.3, 123.7, 123.3, 110.4 (d, JCP = 11 Hz), 104.0, 100.4 (d, JCP = 2.3 Hz), 70.4 (d, 
JCP = 23 Hz), 55.1, 31.3 (d, JCP = 20 Hz), 30.9 (d, JCP = 19 Hz), 27.3 (d, JCP = 14 Hz), 18.8 (d, 
JCP = 11 Hz), 16.5 (d, JCP = 12 Hz); 31P NMR (202 MHz, CDCl3) δ – 19. HRMS (DART) m/z 
calculated for C21H29ONP [M + H]+:  342.1981; found:  342.1981. 
 
 
To a crimp vial was added the azaphosphole 3.49 (535 mg, 1.69 mmol, 1 eq), 2,4,6-
triisopropylbenzylbromide (1.01 g, 3.40 mmol, 2.0 eq). The reaction was inerted with Ar using 
vacuum-purge cycles and Ar-purged THF (5.0 mL) was added. The solution was cooled to –78 
°C. To a second crimp vial was added diisopropylamine (521 µL, 3.72 mmol, 2.2 eq) and THF (1 
mL). The reaction mixture was cooled to –78 °C and a 2.50 M solution of n-BuLi was added 
(1.42 mL, 3.55 mmol, 2.1 eq). The reaction was stired for 20 min at –78 °C and the LDA was 
added via syringe to the first vial. The reaction mixture was stirred for 25 min at –78 °C then 
allowed to warm to 23 °C. UPLC analysis showed 100% conversion. The reaction was quenched 
with 1M HCl (20 mL), extracted with CH2Cl2 (3 x 25 mL) and washed with water and brine. The 
combined organic layers were dried with MgSO4, filtered and concentrated in vacuo. Purification 
of the crude mixture by flash chromatography (gradient, 0–10% MeOH in CH2Cl2) afforded 337 
mg (81%) of 3.51 as an off-white solid. 1H NMR (500 MHz, CDCl3) 7.31 (t, J = 8.2 Hz, 1H), 
7.00 (br s, 2H), 6.84 (t, J = 6.0 Hz, 2H), 6.78 (t, J = 5.8 Hz, 1H), 6.59 (dd, J = 6.48 Hz, J = 2.3 
Hz, 1H), 6.46 (dd, J = 6.6 Hz, J = 3.2 Hz, 1H), 6.24 (d, J = 7.9 Hz, 2H), 3.91 (s, 3H), 3.77–3.72 
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(m, 1H), 3.47–3.43 (m, 2H), 3.16–3.13 (m, 2H), 2.88 (p, J = 5.5 Hz, 1H), 1.27 (d, J = 6.9 Hz, 
9H), 1.16–1.12 (m, 18H); 31P NMR (202 MHz, CDCl3) δ 67.0, 66.9 ppm; 13C NMR (125 MHz, 
CDCl3) δ 162.8 (d, JC−P = 1.2 Hz), 153.2 (d, JC−P = 16.0 Hz), 147.6, 145.5 (d, JC−P = 2.8 Hz), 
135.2 (d, JC−P = 1.35 Hz), 130.8 (d, JC−P = 10.8 Hz), 128.6, 122.5, 121.4, 119.9, 110.3 (d, JC−P = 
7.2 Hz), 106.4, 105.7, 103.4 (d, JC−P = 5.9 Hz), 62.9 (d, JC−P = 58.4 Hz), 55.5, 34.4, 32.7 (d, JC−P 
= 66.8 Hz), 29.3, 27.3, 24.6, 24.5, 24.3, 24.2. HRMS (DART) m/z calculated for C34H47O2NP [M 
+ H]+:  532.3339; found:  532.3337. 
To a 10 mL Schlenk flask with magnetic stir bar was charged azaphosphole 3-oxide 3.51 
(600 mg, 1.13 mmol, 1.0 eq). A reflux condenser was added, and the reaction was inerted with 
Ar using vacuum-purge cycles. PhMe (3.0 mL) was as added followed by triethylamine (315 µL, 
2.26 mmol, 2.0 eq) and HSiCl3 (170 µL, 1.69 mmol, 1.5 eq). The mixture was then immersed in 
an oil bath at 60 °C and monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled 
to 23 °C and quenched with 4 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was 
then allowed to vigorously stir at 23 °C for 1 h. The aqueous layer was removed and 
subsequently extracted under Ar with MTBE (3 × 5 mL). The combined organics were dried 
with MgSO4, filtered quickly through a pad of Celite, and immediately concentrated in vacuo. 
The crude residue was chromatographed on the bench by dissolving the crude solid in CH2Cl2 
and loading the mixture onto a short pad of silica gel and eluting with degassed (Ar sparge) 20% 
EtOAc in hexanes using Ar to pressurize the flash column. The product fractions were 
immediately collected and concentrated in vacuo to afford 520 mg (89%) of 3.L28 as a white 
solid. [a]D25 = + 25.4 (c 0.37, CHCl3);  1H NMR (500 MHz, CDCl3) δ 7.21 (t, J = 8.1 Hz, 1H), 
6.98 (s, 2H), 6.96 (t, J = 7.9 Hz, 2H), 6.79 (t, J = 7.3 Hz, 1H), 6.70 (d, J = 8.1 Hz, 1H), 6.56 (d, J 
= 8.1 Hz, 2H), 6.46 (dd, J = 8.1 Hz, J = 3.7 Hz, 1H), 4.08 (dd, J = 10 Hz, J = 4.0 Hz, 1H), 3.88 
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(s, 3H), 3.04–3.21 (m, 3H), 2.94–3.03 (m, 1H), 2.88 (sept, J = 6.9 Hz, 1H), 1.26 (d, J = 6.9 Hz, 
6H), 1.11–1.89 (m, 6H), 1.10 (d, J = 6.7 Hz, 6H), 0.87 (d, J = 12 Hz, 9H); 13C NMR (125 MHz, 
CDCl3) δ 162.7 (d, JCP = 13 Hz), 151.7, 147.5, 147.3, 145.8 (d, JCP = 2.1 Hz), 131.4 (d, JCP = 15 
Hz), 131.2, 129.1, 128.5, 128.3, 121.7, 121.2, 120.1, 113.5 (d, JCP = 13 Hz), 108.9, 102.3 (d, JCP 
= 2.2 Hz), 66.9 (d, JCP = 21 Hz), 55.3, 34.4, 33.9 (d, JCP = 39 Hz), 30.7 (d, JCP = 22 Hz), 29.4, 
27.7 (d, JCP = 14 Hz), 24.5, 24.3, 24.2, 24.1; 31P NMR (202 MHz, CDCl3) δ 2.3. HRMS (DART) 
m/z calculated for C34H47ONP [M + H]+:  516.3390; found:  516.3390.   
 
 
A solution of 3.30b (0.400 g, 0.949 mmol) and the benzyl bromide derivative (0.422 g, 
1.42 mmol) in 10 mL of THF was prepared under Ar, and the mixture was cooled to –78 °C. A 
solution of LDA (2.0 M in THF/heptane/ethylbenzene, 1.4 mL, 2.8 mmol) was charged 
dropwise. The mixture was agitated at –78 °C for 1 h and then allowed to warm to 23 °C and 
stirred an additional 1 h. Aqueous NH4Cl (10%, 10 mL) was then charged, and volatile organics 
were removed in vacuo. The aqueous residue was then extracted with EtOAc (3 x 15 mL). The 
combined organics were dried with anhydrous Na2SO4 and concentrated in vacuo. The crude 
residue was then purified by flash chromatography (gradient, 0 to 30% EtOAc in hexanes) to 
afford 304 mg (70%) of 3.32c as an off-white solid. 1H NMR (400 MHz, CDCl3) δ 7.44 (td, J = 
7.9 Hz, J = 0.8 Hz, 1H), 7.31 (t, J = 8.4 Hz, 1H), 7.11 (dd, J = 8.1 Hz, J = 0.5 Hz, 1H), 7.03 (s, 
2H), 6.89 (dd, J = 7.2 Hz, J = 0.6 Hz, 1H), 6.86 (t, J = 8.4 Hz, 2H), 6.73 (t, J = 7.0 Hz, 1H), 6.67 
(d, J = 8.4 Hz, 1H), 6.57 (d, J = 8.2 Hz, 1H), 6.34 (d, J = 8.0 Hz, 2H), 3.83 (s, 3H), 3.76 (s, 3H), 
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3.69–3.77 (m, 1H), 3.48–3.57 (m, 1H), 3.34–3.44 (m, 1H), 3.14 (sept, J = 6.8 Hz, 2H), 2.91 
(sept, J = 7.0 Hz, 1H), 1.29 (d, J = 6.9 Hz, 6H), 1.05–1.24 (m, 12 H), 0.86 (d, J = 15 Hz, 9H); 
13C NMR (100 MHz, CDCl3) δ 159.2, 157.2, 150.5 (d, JCP = 18 Hz), 147.6, 145.3 (d, JCP = 2.5 
Hz), 140.3 (d, JCP = 4.7 Hz), 132.8 (d, JCP = 1.7 Hz), 131.3 (d, JCP = 11 Hz), 129.6, 128.5, 125.0 
(d, JCP = 8.7 Hz), 121.5, 121.4, 118.5, 118.3 (d, JCP = 88 Hz), 116.7 (d, JCP = 2.6 Hz), 116.1, 
116.0, 104.3, 102.8, 62.7 (d, JCP = 60 Hz), 56.0, 55.3, 34.4, 32.5 (d, JCP = 65 Hz), 29.3, 26.6, 
24.7 (br), 24.33, 24.28, 23.9; 31P NMR (162 MHz, CDCl3) δ 63 ppm. HRMS (DART) m/z 
calculated for C41H53O3NP [M + H]+:  638.3758; found:  638.3758.  
To a 10 mL Schlenk flask with magnetic stir bar was charged azaphosphole 3-oxide 
3.32c (274 mg, 0.431 mmol). A reflux condenser was added, and the reaction was inerted with 
Ar using vacuum-purge cycles. Toluene (6 mL) was added followed by triethylamine (172 µL, 
1.29 mmol) and HSiCl3 (108 µL, 1.08 mmol). The mixture was then immersed in an oil bath at 
60 °C and monitored by 31P NMR spectroscopy. After 3 h, the reaction was cooled to 23 °C and 
quenched with 15 mL of degassed (Ar sparge) 30% NaOH (aq.). The mixture was then allowed 
to vigorously stir at 23 °C for 0.5 h. The aqueous layer was removed and subsequently extracted 
under Ar with MTBE (3 × 5 mL). The combined organics were dried with MgSO4, filtered 
quickly through a pad of Celite, and immediately concentrated in vacuo. The crude residue was 
chromatographed on the bench by dissolving the crude solid in 10% EtOAc/hexanes and loading 
the mixture onto a short pad of silica gel and eluting with degassed (Ar sparge) 10% EtOAc in 
hexanes using Ar to pressurize the flash column. The product fractions were immediately 
collected and concentrated in vacuo to afford 206 mg (77%) of 3.L29 as a white solid. [α]D24 = – 
94.1 (c 0.25, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.20–7.30 (m, 2H), 7.02 (d, J = 8.0 Hz, 1H), 
6.93 (s, 2H), 6.84 (t, J = 7.4 Hz, 2H), 6.78 (dd, J = 7.4 Hz, J = 3.2 Hz, 1H), 6.66 (t, J = 7.0 Hz, 
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1H), 6.62 (d, J = 8.2 Hz, 1H), 6.55 (d, J = 8.4 Hz, 1H), 6.43 (d, J = 8.1 Hz, 2H), 3.98 (dd, J = 11 
Hz, J = 2.8 Hz, 1H), 3.73 (s, 3H), 3.69 (s, 3H), 3.13–3.24 (m, 1H), 2.95–3.13 (m, 3H), 2.82 (sept, 
J = 6.9 Hz, 1H), 1.20 (d, J = 7.0 Hz, 6H), 1.08 (d, J = 6.6 Hz, 6H), 1.04 (d, J = 6.8 Hz, 6H), 0.61 
(d, J = 12 Hz, 9H); 13C NMR (100 MHz, CDCl3) δ 157.9, 157.1, 149.6, 147.4, 147.3, 145.9 (d, 
JCP = 1.9 Hz), 139.8 (d, JCP = 19 Hz), 131.8 (d, JCP = 17 Hz), 129.5, 128.9, 128.3, 123.5, 123.4, 
121.2, 120.8, 120.2, 118.7, 114.5, 104.7, 103.6, 66.9 (d, JCP = 20 Hz), 56.0, 55.4, 34.3 33.6 (d, 
JCP = 39 Hz), 30.2 (d, JCP = 20 Hz), 29.3, 27.4 (d, JCP = 15 Hz), 24.6, 24.3, 24.2, 24.0; 31P NMR 
(162 MHz, CDCl3) δ 11. HRMS (DART) m/z calculated for C41H53O2NP [M + H]+:  622.3808; 
found:  622.3813.  
 
3.8.2.2 Substrate Synthesis 
 
A round bottom flask equipped with a magnetic stir bar was heat-dried under reduced 
pressure, and then cooled under a N2 atmosphere. Wittig reagent 3.5214 (5.30 g, 9.42 mmol, 1.0 
equiv) was added and the flask backfilled with N2 three times. DMAc (0.25 M, 38 mL) was 
added and the reaction cooled to 0 °C in an ice/water bath. t-BuOK (1.16 g, 10.4 mmol, 1.1 
equiv) was added in one portion and the solution turned bright orange. After 1 min, freshly 
distilled benzaldehyde (1.0 g, 9.42 mmol, 1.0 equiv) was added dropwise over 3 min and the 
reaction was left to run at 0 °C for 20 min. The reaction was then quickly transferred to a 
separatory funnel with EtOAc (5 mL) and quenched with deionized water (20 mL). The layers 
were separated and the resulting aqueous layer was extracted with EtOAc (3 x 20 mL). The 
organic layers were combined and washed with deionized water (4 x 10 mL), brine (2 x 10 mL), 
PtO2 (10 mol%)
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dried over Na2SO4, and the volatiles were removed under reduced pressure. The resulting crude 
residue was purified by flash chromatography (Hexanes → 9:1 Hexanes:EtOAc) to yield 2.36 g 
(81%) of olefin 3.53 as an E/Z mixture that was used directly in the next step. 
To a 100 mL bomb was charged alkene 3.53 (2.36 g, 7.62 mmol, 1.0 equiv) and PtO2 
(173 mg, 0.76 mmol, 0.10 equiv). EtOH (51 mL) was added, and the vessel was sealed and 
placed under N2 by pressurizing the vessel to ~100 psi of N2 followed by venting. This was 
repeated 2x. The reactor was then placed under a H2 atmosphere by pressurizing the reactor to 50 
psi H2 followed by venting. This process was performed 3x. The reactor was then pressurized 
with 50 psi of H2 and agitated at 23 °C with mechanical stirring for 2 h. The reaction was then 
vented and filtered through a pad of celite with EtOAc as the eluent, and the volatiles were 
removed under reduced pressure. The resulting crude residue was purified by flash 
chromatography (Hexanes → 9:1 Hexanes:EtOAc) to yield 2.09 g (88%) of bromide 3.37d as a 
colorless oil. 1H NMR (500 MHz, CDCl3): δ 8.35 (d, J = 8.5, 1H), 7.80 (d, J = 8.3, 1H), 7.72 (d, 
J = 8.3, 1H), 7.59 (t, J = 7.8, 1H), 7.50 (t, J = 7.8, 1H), 7.33–7.26 (m, 5H), 7.25–7.22 (m, 1H), 
3.29 (t, J = 8.3, 2H), 3.01 (t, J = 8.3, 2H); 13C NMR (125 MHz, CDCl3): δ 141.6, 139.3, 133.4, 
132.8, 128.7, 128.6, 128.3, 128.2, 127.7, 127.5, 127.4, 126.2, 126.1, 123.9, 39.8, 36.5. HRMS 
(DART) calculated for C18H15Br [M]+:  310.0357; found [M]+:  310.0353. 
 
 
A round bottom flask equipped with a magnetic stir bar was heat-dried under reduced 
pressure, and then cooled under a N2 atmosphere. Wittig reagent 3.5214 (1.87 g, 3.33 mmol, 1.0 
Br
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H
O
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H
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equiv) was added and the flask backfilled with N2 three times. DMAc (0.25 M, 13 mL) was 
added and the reaction cooled to 0 °C in an ice/water bath. t-BuOK (0.411g, 3.66 mmol, 1.1 
equiv) was added in one portion and the solution turned bright orange. After 1 min, freshly 
distilled benzyloxyacetaldehyde (0.500 g, 3.33 mmol, 1.0 equiv) was added dropwise over 3 min 
and the reaction was left to run at 0 °C for 20 min. The reaction was then quickly transferred to a 
separatory funnel with EtOAc (5 mL) and quenched with deionized water (20 mL). The layers 
were separated and the resulting aqueous layer was extracted with EtOAc (3 x 20 mL). The 
organic layers were combined and washed with deionized water (4 x 10 mL), brine (2 x 10 mL), 
dried over Na2SO4, and the volatiles were removed under reduced pressure. The resulting crude 
residue was purified by flash chromatography (Hexanes → 20:1 Hexanes:EtOAc) to yield 1.11 g 
(94%) of olefin 3.54 as a light green oil (5:1 mixture Z:E). 1H NMR (500 MHz, CDCl3): δ 8.33 
(d, J = 8.6, 1H), 7.80 (d, J = 8.6, 1H), 7.71 (d, J = 8.2, 1H), 7.60–7.56 (m, 1H), 7.53–7.47 (m, 
1H), 7.42–7.36 (m, 1H), 7.33–7.31 (m, 1H), 7.29–7.28 (m, 3H), 7.26–7.23 (m, 1H), 6.92 (d, J = 
11.9, 1H), 6.07 (dd, J = 13.8, 7.1, 1H), 4.48 (s, 2H), 4.16 (d, J = 6.7, 2H); 13C NMR (125 MHz, 
CDCl3): (35 of 36 signals observed) δ 138.2, 138.1, 134.9, 134.2, 133.9, 133.6, 133.0, 132.6, 
132.3, 132.2, 129.9, 129.6, 128.4, 128.3, 128.0, 127.9, 127.9, 127.7, 127.7, 127.7, 127.6, 127.6, 
127.6, 127.6, 127.2, 127.1, 126.6, 126.6, 126.3, 123.8, 123.7, 72.4, 72.3, 70.7, 66.6. 
To an Endeavor test tube was charged alkene 3.54 (713.1 mg, 2.02 mmol, 1.0 equiv) and 
Pt/V on carbon (179.0 mg, 0.50 mmol, 0.25 equiv). EtOAc (7.2 mL) was added and the reaction 
placed in an Endeavor reactor under 200 psi H2 gas and 23 °C for 36 h. The reaction was then 
filtered through a plug of celite with EtOAc as the eluent (10 mL) and the volatiles were 
removed under reduced pressure. The resulting crude residue was purified by flash 
chromatography (Hexanes → 9:1 Hexanes:EtOAc) to yield bromide 3.37e (716.5 mg, 99% 
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yield) as a light brown oil. 1H NMR (500 MHz, CDCl3): δ 8.31 (d, J = 8.8, 1H), 7.78 (d, J = 8.4, 
1H), 7.71 (d, J = 8.4, 1H), 7.57 (t, J = 7.7, 1H), 7.47 (t, J = 7.7, 1H), 7.37–7.33 (m, 5H), 7.30–
7.27 (m, 1H), 4.54 (s, 2H), 3.56 (t, J = 6.5, 2H), 3.10 (t, J = 7.7, 2H), 2.06–2.01 (m, 2H); 13C 
NMR (125 MHz, CDCl3): δ 139.7, 138.7, 133.4, 132.8, 128.5, 128.4, 128.1, 127.8, 127.7, 127.6, 
127.4, 127.4, 125.9, 123.9, 73.1, 69.6, 34.2, 30.1. HRMS (DART) calculated for C20H20BrO [M 
+ H]+:  355.0698; found [M + H]+:  355.0693. 
 
 
A round bottom flask equipped with a magnetic stir bar was heat-dried under reduced 
pressure, and then cooled under a N2 atmosphere. Wittig reagent 3.5214 (1.76 g, 3.122 mmol, 1.0 
equiv) was added and the flask backfilled with N2 three times. DMAc (0.25 M, 12.5 mL) was 
added and the reaction cooled to 0 °C in an ice/water bath. t-BuOK (385.4 mg, 3.434 mmol, 1.1 
equiv) was added in one portion and the solution turned bright orange. After 1 min, freshly 
distilled furfural (300.0 mg, 3.122 mmol, 1.0 equiv) was added dropwise over 3 min and the 
reaction was left to run at 0 °C for 20 min. The reaction was then quickly transferred to a 
separatory funnel with EtOAc (5 mL) and quenched with deionized water (20 mL). The layers 
were separated and the resulting aqueous layer was extracted with EtOAc (3 x 20 mL). The 
organic layers were combined and washed with deionized water (4 x 10 mL), brine (2 x 10 mL), 
dried over Na2SO4, and the volatiles were removed under reduced pressure. The resulting crude 
residue was purified by flash chromatography (Hexanes → 9:1 Hexanes:EtOAc) to yield 760 mg 
(82%) of olefin 3.55 as a white solid (1:1 mixture Z:E). 1H NMR (500 MHz, CDCl3): δ 8.35 (dd, 
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J = 8.5, 5.8, 2H), 7.83–7.70 (m, 6H), 7.61–7.57 (m, 2H), 7.54–7.48 (m, 4H), 7.25 (app. s, 1H), 
6.98 (d, J = 16.2, 1H), 6.69 (d, J = 12.4, 1H), 6.57 (d, J = 12.4, 1H), 6.47 (app. s, 2H), 6.27–6.26 
(m, 1H), 6.10 (d, J = 3.2, 1H); 13C NMR (125 MHz, CDCl3): (30 of 32 signals observed) δ 153.3, 
151.9, 142.9, 142.2, 136.4, 134.5, 133.9, 133.9, 133.0, 132.6, 128.2, 128.2, 128.1, 128.0, 127.9, 
127.8, 127.5, 127.4, 127.1, 126.9, 126.7, 126.7, 124.3, 123.6, 119.7, 119.5, 112.0, 111.5, 110.6, 
109.9. 
To a 100 mL bomb was charged alkene 3.55 (0.700 g, 2.35 mmol, 1.0 equiv), 163 mg 
(0.176 mmol) of (PPh3)3RhCl, and 17 mL of a 1:1 mixture of THF:t-BuOH. The vessel was 
sealed and placed under N2 by pressurizing the vessel to ~100 psi of N2 followed by venting. 
This was repeated 2x. The reactor was then placed under a H2 atmosphere by pressurizing the 
reactor to 50 psi H2 followed by venting. This process was performed 3x. The reactor was then 
pressurized with 300 psi of H2 and agitated at 23 °C with mechanical stirring for 6 h. The 
reaction was then vented and filtered through a pad of celite with EtOAc as the eluent, and the 
volatiles were removed under reduced pressure. The resulting crude residue was purified by flash 
chromatography (Hexanes → 9:1 Hexanes:EtOAc) to yield 513 mg (73%) of bromide 3.37f. 
1HNMR (500 MHz, CDCl3): δ 8.33 (d, J = 8.6, 1H), 7.79 (d, J = 8.1, 1H), 7.71 (d, J = 8.3, 1H), 
7.58 (t, J = 7.4, 1H), 7.48 (t, J = 7.3, 1H), 7.34 (d, J = 1.2 Hz, 1H), 7.27 (d, J = 8.4 Hz, 1H), 6.28 
(dd, J = 3.0 Hz, J = 1.2 Hz, 1H), 5.99 (d, J = 3.0 Hz, 1H),  3.26 (t, J = 8.3 Hz, 2H), 3.03 (t, J = 
8.3 Hz, 2H); 13CNMR (125 MHz, CDCl3): δ 155.1, 141.2, 138.8, 133.5, 132.7, 128.2, 128.1, 
127.7, 127.5, 127.4, 126.1, 123.9, 110.3, 105.6, 36.3, 28.5. HRMS (DART) calculated for 
C16H14BrO [M + H]+:  301.0228; found [M + H]+:  301.0223. 
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To a solution of 5.0 g (26.7 mmol) of phenol 3.56 in 50 mL of acetone under N2 was 
charged 8.87 g (64.2 mmol) of K2CO3 and 10.0 g (58.8 mmol) of i-PrI. The mixture was then 
agitated at reflux for 14 h. The reaction was then cooled to 23 °C and diluted with 60 mL of 
water. The layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 x 70 mL). 
The combined organic layers were then washed with water, brine, and dried with anhydrous 
Na2SO4. Volatile material was then removed in vacuo and the crude residue purified by flash 
chromatography (gradient, hexanes to 2:1 hexanes:EtOAc) to afford 6.03 g (98%) of the desired 
bromide 3.57 as a light brown oil. 1H NMR (500 MHz, CDCl3): δ 7.11 (t, J = 7.8, 1H), 6.84 (d, J 
= 7.5, 1H), 6.75 (d, J = 8.2, 1H), 4.53 (sept, J = 6.1, 1H), 2.41 (s, 3H), 1.38 (d, J = 6.1, 6H); 13C 
NMR (125 MHz, CDCl3): δ 154.8, 140.0, 127.4, 123.1, 116.6, 113.1, 72.28, 23.62, 22.26. 
HRMS (DART) calculatedd for C10H14BrO [M + H]+:  229.0228; found [M + H]+:  229.0223. 
 
 
To a solution of 3.08 g (16.5 mmol) of phenol 3.56 and 405 mg (0.823 mmol) of 
Sc(OTf)3 under N2 in 25 mL of CH2Cl2 was charged 8.27 g (37.9 mmol) of Boc2O. The mixture 
was allowed to stir at 23 °C for 2 h. An additional 4.32 g (19.8 mmol) of Boc2O was then 
charged and stirring was continued at 23 °C. After a further 5 h, another charge of 4.32 g (19.8 
mmol) of Boc2O was added, and the mixture was stirred at 23 °C for an additional 17 h. To the 
reaction was then charged 2 M aqueous NaOH (30 mL), and the mixture was agitated for 30 min. 
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The layers were then separated, and the aqueous was extracted with CH2Cl2 (2x). Combined 
organics were washed with water, brine, dried with anhydrous Na2SO4, and concentrated in 
vacuo. The crude residue was purified by flash chromatography (gradient, hexanes to 10% 
EtOAc/hexanes) to afford 3.0 g (75%) of the desired bromide 3.58 as a colorless oil. 1H NMR 
(500 MHz, CDCl3): δ 7.08 (t, J = 7.9, 1H), 6.94 (d, J = 8.2 Hz, 1H), 6.93 (d, J = 7.5 Hz, 1H), 
2.41 (s, 3H), 1.44 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 153.5, 139.7, 126.7, 125.1, 121.8, 
120.8, 81.05, 29.06, 23.78. HRMS (DART) calculated for C11H16BrO [M + H]+:  243.0385; 
found [M + H]+:  243.0381. 
 
(2-Methylnaphthalen-1-yl)boronic acid (3.16a) was synthesized using the 
literature procedure.15 1H NMR (400 MHz, CDCl3): δ 8.48 (s, 2H), 7.88 (dd, J = 
8.0, 1.0 Hz, 1H), 7.80 (d, J = 8.3 Hz, 2H), 7.52-7.43 (m, 2H), 7.36 (d, J = 8.3 Hz, 1H), 
2.52 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 136.8, 135.2, 131.2, 128.6, 128.5, 128.2, 127.6, 
125.9, 124.9, 22.7. HRMS (DART-TOF+): mass [M+H] calculated for C11H11O2B 186.08466, 
found 186.08478. 
 
2-(2-Methylnaphthalen-1-yl)-1,3,2-dioxaborolane (3.16b) was prepared 
according to a literature procedure16 with a slight modification of the solvent. To a 
10 mL dram vial equipped with a stir bar, were added (2-methylnaphthalen-1-
yl)boronic acid (0.25g, 1.34 mmol, 1 equiv), molecular sieves 4Å activated powder (1 g) and 
tert-butyl methyl ether, MTBE (2 mL) under nitrogen. To the resulting mixture was added 
anhydrous ethylene glycol (83.42 mg, 1.34 mmol, 1.0 equiv), sealed with a lid and stirred for 12 
h at 23 °C. The molecular sieves were collected by the filtration and rinsed the solids with 
additional MTBE (1 ml). The combined fractions were dried concentration under reduced 
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pressure to afford 293 mg (100%) of 2-(2-Methylnaphthalen-1-yl)-1,3,2-dioxaborolane 3.16b as 
clear oil. The oil was used directly without further purification for the coupling reactions. 1H 
NMR (400 MHz, CDCl3) δ  8.12 (d, J = 8.4 Hz, 1H), 7.76 (d, J = 8.3 Hz, 2H), 7.46-7.36 (m, 
2H), 7.29 (d, J = 8.5 Hz, 1H), 4.48 (s, 4H), 2.61 (s, 3H); 11B NMR (128.3 MHz, CDCl3) δ  33.0 
ppm, 13C NMR (100 MHz, CDCl3) δ  142.1, 136.7, 131.4, 129.9, 128.8, 128.5, 128.1, 127.8, 
126.1, 124.7, 65.9, 23.0.   
 
4,4,5,5-tetramethyl-2-(2-methylnaphthalen-1-yl)-1,3,2-dioxaborolane (3.16c) 
was prepared according to the literature procedure.17 
 
 
Potassium trifluoro(2-methylnaphthalen-1-yl)borate (3.16d) was prepared 
according to a literature procedure.18 White solid, 1H NMR (400 MHz, CD3CN): 
δ  8.69 (d, J = 8.5 Hz, 1H), 7.70 (dd, J = 7.8, 1.7 Hz, 1H), 7.56 (d, J = 8.30 Hz, 1H), 7.35-7.27 
(m, 2H), 7.21 (d, J = 8.3 Hz, 1H), 2.63 (q, J = 1.9 Hz, 3H); 19F NMR (376.4 MHz, CD3CN): δ  -
129.0 ppm (m); 13C NMR (100 MHz, CD3CN): δ  139.1, 138.4, 132.5, 130.8 (q, J = 4.3 Hz), 
130.3, 127.9, 126.2, 124.2, 123.6, 117.9, 23.3 (q, J = 3.4 Hz).   
 
2-(2-ethylnaphthalen-1-yl)-1,3,2-dioxaborolane (3.38a) was prepared 
according to the literature.16 Clear oil (92% yield); 1H NMR (400 MHz, 
CDCl3): δ  8.04 (dd, J = 8.3, 0.7 Hz, 1H), 7.80 (d, J = 8.4 Hz, 2H), 7.78 (dd, J 
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= 8.0, 1.3, 2H), 7.47-7.37 (m, 2H), 7.34 (d, J = 8.5 Hz, 1H), 4.51 (s, 4H), 2.88 (q, J = 7.6 Hz, 
2H), 1.29 (t, J = 7.6 Hz, 3H);  13C NMR (100 MHz, CDCl3): δ 148.1, 136.5, 131.4, 130.0, 129.1, 
128.1, 127.8, 127.1, 125.9, 124.7, 65.9, 30.2, 17.0. 
 
3.8.2.3 General Procedure for the Asymmetric Suzuki–Miyaura Cross-Coupling 
To a 10 mL screw-cap threaded vial with a stir bar were charged aryl bromide (0.2 mmol, 
1.0 equiv), arylboronic acid (1 mmol, 5.0 equiv), Pd(OAc)2 (0.01 mmol, 5 mol%), ligand (SP)-
3.L7 (0.02 mmol, 10 mol%, Pd/ligand ratio = 1:2) followed by potassium phosphate tribasic (1.0 
mmol, 5.0 equiv). The vial was briefly inerted with argon and then charged dry THF (1 mL). The 
mixture was stirred at reflux (65 °C) for 24 h (unless otherwise mentioned) and then quenched 
with 2% ammonium chloride solution (2 mL). The resulting mixture was extracted with EtOAc 
(4 mL) and organics were dried over sodium sulfate, concentrated, and purified by silica gel 
column chromatography to provide chiral tetra-ortho-substituted bisnaphthalene products. 
Enantiomeric ratios were determined by chiral HPLC or SFC. 
 
3.8.2.4 General Procedure for the Asymmetric Negishi Cross-Coupling 
A 10-mL microwave vial equipped with a magnetic stir bar was heat-dried under reduced 
pressure, and then cooled under a N2 atmosphere. The aryl bromide (1.5 equiv) was then added 
under N2, followed by THF (0.42 M). The reaction was then cooled to –78 °C where a solution 
of t-BuLi in pentanes (1.7 M, 3.0 equiv) was added dropwise over 10 min while keeping the 
reaction at –78 °C. After 20 min, a solution of ZnBr2 (2.0 equiv) in THF (0.56 M) was added 
dropwise to the reaction over 5 min while keeping the reaction at –78 °C. After ~2 min, the 
reaction was allowed to warm to 23 °C.  During this time, a second 10-mL microwave vial 
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equipped with a magnetic stir bar was heat-dried under reduced pressure and then cooled under a 
N2 atmosphere. Aryl bromide (70.0 mg, 1.0 equiv), Pd2(dba)3 (2.5 mol%), and ligand (7.5 mol%) 
were added, and the vial inerted with N2 using vacuum-purge cycles (3x). The organozinc 
solution was then cannulated into the second vial. The combined mixture was then placed in a 
pre-heated 60 °C oil bath and allowed to stir for 16 h. Once at 23 °C, the reaction mixture was 
quenched with 2.0 M HCl (3 mL), and then transferred to a separatory funnel with EtOAc (2 
mL). The layers were separated, and the aqueous layer extracted with EtOAc (3 x 4 mL). The 
organic layers were combined and washed brine (5 mL), and dried over MgSO4. The volatiles 
were removed under reduced pressure. The resulting crude residue was purified by flash 
chromatography (Hexanes → 9:1 Hexanes:EtOAc) to yield the desired biaryl compounds. 
 
3.8.2.5 Analytical Data of Cross-Coupling Products 
3.8.2.5.1 Asymmetric Suzuki–Miyaura Reaction 
 (S)-2,2'-Dimethyl-1,1'-binaphthalene (S)-3.18: This product was purified with 
silica gel chromatography (eluent: 0-15% EtOAc in hexanes). Thick oil (40.1 
mg, 97% corrected yield, containing 10% regiosiomer); 89% ee; Enantiomeric 
excess was determined by chiral HPLC on a Chiralcel OD-H (4.6 x 250 mm, hexanes, isocratic, 
0.8 mL/min, run time: 25 min, 25 oC, 11.12 min (S), 14.87 min (R)).  1H NMR (400 MHz, 
CDCl3): δ 7.89–7.85 (m, 4H), 7.49 (d, J = 8.4 Hz, 2H), 7.38 (m, 2H), 7.19 (m, 2H), 7.04 (d, J = 
8.4 Hz), 2.02 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 135.1, 134.3, 132.7, 132.2, 128.7, 127.9, 
127.4, 126.0, 125.6, 124.9, 20.05. HRMS (DART): mass [M+H] calculated for C22H16 
282.14030, found 282.14042. Analytical data was in agreement with the reported literature.19 
Absolute configuration was confirmed by comparison of the optical rotation to the literature 
(S)-3.18
Me
Me
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value:  [a]D25 = + 36.5 (c 0.31, CHCl3, 95:5 er), lit.19 [a]D20 = – 37.1 (c 1, CHCl3, 95% ee, R-
isomer). 
Chiral HPLC (Chiralcel OD-H,100% hexanes, 220 nm) analysis of Suzuki Reaction product (S)-
3.18: 
Asymmetric Reaction:                     Racemic Reaction: 
 
 
 
(S)-2,2'-diethyl-1,1'-binaphthalene (S)-3.39a: Arylbromide (1.0 equiv), 2-(2-
ethylnaphthalen-1-yl)-1,3,2-dioxaborolane, 3.38a (2.0 equiv), K3PO4 (3.0 equiv) 
and rest as described in the general procedure using ligand (SP)-3.L7. This 
product was purified with silica gel chromatography ((eluent: 0-10% EtOAc in hexanes). Clear 
(S)-3.39a
Et
Et
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oil (27% yield); 76% ee; Enantiomeric excess was determined by chiral HPLC on a Chiralcel 
OD-H (4.6 x 250 mm, hexanes, isocratic, 0.8 mL/min, run time: 25 min, 25 oC, 9.73 min (S), 
12.6 min (R)). Rf = 0.38 in 100% hexanes. 1H NMR (500 MHz, CDCl3): δ 7.90 (d, J = 8.5 Hz, 
2H), 7.88 (d, J = 8.1 Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 7.39-7.37 (m, 2H), 7.20-7.16 (m, 2H), 
7.03 (d, J = 8.5 Hz), 2.40-2.28 (m, 4H), 1.01(t, J = 7.6 Hz, 6H); 13C NMR (125 MHz, CDCl3): δ 
140.2, 134.1, 133.2, 132.1, 127.7 (d, J = 3.8 Hz), 126.8, 126.3, 125.8, 124.9, 26.7, 14.8. HRMS 
(DART) m/z calculated for C24H22 [M]+:  310.1716; found [M]+:  310.1719. Analytical data was 
in agreement with the reported literature.20  
Asymmetric Reaction:                     Racemic Reaction: 
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 (S)-2,2'-dimethoxy-1,1'-binaphthalene (S)-3.39b: This product was purified 
with silica gel chromatography ((eluent: 0-30% EtOAc in hexanes). White solid 
(18.0 mg, 26% yield); 77%  ee; Enantiomeric excess was determined by chiral 
SFC (Lux Cel 1, MeOH, flow rate: 3 mL/min, BPR pressure: 150 bar, 10min, 35 oC, Gradient: 1 
– 3% MeOH in 3 min to 50% MeOH in 5 min, then hold at 50% MeOH for 1 min, 5.10 min (R), 
5.72 min (S)). 1H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 9.0 Hz, 2H), 7.86 (d, J = 8.2 Hz, 2H), 
7.50 (d, J = 9.0 Hz, 2H), 7.32–7.28 (m, 2H), 7.21–7.17 (m, 2H), 7.09 (d, J = 8.5 Hz, 2H), 3.75 (s, 
6H); 13C NMR (100 MHz, CDCl3): δ 154.9, 134.0, 129.4, 129.2, 127.9, 126.3, 125.2, 123.5, 
119.6, 114.2, 56.9. HRMS (DART) m/z calculated for C22H19O2 [M+H]+: 315.1380; found:  
315.1380. Analytical data was in agreement with the reported literature.50  
Chiral SFC (Lux Cel 3, gradient:  1 – 3% MeOH (3 min); 50% MeOH (5 min), 220 nm) 
analysis: 
Asymmetric Reaction:    
                             
 
 
(S)-3.39b
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Racemic reaction: 
 
3.8.2.5.2 Asymmetric Negishi Reaction 
 (R)-2,2’-dimethyl-1,1’-binaphthalene (R)-3.18: Arylzinc formation:  89.3 mg 
(0.43 mmol) aryl bromide, 0.52 mL (0.88 mmol) 1.7 M t-BuLi in pentane, 1 mL 
THF, 136 mg (0.604 mmol) ZnBr2 in 1 mL of THF. Cross-coupling:  59.1 mg 
(0.267 mmol) aryl bromide, 6.1 mg (0.0067 mmol) Pd2(dba)3, 8.4 mg (0.020 
mmol) ligand (Rp)-3.L13, and the arylzinc solution afforded 71.1 mg (94%) of biaryl (R)-3.16 as 
a colorless oil. Spectral data was consistent with the literature.19 Absolute configuration was 
confirmed by comparison of the optical rotation to the literature value:  [a]D25 = – 24.3 (c 1, 
CHCl3, 85:15 er), lit.19 [a]D20 = – 37.1 (c 1, CHCl3, 95% ee).  
 
 (R)-2,2’-diethyl-1,1’-binaphthalene (R)-3.39a: Arylzinc formation:  105 mg 
(0.447 mmol) aryl bromide, 0.52 mL (0.89 mmol) 1.7 M t-BuLi in pentane, 1.1 
mL THF, 134 mg (0.593 mmol) ZnBr2 in 1.1 mL of THF. Cross-coupling:  70.0 
mg (0.298 mmol) aryl bromide, 6.7 mg (0.0073 mmol) Pd2(dba)3, 8.3 mg (0.022 mmol) ligand 
(Rp)-3.L13, and the arylzinc solution afforded 74.1 mg (80%) of biaryl (R)-3.39a.  
 
(R)-3.18
Me
Me
(R)-3.39a
Et
Et
 242 
 
 (R)-2,2’-dimethoxy-1,1’-binaphthalene (R)-3.39b:  Arylzinc formation:  105 
mg (0.443 mmol) aryl bromide, 0.52 mL (0.89 mmol) 1.7 M t-BuLi in pentane, 
1 mL THF, 131 mg (0.576 mmol) ZnBr2 in 0.95 mL of THF. Cross-coupling: 
70.0 mg (0.295 mmol) aryl bromide, 6.7 mg (0.0073 mmol) Pd2(dba)3, 8.8 mg 
(0.022 mmol) ligand (Rp)-3.L13, and the arylzinc solution afforded 28.6 mg (31%) of biaryl (R)-
3.39b as a colorless oil. Spectral data was consistent with the literature. Absolute configuration 
was confirmed by comparison of the optical rotation to the literature value:  [α]D25 = + 48.6 (c 
0.19, THF, 75:25 er), lit.20 [α]D20 = + 72.8 (c 1.2, THF).   
 
 (R)-2,2’,3,3’-tetramethyl-1,1’-binaphthalene (R)-3.39c: Arylzinc formation: 105 
mg (0.447 mmol) aryl bromide, 0.52 mL (0.89 mmol) 1.7 M t-BuLi in pentane, 1 
mL THF, 134 mg (0.595 mmol) ZnBr2 in 1 mL of THF. Cross-coupling: 70.0 mg 
(0.298 mmol) aryl bromide, 6.7 mg (0.0073 mmol) Pd2(dba)3, 8.9 mg (0.022 
mmol) ligand (Rp)-3.L13, and the arylzinc solution afforded 26.4 mg (29%) of biaryl (R)-3.39c 
as a white solid after prep. TLC (10% CH2Cl2 in hexanes). 1H NMR (400 MHz, CDCl3): δ 7.80 
(d, J = 8.1 Hz, 2H), 7.74 (s, 2H), 7.35 (m, 2H), 7.11 (m, 2H), 6.94 (d, J = 8.6 Hz, 2H), 2.54 (s, 
6H), 1.94 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 135.8, 135.5, 134.3, 132.3, 131.7, 127.2, 
127.1, 126.0, 125.1, 124.9, 21.2, 16.8. HRMS (DART) m/z calculated for C24H23 [M + H]+:  
311.1794; found:  311.1794.  
Chiral HPLC ((R,R)-Whelk-01, 100% heptane, 1.3 mL/min, 220 nm) analysis: 
Asymmetric Reaction:                      Racemic Reaction: 
 
 
(R)-3.39b
OMe
OMe
(R)-3.39c
Me
Me
Me
Me
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 (R)-2,2’-diphenethyl-1,1’-binaphthalene (R)-3.39d: Arylzinc formation: 105 
mg (0.337 mmol) aryl bromide, 0.40 mL (0.68 mmol) 1.7 M t-BuLi in 
pentane, 0.8 mL THF, 101 mg (0.450 mmol) ZnBr2 in 0.8 mL of THF. Cross-
coupling: 70.0 mg (0.225 mmol) aryl bromide, 5.1 mg (0.0056 mmol) Pd2(dba)3, 6.7 mg (0.017 
mmol) ligand (Rp)-3.L13, and the arylzinc solution afforded 86.0 mg (83%) of biaryl (R)-3.39d 
as a colorless oil.  1H NMR (400 MHz, CDCl3): δ 7.92 (t, J = 9.0, 4H), 7.56 (d, J = 8.6, 2H), 7.41 
(t, J = 7.4, 2H), 7.21 (t, J = 7.4, 2H), 7.13–7.05 (m, 8H), 6.73 (d, J = 7.4, 4H), 2.74–2.51 (m, 
8H); 13C NMR (125 MHz, CDCl3): δ 142.0, 138.2, 134.7, 133.5, 132.5, 128.3, 128.3, 128.0, 
(R)-3.39d
Ph
Ph
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128.0, 127.7, 126.6, 126.2, 125.9, 125.4, 37.1, 36.5. HRMS (APCI) m/z calculated for C36H29 [M 
– H]:  439.2270; found:  461.2264. 
Chiral SFC (Lux Cel 3, gradient:  1 – 3% IPA (3 min); 50% IPA (5 min), 220 nm) analysis: 
Asymmetric Reaction:                                 Racemic Reaction: 
 
 
 
 
 (R)-2,2’-bis(3-(benzyloxy)propyl)-1,1’-binaphthalene (R)-3.39e: arylzinc 
formation: 105 mg (0.296 mmol) aryl bromide, 0.35 mL (0.59 mmol) 1.7 M t-
BuLi in pentane, 0.7 mL THF, 88.7 mg (0.394 mmol) ZnBr2 in 0.7 mL of THF. 
Cross-coupling: 70.0 mg (0.192 mmol) aryl bromide, 4.5 mg (0.0049 mmol) 
Pd2(dba)3, 5.9 mg (0.015 mmol) ligand (Rp)-3.L13, and the arylzinc solution afforded 92.2 mg 
(87%) of biaryl (R)-3.39e as an amorphous solid. 1H NMR (500 MHz, CDCl3): δ 7.89 (d, J = 8.6 
Hz, 2H), 7.87 (d, J = 8.2 Hz, 2H), 7.55 (d, J = 8.5 Hz, 2H), 7.34 (t, J = 7.2 Hz, 2H), 7.20–7.29 
(R)-3.39e
BnO
BnO
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(m, 6H), 7.17 (t, J = 7.1 Hz, 2H), 7.13 (d, J = 6.9 Hz, 4H), 7.02 (d, J = 8.5 Hz, 2H), 4.21 (d, J = 
12 Hz, 2H), 4.19 (d, J = 12 Hz, 2H), 3.16–3.28 (m, 4H), 2.33–2.51 (m, 4H), 1.66–1.77 (m, 4H); 
13C NMR (100 MHz, CDCl3): δ 138.6, 138.5, 134.6, 133.4, 132.3, 128.4, 128.0, 127.9, 127.64, 
127.62, 127.5, 126.5, 126.1, 125.2, 72.4, 69.9, 30.5, 30.3. HRMS (DART) m/z calculated for 
C40H39O2 [M + H]+:  551.2950; found:  551.2946.  
Chiral SFC (Lux Cel 3, gradient:  1 – 3% MeOH (3 min); 50% MeOH (5 min), 220 nm) 
analysis: 
Asymmetric Reaction:                                              Racemic Reaction: 
 
 
 (R)-2,2’-bis(2-(furan-2-yl)ethyl)-1,1’-binaphthalene (R)-3.39f: Arylzinc 
formation: 105 mg (0.349 mmol) aryl bromide, 0.41 mL (0.70 mmol) 1.7 M 
t-BuLi in pentane, 0.85 mL THF, 105 mg (0.465 mmol) ZnBr2 in 0.85 mL of 
THF. Cross-coupling: 70.0 mg (0.232 mmol) aryl bromide, 5.3 mg (0.0058 (R)-3.39f
O
O
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mmol) Pd2(dba)3, 7.0 mg (0.017 mmol) ligand (Rp)-3.L13, and the arylzinc solution afforded 
62.3 mg (61%) of biaryl (R)-3.39f as a yellow solid. 1H NMR (500 MHz, CDCl3): δ 7.89 (t, J = 
8.3, 4H), 7.47 (d, J = 8.4, 2H), 7.40 (t, J = 7.5, 2H), 7.21–7.18 (m, 4H), 7.02 (d, J = 8.4, 2H), 
6.14 (t, J = 2.4, 2H), 5.68 (d, J = 3.1, 2H), 2.75–2.64 (m, 8H); 13C NMR (100 MHz, CDCl3): δ 
155.4, 140.9, 137.5, 134.7, 133.4, 132.5, 128.1, 128.0, 127.4, 126.5, 126.2, 125.4, 110.1, 105.2, 
32.5, 28.7. HRMS (APCI) m/z calculated for C32H27O2 [M + H]+:  443.2011; found:  443.2006.   
Chiral SFC (Lux Cel 3, gradient:  1 – 3% MeOH (3 min); 50% MeOH (5 min), 220 nm) 
analysis: 
Asymmetric Reaction:                    Racemic Reaction: 
 
 
 
2,2’-dimethoxy-6,6’-dimethyl-1,1’-biphenyl (3.43a): Arylzinc formation: 88.4 
mg (0.440 mmol) aryl bromide, 0.52 mL (0.88 mmol) 1.7 M t-BuLi in pentane, 
3.43a
Me
OMeMe
MeO
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1.1 mL THF, 132 mg (0.586 mmol) ZnBr2 in 1.1 mL of THF. Cross-coupling: 60.0 mg (0.293 
mmol) aryl bromide, 6.7 mg (0.0073 mmol) Pd2(dba)3, 8.8 mg (0.022 mmol) ligand (Rp)-3.L13, 
and the arylzinc solution afforded 37.0 mg (52%) of biaryl 3.43a as a colorless oil. Spectal data 
was consistent with the literature.51   
Chiral HPLC (Chiralcel IC-3, 99:1 heptane:isopropanol, 220 nm) analysis: 
Asymmetric Reaction:                 Racemic Reaction: 
 
 
2,2’-di-isopropoxy-6,6’-dimethyl-1,1’-biphenyl (3.43b):  Arylzinc formation: 
105 mg (0.459 mmol) aryl bromide, 0.54 mL (0.92 mL) 1.7 M t-BuLi in 
pentane, 1.1 mL THF, 138 mg (0.612 mmol) ZnBr2 in 1.1 mL of THF. Cross-
coupling: 70.0 mg (0.306 mmol) aryl bromide, 7.0 mg (0.0077 mmol) Pd2(dba)3, 9.2 mg (0.023 
mmol) ligand (Rp)-3.L13, and the arylzinc solution afforded 70.0 mg (81%) of biaryl 3.43b as a 
colorless oil. 1H NMR (500 MHz, CDCl3): δ 7.10 (t, J = 7.9, 2H), 6.88 (d, J = 7.9, 2H), 6.85 (d, J 
3.43b
Me
Oi-PrMe
i-PrO
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= 7.9, 2H), 1.99 (s, 6H), 1.22 (s, 18H); 13C NMR (125 MHz, CDCl3): δ 154.0, 138.7, 131.5, 
126.7, 122.5, 116.4, 77.7, 29.2, 20.3. HRMS (DART) m/z calculated for C20H27O2 [M + H]+:  
299.2011; found:  299.2006. 
Chiral HPLC (Chiral AGP, 0.1% H3PO4 in water/MeCN, gradient:  0 min; 10% MeCN, 5.0 min; 
30% MeCN, 15 min; 50% MeCN, 220 nm) analysis: 
Asymmetric Reaction:                      Racemic Reaction: 
 
 
 
2,2’-di-tert-butoxy-6,6’-dimethyl-1,1’-biphenyl (3.43c): Arylzinc formation: 
105 mg (0.432 mmol) aryl bromide, 0.51 mL (0.86 mmol) 1.7 M t-BuLi in 
3.43c
Me
Ot-BuMe
t-BuO
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pentane, 1 mL THF, 136 mg (0.604 mmol) ZnBr2 in 1 mL of THF. Cross-coupling: 70.0 mg 
(0.288 mmol) aryl bromide, 6.6 mg (0.0072 mmol) Pd2(dba)3, 8.7 mg (0.022 mmol) ligand (Rp)-
3.L13, 1 mL of THF, and the arylzinc solution afforded 60.3 mg (67%) of biaryl 3.41c as a 
colorless oil. 1H NMR (500 MHz, CDCl3): δ 7.10 (t, J = 7.9, 2H), 6.88 (d, J = 7.9, 2H), 6.85 (d, J 
= 7.9, 2H), 1.99 (s, 6H), 1.22 (s, 18H); 13C NMR (125 MHz, CDCl3): δ 154.0, 138.7, 131.5, 
126.7, 122.5, 116.4, 77.7, 29.2, 20.3. HRMS (DART) m/z calculated for C22H31O2 [M + H]+:  
327.2324; found:  327.2320. 
Chiral HPLC (Chiral AGP, 0.1% H3PO4 in water/MeCN, gradient:  0 min; 20% MeCN, 5.0 min; 
30% MeCN, 15 min; 50% MeCN, 220 nm) analysis: 
Asymmetric Reaction:                                       Racemic Reactions: 
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3.8.2.6 Details of Computational Studies 
Optimizations of intermediates and transition states were performed using Gaussian 0952 
software with spin-restricted DFT using the RB3LYP53 functional and split basis set [6-31G(d) 
for C, P, N, O, H, Br and LANL2DZ for Pd] in the gas phase. For Suzuki coupling, RB3LYP 
with Grimme dispersion correction D354 was used instead. The method is based on those 
successfully used before for description of Suzuki couplings.55 However, unlike regular 
B3LYP56, it accounts for dispersion interactions. They may be of a paramount importance for the 
reaction and have been considered in the recent computational studies of Suzuki couplings.57 We 
have also tested other methods and their combinations. Thus, we analyzed the performance of 
B3LYP/6-31G(d),LANL2DZ; B3LYP-D3/6-31G(d),LANL2DZ, SMD: THF, Gaussian-2 
theories M06/6-311+G(d,p),LANL2DZ, SMD:THF//B3LYP/6-31G(d),LANL2DZ and M06/6-
311+G(d,p),LANL2DZ, SMD:THF//B3LYP-D3/6-31G(d),LANL2DZ. However, RB3LYP-
D3/6-31G(D),LANL2DZ proved to be the best method, allowing us to obtain data that is in good 
standing with experimental findings. Given the massive number of intricately connected 
transition states that define selectivity in this model, it is highly unlikely that success of the 
approach is a fortuitous discovery. Rather, we attribute the suitability of the method to its ability 
to appropriately treat a large number of dispersion interactions, that seem to be crucial for the 
stereoselectivity of the reaction. 
For all species, vibrational frequencies were also computed at the specified level of 
theory to obtain thermal Gibbs Free Energy corrections (at 298 K) and to characterize the 
stationary points as transition states (one and only one imaginary frequency) or minima (zero 
imaginary frequencies). For Negishi coupling analysis, single point energy calculations were 
performed on optimized geometries in THF solvent using the SMD58-solvation model, M0659 
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functional, and split basis set [6-311+G(d,p) for C, P, N, O, H; LANL2DZ  for Pd]. The single-
point energies were converted to the enthalpies and Gibbs free energies using corrections from 
gas-phase frequency analysis. Extensive conformational analysis of the transition states and 
intermediates was performed manually. For determination of the selectivities of elementary 
steps, we calculated the weight of each conformation using Boltzmann distribution: 
!! = exp −!! !"#!"  
Where !! !"#is the relative energy (Gibbs Free energy was used for Negishi coupling 
analysis and enthalpy was used for Suzuki coupling) of conformation i. The relative contribution 
of the given conformation to the overall step is:  !! = !!!!!  
For each of the steps analyzed, we provide a table with the list of transition states 
conformations, their relative energies and Boltzmann weights !!. Only those conformations that 
have high !! values, contribute to the selectivity of the process (corresponding entries 
highlighted in bold). Coordinates and thermochemical data are provided for those conformations. 
In Table 1 we also provide relative contribution values, !!, to show how ee values were 
calculated.  
 
3.8.2.7 Coordinates and Thermochemical Data for Computed Intermediates and Transition 
States 
Coordinates and thermochemical data for computed intermediates and transition states were 
reported in the literature.60 
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3.9 Spectra Relevant to Chapter Three: 
 
Computationally Assisted Mechanistic Investigation and Development of Pd-Catalyzed 
Asymmetric Suzuki–Miyaura and Negishi Cross-Coupling Reactions for Tetra-ortho-
Substituted Biaryl Synthesis 
Nitinchandra Dahyabhai Patel, Joshua D. Sieber, Sergei Tcyrulnikov, Bryan J. Simmons, Daniel 
Rivalti, Krishnaja Duvvuri, Yongda Zhang, Donghong A. Gao, Keith R. Fandrick, Nizar Haddad, 
Kendricks So Lao, Hari Prasad Reddy Mangunuru, Soumik Biswas, Bo Qu, Nelu Grinberg, Scott 
Pennino, Heewon Lee, Jinhua J. Song, B. Frank Gupton, Neil K. Garg, Marisa C. Kozlowski, and 
Chris H. Senanayake 
ACS Catal. 2018, 8, 10190–10209. 
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Figure 3.20 1H NMR (500 MHz, CDCl3) of compound 3.31a. 
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Figure 3.21 13C NMR (125 MHz, CDCl3) of compound 3.31a. 
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Figure 3.22 31P NMR (202 MHz, CDCl3) of compound 3.31a. 
 
Figure 3.23 1H NMR (400 MHz, CDCl3) of compound 3.L3. 
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Figure 3.24 13C NMR (100 MHz, CDCl3) of compound 3.L3. 
 
Figure 3.25 31P NMR (162 MHz, CDCl3) of compound 3.L3. 
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Figure 3.26 1H NMR (500 MHz, CDCl3) of compound 3.31b. 
 
Figure 3.27 13C NMR (125 MHz, CDCl3) of compound 3.31b. 
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Figure 3.28 31P NMR (202 MHz, CDCl3) of compound 3.31b. 
 
Figure 3.29 1H NMR (400 MHz, CDCl3) of compound 3.31d. 
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Figure 3.30 13C NMR (100 MHz, CDCl3) of compound 3.31d. 
 
Figure 3.31 31P NMR (162 MHz, CDCl3) of compound 3.31d. 
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Figure 3.32 1H NMR (500 MHz, CDCl3) of compound 3.L5. 
 
Figure 3.33 13C NMR (125 MHz, CDCl3of compound 3.L5. 
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Figure 3.34 31P NMR (202 MHz, CDCl3) of compound 3.L5. 
 
Figure 3.35 1H NMR (400 MHz, CDCl3) of compound 3.31f. 
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Figure 3.36 13C NMR (100 MHz, CDCl3) of compound 3.31f. 
 
Figure 3.37 31P NMR (162 MHz, CDCl3) of compound 3.31f. 
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Figure 3.38 1H NMR (500 MHz, CDCl3) of compound 3.L6. 
 
Figure 3.39 13C NMR (125 MHz, CDCl3) of compound 3.L6. 
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Figure 3.40 31P NMR (202 MHz, CDCl3) of compound 3.L6. 
 
Figure 3.41 1H NMR (500 MHz, CDCl3) of compound 3.31g. 
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Figure 3.42 13C NMR (125 MHz, CDCl3) of compound 3.31g. 
 
Figure 3.43 31P NMR (202 MHz, CDCl3) of compound 3.31g. 
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Figure 3.44 1H NMR (500 MHz, CDCl3) of compound 3.31h. 
 
Figure 3.45 13C NMR (125 MHz, CDCl3) of compound 3.31h. 
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Figure 3.47 1H NMR (400 MHz, CDCl3) of compound 3.L7. 
 
Figure 3.46 31P NMR (202 MHz, CDCl3) of compound 3.31h. 
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Figure 3.48 13C NMR (100 MHz, CDCl3) of compound 3.L7. 
 
Figure 3.49 31P NMR (162 MHz, CDCl3) of compound 3.L7. 
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Figure 3.50 1H NMR (400 MHz, CDCl3) of compound 3.31i. 
 
Figure 3.51 13C NMR (100 MHz, CDCl3) of compound 3.31i. 
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Figure 3.52 31P NMR (162 MHz, CDCl3) of compound 3.31i. 
 
Figure 3.53 1H NMR (400 MHz, CDCl3) of compound 3.L8. 
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Figure 3.54 13C NMR (100 MHz, CDCl3) of compound 3.L8. 
 
Figure 3.55 31P NMR (162 MHz, CDCl3) of compound 3.L8. 
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Figure 3.56 1H NMR (400 MHz, CDCl3) of compound 3.L11. 
 
Figure 3.57 13C NMR (100 MHz, CDCl3) of compound 3.L11. 
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Figure 3.58 31P NMR (202 MHz, CDCl3) of compound 3.L11. 
 
Figure 3.59 1H NMR (400 MHz, CDCl3) of compound 3.L12. 
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Figure 3.60 13C NMR (100 MHz, CDCl3) of compound 3.L12. 
 
Figure 3.61 31P NMR (202 MHz, CDCl3) of compound 3.L12. 
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Figure 3.62 1H NMR (400 MHz, CDCl3) of compound 3.31m. 
 
Figure 3.63 13C NMR (100 MHz, CDCl3) of compound 3.31m. 
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Figure 3.64 31P NMR (202 MHz, CDCl3) of compound 3.31m. 
 
Figure 3.65 1H NMR (500 MHz, CDCl3) of compound 3.L13. 
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Figure 3.66 13C NMR (100 MHz, CDCl3) of compound 3.L13. 
 
Figure 3.67 31P NMR (162 MHz, CDCl3) of compound 3.L13. 
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Figure 3.68 1H NMR (400 MHz, CDCl3) of compound 3.L14. 
 
Figure 3.69 13C NMR (100 MHz, CDCl3) of compound 3.L14. 
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Figure 3.70 31P NMR (202 MHz, CDCl3) of compound 3.L14. 
 
Figure 3.71 1H NMR (400 MHz, CDCl3) of compound 3.31o. 
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Figure 3.72 13C NMR (100 MHz, CDCl3) of compound 3.31o. 
 
Figure 3.73 31P NMR (202 MHz, CDCl3) of compound 3.31o. 
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Figure 3.74 1H NMR (400 MHz, CDCl3) of compound 3.L15. 
 
Figure 3.75 13C NMR (100 MHz, CDCl3) of compound 3.L15. 
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Figure 3.76 31P NMR (202 MHz, CDCl3) of compound 3.L15. 
 
Figure 3.77 1H NMR (400 MHz, CDCl3) of compound 3.31q. 
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Figure 3.78 13C NMR (100 MHz, CDCl3) of compound 3.31q. 
 
Figure 3.79 31P NMR (162 MHz, CDCl3) of compound 3.31q. 
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Figure 3.80 1H NMR (400 MHz, CDCl3) of compound 3.L16. 
 
Figure 3.81 13C NMR (100 MHz, CDCl3) of compound 3.L16. 
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Figure 3.82 31P NMR (162 MHz, CDCl3) of compound 3.L16. 
 
Figure 3.83 1H NMR (400 MHz, CDCl3) of compound 3.31s. 
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Figure 3.84 13C NMR (100 MHz, CDCl3) of compound 3.31s. 
 
Figure 3.85 31P NMR (162 MHz, CDCl3) of compound 3.31s. 
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Figure 3.86 1H NMR (500 MHz, CDCl3) of compound 3.L17. 
 
Figure 3.87 13C NMR (125 MHz, CDCl3) of compound 3.L17. 
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Figure 3.89 1H NMR (400 MHz, CDCl3) of compound 3.31t. 
 
Figure 3.88 31P NMR (202 MHz, CDCl3) of compound 3.L17. 
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Figure 3.90 13C NMR (100 MHz, CDCl3) of compound 3.31t. 
 
Figure 3.91 31P NMR (162 MHz, CDCl3) of compound 3.31t. 
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Figure 3.92 1H NMR (400 MHz, CDCl3) of compound 3.31u. 
 
Figure 3.93 13C NMR (100 MHz, CDCl3) of compound 3.31u. 
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Figure 3.94 31P NMR (162 MHz, CDCl3) of compound 3.31u. 
 
Figure 3.95 1H NMR (400 MHz, CDCl3) of compound 3.L18. 
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Figure 3.96 13C NMR (100 MHz, CDCl3) of compound 3.L18. 
 
Figure 3.97 31P NMR (162 MHz, CDCl3) of compound 3.L18. 
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Figure 3.98 1H NMR (500 MHz, CDCl3) of compound 3.35a. 
 
Figure 3.99 13C NMR (100 MHz, CDCl3) of compound 3.35a. 
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Figure 3.100 31P NMR (202 MHz, CDCl3) of compound 3.35a. 
 
Figure 3.101 1H NMR (500 MHz, CDCl3) of compound 3.35b. 
 
P
O
t-Bu
Me
3.35b
Oi-Pri-PrO
Me Me
O
 294 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure 3.102 13C NMR (100 MHz, CDCl3) of compound 3.35b. 
 
Figure 3.103 31P NMR (202 MHz, CDCl3) of compound 3.35b. 
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Figure 3.104 1H NMR (400 MHz, CDCl3) of compound 3.L21. 
 
Figure 3.105 13C NMR (100 MHz, CDCl3) of compound 3.L21. 
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Figure 3.106 31P NMR (202 MHz, CDCl3) of compound 3.L21. 
 
Figure 3.107 1H NMR (500 MHz, CDCl3) of compound 3.35c. 
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Figure 3.108 13C NMR (100 MHz, CDCl3) of compound 3.35c. 
 
Figure 3.109 31P NMR (202 MHz, CDCl3) of compound 3.35c. 
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Figure 3.110 1H NMR (500 MHz, CDCl3) of compound 3.35d. 
 
Figure 3.111 13C NMR (100 MHz, CDCl3) of compound 3.35d. 
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Figure 3.112 31P NMR (202 MHz, CDCl3) of compound 3.35d. 
 
Figure 3.113 1H NMR (500 MHz, CDCl3) of compound 3.35e. 
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Figure 3.114 13C NMR (100 MHz, CDCl3) of compound 3.35e. 
 
Figure 3.115 31P NMR (162 MHz, CDCl3) of compound 3.35e. 
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Figure 3.116 1H NMR (500 MHz, CDCl3) of compound 3.L22. 
 
Figure 3.117 13C NMR (100 MHz, CDCl3) of compound 3.L22. 
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Figure 3.118 13P NMR (202 MHz, CDCl3) of compound 3.L22. 
 
Figure 3.119 1H NMR (500 MHz, CDCl3) of compound 3.30a. 
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Figure 3.120 13C NMR (100 MHz, CDCl3) of compound 3.30a. 
 
Figure 3.121 31P NMR (202 MHz, CDCl3) of compound 3.30a. 
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Figure 3.122 1H NMR (400 MHz, CDCl3) of compound 3.L24. 
 
Figure 3.123 13C NMR (100 MHz, CDCl3) of compound 3.L24. 
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Figure 3.124 31P NMR (202 MHz, CDCl3) of compound 3.L24. 
 
Figure 3.125 1H NMR (400 MHz, CDCl3) of compound 3.32a. 
 
P
Ph
N
t-Bu
3.32a
OMeMeO
Me
O
 306 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure 3.126 13C NMR (100 MHz, CDCl3) of compound 3.32a. 
 
Figure 3.127 1H NMR (400 MHz, CDCl3) of compound 3.L25. 
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Figure 3.128 13C NMR (100 MHz, CDCl3) of compound 3.L25. 
 
Figure 3.129 31P NMR (162 MHz, CDCl3) of compound 3.L25. 
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Figure 3.130 1H NMR (500 MHz, CDCl3) of compound 3.30c. 
 
Figure 3.131 1H NMR (500 MHz, CDCl3) of compound 3.30d. 
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Figure 3.132 13C NMR (100 MHz, CDCl3) of compound 3.30d. 
 
Figure 3.133 31P NMR (202 MHz, CDCl3) of compound 3.30d. 
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Figure 3.134 1H NMR (500 MHz, CDCl3) of compound 3.32b. 
 
Figure 3.135 13C NMR (100 MHz, CDCl3) of compound 3.32b. 
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Figure 3.136 31P NMR (202 MHz, CDCl3) of compound 3.32b. 
 
Figure 3.137 1H NMR (400 MHz, CDCl3) of compound 3.L26. 
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Figure 3.138 13C NMR (100 MHz, CDCl3) of compound 3.L26. 
 
Figure 3.139 31P NMR (202 MHz, CDCl3) of compound 3.L26. 
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Figure 3.140 1H NMR (500 MHz, CDCl3) of compound 3.47. 
 
Figure 3.141 13C NMR (125 MHz, CDCl3) of compound 3.47. 
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Figure 3.142 31P NMR (202 MHz, CDCl3) of compound 3.47. 
 
Figure 3.143 1H NMR (500 MHz, CDCl3) of compound 3.48. 
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Figure 3.144 13C NMR (125 MHz, CDCl3) of compound 3.48. 
 
Figure 3.145 31P NMR (202 MHz, CDCl3) of compound 3.48. 
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Figure 3.146 1H NMR (500 MHz, CDCl3) of compound 3.49. 
 
Figure 3.147 13C NMR (125 MHz, CDCl3) of compound 3.49. 
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Figure 3.148 1H NMR (500 MHz, CDCl3) of compound 3.50. 
 
Figure 3.149 13C NMR (125 MHz, CDCl3) of compound 3.50. 
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Figure 3.150 1H NMR (500 MHz, CDCl3) of compound 3.L27. 
 
Figure 3.151 13C NMR (125 MHz, CDCl3) of compound 3.L27. 
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Figure 3.152 31P NMR (202 MHz, CDCl3) of compound 3.L27. 
 
Figure 3.153 1H NMR (500 MHz, CDCl3) of compound 3.51. 
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Figure 3.154 13C NMR (125 MHz, CDCl3) of compound 3.51. 
 
Figure 3.155 1H NMR (500 MHz, CDCl3) of compound 3.L28. 
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Figure 3.156 13C NMR (125 MHz, CDCl3) of compound 3.L28. 
. 
Figure 3.157 31P NMR (202 MHz, CDCl3) of compound 3.L28. 
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Figure 3.158 1H NMR (400 MHz, CDCl3) of compound 3.32c. 
 
Figure 3.159 13C NMR (100 MHz, CDCl3) of compound 3.32c. 
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Figure 3.160 31P NMR (202 MHz, CDCl3) of compound 3.32c. 
 
Figure 3.161 1H NMR (400 MHz, CDCl3) of compound 3.L29. 
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Figure 3.162 13C NMR (100 MHz, CDCl3) of compound 3.L29. 
 
Figure 3.163 31P NMR (162 MHz, CDCl3) of compound 3.L29. 
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Figure 3.164 1H NMR (400 MHz, CDCl3) of compound 3.18. 
 
Figure 3.165 13C NMR (100 MHz, CDCl3) of compound 3.18. 
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Figure 3.166 1H NMR (500 MHz, CDCl3) of compound 3.18. 
 
Figure 3.167 1H NMR (500 MHz, CDCl3) of compound 3.39a. 
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Figure 3.168 13C NMR (125 MHz, CDCl3) of compound 3.39a. 
 
Figure 3.169 1H NMR (400 MHz, CDCl3) of compound 3.39b. 
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Figure 3.170 13C NMR (100 MHz, CDCl3) of compound 3.39b. 
 
Figure 3.171 1H NMR (400 MHz, CDCl3) of compound 3.39c. 
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Figure 3.172 13C NMR (100 MHz, CDCl3) of compound 3.39c. 
 
Figure 3.173 1H NMR (400 MHz, CDCl3) of compound 3.39d. 
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Figure 3.174 13C NMR (125 MHz, CDCl3) of compound 3.39d. 
 
Figure 3.175 1H NMR (500 MHz, CDCl3) of compound 3.39e. 
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Figure 3.176 13C NMR (100 MHz, CDCl3) of compound 3.39e. 
 
Figure 3.177 1H NMR (500 MHz, CDCl3) of compound 3.39f. 
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Figure 3.178 13C NMR (100 MHz, CDCl3) of compound 3.39f. 
 
Figure 3.179 1H NMR (500 MHz, CDCl3) of compound 3.43b. 
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Figure 3.180 13C NMR (125 MHz, CDCl3) of compound 3.43b. 
 
Figure 3.181 1H NMR (500 MHz, CDCl3) of compound 3.43c. 
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Figure 3.182 13C NMR (125 MHz, CDCl3) of compound 3.43c. 
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CHAPTER FOUR 
 
Generation and Regioselective Trapping of a 3,4-Piperidyne for the  
Synthesis of Functionalized Heterocycles 
Travis C. McMahon, Jose M. Medina, Yun-Fang Yang, Bryan J. Simmons,  
K. N. Houk, and Neil K. Garg 
J. Am. Chem. Soc. 2015, 137, 4082–4085. 
 
4.1 Abstract  
 We report the generation of the first 3,4-piperidyne and its use as a building block for the 
synthesis of annulated piperidines. Experimental and computational studies of this intermediate 
are disclosed, along with comparisons to the well-known 3,4-pyridyne. The distortion/interaction 
model is used to explain the observed regioselectivities. 
 
4.2 Introduction 
Heterocycles containing one or more nitrogen atoms comprise nearly 60% of all small-
molecule drugs that have been approved by the U.S. Food and Drug Administration.1 The most 
prevalent of N-containing heterocycles is the piperidine ring, which is found in 72 currently 
marketed small-molecule drugs. Notable examples include the blockbuster drugs clopidogrel 
(Plavix), tadalafil (Cialis), and solifenacin (VESIcare) (Figure 4.1). Given the importance of this 
medicinally privileged scaffold, new methods to rapidly access annulated piperidines from 
simple precursors are highly sought after.   
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With the aim of developing a new method for the synthesis of decorated piperidines, we 
questioned if the unusual 3,4-piperidyne intermediate 4.1 could be generated and used as a new 
synthetic building block (Figure 4.1). Notably, 3,4-piperidynes have never been accessed 
previously. The most closely related studies have involved the isomeric 2,3-piperidyne 4.2, 
which has been the subject of two seminal investigations. In 1988, Wentrup and coworkers 
generated 4.2 (R = H) using flash vacuum pyrolysis.2 Although 4.2 was deemed unstable above  
–150 °C and was never utilized in any synthetic application, Wentrup’s studies validated the 
notion that 4.2 could be generated. Additionally, during the preparation of this manuscript, 
Danheiser disclosed an efficient means to access 4.2 (R = Ts) and performed a series of 
synthetically useful trapping reactions.3 Interestingly, whereas piperidynes have been rarely 
studied,4 the corresponding aromatic pyridynes 4.35 and 4.4,6 along with many other arynes and 
hetarynes, have been widely pursued for more than half a century.7,8,9  
 Herein we report: (a) the first generation of a 3,4-piperidyne 4.1; (b) the strategic use of 
4.1 to construct a range of functionalized piperidines, many of which possess significant 
aliphatic character10 and represent new heterocyclic scaffolds; (c) regioselectivity predictions, 
observations, and explanations involving the 3,4-piperidyne, which are in accord with the 
distortion/interaction model;7a,7d,8a and (d) an explanation for the lack of selectivity observed in 
trapping experiments of the 3,4-pyridyne (4.3), which has been unresolved for many decades. 
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Figure 4.1. Piperidine-containing drugs, piperidynes 4.1 and 4.2, and pyridynes 4.3 and 4.4 
 
4.3 Prediction of Regioselectivities Based on the Distortion/Interaction Model 
We initiated our studies by applying the distortion/interaction model to our targeted 
piperidyne, Cbz-derivative 4.1a, 11  in order to assess its likelihood that it would undergo 
regioselective trapping in reactions with nucleophiles and cycloaddition partners (Figure 4.2). In 
previous studies, we have shown that the degree of distortion present in the ground state of 
arynes and strained alkynes correlates to observed regioselectivities due to the intermediate being 
pre-distorted toward one of two competing transition states.7a,7d,8a,9 Geometry optimization using 
DFT calculations (B3LYP/6-31G(d)) revealed that 4.1a is significantly distorted (ca. 10° 
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difference in internal angles at C4 and C3) such that nucleophilic addition should occur 
preferentially at the more linear terminus (C4). As a key point of comparison, we also studied the 
3,4-pyridyne (4.3), which is well-known to react with poor regioselectivity, 7a,7d,8a,12 as alluded to 
earlier. In contrast to 4.1a, the geometry-optimized structure of 4.3 shows little unsymmetrical 
distortion. Given this interesting dichotomy, we envisioned that experimental studies of 3,4-
piperidyne 4.1a would not only test our regioselectivity predictions, but could also ultimately 
shed light on why the 3,4-pyridyne (4.3) is not significantly distorted and, accordingly, reacts 
with poor regioselectivity.  
 
 
Figure 4.2. Optimized structures of 4.1a and 4.3 obtained at the B3LYP/6-31G(d) level 
 
4.4 Synthesis of Silyl Triflate Precursor 
The success of our study would rely on the development of an efficient synthesis of a 
suitable 3,4-piperidyne precursor. After identifying silyl triflate 4.8 as our target,11, 13  we 
developed the robust and scalable three-step route shown in Scheme 4.1. Beginning from 
commercially available 4-methoxypyridine (4.5), a known procedure was employed to effect 
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ortho silylation to yield silyl pyridine 4.6.14 Next, a one-pot procedure involving reductive 
carbamoylation and hydrolysis15 provided vinylogous amide 4.7 in excellent yield. Finally, 
conjugate reduction followed by trapping of the resultant enolate with Tf2O16 provided silyl 
triflate 4.8. The sequence was performed on gram scale and provided 4.8 in 51% overall yield 
from 4.5.17 
 
Scheme 4.1. Synthesis of silyl triflate 4.8 
 
 
4.5 Generation & Trapping of 3,4-Piperidyne 4.1a 
 To validate that the 3,4-piperidyne could be generated, we performed a series of Diels–
Alder trapping experiments to produce a variety of annulated products (Table 4.1). Specifically, 
silyl triflate 4.8 was treated with CsF in the presence of several trapping agents (3 equiv) in 
acetonitrile at 60 °C. The use of tetracyclone as the trapping agent delivered a 
tetrahydroisoquinoline product in 76% yield via cycloaddition, followed by loss of CO (entry 1). 
An alternate tetrahydroisoquinoline was accessed upon trapping of the intermediate 3,4-
piperidyne with 2-pyrone, by way of a Diels–Alder, retro-Diels–Alder sequence with 
concomitant loss of CO2 (entry 2). Additionally, cycloadditions with 2,5-dimethylfuran or N-
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Boc-pyrrole provided the corresponding piperidine-fused [2.2.1]-bridged bicyclic products 
(entries 3 and 4). 
 
Table 4.1. Diels–Alder cycloadditions of 3,4-piperidyne 4.1a 
 
a Reported yields are the average of two experiments and are based on the 
amount of isolated products.  
 
Encouraged by our initial success, we carried out trapping experiments of 3,4-piperidyne 
4.1a with a variety of nucleophiles and unsymmetrical cycloaddition partners (Table 4.2). In 
addition to acting as a probe for our regioselectivity predictions, some of the transformations 
provide access to interesting heterocyclic products. Nucleophilic addition experiments were 
performed with imidazole and morpholine (entries 1 and 2). In both cases, addition occurred 
exclusively at C4, consistent with our earlier prediction and differing from the known trends of 
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3,4-pyridyne reactions. An analogous regiochemical preference was observed in a series of 
cycloaddition reactions. For example, trapping with a nitrone afforded isoxazoline products in 
good yield and with a significant regiochemical preference of 12.7 to 1 (entry 3). (3+2) 
Cycloadditions using either azide or diazo coupling partners provided triazole and pyrazole 
products, respectively (entries 4 and 5). Pyridine- and N-Ph pyrazole-containing annulated 
products could be obtained as well, albeit with lower selectivities (entries 6 and 7).18 
 Several salient features regarding this methodology and the products shown in Tables 4.1 
and 4.2 should be noted. (a) Analogous to known reactions of arynes using silyl triflate 
precursors, 3,4-piperidyne trapping experiments are operationally trivial to perform and 
generally do not require the rigorous exclusion of oxygen or moisture. (b) Silyl triflate 4.8, which 
is now being commercialized to enable its widespread use in drug discovery,17 can be used as a 
single precursor in order to access a variety of annulated piperidines. This stands in contrast to 
more conventional strategies, which would involve developing independent syntheses of each 
annulated piperidine desired. (c) Several of the products accessed by our methodology represent 
new scaffolds, including those unique compounds shown in entries 3 and 4 in Table 4.1 and 
those highlighted in entries 3 and 6 of Table 4.2.19  (d) Several of the cycloaddition adducts 
shown in Table 4.2 are new analogs of known medicinally important scaffolds.  For example, 
compounds related to those in entries 4, 5, and 7 show promise for the treatment of 
inflammation,20 diabetes,21 cancer,22 hepatitis C,23 or other illnesses. (e) Finally, with regard to 
regioselectivity, it should be emphasized that 3,4-piperidyne 4.1a uniformly reacts with a 
preference for initial attack occurring at C4, which is the same trend seen in reactions of the 
well-studied 3,4-pyridyne (4.3). However, the observed selectivities in the case of 4.1a are 
generally greater compared to the selectivities seen in the trapping of 3,4-pyridynes.24 
 357 
Table 4.2. Reactions of silyl triflate 4.8 with nucleophiles and cycloaddition partners 
 
aReported yields are the average of two experiments and are based on the amount of 
isolated products. bYield was determined using 1,3,5-trimethoxybenzene as an 
external standard. 
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4.6 Comparison of Transition States & Distortion Present in 4.1a and 4.3 
 To understand the disparity in the regioselectivities of the reactions of the 3,4-pyridyne 
(4.3) and 3,4-piperidyne 4.1a, we used DFT calculations to analyze the competing transition 
states for the nucleophilic addition of morpholine to 4.3, and compared the results to the 
corresponding transition states involving 4.1a (Figure 4.3). In the reactions of 4.3 with 
morpholine, the difference in energies for attack at C4 versus C3 (TS4.1 and TS4.2, 
respectively) is negligible. This is consistent with the low regioselectivity seen 
experimentally.24,25 Given that these are very early transition states, the distortion energy (ΔEdist), 
or the energy required to alter the alkyne geometry toward the transition state, is expected to be 
small; in fact, we do calculate a slightly greater ΔEdist of the alkyne for TS4.2 than TS4.1 (ca. 0.2 
kcal/mol). In contrast, the addition of morpholine to C4 of 3,4-piperidyne 4.1a (TS4.3) is 
predicted to be favored over attack at C3 (TS4.4) by roughly 1.7 kcal/mol. Notably, the disparity 
in distortion energy (ΔEdist) accounts for most of the energetic difference and the resulting high 
regioselectivity observed experimentally (see Table 4.2, entry 2). These results validate that the 
distortion/interaction model correctly predicts and explains regioselectivities in reactions of both 
the 3,4-pyridyne (4.3) and 3,4-piperidyne 4.1a.   
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Figure 4.3. Optimized transition states for nucleophilic addition of morpholine to 4.3 and 4.1a 
using B3LYP/6-31G(d). Single-point energies were calculated at the B3LYP-D3/6-311+G(d,p) 
level with CPCM solvent model for MeCN. Energies are provided in kcal mol–1. 
 
As noted earlier, the lack of regioselectivity seen in reactions of 3,4-pyridynes has been a 
long-standing problem. Thus, we sought to probe one remaining critical question: why is the 3,4-
piperidyne significantly distorted, while the 3,4-pyridyne is not? The explanation is summarized 
in Figure 4.4. The distortion of 3,4-piperidyne 4.1a is caused by the electronegativity of the N-
heteroatom that deforms the triple bond as a result of Bent’s rule.26 The internal bond angle at C3 
is decreased, mixing in p character at C3 and releasing electron density toward the 
electronegative N-atom. Although the analogous effect is also present in 3,4-pyridyne (4.3), it is 
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offset by the in-plane overlap of the nitrogen lone pair with the π and π* orbitals at C3, which 
causes C3 to move toward the N-atom (for further discussion of these competing effects, see the 
Experimental Section). Such an effect is not seen in 4.1a, as the nitrogen lone pair is orthogonal 
to the π and π* orbitals of the alkyne. 
 
 
 
Figure 4.4. Explanation for differing distortion seen in 4.1a and 4.3 
 
 
4.7 Conclusion 
In summary, we have synthesized the first 3,4-piperidyne, 4.1a, and demonstrated that 
this reactive intermediate can be utilized in a variety of cycloadditions to form annulated 
piperidine scaffolds. The regioselectivity trends observed in reactions of 4.1a with nucleophiles 
and unsymmetrical cycloaddition partners are predicted and rationalized by the 
distortion/interaction model. Moreover, we have explained the inductive effect that causes the 
distortion seen in 4.1a, in addition to the competing inductive effects and orbital interactions that 
result in the lack of regioselectivity observed in reactions of the well-studied 3,4-pyridyne (4.3). 
Our findings not only provide a new platform to access medicinally-privileged piperidine 
scaffolds, but also lay the foundation for further studies geared toward strategically harnessing 
strained heterocyclic alkynes as useful synthetic building blocks. 
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4.8 Experimental Section 
4.8.1 Materials and Methods  
Unless stated otherwise, reactions were conducted in flame-dried glassware under an 
atmosphere of nitrogen using anhydrous solvents (freshly distilled or passed through activated 
alumina columns). All commercially obtained reagents were used as received unless otherwise 
specified. Cesium fluoride (CsF) was obtained from Strem Chemicals. Trifluoromethanesulfonic 
anhydride (Tf2O) and trimethylsilyl chloride (TMSCl) were obtained from Oakwood Products, 
Inc. and distilled before use. N-tert-butyl-α-phenylnitrone and methyl 2-acetamidoacrylate were 
obtained from Alfa Aesar. Ethyl diazoacetate, (trimethylsilyl)diazomethane (1 M in Et2O), 
tetracyclone, 2,5-dimethylfuran, N-Boc-pyrrole, and L-selectride (1 M in THF) were obtained 
from Sigma Aldrich. Benzyl chloroformate and 2-pyrone were obtained from Acros Organics. 
Morpholine was obtained from Spectrum Chemical and distilled before use. Reaction 
temperatures were controlled using an IKAmag temperature modulator and, unless stated 
otherwise, reactions were performed at room temperature (rt, approximately 23 °C). Thin layer 
chromatography (TLC) was conducted with EMD gel 60 F254 pre-coated plates (0.25 mm) and 
visualized using a combination of UV light and potassium permanganate staining. Preparative 
thin layer chromatography (TLC) was conducted with EMD gel 60 F254 pre-coated plates (0.5 
mm) and visualized using UV light. Silicycle Siliaflash P60 (particle size 0.040–0.063 mm) was 
used for flash column chromatography. 1H NMR and 2D-NOESY spectra were recorded on 
Bruker spectrometers (500 MHz) and are reported relative to deuterated solvent signals. Data for 
1H NMR spectra are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant 
(Hz) and integration. 13C NMR spectra were recorded on Bruker spectrometers (125 MHz) and 
are reported relative to deuterated solvent signals. Data for 13C NMR spectra are reported in 
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terms of chemical shift and, when necessary, multiplicity, and coupling constant (Hz). For 
mixtures of regioisomers, the major regioisomer is reported with the minor regioisomer in 
parentheses for both 1H NMR and 13C NMR spectra. IR spectra were obtained using a Perkin-
Elmer 100 spectrometer and are reported in terms of frequency absorption (cm–1). High-
resolution mass spectra were obtained on Waters LCT Premier with ACQUITY LC and Thermo 
ScientificTM Exactive Mass Spectrometers with DART ID-CUBE. 
 
4.8.2 Experimental Procedures 
4.8.2.1 Synthesis of 3,4-Piperidyne Precursor 
 
 
Vinylogous Amide 4.7. To a solution of known silyl pyridine 4.627 (1.00 g, 5.52 mmol, 1 equiv) 
in MeOH (11 mL) was added NaBH4 (0.230 g, 6.07 mmol, 1.1 equiv) at –78 °C. After stirring 
for 20 min, benzyl chloroformate (0.87 mL, 6.07 mmol, 1.1 equiv) in Et2O (1.1 mL) was then 
added dropwise over 15 min. After stirring for 1 h at –78 °C, H2O (9.2 mL) was added and the 
reaction was warmed to room temperature. After 1.5 h, the reaction mixture was diluted with 
H2O (20 mL) and extracted with EtOAc (3 × 15 mL). The combined organic layers were washed 
with H2O (2 × 20 mL) and brine (20 mL), dried over Na2SO4, filtered, and concentrated in 
vacuo. The resulting crude product was purified by flash chromatography (9:1 hexanes : EtOAc) 
to provide vinylogous amide 4.7 (1.45 g, 87% yield) as a colorless oil. Vinylogous Amide 4.7: Rf  
0.52 (4:1 hexanes : EtOAc); 1H NMR (500 MHz, CDCl3, 55 °C): δ 7.85 (s, 1H), 7.40–7.36 (m, 
5H), 5.28 (s, 2H), 4.01 (t, J = 7.4, 2H), 2.52 (t, J = 7.3, 2H), 0.17 (s, 9H); 13C NMR (125 MHz, 
i.   NaBH4, MeOH, –78 °C
ii.  CbzCl, Et2O, –78 °C
iii. H2O, –78 → 23 °C
          (87% yield)
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CDCl3, 55 °C): δ 196.2, 153.1, 147.3, 135.6, 128.9, 128.8, 128.4, 116.7, 69.0, 42.9, 36.3, –1.24; 
IR (film): 1723, 1655, 1576, 1391, 1344, 1298 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for 
C16H22NO3Si, 304.1364; found 304.1350. 
 
 
Silyl Triflate 4.8. To a stirred solution of vinylogous amide 4.7 (2.91 g, 9.56 mmol, 1 equiv) in 
THF (43 mL) was added L-selectride (1.0 M in THF, 10.5 mL, 10.5 mmol, 1.1 equiv) at –78 °C. 
After stirring for 15 min, Tf2O (1.26 mL, 10.5 mmol, 1.1 equiv) was added dropwise over 15 
min. The reaction was stirred for 20 min at –78 °C and then a saturated aqueous solution of 
NaHCO3 (30 mL) was added and the reaction was warmed to room temperature. After stirring 
for 2 h, the layers were separated and the aqueous layer was extracted with EtOAc (3 × 20 mL), 
washed with brine (1 × 50 mL), dried over Na2SO4, filtered, and concentrated in vacuo. The 
resulting crude product was purified by flash chromatography with basic Brockman Grade I 58 Å 
Al2O3 (hexanes), followed by a silica gel column (3:2 hexanes : EtOAc) to give silyl triflate 4.8 
(2.60 g, 76% yield) as a colorless oil. Silyl Triflate 4.8: Rf  0.60 (4:1 hexanes : EtOAc); 1H NMR 
(500 MHz, CDCl3, 55 °C): δ 7.37–7.35 (m, 5H), 5.18 (s, 2H), 4.13 (t, J = 2.5, 2H), 3.68 (t, J = 
5.9, 2H), 2.57–2.55 (m, 2H), 0.25 (s, 9H); 13C NMR (125 MHz, CDCl3, 55 °C): δ 155.1, 151.8, 
136.8, 128.7, 128.3, 128.1, 126.3, 118.6 (q, J = 320.0), 67.7, 45.4, 41.0, 28.9, –1.32; IR (film): 
1702, 1656, 1412, 1243, 1204, 1141 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C17H23-
NF3O5SiS, 438.1013; found, 438.0992. 
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4.8.2.2 Trapping Experiments of 3,4-Piperidyne 
 
Representative Procedure (Preparation of piperidine 4.12 is used as an example). 
Piperidine 4.12 (Table 4.1, Entry 1). To a stirred solution of silyl triflate 4.8 (51.6 mg, 0.118 
mmol, 1 equiv) and tetracyclone (133 mg, 0.345 mmol, 3.0 equiv) in MeCN (1.2 mL) was added 
CsF (88.0 mg, 0.575 mmol, 5.0 equiv). The reaction vessel was sealed and placed in a preheated 
aluminum heating block maintained at 60 °C for 3 h. After cooling to 23 °C, the reaction mixture 
was filtered over silica gel (EtOAc eluent, 12 mL). Evaporation under reduced pressure and 
further purification by preparative thin layer chromatography (6:1:1 hexanes : EtOAc : PhH) 
afforded 4.12 as a pale yellow oil (76% yield, average of two experiments). 4.12: Rf  0.25 (9:1 
hexanes : EtOAc); 1H NMR (500 MHz, C6D6, 80 °C): δ 7.12–6.98 (m, 19H), 6.78–6.74 (m, 4H), 
6.67–6.64 (m, 2H), 5.11 (s, 2H), 4.55 (s, 2H), 3.53 (m, 2H), 2.58 (t, J = 6.1, 2H); 13C NMR (125 
MHz, C6D6, 80 °C): δ 155.4, 141.1, 141.0, 140.8, 140.7, 140.2, 139.9, 139.8, 139.6, 137.9, 
133.2, 132.3, 131.8, 130.7, 130.5, 128.6, 128.4, 128.2, 128.1, 128.1, 128.0, 127.9, 127.1, 126.9, 
126.6, 125.8, 125.8, 67.2, 46.1, 42.2, 28.8; IR (film): 3034, 1702, 1478, 1442, 1428, 1269 cm–1; 
HRMS-ESI (m/z) [M + H]+ calcd for C41H34NO2, 572.2584; found 572.2552. 
 
Any modifications of the conditions shown in this representative procedure are specified in the 
following schemes, which depict all of the results shown in Tables 4.1 and 4.2. 
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Piperidine 4.13 (Table 4.1, Entry 2). Purification by preparative thin layer chromatography (2:1 
hexanes : EtOAc) afforded 4.13 (62% yield, average of two experiments) as a colorless oil. 4.13: 
Rf  0.25 (9:1 hexanes : EtOAc); 1H NMR (500 MHz, C6D6, 80 °C): δ 7.27 (d, J = 7.6, 2H), 7.14–
7.11 (m, 2H), 7.08–7.05 (m, 1H), 6.96–6.92 (m, 2H), 6.81–6.79 (m, 1H), 6.74 (br s, 1H), 5.16 (d, 
J = 4.4, 2H), 4.50 (s, 2H), 3.46 (br s, 2H), 2.43 (app t, J = 5.3, 2H); 13C NMR (125 MHz, C6D6, 
80 °C): δ 155.5, 137.8, 135.0, 134.0, 128.9, 128.7, 128.4, 128.1, 126.6, 126.6, 126.5, 67.3, 46.2, 
41.9, 29.1; IR (film): 1699, 1452, 1428, 1294, 1226, 1119 cm–1; HRMS-ESI (m/z) [M + H]+ 
calcd for C17H18NO2, 268.1332; found 268.1317. 
 
 
Piperidine 4.14 (Table 4.1, Entry 3). Purification by preparative thin layer chromatography (2:1 
hexanes : EtOAc) afforded 4.14 (61% yield, average of two experiments) as a colorless oil. 4.14: 
Rf  0.20 (4:1 hexanes : EtOAc); 1H NMR (500 MHz, C6D6, 80 °C): δ 7.24 ( d, J = 7.6, 2H), 7.11 
(d, J = 7.6, 2H), 7.05 (app t, J = 7.3, 1H), 6.58 (m, 2H), 5.14 (s, 2H), 4.17 (dd, J = 15.0, 2.9, 1H), 
3.74 (d, J = 17.8, 1H), 3.45–3.42 (m, 1H), 3.30–3.29 (m, 1H), 2.06–2.02 (m, 1H), 1.59–1.54 (m, 
1H), 1.41 (s, 3H), 1.38 (s, 3H); 13C NMR (125 MHz, C6D6, 80 °C): δ 155.7, 150.9, 149.3, 148.3, 
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148.2, 137.9, 128.7, 128.4, 128.0, 90.9, 90.3, 67.4, 43.3, 41.4, 23.5, 15.0, 14.9; IR (film): 1701, 
1424, 1290, 1234, 1106, 860.1 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C19H22NO3, 312.1594; 
found 312.1580. 
 
 
Piperidine 4.15 (Table 4.1, Entry 4). Purification by preparative thin layer chromatography (4:1 
hexanes : EtOAc) afforded 4.15 (66% yield, average of two experiments) as a colorless oil. 4.15: 
Rf  0.25 (4:1 hexanes : EtOAc); 1H NMR (500 MHz, CD3CN, 55 °C): δ 7.38–7.31 (m, 5H), 7.02–
7.00 (m, 2H), 5.13 (s, 2H), 4.95–4.91 (m, 2H), 4.28 (dt, J = 18.0, 3.2, 1H), 3.90 (dt, J = 18.0, 3.3, 
1H), 3.51–3.48 (m, 2H), 2.47–2.44 (m, 1H), 2.09–2.04 (m, 1H), 1.4 (s, 9H); 13C NMR (125 
MHz, CD3CN, 55 °C): δ 156.9, 156.3, 149.8, 148.0, 144.5, 144.3, 139.1, 129.9, 129.3, 129.2, 
81.3, 70.4, 68.9, 68.2, 45.6, 42.7, 29.1, 26.6; IR (film): 1700, 1455, 1423, 1366, 1332, 1228 cm–
1; HRMS-ESI (m/z) [M + H]+ calcd for C22H27N2O4, 383.1965; found 383.1947. 
 
 
Piperidine 4.16 (Table 4.2, Entry 1). Purification by preparative thin layer chromatography (9:1 
CH2Cl2 : MeOH) afforded 4.16 (78% yield, average of two experiments) as a colorless oil. 4.16: 
Rf  0.41 (9:1 CH2Cl2 : MeOH) ; 1H NMR (500 MHz, CD3CN, 55 °C): δ 7.67 (s, 1H), 7.42–7.32 
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(m, 5H), 7.22 (s, 1H), 7.01 (s, 1H), 5.88–5.87 (m, 1H), 5.18 (s, 2H), 4.13 (m, 2H), 3.75 (t, J = 
3.8, 2H), 2.62–2.58 (m, 2H); 13C NMR (125 MHz, CD3CN, 55 °C): δ 158.5, 138.8, 136.1, 134.1, 
130.7, 139.8, 129.3, 129.0, 125.1, 113.8, 68.2, 43.6, 41.7, 28.4; IR (film): 1699, 1493, 1428, 
1233, 1213, 1112 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C16H18N3O2, 284.1394; found 
284.1379. 
 
 
Piperidine 4.17 (Table 4.2, Entry 2). Evaporation under reduced pressure afforded 4.17 (99% 
yield). The yield was determined by 1H NMR analysis of the crude reaction mixture using 1,3,5-
trimethoxybenzene (5.6 mg, 0.72 equiv) as an external standard. 4.17 was found to hydrolyze to 
the corresponding ketone28 4.18 upon exposure to silica gel. 4.18: Rf  0.45 (3:1 PhH : EtOAc). 
The regioselectivity of the nucleophilic attack was verified by the isolation of 4.18. 4.17: 1H 
NMR (500 MHz, C6D6, 80 °C): δ 7.28 (d, J = 7.4, 2H), 7.13 (t. J = 7.5, 2H), 7.07 (t, J = 7.5, 1H), 
5.18 (s, 2H), 4.23 (m, 1H), 3.99 (br s, 2H), 3.46 (t, J = 4.8, 6H), 2.41 (t, J = 4.8, 4H), 1.8 (m, 
2H); 13C NMR (125 MHz, CD3CN, 55 °C): δ 146.1, 139.0, 129.8, 129.1, 129.0, 118.3, 97.4, 
67.8, 67.8, 49.5, 44.1, 42.2, 41.7, 27.7, 1.88; IR (film): 1699, 1362, 1329, 1290, 1267, 1033 cm–
1; HRMS-ESI (m/z) [M + H]+ calcd for C17H23N2O3, 303.1703; found 303.1690. 
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Piperidines 4.19 and 4.20 (Table 4.2, Entry 3). Purification by preparative thin layer 
chromatography (7:3 hexanes : EtOAc) afforded 4.19 and 4.20 (84% yield, average of two 
experiments, 12.7:1 ratio) as a colorless oil. 4.19: Rf  0.63 (7:3 hexanes : EtOAc); 1H NMR (500 
MHz, CDCl3, 55 °C): δ 7.36–7.29 (m, 9H), 7.26–7.24 (m, 1H), 5.12 (s, 2H), 5.02 (br s, 1H), 3.95 
(app d, J = 15.7, 1H), 3.83 (app dt, J = 13.2, 5.2, 1H), 3.55–3.47 (m, 2H), 2.29 (br s, 2H), 1.14 (s, 
9H); 13C NMR (125 MHz, CDCl3, 55 °C): δ 155.8, 147.2, 143.0, 137.1, 128.7, 128.6, 128.1, 
128.0, 127.6, 127.3, 104.5, 69.3, 67.4, 60.7, 41.1, 41.1, 25.3, 22.3; IR (film): 1700, 1454, 1423, 
1286, 1212, 1132  cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C24H29N2O3, 393.2173; found 
393.2154. 
 
The structure of 4.19 was verified by 2D-NOESY, as the following interaction was observed:  
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Piperidines 4.21 and 4.22 (Table 4.2, Entry 4). Purification by preparative thin layer 
chromatography (3:2 EtOAc : hexanes) afforded an inseparable mixture of triazoles 4.21 and 
4.22 (81% yield, average of two experiments, 5.3:1 ratio) as a white solid. Compounds 4.21 and 
4.22 were characterized as a mixture of regioisomers. Rf  0.40 (3:2 EtOAc : hexanes); 1H NMR 
(500 MHz, C6D6, 80 °C): δ 7.21–7.20 (7.21–7.20) (m, 2H), 7.15 (7.15) (m, 1H), 7.13–7.10 
(7.13–7.10) (m, 2H), 7.07–7.06 (7.07–7.06) (m, 1H), 7.01–7.00 (7.01–7.00) (m, 3H), 6.92–6.90 
(6.92–6.90) (m, 2H), 5.07 (5.06) (app s, 2H), 4.92 (4.89) (s, 2H), 4.61 (4.11) (s, 2H), 3.30 (3.30) 
(app t, J = 5.2, 2H), 1.95 (2.56) (app t, J = 5.6, 2H); 13C NMR (125 MHz, CDCl3, 55 °C): δ 
155.7, 155.6, 142.4, 141.3, 136.7, 136.6, 134.7, 134.2, 130.6, 129.3, 129.2, 128.8, 128.7, 128.6, 
128.6, 128.3, 128.2, 128.2, 128.1, 127.9, 127.7, 127.7, 67.8, 67.7, 52.7, 52.3, 42.1, 42.0, 41.2, 
40.3, 22.8, 21.0; IR (film): 1698, 1455, 1424, 1223, 1198, 1100 cm–1; HRMS-ESI (m/z) [M + H]+ 
calcd for C20H21N4O2, 349.1659; found 349.1638. 
 
The structure of 4.21 was verified by 2D-NOESY and 2D-HMBC of the mixture, as the 
following interactions were observed:  
N
OTf
SiMe3
4.8
 (3 equiv)
CsF (5 equiv)
MeCN, 60 °C
(81% yield,
5.3:1 ratio) 4.21
N
N
N
Bn
N N
N
N
Bn
N N
N
N
Bn
+
4.22
Cbz Cbz Cbz
 370 
 
 
 
Piperidines 4.23 and 4.24 (Table 4.2, Entry 5). Purification by preparative thin layer 
chromatography (3:2 EtOAc : hexanes) afforded 4.23 (64% yield, average of two experiments) 
as a colorless oil and 4.24 (14% yield, average of two experiments) as a colorless oil. 4.23: Rf  
0.43 (3:2 EtOAc : hexanes); 1H NMR (500 MHz, CDCl3, 55 °C): δ 7.37–7.28 (m, 5H), 5.19 (s, 
2H), 4.69 (s, 2H), 4.37 (q, J = 7.2, 2H), 3.74 (t, J = 5.8, 2H), 2.87 (t, J = 5.6, 2H), 1.36 (t, J = 7.0, 
3H); 13C NMR (125 MHz, CDCl3, 55 °C): δ 160.3, 155.8, 145.9, 136.8, 132.1, 128.6, 128.2, 
128.0, 118.2, 67.6, 61.1, 42.5, 42.0, 21.9, 14.4; IR (film): 3219, 2931, 1701, 1470, 1427, 1226 
cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C17H20N3O4, 330.1448; found 330.1426. 4.24: Rf  0.25 
(2:3 Hexanes : EtOAc); 1H NMR (500 MHz, CDCl3, 55 °C): δ 7.38–7.30 (m, 5H), 5.20 (s, 2H), 
4.74 (s, 2H), 4.39 (q, J = 7.1, 2H), 3.79 (t, J = 5.8, 2H), 2.82 (t, J = 5.7, 2H), 1.38 (t, J = 7.0, 3H); 
13C NMR (125 MHz, CDCl3, 55 °C): δ 160.5, 155.9, 145.9, 137.0, 132.6, 128.7, 128.2, 128.1, 
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117.0, 67.6, 61.3, 41.7, 41.6, 23.3, 14.4; IR (film): 3244, 2957, 1699, 1424, 1269, 1222 cm–1; 
HRMS-ESI (m/z) [M + H]+ calcd for C17H20N3O4, 330.1448; found 330.1429. 
 
The structures of 4.23 and 4.24 were verified by 2D-HMBC, as the following interactions were 
observed:  
 
 
 
Piperidines 4.25 and 4.26 (Table 4.2, Entry 6). Purification by preparative thin layer 
chromatography (3:1 PhH : EtOAc) afforded an inseparable mixture of pyridines 4.25 and 4.26 
(57% yield, average of two experiments, 2.1:1 ratio) as a colorless oil. Compounds 4.25 and 4.26 
were characterized as a mixture of regioisomers. Rf  0.40 (1:1 PhH : EtOAc); 1H NMR (500 
MHz, CDCl3, 55 °C): δ 7.76 (7.73) (s, 1H), 7.38–7.36 (7.35–7.32) (m, 5H), 5.21 (5.19) (s, 2H), 
4.62 (4.69) (s, 2H), 3.98 (3.98) (s, 3H), 3.75 (3.80) (t, J = 5.9, 2H), 2.89 (2.81) (t, J = 5.7, 2H), 
2.54 (2.56) (s, 3H); 13C NMR (125 MHz, CDCl3, 55 °C): δ 166.1, 166.1, 166.1, 166.1, 158.0, 
155.9, 155.6, 155.4, 145.6, 145.3, 144.4, 143.1, 136.8, 136.8, 132.4, 131.5, 128.8, 128.4, 128.2, 
128.2, 123.6, 120.9, 67.8, 67.8, 52.8, 52.7, 45.8, 44.1, 41.2, 40.7, 29.1, 26.2, 22.3, 21.8; IR 
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(film): 1740, 1702, 1433, 1340, 1242, 1217 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for 
C19H21N2O4, 341.1496; found 341.1482. 
 
The structures of 4.25 and 4.26 were verified by 2D-NOESY, as the following interactions were 
observed:  
 
 
 
Piperidines 4.27 and 4.28 (Table 4.2, Entry 7). The sydnone trapping agent was synthesized 
using a known procedure.29 Purification by preparative thin layer chromatography (9:1 PhH : 
Et2O) afforded pyrazoles 4.27 and 4.28 (87% yield, average of two experiments, 1.3:1 ratio) both 
as amorphous white solids. 4.27: Rf  0.43 (9:1 PhH : Et2O); 1H NMR (500 MHz, CD3CN, 55 °C): 
δ 7.85 (s, 1H), 7.68–7.66 (m, 2H), 7.46–7.43 (m, 2H), 7.40–7.35 (m, 4H), 7.33–7.29 (m, 1H), 
7.27 (t, J = 7.5, 1H), 5.15 (s, 2H), 4.64 (s, 2H), 3.72 (t, J = 5.8, 2H), 2.69 (t, J = 5.8, 2H); 13C 
NMR (125 MHz, CD3CN, 55 °C): δ 156.8, 148.9, 141.2, 138.7, 130.7, 129.7, 129.1, 128.9, 
127.2, 125.7, 119.8, 117.5, 68.1, 44.0, 43.5, 21.8; IR (film): 2929, 1698, 1599, 1504, 1425, 1385 
cm–1; HRMS-ESI (m/z) [M + H]+ calcd for C20H20N3O2, 334.1550; found 334.1537. 4.28: Rf  0.42 
4.26
N
4.25
andN
CO2Me
HH H
H H CH3
N
N
CH3H H
H H H
CO2MeCbz Cbz
N
OTf
SiMe3
4.8
 (3 equiv)
CsF (5 equiv)
MeCN, 60 °C
(87% yield,
1.3:1 ratio)
4.27 4.28
O
NPh
N
O
N
NPh
N N
N
NPh+
Cbz Cbz Cbz
 373 
(9:1 PhH : Et2O); 1H NMR (500 MHz, CD3CN, 55 °C): δ 7.86 (s, 1H), 7.68–7.66 (m, 2H), 7.45–
7.43 (m, 2H), 7.39–7.35 (m, 4H), 7.32–7.29 (m, 1H), 7.26 (t, J = 7.4, 1H), 5.15 (s, 2H), 4.58 (s, 
2H), 3.78 (t, J = 5.8, 2H), 2.79, (t, J = 5.9, 2H); 13C NMR (125 MHz, CD3CN, 55 °C): δ 156.7, 
149.8, 141.7, 138.7, 130.7, 129.7, 129.2, 128.9, 127.2, 124.2, 119.7, 116.7, 68.1, 43.3, 41.6, 
24.7; IR (film): 1698, 1599, 1505, 1426, 1384, 1223 cm–1; HRMS-ESI (m/z) [M + H]+ calcd for 
C20H20N3O2, 334.1550; found 334.1530. 
 
The structures of 4.27 and 4.28 were verified by 2D-NOESY, as the following interactions were 
observed:  
 
 
 
Piperidine 4.29. Evaporation under reduced pressure afforded 4.18 (91% yield). The yield was 
determined by 1H NMR analysis of the crude reaction mixture using trimethoxybenzene (5.3 mg, 
0.75 equiv) as an external standard. 4.29 was not observed; however, its intermediacy was 
inferred by the isolation of the hydrolysis product, known ketone 4.18.28 4.18: Rf  0.45 (3:1 PhH : 
EtOAc). The regioselectivity of the nucleophilic attack was verified by the isolation of 4.18. 
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4.8.3 Computational Methods 
All calculations were carried out with the Gaussian 09 package.30 Geometry optimization and 
energy calculations were performed with B3LYP.31 The 6-31G (d) basis set32 was used for all of 
the atoms. Frequency analysis was conducted at the same level of theory to verify the stationary 
points to be real minima or saddle points and to obtain the thermodynamic energy corrections. A 
quasiharmonic correction was applied during the entropy calculation by setting all positive 
frequencies that are less than 100 cm−1 to 100 cm−1.33 This method has been found to give 
relatively accurate energetics for cycloadditions. Single-point energies were calculated at the 
B3LYP-D334/6-311+G(d,p) level. Solvent effect (solvent = acetonitrile) was calculated by using 
the CPCM35 solvation model. Computed structures are illustrated using CYLVIEW.36 
 
4.8.3.1 Bent´s Rule & Alkyne Distortion Determine Regioselectivity of Nucleophilic 
Addition 
Bent’s rule, as stated in 1961, is that “atomic s character concentrates in orbitals directed 
toward electropositive substituents.” In other words, bonds between elements of different 
electronegativities are polarized in a way such that the electron density will be shifted towards 
the more electronegative element. Due to the inherent higher stability of s orbitals, the hybrid 
orbitals from the more electronegative atoms will increase their s character in order to stabilize 
the withdrawn electron density. To compensate for this shift in electron density, the less 
electronegative atoms will direct hybrid orbitals with an increased p character toward the more 
electronegative atoms to which they are bound, without a significant energic penalty. As a result, 
the hybrid orbitals that constitute these polarized bonds deviate from ideal spn (n = 1, 2 or 3) 
hybridizations, which translates into distorted geometries. 
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4.8.3.2 n→p* interaction in 3,4-pyridyne The delocalization of the lone pair of electrons (n) 
from the nitrogen atom to the antibonding orbital (p*) of the alkyne moiety is an attractive 
electronic interaction that stabilizes 3,4-pyridyne. Figure 4.5 shows this favorable two-electron, 
two-orbital interaction between the nitrogen lone pair (n) and the antibonding orbital (p*) of the 
alkyne. The result of this interaction is the formation of a lower energy orbital, (n+p*), and a 
higher energy orbital, (n-p*). The (n+p*) orbital is computed to be HOMO-2, and it is stabilized 
by the favorable orbital overlap between the nitrogen lone pair (n) and the p orbital at C-3 of the 
antibonding orbital (p*), which is in closer proximity compared with that of C-4. The maximum 
stabilization occurs in the system when there is greater orbital overlap between n and C3. As a 
result, the alkyne reorients itself in a manner where C3 of the alkyne moves toward the nitrogen 
atom to maximize this stabilizing interaction. This counteracts the inductive effect of the 
electronegative nitrogen atom, which would distort the alkyne in the opposite manner in accord 
with Bent’s rule (see: Figure 4.4). It is the sum of these two opposing effects that leads to the two 
internal angles at C3 and C4 (124° and 126°) being very similar and showing little distortion, and 
consequently, no significant regioselectivity in nucleophilic additions. 
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Figure 4.5. n→p* interaction in 3,4-pyridyne 
 
4.8.3.3 Energies, Enthalpies, and Free Energies 
Table 4.3. Energies, enthalpies, and free energies of the structures calculated at the B3LYP-
D3/6-311+G(d,p)(CPCMMeCN)//B3LYP/6-31G(d). 
Structures ZPE DE DH DG E H G 
Imaginary 
Frequency 
4.3 0.154569 0.164225 0.165169 0.11937 -477.409844 -477.244675 -477.290474 — 
TS4.1 0.200137 0.211205 0.212149 0.170824 -534.923275 -534.711126 -534.752451 -41.505 
TS4.2 0.200204 0.211238 0.212182 0.163959 -534.923580 -534.711398 -534.759621 -42.130 
4.1a 0.063685 0.067966 0.068910 0.036450 -247.022283 -246.953373 -246.985833 — 
TS4.3 0.291685 0.307621 0.308565 0.245795 -765.314031 -765.005466 -765.068236 -21.426 
TS4.4 0.292273 0.307920 0.308864 0.247304 -765.312285 -765.003421 -765.064981 -68.745 
 
4.8.3.4 Cartesian Coordinates of the Relevant Structures  
Cartesian coordinates for the optimized structures were reported in the literature.37 
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4.9 Spectra Relevant to Chapter Four: 
 
Generation and Regioselective Trapping of a 3,4-Piperidyne for the  
Synthesis of Functionalized Heterocycles 
Travis C. McMahon, Jose M. Medina, Yun-Fang Yang, Bryan J. Simmons,  
K. N. Houk, and Neil K. Garg  
J. Am. Chem. Soc. 2015, 137, 4082–4085.  
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Figure 4.6 1H NMR (500 MHz, CDCl3) of compound 4.7. 
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Figure 4.7 13C NMR (125 MHz, CDCl3) of compound 4.7. 
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Figure 4.8 1H NMR (500 MHz, CDCl3) of compound 4.8. 
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Figure 4.9 13C NMR (125 MHz, CDCl3) of compound 4.8. 
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Figure 4.10 1H NMR (500 MHz, C6D6) of compound 4.12. 
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Figure 4.11 13C NMR (125 MHz, CDCl3) of compound 4.12. 
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Figure 4.12 1H NMR (500 MHz, C6D6) of compound 4.13. 
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Figure 4.13 13C NMR (125 MHz, CDCl3) of compound 4.13. 
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Figure 4.15 13C NMR (125 MHz, CDCl3) of compound 4.14. 
Figure 4.14 1H NMR (500 MHz, CDCl3) of compound 4.14. 
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Figure 4.16 1H NMR (500 MHz, CD3CN) of compound 4.15. 
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2 Current Data Parameters
NAME       JMM-4-28(80)
EXPNO                 2
PROCNO                1
F2 - Acquisition Parameters
Date_          20141015
Time              17.36
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  595
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                353.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 5.75 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8078790 MHz
WDW                  EM
SSB      0
LB                 3.00 Hz
GB       0
PC                 1.40
default carbon parameters (proton decoupled)
Figure 4.17 13C NMR (125 MHz, CDCl3) of compound 4.15. 
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Current Data Parameters
NAME     TCM-II-170-75C
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141019
Time              18.40
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CD3CN
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                  114
DW               50.000 usec
DE                 6.00 usec
TE                348.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300125 MHz
WDW                  EM
SSB      0
LB       0 Hz
GB       0
PC                 1.00
TCM-II-170-75C
4.16
N
N N
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Current Data Parameters
NAME     TCM-II-170-75C-C13
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141019
Time              18.44
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CD3CN
NS                 1024
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                348.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.20 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2              120.00 dB
PL12              16.10 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8079004 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
TCM-II-170-75C-C13
Figure 4.19 13C NMR (125 MHz, CD3CN) of compound 4.16. 
Figure 4.18 1H NMR (500 MHz, CD3CN) of compound 4.16. 
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Current Data Parameters
NAME           JMM-4-43
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141024
Time              17.48
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT            C6D6
NS                   21
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                161.3
DW               50.000 usec
DE                 6.00 usec
TE                333.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300094 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
default proton parameters
4.17
N
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Figure 4.20 1H NMR (500 MHz, C6D6) of compound 4.17. 
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9 Current Data Parameters
NAME           JMM-4-43
EXPNO                 3
PROCNO                1
F2 - Acquisition Parameters
Date_          20141024
Time              19.59
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CD3CN
NS                 1800
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG              10321.3
DW               15.300 usec
DE                 6.00 usec
TE                333.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 5.75 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8079052 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
default carbon parameters (proton decoupled)
Figure 4.21 13C NMR (125 MHz, CD3CN) of compound 4.17. 
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Current Data Parameters
NAME     TCM-II-174-58C
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141028
Time              13.12
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                  114
DW               50.000 usec
DE                 6.00 usec
TE                331.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300207 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
TCM-II-174-58C
Figure 4.22 1H NMR (500 MHz, CDCl3) of compound 4.19. 
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1 Current Data Parameters
NAME     TCM-II-174-58C-C13
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141028
Time              13.17
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                 1024
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                331.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.20 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2              120.00 dB
PL12              16.10 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080473 MHz
WDW                  EM
SSB      0
LB                 5.00 Hz
GB       0
PC                 1.40
TCM-II-174-58C-C13
Figure 4.23 13C NMR (125 MHz, CDCl3) of compound 4.19. 
4.19
N
N
O
t-Bu
Ph
Cbz
 387 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1.
94
3
1.
95
4
1.
96
5
2.
55
4
2.
56
5
2.
57
6
3.
29
0
3.
30
0
3.
31
1
4.
10
8
4.
60
9
4.
88
9
4.
92
1
5.
05
7
5.
07
2
6.
90
4
6.
90
8
6.
91
4
6.
91
8
6.
92
3
6.
99
8
7.
00
5
7.
00
8
7.
01
2
7.
01
6
7.
01
9
7.
06
0
7.
07
4
7.
08
9
7.
09
6
7.
09
8
7.
10
8
7.
11
1
7.
12
2
7.
12
5
7.
15
1
7.
16
0
7.
20
0
7.
21
5
2.
01
8
0.
47
2
2.
46
6
0.
43
5
2.
00
0
0.
45
1
2.
00
6
2.
42
3
2.
21
0
3.
12
7
1.
08
2
2.
35
0
0.
93
1
2.
45
0
Current Data Parameters
NAME     JMM-TCM-N3-c6d6(80)
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141020
Time              13.33
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT            C6D6
NS                   26
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                   64
DW               50.000 usec
DE                 6.00 usec
TE                353.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300075 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
default proton parameters
Figure 4.24 1H NMR (500 MHz, C6D6) of compound 4.21 and 4.22. 
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5 Current Data Parameters
NAME     JMM-TCM-C13-N3
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141024
Time              21.39
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                16991
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                333.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 5.75 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080565 MHz
WDW                  EM
SSB      0
LB       0 Hz
GB       0
PC                 1.40
default carbon parameters (proton decoupled)
Figure 4.25 13C NMR (125 MHz, CDCl3) of compound 4.21 and 4.22. 
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Current Data Parameters
NAME     TCM-II-155major-55C
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141002
Time              12.50
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                   57
DW               50.000 usec
DE                 6.00 usec
TE                328.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300207 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
TCM-II-155major-55C
Figure 4.26 1H NMR (500 MHz, CDCl3) of compound 4.23. 
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9 Current Data Parameters
NAME     TCM-II-155major-55C-C13
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141002
Time              12.57
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  512
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                328.0 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.20 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2              120.00 dB
PL12              16.10 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080585 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
TCM-II-155major-55C-C13
Figure 4.27 13C NMR (125 MHz, CDCl3) of compound 4.23. 
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Current Data Parameters
NAME     TCM-II-155minor-55C
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141001
Time              14.10
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                161.3
DW               50.000 usec
DE                 6.00 usec
TE                328.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300207 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
TCM-II-155minor-55C
Figure 4.28 1H NMR (500 MHz, CDCl3) of compound 4.24. 
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Current Data Parameters
NAME     JMM-TCM-diazoesterminor
EXPNO                 2
PROCNO                1
F2 - Acquisition Parameters
Date_          20141028
Time              19.33
INSTRUM           av500
PROBHD   5 mm DCH 13C-1
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                 2190
DS                    2
SWH           31250.000 Hz
FIDRES         0.476837 Hz
AQ            1.0485760 sec
RG               204.54
DW               16.000 usec
DE                18.00 usec
TE                333.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        125.7726284 MHz
NUC1                13C
P1                 9.63 usec
PLW1        23.00000000 W
======== CHANNEL f2 ========
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.13500001 W
F2 - Processing parameters
SI               131072
SF          125.7577583 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
default carbon parameters
Figure 4.29 13C NMR (125 MHz, CDCl3) of compound 4.24. 
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Current Data Parameters
NAME      JMM-3-276(60)
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20141020
Time              10.25
INSTRUM           av500
PROBHD   5 mm DCH 13C-1
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   21
DS                    0
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Figure 4.30 1H NMR (500 MHz, CDCl3) of compound 4.25 and 4.26. 
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Figure 4.31 13C NMR (125 MHz, CDCl3) of compound 4.25 and 4.26. 
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Figure 4.32 1H NMR (500 MHz, CD3CN) of compound 4.27. 
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Figure 4.33 13C NMR (125 MHz, CD3CN) of compound 4.27. 
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Figure 4.34 1H NMR (500 MHz, CD3CN) of compound 4.28. 
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Figure 4.35 13C NMR (125 MHz, CD3CN) of compound 4.28. 
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CHAPTER FIVE 
 
Understanding and Interrupting the Fischer Azaindolization Reaction  
Bryan J. Simmons, Marie Hoffmann, Pier Alexandre Champagne, Elias Picazo,  
Katsuya Yamakawa, Lucas A. Morrill, K. N. Houk, and Neil K. Garg. 
J. Am. Chem. Soc. 2017, 139, 14833–14836. 
 
5.1 Abstract 
Experimental and computational studies pertaining to the Fischer azaindolization reaction 
are reported. These studies explain why pyridylhydrazines are poorly reactive in Fischer 
indolization reactions, in addition to the origin of hydrazine substituent effects. Additionally, an 
interrupted variant of Fischer azaindolization methodology is disclosed, which provides a 
synthetic entryway into fused azaindoline scaffolds.  
 
5.2 Introduction 
The Fischer indolization reaction, first described in 1883,1 remains a powerful tool in 
modern chemical synthesis.2 The transformation, which typically involves the acid-mediated 
reaction of aryl hydrazines with ketones or aldehydes to give indoles, has many applications in 
medicinal chemistry.2 The Fischer indolization has also been used extensively in natural product 
synthesis, including several recent examples, to generate remarkable structural complexity.3 
One deficiency associated with the Fischer indolization involves the variant in which 
pyridylhydrazines are employed to furnish azaindole products (a.k.a., Fischer azaindolization).4 
This transformation was first tested over 100 years ago.5 It is now known, particularly via the 
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studies of Parrick4a,b and Robinson4c that the azaindolization can proceed under extreme thermal 
conditions. For the corresponding acid-mediated process to take place, certain substituents on the 
hydrazine (e.g., methoxy, halides) can be used to improve reactivity, but the origins of such 
beneficial effects have remained unknown.4d−g 
The present study answers two key questions. (A) What factors govern the success or 
failure of the Fischer azaindolization reaction? (B) Could a general “interrupted” variant of the 
Fischer azaindolization6 be developed as a method to access fused azaindoline scaffolds? 
Although fused azaindoline frameworks are uncommon,7 the parent azaindole heterocycle serves 
as a bioisostere for indoles8 and is present in compounds of medicinal relevance. In fact, more 
than 74,000 bioactive azaindoles are known,9 including the currently marketed drugs Zelboraf 
(5.1, Figure 5.1) and Venclexta.10 Fused indolines are present in more than 22,000 bioactive 
molecules, more than 870 of which are natural products (e.g., 5.2).6c,9,11 We now report 
mechanistic insights into the Fischer azaindolization reaction, the scope of the interrupted variant 
(5.3 + 5.4 → 5.5), and the use of this methodology to access aza-analogues of bioactive 
compounds. 
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Figure 5.1 Zelboraf (5.1), (–)-aspidophylline A (5.2), and interrupted Fischer azaindolization 
reaction. 
 
5.3 Computational Study of the Fischer Azaindolization Reaction 
With the goal of understanding the factors that lead to success or failure of the Fischer 
azaindolization reaction, we performed a series of SCS-MP2 calculations.12 We first investigated 
if the activation barrier for [3,3]-sigmatropic rearrangement varies significantly based on the aryl 
hydrazine employed. Thus, as summarized in Figure 5.2, the ΔG‡ was calculated for this step 
under four scenarios:13 (a) the neutral phenylhydrazone, (b) protonation of the β-nitrogen of 
phenylhydrazone,14 (c) protonation of the β-nitrogen of 3-pyridylhydrazone, and (d) protonation 
of the β-nitrogen of methoxy-substituted 3-pyridylhydrazone. In all cases, we used 
propionaldehyde as the Fischer indolization reaction partner. For three of the scenarios 
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(transition states 5.6, 5.7, and 5.9), the calculations were in good accord with experimental 
trends. However, for transition state 5.8 involving the experimentally problematic 3-
pyridylhydrazine, the activation barrier was calculated to be reasonable (i.e., 13.5 kcal/mol). 
Thus, we sought an alternative explanation for the poor reactivity of 3-pyridylhydrazones in 
Fischer indolization reactions. 
 
 
Figure 5.2 [3,3]-sigmatropic rearrangement transition states of various arylhydrazines. 
 
We next considered if the pyridine nitrogen might be protonated (Figure 5.3). Indeed, 
protonation of this nitrogen is much preferred over hydrazone protonation, and pyridinium salt 
5.10 is the global minimum of the pathway. To convert 5.10 to 5.11 requires 21.8 kcal/mol, 
leading to a high total barrier of 35.3 kcal/mol for the tautomerization and [3,3]-sigmatropic 
rearrangement (5.10 → 5.8). As noted earlier, it is known that introduction of a methoxy 
substituent on the pyridylhydrazine (e.g., see 5.9, Figure 5.2) leads to improved yields in 
experimental studies.4d−g This has previously been rationalized by a “push/ pull” effect4d which, 
in turn, makes the [3,3]-sigmatropic rearrangement more favorable. Instead, we suggest that the 
methoxy group reduces the basicity of the pyridine nitrogen, thus rendering the proton 
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transfer/tautomerization more feasible. We calculate that the tautomerization between the 2-
methoxy analogues of 5.10 and 5.11 is only 14.9 kcal/mol (versus 21.8 kcal/mol for 5.10 to 
5.11).12 Consequently, the better performance in Fischer azaindolizations of methoxy-substituted 
pyridylhydrazines compared to the parent pyridylhydrazines can be attributed to the diminished 
basicity of the pyridine nitrogen in the former case. 
 
 
Figure 5.3 Unfavorable equilibrium between 5.10 and 5.11.  
 
5.4 Interrupted Fischer Azaindolization Reaction 
We also explored the interrupted variant of the Fischer azaindolization to access fused 
azaindolines since only a single example of this transformation is available in the literature6d and 
no methodology studies have been reported. To initiate our efforts in this area, we used methoxy-
substituted pyridylhydrazine salt 5.12 (Table 5.1), due to its previously established favorable 
reactivity in Fischer azaindolization reactions. Following an initial survey of reaction conditions, 
mainly involving variation of solvent, acid sources, time, and temperature, we found that 5.12 
underwent interrupted Fischer azaindolization with a variety of aldehyde surrogates to give fused 
4-azaindoline products 5.13. Of note, the transformation introduces two stereocenters, one of 
which is quaternary. Results are depicted based on optimization of individual substrates. Upon 
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treatment of 5.12 with lactol 5.14, furanoazaindoline 5.15 was obtained in 97% yield (entry 1). 
Alternate substituents on the lactol were tolerated, as demonstrated by the successful interrupted 
Fischer azaindolization of phenyl lactol 5.16 and allyl lactol 5.18 to furnish adducts 5.17 and 
5.19, respectively (entries 2 and 3). The 6-membered lactol 5.20 was also deemed a suitable 
reaction partner, as demonstrated by the formation of 6,5,6-tricycle 5.21 (entry 4). In addition, 
we evaluated several hemiaminal substrates for the synthesis of azapyrrolidinoindolines. The use 
of methyl substituted N-Ts hemiaminal 5.22 led to 5.23 (entry 5), whereas employment of allyl 
derivative 5.24 gave azaindoline 5.25 (entry 6). Lastly, we evaluated carbamate-containing 
hemiaminal substrate 5.26, which furnished 5.27 in 82% yield (entry 7). 
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Table 5.1 Scope of the aldehyde surrogate in the interrupted Fischer azaindolization. 
 
 
Having established the tolerance of the interrupted Fischer azaindolization methodology 
toward variation in the aldehyde surrogate, we shifted our attention to assessing changes in the 
hydrazine component (Table 5.2). Halohydrazines 5.29 and 5.31 underwent interrupted Fischer 
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azaindolization with lactol 5.14 to deliver 4-azaindoline products 5.30 and 5.32, respectively 
(entries 1 and 2). Interestingly, the use of methoxyhydrazine 5.33 led to azaindoline product 
5.34, albeit in a lower yield (entry 3).15 Efforts to further optimize this transformation were 
unsuccessful. Isomeric hydrazines 5.35, 5.37, and 5.39 were also evaluated with the hopes of 
accessing 5-, 6-, and 7-substituted azaindolines. Whereas the interrupted Fischer azaindolization 
reaction failed to produce 5-azaindoline 5.36 (entry 4), the methodology furnished 6-azaindoline 
5.38 (entry 5) and 7-azaindoline 5.40 (entry 6), albeit with a modest yield in the latter case. 
Finally, unsubstituted 3-pyridylhydrazine 5.41 was tested as a point of comparison (entry 7). 
Consistent with expectations based on the literature4 and our calculations (see Figure 5.3), the 
transformation proved problematic and gave 5.42 in a poor yield of 11%.16 
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Table 5.2 Scope of hydrazine and correlation to calculated free energies. 
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To complement these experimental studies, calculations were performed for the reaction 
of each hydrazine depicted in Table 5.2, with propionaldehyde as a model aldehyde under acidic 
conditions.12 Earlier, we hypothesized that the success or failure of the Fischer azaindolization 
methodology hinges on the feasibility of enehydrazine formation, rather than [3,3]-sigmatropic 
rearrangement. Consistent with this notion, we found the computed activation barriers for [3,3]-
sigmatropic rearrangement (ΔG‡[3,3]) were uniformly accessible and ranged from 13.4 to 16.6 
kcal/mol. On the other hand, the calculated tautomerization equilibria (ΔG[H+]) varied 
considerably between 11.5 and 23.7 kcal/mol. In cases where the calculated ΔG[H+] is high, the 
reaction is experimentally problematic (entries 4 and 7). In the cases of entries 3 and 6, the 
ΔG[H+] is slightly more favorable leading to modest yields of product. However, if ΔG[H+] is 
sufficiently low (i.e., less than 15 kcal/mol), the reaction proceeds more efficiently (Table 5.2, 
entries 1, 2, 5, and Table 5.1). Overall, hydrazines with poorly basic pyridine nitrogens had the 
smallest ΔG[H+]. 
 
5.5 Interrupted Fischer Azaindolization Reaction in Bioactive Molecule Synthesis 
The interrupted Fischer azaindolization methodology can be used to synthesize new aza-
analogues of bioactive molecules (Figure 5.4). Treatment of benzyloxyhydrazine 5.43 with lactol 
5.14 under acidic conditions delivered furanoazaindoline 5.44 in 81% yield. Using a 
straightforward 3-step sequence, 5.44 was elaborated to carbamate 5.45, a new analogue of the 
potent acetylcholinesterase inhibitor phensvenine.17 Switching to a significantly more complex 
system, we performed the interrupted Fischer azaindolization of hydrazine 5.12 and known3j 
ketolactone 5.46. Following the acid-mediated rearrangement and subsequent hydrolysis in the 
 408 
same pot, a straightforward methylation gave pentacycle 5.47. In turn, azaindoline 5.47 was 
converted in two steps to 5.48, an analogue of the anticancer agent (–)-aspidophylline A.11  
 
 
Figure 5.4 Synthesis of aza-analogues. 
 
5.6 Conclusion 
We have performed an experimental and computational study of the Fischer 
azaindolization reaction, related to a transformation first attempted more than 100 years ago. 
Calculations were used to explain the difficulty in employing pyridylhydrazines in Fischer 
OHO
MeNBnO
N
H
NH2
• HCl N
N
H
O
BnO
Me
H
4% aq H2SO4
60 °C
(81% yield)
(61% yield, three steps)
N
N
Me
O
O
Me
H
H
N
O
Ph
5.45
Aza-analogue
of Phensvenine
Ns
N
Me
H
H
O O
ONMeO
N
H
NH2
• HCl
N
N
OH
N
Me
H
CO2Me
H
MeO
+
N
N
OH
N
Me
H
CO2Me
H
OHC
MeO 5.48
Aza-analogue of 
(–)-Aspidophylline A
1. TFA, 1,2-dichloroethane, 40 °C;
     LiOH, H2O, THF, 60 °C
2. TMSCHN2, MeOH, THF, 23 °C
1. MetSThiol®, Cs2CO3  
    MeCN, 65 °C
2. formic acid, EDAC
    DMAP, CH2Cl2, 0 °C
1. NaH, MeI, DMF, 0 → 23 °C
2. BCl3, CH2Cl2, –40 → 23 °C
3. PhNCO, PhH, 23 °C
Ns
(63% yield, two steps)
(42% yield, two steps)
5.43 5.14 5.44
5.12
5.46
5.47
Synthesis of Aza-Derivative of (–)-Aspidophylline A
Synthesis of Aza-Derivative of Phensvenine
 409 
indolizations, in addition to the origin of hydrazine substituent effects. Rather than the [3,3]-
sigmatropic rearrangement step being the single determining factor, we find that reactions suffer 
if the pyridine nitrogen is too basic, making the tautomerization step prohibitively challenging. 
We have also developed an interrupted Fischer azaindolization methodology, which provides a 
synthetic entryway into fused azaindoline scaffolds. The syntheses of new aza-analogues of 
phensvenine and (–)-aspidophylline A underscore the potential of this methodology to deliver 
new aza-derivatives of medicinally privileged fused indoline-containing compounds. 
 
5.7 Experimental Section 
5.7.1 Materials and Methods 
Unless stated otherwise, reactions were conducted in flame-dried glassware under an 
atmosphere of air and commercially obtained reagents were used as received. Di-tert-buyl 
hydrazodiformate (5.52), amine 5.50, boronate ester 5.57, Pd2(dba)3, Cu(OAc)2, and dppf were 
obtained from Sigma-Aldrich and used as received. Di-tert-butyl azodicarboxylate (5.55), 
bromopyridines 5.51, 5.60, amine 5.49, and boronate ester 5.62 were obtained from Combi-
Blocks and used as received. Amines 5.59 and 5.61 were obtained from Oakwood and used as 
received. Boronic acid 5.54 was obtained from Frontier Scientific and used as received. Solid 
supported thiol-resin MetSThiol® was obtained from SiliCycle (Product # R51030B). Reaction 
temperatures were controlled using an IKAmag temperature modulator, and unless stated 
otherwise, reactions were performed at elevated temperatures (approximately 120 °C). Thin-
layer chromatography (TLC) was conducted with EMD gel 60 F254 pre-coated plates (0.25 mm 
for analytical chromatography and 0.50 mm for preparative chromatography) and visualized 
using a combination of UV, anisaldehyde, iodine, and potassium permanganate staining 
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techniques. Silicycle Siliaflash P60 (particle size 0.040–0.063 mm) was used for flash column 
chromatography. 1H NMR spectra were recorded on Bruker spectrometers (at 300, 400 and 500 
MHz) and are reported relative to residual solvent signals. Data for 1H NMR spectra are reported 
as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz), integration. Data for 13C 
NMR are reported in terms of chemical shift (at 100 and 125 MHz). IR spectra were recorded on 
a Perkin-Elmer UATR Two FT-IR spectrometer and are reported in terms of frequency 
absorption (cm–1). DART-MS spectra were collected on a Thermo Exactive Plus MSD (Thermo 
Scientific) equipped with an ID-CUBE ion source and a Vapur Interface (IonSense Inc.). Both 
the source and MSD were controlled by Excalibur software v. 3.0.  The analyte was spotted onto 
OpenSpot sampling cards (IonSense Inc.) using volatile solvents (e.g. chloroform, 
dichloromethane). Ionization was accomplished using UHP He (Airgas Inc.) plasma with no 
additional ionization agents.  The mass calibration was carried out using Pierce LTQ Velos ESI 
(+)  and (–) Ion calibration solutions (Thermo Fisher Scientific). Optical rotations were measured 
with a Rudolf Autopol III Automatic Polarimeter. 
 
5.7.2 Experimental Procedures 
Note: Experimental information for compounds 5.1418, 5.1618, 5.1818, 5.2018, 5.2218, 5.2418, 
5.2619, and 5.463d have previously been reported. 
 
 
Representative Procedure A for the synthesis of hydrazine substrates from Tables 5.1 and 
5.2. (5.37 is used as an example). Hydrazine 5.37. To a solution of aniline 5.49 (200.0 mg, 1.60 
i. NaNO2, H2O, 0 °C
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mmol, 1.0 equiv) in 6 M HCl (3.0 mL, 0.5 M) at 0 °C was added dropwise a solution of NaNO2 
(107.0 mg, 1.55 mmol, 1.0 equiv) in deionized H2O (4.0 mL, 0.4 M) over 1 min under an air 
atmosphere. After stirring at 0 °C for 30 min, a solution of SnCl2•2 H2O (878.0 mg, 3.90 mmol, 
2.5 equiv) in 6 M HCl (3.0 mL, 1.3 M) was added dropwise over 1 min. The reaction was 
allowed to stir at 0 °C for 1 h, then quenched with a solution of 40% w/w KOH in deionized H2O 
until a pH of 12 had been reached (ca. 10 mL). The solution was transferred to a separatory 
funnel and extracted with EtOAc (4 x 20 mL). The organic layers were combined, dried over 
MgSO4, and the volatiles were removed under reduced pressure. The resulting crude residue was 
taken up in EtOAc (6.0 mL) and cooled to 0 °C. Next, 1 M HCl in EtOH (8.0 mL, 0.2 M) was 
added dropwise over 1 min. The resulting precipitate was collected by filtration through a 
vacuum filter. The solid residue was washed with CH2Cl2 (5 mL) and dried under reduced 
pressure to yield hydrazine 5.37 as a solid (252.8 mg, 90% yield). Hydrazine 5.37: mp: 151–152 
ºC; Rf 0.57 (EtOAc); 1H NMR (500 MHz, DMSO-d6): δ 10.40 (br. s, 3H), 8.09 (br. s, 2H), 7.72 
(dd, J = 5.1, 1.5, 1H), 7.40 (dd, J = 7.7, 1.5, 1H), 6.94 (dd, J = 7.7, 5.1, 1H) 3.90 (s, 3H); 13C 
NMR (125 MHz, DMSO-d6): δ 152.3, 138.0, 129.4, 120.8, 117.0, 53.4; IR (film): 3347, 3091, 
2589, 1565, 788 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C6H10N3O+, 140.0818; found 
140.0816. 
 
 
Representative Procedure B for the synthesis of hydrazine substrates from Table 5.2 (5.41 
is used as an example). Hydrazine 5.41. To a solution of aniline 5.50 (1.0 g, 10.60 mmol, 1.0 
i. NaNO2, H2O, 0 °C
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equiv) in 12 M HCl (10.0 mL, 1.1 M) at 0 °C was added dropwise a solution of NaNO2 (768.0 
mg, 11.10 mmol, 1.0 equiv) in deionized H2O (10.0 mL, 1.1 M) over 1 min under an air 
atmosphere. After stirring at 0 °C for 30 min, a solution of SnCl2•2 H2O (6.0 g, 26.50 mmol, 2.5 
equiv) in 12 M HCl (10.0 mL, 2.6 M) was added dropwise over 1 min. The reaction was allowed 
to stir at 0 °C for 30 min. The precipitate was then removed by vacuum filtration. The filtrate 
was left to evaporate over 48 h allowing crystals to form. The resulting solid was transferred to a 
filter paper, washed with Et2O (10 mL), and dried under reduced pressure to yield hydrazine 5.41 
as a solid (1.03 g, 67% yield). Hydrazine 5.41: mp: 181–183 ºC; Rf 0.08 (EtOAc); 1H NMR (500 
MHz, DMSO-d6): δ 11.45 (br. s, 3H), 9.54 (br. s, 1H), 8.45–8.43 (m, 2H), 8.04–8.02 (m, 1H), 
7.96–7.93 (m, 1H); 13C NMR (125 MHz, DMSO-d6): δ 144.9, 133.8, 129.3, 127.3, 126.8; IR 
(film): 3500, 3060, 2656, 1548, 787 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C5H8N3+, 
110.0713; found 110.0711. 
 
 
Representative Procedure C for the synthesis of hydrazine substrates from Table 5.2. (5.39 
is used as an example). Boc-Hydrazine 5.53. To a A 1-dram vial charged with a magnetic stir 
bar and Cs2CO3 (876.7 mg, 2.69 mmol, 1.25 equiv) was flame-dried under reduced pressure, and 
allowed to cool under a N2 atmosphere. Bromide 5.51 (505.9 mg, 2.69 mmol, 1.25 equiv) and di-
tert-butyl hydrazodiformate (5.52) (500.0 mg, 2.15 mmol, 1.0 equiv) were added and the vial 
was flushed with N2 for 5 min. The vial was taken into a glovebox and charged with Pd2(dba)3 
(98.5 mg, 0.11 mmol, 0.05 equiv), dppf (179.1 mg, 0.32 mmol, 0.15 equiv), and toluene (3.6 mL, 
Pd2(dba)3 
dppf 
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0.75 M). The vial was then capped with a Teflon-lined screw cap and taken out of the glovebox 
where it was placed in a pre-heated aluminum block and allowed to stir at 100 °C for 24 h. After 
cooling to room temperature, the reaction mixture was diluted with CH2Cl2 (15 mL) and filtered 
through a plug of celite (30 mL of CH2Cl2 as eluent). The organics were transferred to a 
separatory funnel and washed sequentially with deionized water (2 x 15 mL), saturated aqueous 
NaCl (15 mL), and dried over Na2SO4. The volatiles were removed under reduced pressure. The 
resulting crude residue was purified by flash chromatography (1:1 Hexanes:EtOAc) to yield Boc-
hydrazine 5.53 (253.9 mg, 35% yield) as a light brown solid.  
 
 
Hydrazine 5.39. A 20 mL scintillation vial equipped with a magnetic stir bar was charged with 
Boc-hydrazine 5.53 (269.5 mg, 0.79 mmol, 1.0 equiv) and 4 M HCl in dioxane (5.3 mL, 0.15 
M). After stirring at 23 °C for 16 h, the volatiles were removed under reduced pressure. The 
resulting crude solid was transferred to a filter paper, washed with EtOAc (5 mL), and dried 
under reduced pressure to yield hydrazine 5.39 (141.1 mg, 99% yield) as a yellow solid. 
Hydrazine 5.39: mp: 198–200 ºC; Rf 0.09 (EtOAc); 1H NMR (500 MHz, DMSO-d6): δ 9.71 (br. 
s, 3H), 9.03 (br. s, 1H), 7.88 (d, J = 2.8, 1H), 7.44 (dd, J = 9.1, 2.8, 1H), 6.88 (app. dd, J = 9.1, 
2.8, 1H), 3.78 (s, 3H); 13C NMR (125 MHz, DMSO-d6): 150.8, 150.3, 130.3, 126.6, 110.6, 56.0; 
IR (film): 3308, 2940, 2646, 1620, 1584 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for 
C6H10N3O+, 140.0818; found 140.0816. 
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Representative Procedure D for the synthesis of hydrazine substrates from Table 5.2. (5.33 
is used as an example). Boc-Hydrazine 5.56. A 20 mL scintillation vial was charged with a 
magnetic stir bar, flame-dried under reduced pressure, and allowed to cool under a N2 
atmosphere. Boronic acid 5.54 (300.0 mg, 1.76 mmol, 1.0 equiv), di-tert-butyl azodicarboxylate 
(5.55) (444.6 mg, 1.93 mmol, 1.1 equiv), Cu(OAc)2 (31.9 mg, 0.17 mmol, 0.10 equiv), and 
MeOH (7.0 mL, 0.25 M) were added under an atmosphere of air. The vial was capped with a 
Teflon-lined screw cap, placed in a pre-heated aluminum block, and allowed to stir at 50 °C for 3 
h. After cooling to room temperature, the volatiles were removed under reduced pressure. The 
reaction mixture was then transferred to a separatory funnel with deionized water (5 mL) and 
CH2Cl2 (5 mL). The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x 
5 mL). The organic layers were combined, washed with saturated aqueous NaCl (15 mL), and 
then dried over Na2SO4. The volatiles were removed under reduced pressure. The resulting crude 
residue was purified by flash chromatography (1:10 Hexanes:EtOAc, 2% Et3N) to yield Boc-
hydrazine 5.56 (221.7 mg, 37% yield) as a white solid. 
 
 
Hydrazine 5.33. A 20 mL scintillation vial equipped with a magnetic stir bar was charged with 
Boc-hydrazine 5.56 (221.7 mg, 0.65 mmol, 1.0 equiv) and 4 M HCl in dioxane (4.4 mL, 0.15 
M). After stirring at 23 °C for 16 h, the volatiles were removed under reduced pressure. The 
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resulting crude residue was transferred to a filter paper, washed with EtOAc (5 mL), and dried 
under reduced pressure to yield hydrazine 5.33 (140.4 mg, 99% yield) as a light brown solid. 
Hydrazine 5.33: mp: 178–180 ºC; Rf 0.07 (EtOAc); 1H NMR (500 MHz, DMSO-d6): δ 8.81 (br. 
s, 1H), 8.52 (dd, J = 6.5, 0.7, 1H), 8.42 (d, J = 0.7, 1H), 7.59 (d, J = 6.5, 1H), 4.14 (s, 3H); 13C 
NMR (125 MHz, DMSO-d6): 158.9, 136.7, 134.2, 124.1, 108.3, 58.1; IR (film): 3382, 3206, 
2851, 2051, 1505 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C6H10N3O+, 140.0818; found 
140.0817. 
 
 
Representative Procedure E for the synthesis of hydrazine substrates from Table 5.2. (5.35 
is used as an example). Boc-Hydrazine 5.58. A 20 mL scintillation vial was charged with a 
magnetic stir bar, flame-dried under reduced pressure, and allowed to cool under a N2 
atmosphere. Boronate ester 5.57 (300.0 mg, 1.28 mmol, 1.0 equiv), di-tert-butyl 
azodicarboxylate (5.55) (326.0 mg, 1.40 mmol, 1.1 equiv), Cu(OAc)2 (23.2 mg, 0.13 mmol, 0.10 
equiv), and MeOH (5.1 mL, 0.25 M) were added under an atmosphere of air. The vial was 
capped with a Teflon-lined screw cap, placed in a pre-heated aluminum block, and then allowed 
to stir at 50 °C for 3 h. After cooling to room temperature, the volatiles were removed under 
reduced pressure. The reaction mixture was then transferred to a separatory funnel with 
deionized water (5 mL) and CH2Cl2 (5 mL). The layers were separated and the aqueous layer 
was extracted with CH2Cl2 (3 x 5 mL). The organic layers were combined, washed with 
saturated aqueous NaCl (15 mL), and then dried over Na2SO4. The volatiles were removed under 
reduced pressure. The resulting crude residue was purified by flash chromatography (1:10 
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Hexanes: EtOAc, 2% Et3N) to yield Boc-hydrazine 5.58 (316.3 mg, 73% yield) as a colorless 
foam. 
 
 
Hydrazine 5.35. A 20 mL scintillation vial equipped with a magnetic stir bar was charged with 
Boc-hydrazine 5.58 (131.8 mg, 0.39 mmol, 1.0 equiv) and 4 M HCl in dioxane (2.6 mL, 0.15 
M). The vial was then capped with a Teflon-lined screw cap and was placed in a pre-heated 
aluminum block at 60 °C for 6 h. Once at room temperature, the volatiles were removed under 
reduced pressure. The resulting crude residue was transferred to a filter paper, washed with 
EtOAc (5 mL), and dried under reduced pressure to yield hydrazine 5.35 (53.7 mg, 79% yield) as 
a yellow solid. Hydrazine 5.35: mp: 225–228 ºC; Rf 0.00 (EtOAc); 1H NMR (500 MHz, DMSO-
d6): δ 9.70 (br. s, 1H), 8.19 (d, J = 6.6, 1H), 8.08 (s, 1H), 7.21 (d, J = 6.6, 1H), 3.94 (s, 3H); 13C 
NMR (125 MHz, DMSO-d6): 149.1, 141.9, 135.7, 120.0, 104.0, 57.2; IR (film): 3366, 3215, 
2834, 1631, 1536 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C6H10N3O+, 140.0818; found 
140.0816. 
 
 
Hydrazine 5.12. Following representative procedure A yielded hydrazine 5.12 (2.42 g, 86% 
yield) as a light brown solid. Hydrazine 5.12: mp: 175–178 ºC; Rf 0.27 (EtOAc); 1H NMR (500 
MHz, DMSO-d6): δ 10.45 (br. s, 4H), 7.99 (d, J = 2.8, 1H), 7.65 (dd, J = 9.1, 2.8, 1H), 6.90 (d, J 
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= 9.1, 1H), 3.83 (s, 3H); 13C NMR (125 MHz, DMSO-d6): 158.8, 136.7, 132.4, 130.3, 110.7, 
54.0; IR (film): 3368, 3201, 2564, 1627, 1562 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for 
C6H10N3O+, 140.0818; found 140.0815. 
 
 
Hydrazine 5.29. Following representative procedure A yielded hydrazine 5.29 (280.7 mg, 81% 
yield) as an orange solid. Hydrazine 5.29: mp: 211–213 ºC; Rf 0.37 (EtOAc); 1H NMR (500 
MHz, DMSO-d6): δ 10.43 (br. s, 3H), 8.69 (br. s, 1H), 8.08 (d, J = 3.0, 1H), 7.56 (d, J = 8.5, 1H), 
7.35 (dd, J = 8.5, 3.0, 1H); 13C NMR (125 MHz, DMSO-d6): 142.1, 136.9, 132.0, 127.7, 125.4; 
IR (film): 3070, 2883, 2645, 1927, 1619 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for 
C5H7N3Br+, 187.9818; found 187.9814. 
 
 
Hydrazine 5.31. Following representative procedure A yielded hydrazine 5.31 (215.3 mg, 77% 
yield) as a light brown solid. Hydrazine 5.31: mp: 208–209 ºC; Rf 0.37 (EtOAc); 1H NMR (500 
MHz, DMSO-d6): δ 10.45 (br. s, 3H), 8.72 (br. s, 1H), 8.10–8.09 (m, 1H), 7.47–7.43 (m, 2H); 
13C NMR (125 MHz, DMSO-d6): 141.9, 141.6, 136.1, 125.5, 124.0; IR (film): 3378, 3197, 2662, 
1617, 1470 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C5H7N3Cl+, 144.0323; found 144.0320. 
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Boc-Hydrazine 5.63. Following representative procedure E. Purification by flash 
chromatography (5:1 Hexanes:EtOAc) yielded Boc-hydrazine 5.63 (560.0 mg, 66% yield) as a 
light yellow solid. 
 
 
Hydrazine 5.43. Following representative procedure E yielded hydrazine 5.43 (280.1 mg, 82% 
yield) as a yellow solid. Hydrazine 5.43: mp: 125–128 ºC; Rf 0.33 (EtOAc); 1H NMR (500 MHz, 
DMSO-d6): δ 10.11 (br. s, 3H), 9.90 (br. s, 1H), 7.89 (d, J = 2.5, 1H), 7.47 (app. dt, J = 8.8, 2.5, 
1H), 7.38 (d, J = 7.3, 2H), 7.33 (t, J = 7.3, 2H), 7.27 (t, J = 7.3, 1H), 6.84 (d, J = 8.8, 1H), 5.26 
(s, 2H); 13C NMR (125 MHz, DMSO-d6): 158.8, 137.4, 136.5, 133.8, 129.2, 128.4, 127.8, 127.7, 
110.8, 67.0; IR (film): 3389, 2894, 2646, 1946, 1556 cm–1; HRMS-APCI (m/z) [M + H]+ calcd 
for C12H14N3O+, 216.1131; found 216.1128. 
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Representative Procedure (azaindoline 5.15 is used as an example). Azaindoline 5.15. A 
scintillation vial containing a magnetic stir bar was charged with lactol 5.14 (23.6 mg, 0.231 
mmol, 1.0 equiv) and deionized H2O (4.6 mL, 0.05 M). Hydrazine 5.12 (60.9 mg, 0.347 mmol, 
1.5 equiv) was added and the vial was capped with a Teflon-lined screw cap. The reaction 
mixture was then placed in a pre-heated aluminum block and allowed to stir at 100 °C for 1 h. 
After cooling to room temperature, the reaction mixture was transferred to a separatory funnel 
with deionized H2O (3 mL) and EtOAc (3 mL). The reaction mixture was then basified to a pH 
of 12 by the addition of 40% w/w KOH in deionized H2O (ca. 4 mL). The layers were separated 
and the aqueous layer was extracted with EtOAc (3 x 5 mL). The combined organic layers were 
washed with saturated aqueous NaCl (5 mL), and then dried over Na2SO4. The volatiles were 
removed under reduced pressure, and the crude residue was purified by preparative thin-layer 
chromatography (2:1 Hexanes:EtOAc) to yield azaindoline 5.15 (97% yield, average of two 
experiments) as a yellow oil. Azaindoline 5.15: Rf 0.55 (1:1 Hexanes:EtOAc); 1H NMR (500 
MHz, CDCl3): δ 6.88 (d, J = 8.4, 1H), 6.43 (d, J = 8.4, 1H), 5.27 (s, 1H), 3.96 (ddd, J = 8.9, 7.6, 
1.7, 1H), 3.87 (s, 3H), 3.53 (ddd, J = 10.9, 8.9, 5.3, 1H), 2.40 (ddd, J = 12.1, 5.3, 1.7, 1H), 2.03 
(ddd, J = 12.1, 10.9, 7.6, 1H), 1.48 (s, 3H); 13C NMR (125 MHz, CDCl3): 159.7, 151.2, 136.8, 
119.7, 107.4, 99.1, 67.6, 54.3, 53.8, 39.6, 22.6; IR (film): 3347, 2961, 2867, 1603, 1471 cm–1; 
HRMS-APCI (m/z) [M + H]+ calcd for C11H15N2O2+, 207.1128; found 207.1124. 
 
 
Azaindoline 5.17. Purification by preparative thin-layer chromatography (2:1 Hexanes:EtOAc) 
yielded azaindoline 5.17 (80% yield, average of two experiments) as an amorphous solid. 
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Azaindoline 5.17: Rf 0.63 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.42 (d, J = 7.8, 
2H), 7.32 (t, J = 7.8, 2H), 7.26–7.21 (m, 1H), 6.94 (d, J = 8.6, 1H), 6.47 (d, J = 8.6, 1H), 5.69 (s, 
1H), 4.39 (s, 1H), 4.18–4.15 (m, 1H), 3.85 (s, 3H), 3.67–3.62 (m, 1H), 2.85–2.82 (m, 1H), 2.65–
2.59 (m, 1H); 13C NMR (125 MHz, CDCl3): 159.8, 149.1, 142.6, 137.6, 128.6, 126.9, 126.5, 
120.5, 108.4, 99.7, 68.6, 62.4, 53.8, 39.7; IR (film): 3341, 2866, 2973, 1602, 1470 cm–1; HRMS-
APCI (m/z) [M + H]+ calcd for C16H17N2O2+, 269.1285; found 269.1269. 
 
 
Azaindoline 5.19. Purification by preparative thin-layer chromatography (3:2 Hexanes:EtOAc) 
yielded azaindoline 5.19 (74% yield, average of two experiments) as a red oil. Azaindoline 5.19: 
Rf 0.62 (1:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3): δ 6.88–6.86 (m, 1H), 6.45–6.42 (m, 
1H), 5.75–5.65 (m, 1H), 5.39 (s, 1H), 5.10–5.06 (m, 1H), 5.03–4.99 (m, 1H), 3.98–3.93 (m, 1H), 
3.87 (s, 3H),  3.53 (ddd, J = 11.2, 8.8, 5.3, 1H), 2.75–2.69 (m, 1H), 2.52–2.47 (m, 1H), 2.34–
2.29 (m, 1H), 2.09 (app. ddd, J = 11.2, 11.2, 7.4, 1H); 13C NMR (100 MHz, CDCl3): 159.8, 
149.9, 137.7, 134.4, 119.9, 118.0, 107.8, 96.8, 67.3, 58.1, 53.9, 40.9, 37.9; IR (film): 3343, 2973, 
2947, 1603, 1471 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C13H17N2O2+, 233.1285; found 
233.1279. 
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Azaindoline 5.21. Purification by preparative thin-layer chromatography (3:2 Hexanes:EtOAc) 
yielded azaindoline 5.21 (62% yield, average of two experiments) as an amorphous solid. 
Azaindoline 5.21: Rf 0.59 (1:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3): δ 6.93 (d, J = 8.1, 
1H), 6.41 (d, J = 8.1, 1H), 4.74 (s, 1H), 4.04 (br. s, 1H), 3.87 (s, 3H), 3.75 (dddd, J = 11.2, 4.0, 
4.0, 1.6, 1H), 3.40 (ddd, J = 11.2, 10.0, 3.0, 1H), 2.45 (dddd, J = 13.3, 4.0, 4.0, 1.6, 1H), 1.62 
(ddd, J = 13.6, 11.8, 4.7, 1H), 1.55–1.47 (m, 1H), 1.47–1.36 (m, 1H), 1.17 (s, 3H); 13C NMR 
(100 MHz, CDCl3): 159.7, 153.0, 136.4, 120.5, 106.2, 94.9, 63.0, 54.0, 44.2, 29.2, 24.7, 22.2; IR 
(film): 3319, 2950, 2851, 1603, 1464 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C12H17N2O2+, 
221.1285; found 221.1278. 
 
 
Azaindoline 5.23. Purification by preparative thin-layer chromatography (2:1 Hexanes:EtOAc) 
yielded azaindoline 5.23 (94% yield, average of two experiments) as a colorless oil. Azaindoline 
5.23: Rf 0.77 (1:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3): δ 7.74 (d, J = 8.3, 2H), 7.32 
(d, J = 8.3, 2H), 6.90 (d, J = 8.4, 1H), 6.44 (d, J = 8.4, 1H), 4.98 (s, 1H), 3.84 (s, 3H), 3.39 (ddd, 
J = 10.5, 8.2, 2.3, 1H), 3.10 (ddd, J = 10.5, 10.5, 6.4, 1H), 2.44 (s, 3H), 2.41 (ddd, J = 12.5, 6.4, 
2.3, 1H), 1.70 (ddd, J = 12.5, 10.5, 8.2, 1H), 1.27 (s, 3H); 13C NMR (100 MHz, CDCl3): 159.9, 
150.2, 143.8, 136.3, 136.0, 129.9, 127.2, 120.9, 107.9, 84.1, 54.6, 53.9, 47.7, 36.1, 22.4, 21.7; IR 
(film): 3375, 2963, 2867, 1597, 1470 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for 
C18H22N3O3S+, 360.1376; found 360.1363. 
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Azaindoline 5.25. Purification by preparative thin-layer chromatography (2:1 Hexanes:EtOAc) 
yielded azaindoline 5.25 (58% yield, average of two experiments) as a colorless oil. Azaindoline 
5.25: Rf 0.70 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.74 (d, J = 7.8, 2H), 7.32 
(d, J = 7.8, 2H), 6.89 (d, J = 8.4, 1H), 6.45 (d, J = 8.4, 1H), 5.54 (dddd, J = 17.4, 10.0, 7.4, 7.4, 
1H), 5.11 (s, 1H), 4.98–4.93 (m, 2H), 4.52 (br. s, 1H), 3.84 (s, 3H), 3.38 (ddd, J = 10.3, 8.3, 2.3, 
1H), 3.10 (ddd, J = 10.3, 10.3, 6.2, 1H), 2.44 (s, 3H), 2.41–2.38 (m, 1H), 2.32–2.27 (m, 2H), 
1.78 (ddd, J = 12.2, 10.2, 8.3, 1H); 13C NMR (125 MHz, CDCl3): 159.8, 149.0, 143.8, 137.0, 
136.0, 133.5, 129.9, 127.3, 120.8, 118.5, 108.2, 81.6, 58.2, 53.9, 47.5, 40.5, 34.2, 21.7; IR (film): 
3376, 3072, 2950, 1598, 1471 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C20H24N3O3S+, 
386.1533; found 386.1511.  
 
 
Azaindoline 5.27. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded azaindoline 5.27 (82% yield, average of two experiments) as an amorphous solid. 
Azaindoline 5.27: Rf 0.46 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3, 58 °C): δ 6.85 (d, 
J = 8.3, 1H), 6.43 (d, J = 8.3, 1H), 5.10 (br. s, 1H), 3.88 (s, 3H), 3.72–3.64 (m, 4H), 3.09–3.04 
(m, 1H), 2.53–2.49 (m, 1H), 2.02–1.95 (m, 1H), 1.42 (s, 3H); 13C NMR (125 MHz, C6D6, Major 
rotational isomer): 160.0, 155.4, 150.2, 137.0, 120.7, 109.0, 82.1, 53.4, 53.2, 51.9, 45.9, 35.4, 
22.2; 13C NMR (125 MHz, C6D6, Minor rotational isomer, 11 of 13 peaks seen): 160.2, 154.4, 
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150.3, 136.6, 120.6, 109.1, 81.4, 54.6, 52.1, 46.4, 22.7; IR (film): 3360, 2956, 2869, 1696, 1605 
cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C13H18N3O3+, 264.1343; found 264.1330. 
 
 
Azaindoline 5.30. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded azaindoline 5.30 (62% yield, average of two experiments) as a light brown solid. 
Azaindoline 5.30: mp: 170–171 ºC; Rf 0.50 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): 
δ 7.08 (d, J = 8.3, 1H), 6.89 (d, J = 8.3, 1H), 5.29 (s, 1H), 4.64 (br. s, 1H), 3.98 (ddd, J = 8.9, 
7.6, 1.6, 1H), 3.52 (dddd, J = 11.3, 8.9, 5.3, 1H), 2.43 (ddd, J = 12.3, 5.3, 1.6, 1H), 2.05 (ddd, J = 
12.3, 11.3, 7.6, 1H), 1.50 (s, 3H); 13C NMR (125 MHz, CDCl3): 156.1, 142.2, 129.8, 126.2, 
116.7, 98.5, 67.7, 54.2, 39.9, 22.8; IR (film): 3328, 2963, 2866, 1595, 1426 cm–1; HRMS-APCI 
(m/z) [M + H]+ calcd for C10H12N2OBr+, 255.0128; found 255.0128. 
 
 
Azaindoline 5.32. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded azaindoline 5.32 (72% yield, average of two experiments) as a brown solid. Azaindoline 
5.32: mp: 143–145 ºC; Rf 0.50 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 6.95 (d, J = 
8.3, 1H), 6.77 (d, J = 8.3, 1H), 5.31 (s, 1H), 4.62 (br. s, 1H), 3.99 (ddd, J = 8.9, 7.6, 1.6, 1H), 
3.53 (ddd, J = 11.3, 8.9, 5.3, 1H), 2.43 (ddd, J = 12.3, 5.3, 1.6, 1H), 2.06 (ddd, J = 12.3, 11.3, 
7.6, 1H), 1.51 (s, 3H); 13C NMR (125 MHz, CDCl3): 155.3, 141.8, 140.5, 122.5, 116.7, 98.6, 
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67.7, 54.2, 39.9, 22.8; IR (film): 3319, 2965, 2867, 1596, 1430 cm–1; HRMS-APCI (m/z) [M + 
H]+ calcd for C10H12N2OCl+, 211.0633; found 211.0633. 
 
 
Azaindoline 5.34. Purification by preparative thin-layer chromatography (EtOAc) yielded 
azaindoline 5.34 (48% yield, average of two experiments) as an amorphous solid. Azaindoline 
5.34: Rf 0.26 (EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.94 (d, J = 5.3, 1H), 6.61 (d, J = 5.3, 
1H), 5.33 (s, 1H), 4.51 (br. s, 1 H), 3.99 (ddd, J = 8.8, 7.6, 1.5, 1H), 3.88 (s, 3H), 3.54 (ddd, J = 
11.2, 8.8, 5.5, 1H), 2.45 (ddd, J = 12.2, 5.5, 1.5, 1H), 2.08 (ddd, J = 12.2, 11.2, 7.6, 1H), 1.53 (s, 
3H); 13C NMR (125 MHz, CDCl3): 154.2, 149.8, 141.9, 132.3, 105.7, 98.8, 67.9, 55.5, 54.9, 
39.8, 22.8; IR (film): 3308, 2926, 2867, 1614, 1498 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for 
C11H15N2O2+, 207.1128; found 207.1121.  
 
 
Azaindoline 5.38. Purification by preparative thin-layer chromatography (2:1 Hexanes:EtOAc) 
yielded azaindoline 5.38 (70% yield, average of two experiments) as a colorless solid. 
Azaindoline 5.38: mp: 143–145 ºC; Rf 0.51 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): 
δ 7.64 (d, J = 5.1, 1H), 6.70 (d, J = 5.1, 1H), 5.34 (s, 1H), 4.48 (br. s, 1H), 3.99–3.95 (m, 4H), 
3.54 (ddd, J = 11.2, 8.7, 5.1, 1H), 2.16 (ddd, J = 12.3, 5.1, 1.6, 1H), 2.07 (ddd, J = 12.3, 11.2, 
7.3, 1H), 1.47 (s, 3H); 13C NMR (125 MHz, CDCl3): 150.0, 142.3, 137.1, 132.9, 112.3, 99.9, 
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67.6, 55.1, 53.2, 40.8, 23.9; IR (film): 3328, 2956, 2867, 1611, 1471 cm–1; HRMS-APCI (m/z) 
[M + H]+ calcd for C11H15N2O2+, 207.1128; found 207.1126. 
 
 
Azaindoline 5.40. Purification by preparative thin-layer chromatography (1:1 Hexanes:EtOAc) 
yielded azaindoline 5.40 (53% yield, average of two experiments) as a yellow solid. Azaindoline 
5.40: mp: 87–90 ºC; Rf 0.13 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.56 (d, J = 
2.7, 1H), 6.95 (d, J = 2.7, 1H), 5.31 (s, 1H), 5.11 (br. s, 1H), 3.97 (ddd, J = 8.8, 7.0, 1.6, 1H), 
3.78 (s, 3H), 3.58 (ddd, J = 10.9, 8.8, 5.4, 1H), 2.13–2.03 (m, 2H), 1.47 (s, 3H); 13C NMR (125 
MHz, CDCl3): 156.7, 150.5, 130.9, 128.8, 120.6, 98.0, 67.2, 56.8, 52.6, 41.5, 24.7; IR (film): 
3206, 2956, 2866, 1627, 1480 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C11H15N2O2+, 
207.1128; found 207.1121. 
 
 
Azaindoline 5.42. Purification by preparative thin-layer chromatography (98:2 EtOAc:Et3N) 
yielded azaindoline 5.42 (11% yield, average of two experiments) as an amorphous solid. 
Azaindoline 5.42: Rf 0.44 (EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.95 (dd, J = 5.1, 1.4, 1H), 
6.93 (dd, J = 7.9, 5.1, 1H), 6.79 (dd, J = 7.9, 1.4, 1H), 5.31 (s, 1H), 4.59 (br. s, 1H), 3.99 (ddd, J 
= 8.9, 7.6, 1.6, 1H), 3.53 (ddd, J = 11.2, 8.9, 5.3, 1H), 2.43 (ddd, J = 12.2, 5.3, 1.6, 1H), 2.09 
(ddd, J = 12.2, 11.2, 7.6, 1H), 1.52 (s, 3H); 13C NMR (125 MHz, CDCl3): 155.0, 142.7, 140.1, 
N
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122.5, 113.9, 98.3, 67.7, 54.0, 40.1, 22.9; IR (film): 3330, 2961, 2867, 1602, 1436 cm–1; HRMS-
APCI (m/z) [M + H]+ calcd for C10H13N2O+, 177.1022; found 177.1009. 
 
 
Azaindoline 5.44. A round-bottom flask containing a magnetic stir bar was charged with lactol 
5.14 (37.2 mg, 0.364 mmol, 1.0 equiv) and 4% aqueous H2SO4 (7.3 mL, 0.05 M). Hydrazine 
5.43 (274.3 mg, 1.092 mmol, 3.0 equiv) was added and the flask equipped with an air condenser. 
The reaction mixture was then placed in a pre-heated oil bath and allowed to stir at 60 °C for 1 h. 
After cooling to room temperature, the reaction mixture was transferred to a separatory funnel 
with deionized H2O (5 mL) and EtOAc (5 mL). The reaction mixture was then basified to a pH 
of 9 with saturated aqueous NaHCO3 (ca. 10 mL). The layers were separated and the aqueous 
layer was extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with 
saturated aqueous NaCl (10 mL), and then dried over Na2SO4. The volatiles were removed under 
reduced pressure, and the crude residue was purified by flash chromatography (2:1 
Hexanes:EtOAc) to yield azaindoline 5.44 (83.2 mg, 81% yield) as a yellow oil. Azaindoline 
5.44: Rf 0.54 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 7.46 (d, J = 7.2, 2H), 7.35 (t, 
J = 7.2, 2H), 7.30–7.28 (m, 1H), 6.87 (d, J = 8.5, 1H), 6.48 (d, J = 8.5, 1H), 5.31 (s, 1H), 5.30 (s, 
1H), 5.27 (s, 1H), 4.25 (br. s, 1H), 3.97 (ddd, J = 9.1, 7.7, 1.7, 1H), 3.53 (ddd, J = 11.1, 9.1, 5.1. 
1H), 2.39 (ddd, J = 12.1, 5.1, 1.7, 1H), 2.04 (ddd, J = 12.1, 11.1 7.7, 1H), 1.48 (s, 3H); 13C NMR 
(125 MHz, CDCl3): 159.1, 151.0, 138.1, 137.1, 128.5, 128.3, 127.8, 119.9, 108.6, 99.2, 68.1, 
67.7, 54.5, 39.7, 22.8; IR (film): 3348, 2963, 2930, 1603, 1447 cm–1; HRMS-APCI (m/z) [M + 
H]+ calcd for C17H19N2O2+, 283.1441; found 283.1434. 
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Azaindoline 5.64. A 1-dram vial was charged with a magnetic stir bar, flame-dried under 
reduced pressure, and allowed to cool under a N2 atmosphere. Azaindoline 5.44 (83.0 mg, 0.294 
mmol, 1.0 equiv) was added and the vial was flushed with N2 for 5 min. DMF (294 µL, 1.0 M) 
was added and the reaction mixture cooled to 0 °C under an N2 atmosphere. NaH (60% 
dispersion in mineral oil, 26.0 mg, 0.647 mmol, 2.2 equiv) was added in one portion and the 
reaction was left to stir for 30 min at 0 °C. MeI (44 µL, 0.706 mmol, 2.4 equiv) was then added 
dropwise over 1 min. After 30 min stirring at 0 °C, the reaction mixture was warmed to 23 °C 
and allowed to stir for 4 h. The reaction mixture was then transferred to a separatory funnel with 
deionized H2O (3 mL) and CH2Cl2 (3 mL). The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were washed sequentially with 
deionized H2O (3 x 3 mL) and saturated aqueous NaCl (10 mL), and then dried over Na2SO4. 
The volatiles were removed under reduced pressure, and the crude residue was purified by flash 
chromatography (3:1 Hexanes:EtOAc) to yield azaindoline 5.64 (61.0 mg, 77% yield) as a 
colorless oil. Azaindoline 5.64: Rf 0.46 (3:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 
7.46 (d, J = 7.5, 2H), 7.35 (t, J = 7.5, 2H), 7.30–7.27 (m, 1H), 6.64 (d, J = 8.3, 1H), 6.50 (d, J = 
8.3, 1H), 5.32–5.27 (m, 2H), 5.04 (s, 1H), 3.96 (ddd, J = 9.0, 7.6, 1.6, 1H), 3.43 (ddd, J = 11.2, 
9.0, 5.6, 1H), 2.88 (s, 3H), 2.36 (ddd, J = 12.2, 5.6, 1.6, 1H), 2.02 (ddd, J = 12.2, 11.2, 7.6, 1H), 
1.47 (s, 3H); 13C NMR (125 MHz, CDCl3): 157.9, 151.5, 139.7, 138.2, 128.4, 128.3, 127.7, 
115.8, 108.0, 104.3, 68.2, 67.7, 53.4, 39.7, 32.0, 22.7; IR (film): 2930, 2864, 1595, 1457, 1421 
cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C18H21N2O2+, 297.1598; found 297.1596. 
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Hydroxyazaindoline 5.65. A 1-dram vial was charged with a magnetic stir bar, flame-dried 
under reduced pressure, and allowed to cool under a N2 atmosphere. Azaindoline 5.64 (3.3 mg, 
0.011 mmol, 1.0 equiv) was added and the vial was flushed with N2 for 5 min. CH2Cl2 (222 µL, 
0.05 M) was added and the reaction mixture cooled to –40 °C. BCl3 (1 M in CH2Cl2, 78.0 µL, 
0.078 mmol, 7.0 equiv) was added dropwise over 1 min and the reaction mixture was stirred at –
40 °C. After 5 min, the reaction mixture was warmed to 23 °C and allowed to stir for 4 h. The 
reaction mixture was then transferred to separatory funnel containing ice-cold deionized H2O (5 
mL). The reaction mixture was basified to a pH of 9 with saturated aqueous NaHCO3 (5 mL) and 
then extracted with EtOAc (5 x 3 mL). The combined organic layers were washed with saturated 
aqueous NaCl (10 mL), and subsequently dried over Na2SO4. The volatiles were removed under 
reduced pressure, and the crude residue was purified by preparative thin-layer chromatography 
(EtOAc) to yield hydroxyazaindoline 5.65 (1.9 mg, 87% yield) as a brown solid. 
Hydroxyazaindoline 5.65: mp: 169–170 ºC; Rf 0.36 (EtOAc); 1H NMR (500 MHz, CDCl3): δ 
6.77 (d, J = 8.5, 1H), 6.49 (d, J = 8.5, 1H), 5.01 (s, 1H), 3.97 (ddd, J = 8.8, 7.4, 1.6, 1H), 3.47 
(ddd, J = 11.2, 8.8, 5.2, 1H), 2.88 (s, 3H), 2.44 (ddd, J = 12.2, 5.2, 1.6, 1H), 2.08 (ddd, J = 12.2, 
11.2, 7.4, 1H), 1.53 (s, 3H); 13C NMR (125 MHz, CDCl3): 159.2, 148.9, 138.5, 118.9, 109.2, 
104.5, 67.9, 53.2, 39.5, 32.3, 22.7; IR (film): 2964, 2926, 2669, 1614, 1488 cm–1; HRMS-APCI 
(m/z) [M + H]+ calcd for C11H15N2O2+, 207.1128; found 207.1123. 
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Aza-phensvenine 5.45. A 1-dram vial was charged with a magnetic stir bar, flame-dried under 
reduced pressure, and allowed to cool under a N2 atmosphere. Hydroxyazaindoline 5.65 (5.0 mg, 
0.024 mmol, 1.0 equiv) was added and the vial was flushed with N2 for 5 min. The vial was then 
charged with a stock solution of PhNCO (1.7 uL, 0.022 mmol, 0.92 equiv) in PhH (200 µL, 
0.075 M), and the reaction mixture was allowed to stir at 23 °C under an N2 atmosphere. After 4 
h, the volatiles were removed under reduced pressure to yield aza-phensvenine 5.45 (7.2 mg, 
91% yield) as an amorphous solid. Aza-phensvenine 5.45: Rf 0.40 (1:1 Hexanes:EtOAc); 1H 
NMR (500 MHz, C6D6): δ 7.27 (d, J = 8.0, 2H), 7.05–7.02 (m, 2H), 6.83–6.80 (m, 1H), 6.77 (d, 
J = 8.1, 1H), 6.61 (br. s, 1H), 6.13 (d, J = 8.1, 1H), 4.86 (s, 1H), 3.65 (ddd, J = 8.9, 7.6, 1.6, 1H), 
3.25 (ddd, J = 11.2, 8.9, 5.4, 1H), 2.52 (s, 3H), 2.26 (ddd, J = 12.2, 5.4, 1.6, 1H), 1.67 (ddd, J = 
12.2, 11.2, 7.6, 1H), 1.32 (s, 3H); 13C NMR (125 MHz, C6D6): 154.0, 152.0, 150.6, 143.5, 138.4, 
129.1, 123.7, 119.0, 114.9, 113.0, 103.9, 67.4, 53.2, 40.2, 30.8, 22.7; IR (film): 3281, 2926, 
1746, 1646, 1597 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for C18H20N3O3+, 326.1499; found 
326.1490. 
 
 
Aza-furoindoline 5.47. A 1-dram vial was charged with a magnetic stir bar, flame-dried under 
reduced pressure, and allowed to cool under a N2 atmosphere. Ketolactone 5.46 (10.0 mg, 0.0238 
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mmol, 1.0 equiv) was added and suspended in 1,2-dichloroethane (1.0 mL, 0.020 M). Hydrazine 
5.12 (35.0 mg, 0.119 mmol, 5.0 equiv) and TFA (10.0 µL, 0.119 mmol, 5.0 equiv) were added to 
the reaction vial. The mixture was degassed via the freeze-pump-thaw method using a –78 °C 
dry ice/acetone bath. After warming to 23 °C, the reaction vessel was placed into a pre-heated 80 
°C aluminum heating block and allowed to stir for 12 h. After cooling to room temperature, the 
reaction mixture was filtered over Na2SO4, washed with CH2Cl2 (10 mL), and concentrated 
under reduced pressure. The resultant residue was suspended in 1:1 THF/H2O (1.0 mL, 0.02 M) 
in a 1-dram vial. LiOH (5.0 mg, 0.238 mmol, 10.0 equiv) was added and the reaction vessel was 
placed into a pre-heated 60 °C aluminum heating block. Upon stirring for 2 h at 60 °C, the 
reaction was cooled to 23°C. The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (4 x 2 mL). The organic layers were combined, dried over Na2SO4, and concentrated 
under reduced pressure. The resultant residue was suspended in 1:1 THF/MeOH (1.0 mL, 0.02 
M) in a 1-dram vial. TMSCHN2 (77.0 µL, 0.046 mmol, 2.0 equiv) was added and the resultant 
solution stirred at room temperature. Upon stirring for 1.5 h, the reaction was diluted with 2 mL 
of H2O and the layers were separated. The aqueous layer was extracted with EtOAc (4 x 2 mL). 
The organic layers were combined, dried over Na2SO4, and then concentrated under reduced 
pressure. The crude residue was purified by flash chromatography (9:1 Hexanes:EtOAc  7:3 
Hexanes:EtOAc) to afford aza-furoindoline 5.47 (8.0 mg, 63% yield) as a yellow oil. Aza-
furoindoline 5.47: Rf 0.50 (1:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.07–8.03 (m, 
1H), 7.69–7.61 (m, 3H), 6.88 (d, J = 8.5, 1H), 6.44 (d, J = 8.2, 1H), 5.53 (q, J = 7.0, 1H), 4.38 
(br. s, 1H), 4.04 (d, J = 15.0, 1H), 3.93 (d, J = 15.0, 1H), 3.78 (br. s, 4H), 3.67 (s, 3H), 3.35–3.28 
(m, 1H), 3.21 (q, J = 3.8, 1H), 3.08–3.00 (m, 1H), 2.90 (d, J = 4.8, 1H), 2.47 (dd, J = 13.6, 5.6, 
1H), 2.06 (dt, J = 13.5, 3.7, 1H), 1.96 (dt, J = 13.3, 2.6, 1H), 1.52 (dd, J = 6.9, 1.8, 3H); 13C 
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NMR (125 MHz, CDCl3): 171.8, 159.8, 151.2, 148.1, 134.4, 134.0, 133.1, 131.5, 131.1, 129.5, 
125.0, 124.4, 120.4, 108.9, 100.8, 68.5, 54.5, 54.2, 53.4, 52.0, 51.7, 48.5, 34.4, 31.2, 30.1, 12.7; 
IR (film): 3360, 2950, 2872, 1742, 1163 cm–1; HRMS-APCI (m/z) [M + H]+ calcd for 
C26H29N4O8S+, 557.1701; found 557.1691; [α]25.9D –165.33° (c = 0.1, CH2Cl2). 
 
 
(–)-10-Methoxy-9-aza-aspidophylline A (5.48). To a 1-dram vial, a suspension of aza-
furoindoline 5.47 (10.0 mg, 0.017 mmol, 1.0 equiv) and Cs2CO3 (18.0 mg, 0.0539 mmol, 3.2 
equiv) in MeCN (1.0 mL, 0.02 M) was added MetSThiol® (58.0 mg, 0.0718 mmol, 4.2 equiv). 
The reaction vessel was placed in an aluminum block and heated to 65 °C. After stirring for 12 h, 
the reaction was cooled to 23 °C and filtered through a plug of celite (100 mg) and washed with 
10 mL of MeCN. The filtrate was concentrated under reduced pressure to afford the 
corresponding secondary amine, which was used subsequently without further purification. 
 In a 20 mL scintillation vial, HCOOH (9.6 µL, 0.255 mmol, 15.0 equiv) was added to a 
solution of DMAP (44 mg, 0.358 mmol, 20.0 equiv) and EDAC•HCl (34 mg, 0.179 mmol, 10.0 
equiv) in CH2Cl2 (3.8 mL, 0.005 M) at 0 °C. This mixture was stirred at 0 °C for 15 min, at 
which point a 400 µL aliquot of this stock solution was added to the crude denosylated product 
in a 1-dram vial equipped with a magnetic stir bar. The reaction mixture was cooled to 0 °C and 
stirred for 1.5 h. The reaction mixture was then quenched with saturated aqueous NaHCO3 (2 
mL). The layers were separated and the aqueous layer was extracted with CH2Cl2 (4 x 2 mL). 
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The organic layers were combined, dried over Na2SO4, and concentrated under reduced pressure. 
The crude mixture was purified via flash chromatography (1:1 Hexanes:EtOAc  1:9 
Hexanes:EtOAc) to afford (–)-10-methoxy-9-aza-aspidophylline A (5.48) as a colorless oil (3.0 
mg, 42% yield). (–)-10-methoxy-9-aza-aspidophylline A (5.48) was observed as a 5:1 mixture of 
rotational isomers in CDCl3. (–)-10-methoxy-9-aza-aspidophylline A (5.48) (Major rotational 
isomer): Rf 0.27 (1:9 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3): δ 8.12 (s, 1H), 6.95 (d, J = 
8.5, 1H), 6.49 (d, J = 8.5, 1H), 5.62 (q, J = 6.8, 1H), 4.38 (d, J = 18.0, 1H), 4.01–3.96 (m, 2H), 
3.85 (t, J = 3.0, 1H), 3.80 (s, 3H), 3.70 (d, J = 3.2, 1H), 3.69 (s, 3H), 3.55–3.47 (m, 1H), 3.31 (q, 
J = 4.1, 1H), 2.95–2.86 (m, 1H), 2.82 (d, J = 4.8, 1H),  2.67 (dd, J = 13.6, 5.6, 1H), 2.10 (dt, J = 
13.3, 2.7, 1H), 2.00 (dt, J = 13.5, 3.8, 1H), 1.54 (br. s, 3H); 13C NMR (125 MHz, CDCl3): 171.6, 
164.3, 160.1, 151.6, 134.1, 129.1, 124.3, 121.4, 109.7, 101.2, 69.2, 54.3, 54.2, 53.5, 52.0, 51.8, 
44.6, 33.2, 30.8, 30.4, 12.9; IR (film): 3318, 2927, 2862, 1744, 1421 cm–1; HRMS-APCI (m/z) 
[M + H]+ calcd for C21H26N3O5+, 400.18670; found 400.18560; [α]28.5D –4.00° (c = 0.1, CH2Cl2). 
 
5.8 Computational Section 
5.8.1 Computational Details 
Ab initio calculations were performed with Gaussion 09.20 Geometries were optimized 
and their vibrational frequencies obtained at the MP2/6-31G(d) level of theory, with the SMD 
solvation model for water.21 MP2 energies were corrected using the “spin-component-scaled” 
(SCS) approach, pioneered by Grimme,22 such as E(SCS-MP2) = E(SCF) + 1.2*(αβ) + 
(1/3)*(αα+ββ) where αα, ββ, and αβ are the “alpha-alpha”, “beta-beta” and “alpha-beta” spin 
contributions, respectively, found in the Gaussian output. In the case of closed-shell calculations 
such as those used in the current study, αα and ββ are identical. This SCS- MP2 correction was 
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found to greatly improve the performance of MP2 calculations, notably for sigmatropic 
rearrangements.23 This SCS-MP2/6-31G(d)/SMD(water)//MP2/6-31G(d)/SMD(water) method 
was also chosen as we have previously shown that it accurately reproduces experimental rates of 
Fischer indolization reactions.24 Normal mode frequency analysis was used to confirm that 
stationary points were either minima (no imaginary frequency) or saddle-points (TS, one (1) 
imaginary frequency) on the potential energy surface. All saddle-points were further analyzed 
with the Intrinsic Reaction Coordinate (IRC) tools to verify that they connected the expected 
minima. ZPE, enthalpy and free energy corrections were obtained using a standard state of 1 
atmosphere of pressure and 298 K. Free energies were computed using Truhlar’s quasiharmonic 
oscillator approximation, setting all frequencies below 100 cm-1 to 100 cm-1.25 The free energies 
reported in this study are thus obtained by adding the quasiharmonic free energy corrections to 
the SCS-MP2 electronic energies. Reported structures are the result of extensive conformation 
sampling on all evaluated compounds. Structures were illustrated using CYLview.26 To obtain 
atomic charges, natural bond orbital (NBO) analysis (pop=nbo keyword in Gaussian 09) was 
performed at the MP2/6-311+G(d,p) level (gas phase) on the MP2/6-31G(d)/SMD(water)-
optimized structures. 
 
5.8.2 Additional Schemes and Discussion 
To study the effects of protonation and substituents on the barriers of the [3,3]-
sigmatropic rearrangement typical of Fischer indolization reactions, we chose a model system 
based on the combination of aryl/pyridyl hydrazines with propanal 5.67. We have previously 
shown that in the case of aryl hydrazines, the [3,3]-sigmatropic rearrangement is the rate-limiting 
step of the reaction and occurs with the substrates being monoprotonated.24 
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Scheme 5.1 Thermal (unprotonated) Fischer indolization reaction of model system. 
 
In the thermal Fischer indolization reaction (Scheme 5.1), hydrazone 5.68 (formed from 
the condensation of aryl hydrazine 5.66 with propanal (5.67) first tautomerizes to ene- hydrazine 
5.69, which can then undergo a [3,3]-sigmatropic rearrangement to form diimine 5.70. This 
intermediate then rearomatizes and goes on to form the indole product 5.71. When all 
compounds are neutral, reaching 5.6 from the hydrazone costs 33.4 kcal/mol. This barrier is 
much higher than what is known experimentally for such reactions.24 
In the acid-catalyzed (monoprotonated) reaction (Scheme 5.2), two pathways are 
available to the substrates. The hydrazone with its α nitrogen protonated, 5.72, is the global 
minimum of the system, but 5.7 has the smallest barrier for the rearrangement. In this case, the 
activation free energy of the reaction is then 23.8 kcal/mol, which is in agreement with 
experimental rates.24 
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Scheme 5.2 Acid-catalyzed (monoprotonated) Fischer indolization reaction of model system. 
 
Therefore, all other systems that we studied were singly protonated. For all pyridyl 
hydrazines, three different nitrogen atoms can be protonated on any intermediate or transition 
state. Moreover, in most cases the [3,3]-sigmatropic rearrangement can occur on two different 
carbons, meaning two transition states and two diimine products are possible for each 
protonation state. The full pathway for the parent pyridyl hydrazine is presented below in 
Scheme 5.3.  
The free energy for the pathway of α-methylpyridine hydrazone is found in Scheme 5.4. 
Once again, the hydrazone protonated at the pyridine nitrogen is the global minimum of the 
system, and because of the increased basicity of the methyl-substituted ene-hydrazine α nitrogen, 
the best transition state goes through with protonation of the α-nitrogen.  
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Scheme 5.3 Reaction pathway for protonated 3-pyridylhydrazine. Free energies in kcal/mol. 
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Scheme 5.4 Reaction pathway for 3-(1-methylhydrazinyl)pyridine. Free energies in kcal/mol. 
 
Relative free energies for all other computed systems can be found in Table 5.3. In all 
cases the global minimum is the hydrazone protonated at the pyridine nitrogen. Moreover, in all 
but one case, the most favored transition state goes through protonation at the β-nitrogen of the 
hydrazone. 
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Table 5.3 Relative free energies (kcal/mol) for each intermediate or transition state on the 
potential energy pathways of different monoprotonated pyridyl hydrazones formed by pyridyl 
hydrazines and propanal. 
 
 
 
 
 
 
N
N
H
NH2
N
N
H
NH2
MeO N
N
H
NH2
Cl N
N
H
NH2
Br N
N
H
NH2
OMe
N
N
H
NH2
OMe
N
N
H
NH2
OMe
N N
H
NH2
MeO
N
H2
N
Me
NR
N
H
NH
Me
NR
H
N
N
H
N
Me
R
N
H2
N
Me
NR
N
H
NH
Me
NR
H
N
N
H
NH
Me
R
N
H2
NH
Me
NR
N
NH
NH2
Me
R
N
H
NH2
Me
NR
cmpd # ΔG cmpd # ΔG cmpd # ΔG cmpd # ΔG cmpd # ΔG cmpd # ΔG cmpd # ΔG cmpd # ΔG
5.79
5.80
5.10
5.81
5.11
5.82
5.83
5.84
5.8
5.106
5.107
5.108
5.109
5.110
5.111
5.112
5.113
5.9
5.123
5.124
5.125
5.126
5.127
5.128
5.129
5.130
5.131
5.141
5.142
5.143
5.144
5.145
5.146
5.147
5.148
5.149
5.159
5.160
5.161
5.162
5.163
5.164
5.165
–
5.166
5.171
5.172
5.173
5.174
5.175
5.176
5.177
–
5.178
5.183
5.184
5.185
5.186
5.187
5.188
5.189
–
5.190
5.195
5.196
5.197
5.198
5.199
5.200
5.201
–
5.202
12.0
11.4
0.0
22.6
21.8
13.9
36.0
37.1
35.3
6.5
5.7
0.0
16.5
14.9
13.9
27.8
32.4
26.3
4.8
2.9
0.0
15.4
12.5
14.3
28.6
30.5
27.6
4.5
2.1
0.0
14.8
12.1
14.2
27.9
29.7
26.8
13.0
12.0
0.0
23.1
20.1
14.6
35.5
34.5
4.2
3.4
0.0
15.8
11.5
12.8
25.6
34.5
17.4
15.4
0.0
28.2
23.7
15.3
42.0
40.3
10.2
8.6
0.0
21.8
18.8
13.3
35.2
32.2
– – – –
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Table 5.3 Continued 
 
 
5.8.3 Origin of Regioselectivity 
Fischer indolization reactions with aza-substituted substrates are regioselective. The 
calculations support these results. In the case of the 2-methoxy-5-hydrazinylpyridine, the [3,3]-
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sigmatropic rearrangement at the 6-position is favored by 4.9 kcal/mol over the rearrangement at 
the 4-position of the pyridine ring.  
The [3,3]-sigmatropic rearrangements are, for all but one aza-substituted system, favored 
by protonation at the β nitrogen. In the only case where the α-protonated TS is favored, it is only 
0.2 kcal/mol lower than the β-protonated TS. We propose the following explanation for the 
regioselectivity (Scheme 5.5). In the transition state, N–N bond cleavage creates two “pieces” of 
the substrate: a neutral enamine piece and a cationic aromatic ring. This ring is attacked at either 
the carbon alpha or gamma from the pyridine nitrogen.  
 
Scheme 5.5 [3,3]-sigmatropic rearrangement with protonated β-nitrogen of ene-hydrazine.  
 
The preference for attack at either position can be predicted from the extent of positive 
charge on these carbons, before or at the transition state. Using NBO analysis, the charge at these 
carbons for the aza-substituted substrate and those with a substituent at the 2-position were 
calculated. The same charges for the two transition states leading to regioisomeric products were 
also calculated. These data are listed below in Table 5.4. 
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Table 5.4 Relative free energies (kcal/mol, from their respective global minima) and NBO 
charges of the β-protonated ene-hydrazine and transition states, for the various 2- substituted 5-
pyridylhydrazines. 
 
For the unsubstituted case (entry 1), the positive charge at C6 is much greater than that of 
C4, both in the ene-hydrazine and in the transition states. Even more important is that this 
difference is very similar in both transition states, even though they lead to different products. 
The greater positive charge at C6 is presumably caused by the proximity of the pyridine nitrogen, 
which acts as an electronegative element.  
For the methoxy-substituted substrate (entry 2), the difference between the partial 
positive charge at the C6 and C4 positions is even greater. Thus, the regioselectivity would be 
predicted to be higher, which is what the calculated activation barriers predict. The increased 
difference is attributed to the methoxy substituent at the 2-position. Indeed, this group is located 
at the meta position of both C4 and C6 and provides a strong electron-withdrawing effect. For 
C6, both the pyridine nitrogen and 2-methoxy combine to make attack at this position much 
easier than at C4.  
For the halogenated substrates (entries 3 and 4), the same explanation is true. The 
electronegative substituents make the charge at C6 more positive, in line with these substrates 
being slightly more regioselective than the unsubstituted case. Once again, the extent of positive 
NR
N
H
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Me
2 6
4
NR
N
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Me NR
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NH2Me
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H
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4
3
2
1
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charge do not vary significantly if the TS happens at C4 or C6, and are very similar to that 
observed in the ene-hydrazine intermediate.  
Therefore, for these Fischer indolization reactions with aza-substituted compounds, 
analysis of the charges on the reactant are a good way to determine which will be the most 
favored regiosiomer formed during the [3,3]-sigmatropic rearrangement.  
5.8.4 Cartesian Coordinates for Reactants and Transition States 
Cartesian coordinates for the optimized structures were reported in the literature.27 
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5.9 Spectra Relevant to Chapter Five: 
 
Understanding and Interrupting the Fischer Azaindolization Reaction 
Bryan J. Simmons, Marie Hoffmann, Pier Alexandre Champagne, Elias Picazo, Katsuya 
Yamakawa, Lucas A. Morrill, K. N. Houk, and Neil K. Garg. 
J. Am. Chem. Soc. 2017, 139, 14833–14836. 
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Figure 5.5 1H NMR (500 MHz, DMSO-d6) of compound 5.37. 
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Figure 5.6 13C NMR (125 MHz, DMSO-d6) of compound 5.37. 
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Figure 5.7 1H NMR (500 MHz, DMSO-d6) of compound 5.41. 
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Figure 5.8 13C NMR (125 MHz, DMSO-d6) of compound 5.41. 
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Figure 5.9 1H NMR (500 MHz, DMSO-d6) of compound 5.39. 
Figure 5.10 13C NMR (125 MHz, DMSO-d6) of compound 5.39 
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Figure 5.11 1H NMR (500 MHz, DMSO-d6) of compound 5.33. 
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Figure 5.12 13C NMR (125 MHz, DMSO-d6) of compound 5.33. 
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Figure 5.13 1H NMR (500 MHz, DMSO-d6) of compound 5.35. 
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Figure 5.14 13C NMR (125 MHz, DMSO-d6) of compound 5.35. 
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D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7578360 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.15 1H NMR (500 MHz, DMSO-d6) of compound 5.12. 
N
N
H
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MeO
Figure 5.16 13C NMR (125 MHz, DMSO-d6) of compound 5.12. 
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Current Data Parameters
NAME     BJS-4-130-SALT
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170314
Time              17.48
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT            DMSO
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                203.2
DW               50.000 usec
DE                 6.00 usec
TE                296.9 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300037 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-130-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170416
Time              11.36 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT            DMSO
NS                   24
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                52.41
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7578324 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.17 1H NMR (500 MHz, DMSO-d6) of compound 5.29. 
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Figure 5.18 13C NMR (125 MHz, DMSO-d6) of compound 5.29. 
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Current Data Parameters
NAME     BJS-3-285-CRUDE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161109
Time              13.37
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT            DMSO
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                  181
DW               50.000 usec
DE                 6.00 usec
TE                297.2 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300046 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-3-285-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170416
Time              11.30 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT            DMSO
NS                   40
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                 37.5
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7578403 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.19 1H NMR (500 MHz, DMSO-d6) of compound 5.31. 
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Cl
Figure 5.20 13C NMR (125 MHz, DMSO-d6) of compound 5.31. 
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Current Data Parameters
NAME     BJS-4-109-SALT
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170222
Time               8.33
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT            DMSO
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                203.2
DW               50.000 usec
DE                 6.00 usec
TE                297.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300220 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-146-SALTCARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170329
Time              18.31 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT            DMSO
NS                 1000
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                30.07
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7578445 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.21 1H NMR (500 MHz, DMSO-d6) of compound 5.43. 
N
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H
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Figure 5.22 13C NMR (125 MHz, DMSO-d6) of compound 5.43. 
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Current Data Parameters
NAME     JYH-1-099-PROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170113
Time              15.47 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     JYH-1-099-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170113
Time              15.51 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                17.16
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577892 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.23 1H NMR (500 MHz, CDCl3) of compound 5.15. 
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Figure 5.24 13C NMR (125 MHz, CDCl3) of compound 5.15. 
 454 
  
  
10 9 8 7 6 5 4 3 2 1 0 ppm
2.
58
6
2.
60
1
2.
60
9
2.
62
4
2.
63
2
2.
64
7
2.
82
1
2.
83
1
2.
84
5
2.
85
5
3.
61
7
3.
62
7
3.
63
5
3.
64
1
3.
64
4
3.
64
4
3.
64
9
3.
65
7
3.
66
7
3.
84
9
4.
15
0
4.
16
6
4.
16
7
4.
18
2
4.
38
6
5.
68
7
6.
47
1
6.
48
7
6.
93
6
6.
95
3
7.
21
4
7.
21
6
7.
23
0
7.
24
4
7.
24
5
7.
25
9
7.
26
0
7.
30
2
7.
31
8
7.
33
3
7.
41
9
7.
43
5
1.
06
5
1.
03
2
1.
06
3
3.
03
1
1.
06
2
0.
96
8
1.
01
7
1.
00
0
0.
99
8
1.
15
7
2.
09
7
2.
09
4
Current Data Parameters
NAME     KY-1-134-PROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170327
Time               8.55
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    9
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                   57
DW               50.000 usec
DE                 6.00 usec
TE                297.1 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300220 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     KY-1-134-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170327
Time               8.56
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 8192
DW               15.300 usec
DE                 6.00 usec
TE                297.3 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080713 MHz
WDW                  EM
SSB      0
LB                 3.00 Hz
GB       0
PC                 1.40
Figure 5.25 1H NMR (500 MHz, CDCl3) of compound 5.17. 
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Figure 5.26 13C NMR (125 MHz, CDCl3) of compound 5.17. 
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Current Data Parameters
NAME       KY-1-96-puri
EXPNO               740
PROCNO                1
F2 - Acquisition Parameters
Date_          20160725
Time              20.26
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                    8
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300176 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     KY-1-96-puri-13C
EXPNO               110
PROCNO                1
F2 - Acquisition Parameters
Date_          20160726
Time              10.35
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  128
DS                    0
SWH           25252.525 Hz
FIDRES         0.385323 Hz
AQ            1.2976128 sec
RG               189.85
DW               19.800 usec
DE                 6.50 usec
TE                299.3 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        100.6243395 MHz
NUC1                13C
P1                10.00 usec
PLW1        52.00000000 W
======== CHANNEL f2 ========
SFO2        400.1324008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             90.00 usec
PLW2        13.00000000 W
PLW12        0.36111000 W
PLW13        0.29249999 W
F2 - Processing parameters
SI                65536
SF          100.6127574 MHz
WDW                  EM
SSB      0
LB                 3.00 Hz
GB       0
PC                 1.40
Figure 5.27 1H NMR (500 MHz, CDCl3) of compound 5.19. 
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Figure 5.28 13C NMR (125 MHz, CDCl3) of compound 5.19. 
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Current Data Parameters
NAME      KY-1-127-puri
EXPNO               180
PROCNO                1
F2 - Acquisition Parameters
Date_          20160814
Time              17.32
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                   32
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300176 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     KY-1-127-puri-13C
EXPNO               260
PROCNO                1
F2 - Acquisition Parameters
Date_          20160815
Time              14.00
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  128
DS                    0
SWH           25252.525 Hz
FIDRES         0.385323 Hz
AQ            1.2976128 sec
RG               189.85
DW               19.800 usec
DE                 6.50 usec
TE                299.3 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        100.6243395 MHz
NUC1                13C
P1                10.00 usec
PLW1        52.00000000 W
======== CHANNEL f2 ========
SFO2        400.1324008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             90.00 usec
PLW2        13.00000000 W
PLW12        0.36111000 W
PLW13        0.29249999 W
F2 - Processing parameters
SI                65536
SF          100.6127596 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.29 1H NMR (500 MHz, CDCl3) of compound 5.21. 
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Figure 5.30 13C NMR (125 MHz, CDCl3) of compound 5.21. 
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Current Data Parameters
NAME      KY-1-106-puri
EXPNO               360
PROCNO                1
F2 - Acquisition Parameters
Date_          20160801
Time              15.45
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG            zg30
TD                52882
SOLVENT           CDCl3
NS                   32
DS                    0
SWH            8012.820 Hz
FIDRES         0.151523 Hz
AQ            3.2998369 sec
RG               155.85
DW               62.400 usec
DE                 6.50 usec
TE                299.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        400.1324008 MHz
NUC1                 1H
P1                15.00 usec
PLW1        13.00000000 W
F2 - Processing parameters
SI                65536
SF          400.1300176 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME      KY-1-106-puri
EXPNO               361
PROCNO                1
F2 - Acquisition Parameters
Date_          20160802
Time              15.34
INSTRUM           av400
PROBHD   5 mm PABBO BB/
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  128
DS                    0
SWH           25252.525 Hz
FIDRES         0.385323 Hz
AQ            1.2976128 sec
RG               189.85
DW               19.800 usec
DE                 6.50 usec
TE                299.5 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
SFO1        100.6243395 MHz
NUC1                13C
P1                10.00 usec
PLW1        52.00000000 W
======== CHANNEL f2 ========
SFO2        400.1324008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             90.00 usec
PLW2        13.00000000 W
PLW12        0.36111000 W
PLW13        0.29249999 W
F2 - Processing parameters
SI                65536
SF          100.6127596 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.31 1H NMR (500 MHz, CDCl3) of compound 5.23. 
N
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Figure 5.32 13C NMR (125 MHz, CDCl3) of compound 5.23. 
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Current Data Parameters
NAME     BJS-4-022-PROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170329
Time               8.56
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                 90.5
DW               50.000 usec
DE                 6.00 usec
TE                296.8 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300224 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-022-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170327
Time               8.47
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                   89
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                297.4 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080652 MHz
WDW                  EM
SSB      0
LB                 2.00 Hz
GB       0
PC                 1.40
Figure 5.33 1H NMR (500 MHz, CDCl3) of compound 5.25. 
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Figure 5.34 13C NMR (125 MHz, CDCl3) of compound 5.25. 
 459 
  
 
10 9 8 7 6 5 4 3 2 1 0 ppm
1.
42
4
1.
95
3
1.
97
5
1.
99
5
2.
01
5
2.
49
0
2.
50
2
2.
51
3
2.
52
7
3.
03
6
3.
05
6
3.
06
9
3.
09
0
3.
64
1
3.
72
5
3.
88
0
5.
09
8
6.
42
2
6.
43
9
6.
84
6
6.
86
3
3.
00
0
1.
12
5
1.
05
4
1.
02
8
4.
16
1
3.
27
1
0.
98
3
1.
03
1
1.
01
2
Current Data Parameters
NAME     MH-2-258-PROTONVT2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170418
Time              11.38
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                  181
DW               50.000 usec
DE                 6.00 usec
TE                330.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                12.25 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300205 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     MH-2-258-CARBONPhH
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170420
Time              18.59 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT            C6D6
NS                 1024
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                14.67
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577429 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.35 1H NMR (500 MHz, CDCl3) of compound 5.27. 
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Figure 5.36 13C NMR (125 MHz, C6D6) of compound 5.27. 
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Current Data Parameters
NAME     BJS-3-291-CHARAC
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170213
Time               9.54
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                 90.5
DW               50.000 usec
DE                 6.00 usec
TE                300.0 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300224 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-3-291-PURECARBON2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170212
Time              15.00
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 6502
DW               15.300 usec
DE                 6.00 usec
TE                297.3 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080672 MHz
WDW                  EM
SSB      0
LB                 3.00 Hz
GB       0
PC                 1.40
Figure 5.37 1H NMR (500 MHz, CDCl3) of compound 5.30. 
N
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Figure 5.38 13C NMR (125 MHz, CDCl3) of compound 5.30. 
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Current Data Parameters
NAME     BJS-3-298-CHARAC
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170213
Time               9.58
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                101.6
DW               50.000 usec
DE                 6.00 usec
TE                296.9 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300221 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
22
.7
58
39
.8
97
54
.1
99
67
.7
05
98
.6
05
11
6.
70
8
12
2.
53
1
14
0.
53
9
14
1.
82
8
15
5.
31
6
Current Data Parameters
NAME     BJS-3-298-PURECARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170212
Time              15.09
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG                 4096
DW               15.300 usec
DE                 6.00 usec
TE                297.2 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080672 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.39 1H NMR (500 MHz, CDCl3) of compound 5.32. 
N
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Cl
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Figure 5.40 13C NMR (125 MHz, CDCl3) of compound 5.32 
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Current Data Parameters
NAME     BJS-4-072-PROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170328
Time               9.00
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   37
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                  181
DW               50.000 usec
DE                 6.00 usec
TE                296.8 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300221 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-072-CARBON2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170328
Time              17.41 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                 1024
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                12.14
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577716 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.41 1H NMR (500 MHz, CDCl3) of compound 5.34. 
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Figure 5.42 13C NMR (125 MHz, CDCl3) of compound 5.34. 
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Current Data Parameters
NAME     BJS-3-299-CRUDE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20161121
Time              13.50 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-3-299-PURECARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170212
Time              15.37
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                   64
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG              14596.5
DW               15.300 usec
DE                 6.00 usec
TE                297.3 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080657 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.43 1H NMR (500 MHz, CDCl3) of compound 5.38. 
N
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Figure 5.44 13C NMR (125 MHz, CDCl3) of compound 5.38. 
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Current Data Parameters
NAME     BJS-4-057-PREP
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170119
Time              13.05
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                161.3
DW               50.000 usec
DE                 6.00 usec
TE                297.2 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300223 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-057-CARBON3
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170119
Time              13.29
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  192
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG               9195.2
DW               15.300 usec
DE                 6.00 usec
TE                297.8 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080642 MHz
WDW                  EM
SSB      0
LB                 3.00 Hz
GB       0
PC                 1.40
Figure 5.45 1H NMR (500 MHz, CDCl3) of compound 5.40. 
N
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H
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Me
O
MeO
Figure 5.46 13C NMR (125 MHz, CDCl3) of compound 5.40. 
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Current Data Parameters
NAME     BJS-4-164-PREPPROTON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170420
Time              11.07 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    5
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-164-PREPCARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170420
Time              11.13 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   88
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                14.67
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577717 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.47 1H NMR (500 MHz, CDCl3) of compound 5.42. 
N
5.42
N
H
H
Me
O
Figure 5.48 13C NMR (125 MHz, CDCl3) of compound 5.42. 
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Current Data Parameters
NAME     BJS-4-101-PREP2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170220
Time               9.25
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   32
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                143.7
DW               50.000 usec
DE                 6.00 usec
TE                297.1 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300221 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-101-PREPCARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170220
Time               9.20
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  128
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG               5160.6
DW               15.300 usec
DE                 6.00 usec
TE                297.4 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080653 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.49 1H NMR (500 MHz, CDCl3) of compound 5.44. 
N
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H
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Figure 5.50 13C NMR (125 MHz, CDCl3) of compound 5.44. 
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Current Data Parameters
NAME     BJS-4-120-PREP
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170305
Time              10.31
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                 80.6
DW               50.000 usec
DE                 6.00 usec
TE                296.9 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300220 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-120-PREPCARBON2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170305
Time              10.44
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG          zgdc30
TD                65536
SOLVENT           CDCl3
NS                  128
DS                    0
SWH           32679.738 Hz
FIDRES         0.498653 Hz
AQ            1.0027008 sec
RG              11585.2
DW               15.300 usec
DE                 6.00 usec
TE                297.3 K
D1           2.00000000 sec
d11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                 6.50 usec
PL1      0 dB
SFO1        125.8231939 MHz
======== CHANNEL f2 ========
CPDPRG[2        waltz16
NUC2                 1H
PCPD2            100.00 usec
PL2      0 dB
PL12              17.52 dB
SFO2        500.3320013 MHz
F2 - Processing parameters
SI                65536
SF          125.8080662 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.51 1H NMR (500 MHz, CDCl3) of compound 5.64. 
N
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Me
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Figure 5.52 13C NMR (125 MHz, CDCl3) of compound 5.64. 
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Current Data Parameters
NAME     BJS-4-139-PREP1
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170322
Time              10.21 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   32
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1300122 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-139-PREP1CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170322
Time              10.27 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                   84
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                12.14
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577719 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.53 1H NMR (500 MHz, CDCl3) of compound 5.65. 
N
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Me
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Figure 5.54 13C NMR (125 MHz, CDCl3) of compound 5.65. 
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Current Data Parameters
NAME     BJS-4-157-CRUDE
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170407
Time              15.29 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG            zg30
TD                65536
SOLVENT            C6D6
NS                   16
DS                    0
SWH           10000.000 Hz
FIDRES         0.305176 Hz
AQ            3.2767999 sec
RG                12.14
DW               50.000 usec
DE                10.00 usec
TE                298.0 K
D1           2.00000000 sec
TD0                   1
SFO1        500.1330008 MHz
NUC1                 1H
P1                10.00 usec
PLW1        13.50000000 W
F2 - Processing parameters
SI                65536
SF          500.1299939 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     BJS-4-165-CARBON
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170418
Time              18.30 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT            C6D6
NS                   40
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG                12.14
DW               16.000 usec
DE                18.00 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
SFO1        125.7722511 MHz
NUC1                13C
P1                10.50 usec
PLW1        23.00000000 W
SFO2        500.1330008 MHz
NUC2                 1H
CPDPRG[2        waltz16
PCPD2             80.00 usec
PLW2        13.50000000 W
PLW12        0.21094000 W
PLW13        0.10610000 W
F2 - Processing parameters
SI               131072
SF          125.7577431 MHz
WDW                  EM
SSB      0
LB                 1.00 Hz
GB       0
PC                 1.40
Figure 5.55 1H NMR (500 MHz, CDCl3) of compound 5.45. 
N
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Figure 5.56 13C NMR (125 MHz, CDCl3) of compound 5.45. 
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Current Data Parameters
NAME     ENP-05-046-monster2
EXPNO                 1
PROCNO                1
F2 - Acquisition Parameters
Date_          20170426
Time              18.00
INSTRUM          drx500
PROBHD   5 mm bb-Z Z800
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   22
DS                    0
SWH           10000.000 Hz
FIDRES         0.152588 Hz
AQ            3.2767999 sec
RG                203.2
DW               50.000 usec
DE                 6.00 usec
TE                297.2 K
D1           2.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                13.30 usec
PL1      0 dB
SFO1        500.3330020 MHz
F2 - Processing parameters
SI                32768
SF          500.3300220 MHz
WDW                  EM
SSB      0
LB                 0.30 Hz
GB       0
PC                 1.00
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Current Data Parameters
NAME     ENP-05-049-carbon
EXPNO                 2
PROCNO              999
F2 - Acquisition Parameters
Date_          20170428
Time              11.40 h
INSTRUM           av500
PROBHD   Z119248_0002 (
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  204
DS                    2
SWH           31250.000 Hz
FIDRES         0.953674 Hz
AQ            1.0485760 sec
RG               204.54
DW               16.000 usec
DE                18.00 usec
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Figure 5.57 1H NMR (500 MHz, CDCl3) of compound 5.47. 
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Figure 5.58 13C NMR (125 MHz, CDCl3) of compound 5.47. 
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Figure 5.59 1H NMR (500 MHz, CDCl3) of compound 5.48. 
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CHAPTER SIX 
 
Synthesis of Fused Indolines by Interrupted Fischer Indolization in a Microfluidic Reactor 
Alexander Tuan-Huy Duong, Bryan J. Simmons, Mohammad Parvez Alam, Jesus Campagna, 
Neil K. Garg, Varghese John. 
Tetrahedron Lett. 2019, 60, 322–326. 
 
6.1 Abstract 
 This study describes our development of a microfluidic reaction scheme for the 
synthesis of fused indoline ring systems found in several bioactive compounds. We have utilized 
a continuous-flow microfluidic reactor for the reaction of hydrazines with latent aldehydes 
through the interrupted Fischer indolization reaction to form fused indoline and azaindoline 
products. We have identified optimal conditions and evaluated the scope of this microfluidic 
reaction using various hydrazine and latent aldehyde surrogates. This green chemistry approach 
can be of general utility to rapidly produce indoline scaffolds and intermediates in a continuous 
manner.  
 
6.2 Introduction 
The discovery and development of efficient methods using microfluidic flow chemistry 
to rapidly synthesize bioactive molecules is of great value for hit-to-lead optimization efforts.1,2,3 
However, microfluidic transformations of basic reactions are still limited due to engineering 
feasibility for translating heterogeneous reactions in a flow reactor.4,5,6,7,8 A vast majority of low 
molecular weight bioactive molecules are heterocyclic, and often comprised of several connected 
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heterocyclic rings.9,10,11 A small subset of molecules that have received substantial interest due to 
their medicinal properties are furoindoline and pyrrolidinoindoline that possess a fused indoline 
motif as shown in Figure 6.1. These scaffolds are present in many naturally occurring 
alkaloids.12,13,14,15,16,17,18,19  
 
 
Figure 6.1. Example of representative bioactive compounds containing fused indolines. 
 
 The Fischer indolization reaction is an efficient way to construct fused indoline ring-
systems, although several alternate methods have also been developed to access these 
biologically important motifs.19,20,21 A variant of this reaction, the Garg interrupted Fischer 
indolization, has the advantage of producing three new bonds, two heterocyclic rings and two 
stereogenic centers, in one reaction.15,16 This methodology is convergent, broad in scope, 
proceeds under mild reaction conditions, and can be used to synthesize a variety of natural 
products.15 In one such example, this transformation has been recently utilized in the total 
synthesis of Aspidophylline A (6.3) and its aza-analog.18,22  
 Continuous-flow microfluidic reactor based approaches allow for rapid synthesis of 
products in a green chemistry mode.2 While there are few reports on Fischer indolization 
reactions using a microfluidic reactor, this is not the case with the interrupted Fisher indolization 
reaction to the best of our knowledge.23,24,25 We describe here the development of a microfluidic 
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reactor process for the preparation of indoline and azaindoline compounds using the interrupted 
Fischer indolization reaction, which complements known batch chemistry (Scheme 6.1).15 This 
microfluidic reaction allows for the synthesis of indoline-containing products by the reaction of 
hydrazines and latent aldehydes under mildly acidic conditions. The methodology allows for 
efficient reagent mixing, smaller reaction volumes, optimal heat transfer, precise reaction 
(retention) times, and the possibility to conduct multistep reactions in a single or continuous 
sequence. Thus, this microfluidic approach can be of general utility for synthesis of such 
biologically relevant molecules in a safe, environmentally friendly, and cost effective manner 
that could be amenable to large scale manufacturing.  
 
Scheme 6.1. General flow reactor scheme. 
 
 
6.3 Results and Discussion 
 Our approach to obtain indoline scaffolds in the microfluidic reactor using the interrupted 
Fischer indole synthesis is shown in Table 6.1.15 As part of developing this transformation we 
initially tried the reaction of phenyl-hydrazine (6.4) and lactol (latent aldehyde) 6.5 in the reactor 
using (1:1) AcOH:H2O at 60 °C and 1 bar pressure to determine if we could obtain furoindoline 
6.6. Unfortunately, we did not get any product under these conditions. Next, we changed the 
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temperature, pressure and retention time in the microfluidic reactor to determine the reaction 
outcome. After several variations we found that successful interrupted Fischer indolization 
reaction occurred at 80 °C, 2 bar pressure, and 20 min retention time in the microfluidic reactor 
affording the desired furoindoline 6.6 in 84% yield (entry 5). Further increasing the temperature, 
pressure and retention time in the microfluidic reactor led to the optimal conditions of 120 °C, 3 
bar pressure and 5 min retention time in the microfluidic reactor affording a 97% yield of 6.6 as 
determined by HPLC (entry 8). Scale up and purification of the product by flash chromatography 
gave furoindoline 6.6 in 65% isolated yield. 
 
Table 6.1. Optimization of interrupted Fischer indolization in a microfluidic reactor.a 
 
 a Synthesis of compound 6.6 was done  under varying conditions (entry 1–
8); two solutions were prepared and introduced by Pump A & B into the 
Asia microfluidic reactor; one contained the phenyl hydrazine 6.4 (1.0 
equiv) in AcOH:H2O (2.5 mL, 1:1 v/v) and the other contained latent 
aldehyde 6.5 (1.1 equiv) in AcOH:H2O (2.5 mL, 1:1 v/v). b Combined flow 
rate from both pumps. c Residence time in microfluidic chip reactor (1000 
mL volume). d HPLC yield from microfluidic flow reactor. e Hydrazine 
added at 0.2 M. Latent aldehyde at 1.1 equiv. f  Hydrazine added at 0.5 M. 
Latent aldehyde at 1.1 equiv. g Scale-up of reaction yielded furoindoline 6.6 
in 65% yield  (details in Supplementary Data). 
 
Yieldd
(%)
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(min)
Flow Rateb
(µL/min)
Temperature
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1 1
2
2
2
2
2
3
3
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 After identifying the optimal microfluidic conditions for the interrupted Fischer 
indolization, we next conducted the reaction using different hydrazines while keeping the latent 
aldehyde (6.5) constant. As shown in Table 6.2, the reaction is broad in scope with respect to the 
hydrazine surrogates. Both para- and ortho- substituents were tolerated under the microfluidic 
reaction condition (entries 1, 2, 4, 5 and 6) and afforded the corresponding furoindoline products 
in good yields. The N-methyl-substituted hydrazine 6.9 was shown to be a competent coupling 
partner (entry 3) and afforded the desired N-methyl furoindoline 6.16 in 68% yield while use of 
the  p-methoxypyridylhydrazine salt 6.13 afforded the furanoazaindoline 6.20 in moderate 40% 
yield (entry 7). Several of the products such as the haloindolines (entries 2, 5, 6), are setup for 
further functionalization by transition-metal-catalyzed cross-coupling chemistry.  
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Table 6.2. Hydrazine variants in the microfluidic interrupted Fischer indolization reaction.a 
 
a The reactions were performed using optimized condition (see Table 
6.1, entry 8); two solutions were prepared and introduced by Pump A 
& B into the Asia microfluidic reactor; one contained the different 
hydrazine surrogates (6.7–6.13) (1.0 equiv) in AcOH:H2O (2.5 mL, 
1:1 v/v) and the other contained latent aldehyde 6.5 (1.1 equiv) in 
AcOH:H2O (2.5 mL, 1:1 v/v). Average isolated yields from at least 
two trials for products (6.14–6.20) are reported. 
+
(1:1) AcOH:H2O
6.5
N
H
NH2
OHO
Me
N
H
O
H
Me
YieldProductHydrazine VariantEntry
1
Me
N
H
NH2
•HCl
Me
N
H
O
H
Me
78%
6.7 6.14
2
Cl
N
H
NH2
•HCl
Cl
N
H
O
H
Me
57%
6.8 6.15
3 N
NH2
N
O
H
Me
68%
6.9 6.16
Me Me
4 N
H
NH2
N
H
O
H
Me
34%
6.10 6.17
F F
5
N
H
NH2
N
H
O
H
Me
55%
6.11 6.18
Br Br
6 N
H
NH2
N
H
O
H
Me
56%
6.12 6.19
Br Br
•HCl
•HCl
•HCl
7
N
N
H
NH2
N
N
H
O
H
Me
40%
6.13 6.20
•HCl
MeO MeO
120 °C, 3 bar
retention time = 5 min
R
R
 483 
We further evaluated the scope of the transformation with nitrogen- or oxygen-containing 
latent aldehyde coupling partners using phenyl hydrazine 6.4 (Table 6.3). The use of five- 
membered oxygen- or nitrogen-containing latent aldehydes afforded the corresponding 
furoindoline 6.24 and pyrrolidinoindoline 6.25 in 49% and 42% yield, respectively. Interestingly, 
even the six-membered homolog (6.26) of the pyrrolidinoindoline framework was obtained using 
this methodology, although in lower yield. 
 
Table 6.3. Variations of the latent aldehyde surrogate in the microfluidic reaction.a 
 
a The reactions were performed using optimized conditions (see Table 
6.1, entry 8); two solutions were prepared and introduced by Pump A 
& B into the Asia microfluidic reactor; one contained the phenyl 
hydrazine (6.4) (1.0 equiv) in AcOH:H2O (0.5 mL, 1:1 v/v) and the 
other contained lactol variant (6.21–6.23) (1.1 equiv) in AcOH:H2O or 
AcOH  (0.5 mL, 1:1 v/v). Average isolated yields from at least two 
trials for products (6.24–6.26) are reported. b Hydrazine added at 0.4 
M. Latent aldehyde at 1.1 equiv due to insolubility of  latent aldehyde 
6.21. c Hydrazine added at 0.1 M. Latent aldehyde at 1.1 equiv due to 
insolubility of  latent aldehyde 6.22. d Hydrazine added at 0.4 M. 
Latent aldehyde at 1.1 equiv due to insolubility of  latent aldehyde 
6.23 & reaction performed in AcOH. 
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+
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6.4
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H
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3d
N
H
H
Me
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OHO
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6.4 Conclusion 
 The use of a microfluidic reactor for the interrupted Fischer indolization resulted in short 
reaction times and led to indoline and azaindoline products in reasonable yields. We were able to 
accelerate the microfluidic reaction by increasing temperature and pressure to achieve yields up 
to 97% with 5 minutes residence time in the reactor. This rapid green chemistry methodology 
should facilitate continuous synthesis of fused indoline ring systems that can potentially be 
coupled with additional microfluidic reactors for multistep synthesis. This approach allows for 
rapid synthesis of these important scaffolds as dual enzyme inhibitors and should prove useful 
for the discovery of new drug candidates. 
 
6.5 Experimental Section 
6.5.1 Materials and Methods 
All chemicals used for synthesis were used as received from commercial sources. 
Phenylhydrazine (6.4), 4-bromophenylhydrazine hydrochloride (6.11), 2-
fluorophenylhydrazine hydrochloride (6.10), and 2-bromophenylhydrazine hydrochloride 
hydrate (6.12) were obtained from TCI. All other chemicals were synthesized as previously 
reported17 from the Garg lab. Analytical thin‒layer chromatographic separations were carried 
out on silica gel (60 Å particle size, 250 µm thickness, F-254, Silicycle) coated glass 
plates; spots were visualized with UV light. HPLC data was gathered using an Agilent 1260 
Infinity instrument and an Agilent Poroshell-120 column (2.7 um particle size, 4.6 mm 
diameter x 50 mm length) using a gradient method of 60:40 (Acetonitrile:H2O) to 98:2 
(Acetonitrile:H2O) over 5 minutes. 1H NMR spectra were recorded using a 400 MHz Bruker 
spectrometer and reported in parts per million (ppm, δ) relative to chemical residual 1H 
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resonance of the solvent CDCl3 at 7.26 ppm. Data for 1H NMR spectra are reported as 
follows: chemical shift (ppm, δ), multiplicity, coupling constant (Hz), and integration. 13C 
NMR spectra are reported in terms of chemical shift (ppm, δ), relative to the central line of 
CDCl3 at 77.16 ppm. 
 
6.5.2 General Information for Flow Reactor Setup 
 The experiments were conducted using the commercially available Asia continuous-flow 
system from Syrris. The system configuration consisted of an Asia Pressurized Input Store, 
Syringe Pump, Reagent Injector, Chip Climate Controller, and Pressure Controller, all 
connected via PTFE tubing (1.6 mm OD x 0.5 mm ID) purchased from Syrris. The 
Pressurized Input Store allowed storage of our mobile solvent phase under an inert nitrogen 
atmosphere. From the Store, solvent would flow to two separate Syringe pumps, then to the 
Reagent Injector, Chip Climate Controller, and Backpressure Regulator. The system’s modular 
design allowed for independent modification t o each reaction parameter. Individual flow rates 
could be independently changed at each Syringe Pump, which determined residence and 
reaction time through the reactor. This time derived from the reactor chip volume, divided 
by the combined flow rate through it. Reaction temperatures could be controlled through the 
Chip Climate Controller, which houses the microfluidic chip reactor, and reaction pressure 
could be changed (as in Table 6.1) through the Backpressure Regulator. 
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Scheme 6.2. Asia flow reactor scheme. 
 
 
 
Figure 6.2. Flow reactor setup. 
 
 
 
Input A Input B 
N2 N2 
Reagent Injector 
Pressurized
Input Store Chip Climate Controller 
Backpressure Regulator 
Syringe Pumps 
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6.5.3 General Procedure for Flow Reactor Syntheses and Purification 
 Unless stated otherwise, reactions were performed in a Syrris 1000 µL glass 
microfluidic chip reactor (part number 2100146). Prepared stock solutions of the 
phenylhydrazine and lactol were charged into separate 1 mL syringes and injected into the 
Reagent Injector Inputs A and B. In cases when reagents did not readily dissolve, sonication and 
heating were used until the reagents were fully dissolved. Reagents were then introduced into 
the microfluidic chip reactor by Pumps A and B. The mixture was pumped through the reactor 
at a predetermined flow rate to achieve desired residence times. Crude product was then purified 
via flash chromatography using a Combiflash Rf 200 instrument and prepacked silica gel (300‒
400 mesh) cartridges (Hexanes, 5 minutes;  100%  Hexanes  → 5:95  (EtOAc:Hexanes),  10  
minutes; 5:95  (EtOAc:Hexanes), 5 minutes; 5:95 (EtOAc:Hexanes) → 1:4 (EtOAc:Hexanes), 
10 minutes; 1:4 (EtOAc:Hexanes) → 7:3 (EtOAc:Hexanes), 5 minutes). Fractions 
corresponding to the product were combined and isolated under vacuum. 
    
6.5.4 Optimization of Flow Parameters and Substrate Synthesis 
 
Representative Procedure. Synthesis of Indoline 6.6 (Table 6.1, entries 1–6). 
Phenylhydrazine 6.4 (0.2 M in AcOH/H2O (1:1 v/v), 50 µL, 0.01 mmol, 1 equiv) was injected 
into Pump A. Lactol 6.5 (0.22 M in AcOH/H2O (1:1 v/v), 50 µL, 0.011 mmol, 1.1 equiv) was 
injected into Pump B. Temperature, pressure, and flow rates were changed to achieve 
designated reaction conditions. The chip was flushed with AcOH/H2O (1:1 v/v) to elute the 
N
H
NH2 +
OHO
Me
(1:1) AcOH:H2O
N
H
O
H
Me
6.4 6.5 6.6
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product. Crude product was collected in a flask. Product yields were determined by HPLC. Yield 
was obtained by percent ratio of the product peak to that for the starting materials. 
 
Representative Procedure. Synthesis of Indoline 6.6 (Table 6.1, entry 7). Phenylhydrazine 
6.4 (0.5 M in AcOH/H2O (1:1 v/v), 50 µL, 0 .025 mmol, 1 equiv) was injected into Pump A. 
Lactol 6.5 (0.55 M in AcOH/H2O (1:1 v/v), 50 µL, 0.028 mmol, 1.1 equiv) was injected into 
Pump B. Chip reactor was preheated to 120 °C and pressure was set to 3 bar. Pumps A and B 
were both set to 50 µL/min flow rates to achieve a 10 min residence time. The chip was flushed 
with AcOH/H2O (1:1 v/v) to elute the product. Crude product was collected in a flask. Product 
yield was determined by HPLC to be 97%. 
 
Representative Procedure. Synthesis of Indoline 6.6 (Table 6.1, entry 8). Phenylhydrazine 
6.4 (0.5 M in AcOH/H2O (1:1 v/v), 5 mL, 2.5 mmol, 1 equiv) was injected into Pump A. Lactol 
6.5 (0.55 M in AcOH/H2O (1:1 v/v), 5 mL, 2.75  mmol, 1.1 equiv) was injected into Pump B. 
Chip reactor was preheated to 120 °C and pressure was set to 3 bar. Pumps A and B were both 
set to 100 µL /min ﬂow rates to achieve a final 200 µL /min flow rate and 5 min residence time in 
the reactor. Crude product was collected in a flask, and crude yield was determined by HPLC. 
The crude product was quenched with a solution of sat. aq. NaHCO3 (2 x 30 mL) and extracted 
with EtOAc (2 x 60 mL). Combined organic phases were dried over Na2SO4  and concentrated 
under reduced pressure. Purification by flash chromatography afforded furoindoline 6.6 
((3aS,8aS)-3a-methyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indole) as a brown oil (285 mg, 65% 
yield). Rf  0.3 (3:1 Hexanes:EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 7.12–7.03 (m, 2H), 
6.77 (t, J= 7.4 Hz, 1H), 6.59 (d, J = 7.8 Hz, 1H), 5.29 (s, 1H), 3.97 (ddd, J = 8.7, 7.2, 1.6 Hz, 
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1H), 3.58 (ddd, J= 11.1, 8.6, 5.2 Hz, 1H), 2.21–2.06 (m, 2H), 1.48 (s, 3H). Spectral data match 
those previously reported.15
 
 
 
Representative Procedure. Synthesis of Indoline 6.14 (Table 6.2, entry 1) is used as an 
example. Phenylhydrazine 6.7 (0.5 M in AcOH/H2O (1:1 v/v), 500 uL, 0.25 mmol, 1.0 equiv) 
was injected into Pump A. Lactol 6.5 (0.55 M in AcOH/H2O (1:1 v/v), 500 uL, 0.28 mmol, 
1.1 equiv) was injected into Pump B. Chip reactor was preheated to 120 °C and pressure was set 
to 3 bar. Pumps A and B were both set to 100 µL/min flow rates to achieve a 5 min residence 
time. The crude product was quenched with a solution of sat. aq. NaHCO3 (20 mL) and 
extracted with EtOAc (3 x 20 mL). Combined organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography afforded 
furoindoline 6 . 1 4  ((3aS,8aS)-3a,7- dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indole) as a 
brown solid (78% yield, average of two experiments). Rf 0.4 (3:1 Hexanes:EtOAc); 
1
H NMR 
(400 MHz, CDCl3) δ 6.95 (d, J = 7.9 Hz, 1H), 6.91 (d, J = 6.4 Hz, 1H), 6.72 (t, J = 7.4 Hz, 
1H), 5.32 (s, 1H), 3.95 (ddd, J = 8.8, 7.2, 1.7 Hz, 1H), 3.68–3.45 (m, 1H), 2.21–2.17 (m, 1H), 
2.15 (s, 3H), 2.13–2.04 (m, 1H), 1.48 (s, 3H). Spectral data match those previously reported.15 
 
Any modifications of the conditions shown in this representative procedure are specified in the 
following schemes, which depict all of the reactions in Table 6.2. 
 
N
H
NH2 +
OHO
Me
(1:1) AcOH:H2O
N
H
O
H
Me
6.7 6.5 6.14
Me
•HCl
120 °C, 3 bar, 5 min
(78% yield)
Me
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Indoline 6.15 (Table 6.2, entry 2). Purification by flash chromatography afforded 
furoindoline 6.15 ((3aS,8aS)-7-chloro-3a-methyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indole) as a 
yellow  solid (57% yield, average of two experiments). Rf 0.4 (3:1 Hexanes:EtOAc); 
1
H 
NMR (400 MHz, CDCl3) δ 7.05 (d, J = 9.1 Hz, 1H), 6.96 (d, J = 8.4 Hz, 1H), 6.71–6.65 (m, 
1H), 5.33 (s, 1H), 3.97 (ddd, J = 8.8, 7.1, 1.7 Hz, 1H), 3.57 (ddd, J = 11.1, 8.7, 5.2 Hz, 1H), 
2.16 (ddd, J = 11.7, 5.2, 1.4 Hz, 1H), 2.13–2.04 (m, 1H), 1.48 (s, 3H). Spectral data match 
those previously reported.
 15 
 
 
Indoline 6.16 (Table 6.2, entry 3). Purification by flash chromatography afforded 
furoindoline 6.16 ((3aS,8aS)-3a,8-dimethyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indole) as a 
colorless oil (68% yield, average of two experiments). Rf 0.5 (3:1 Hexanes:EtOAc); 
1
H 
NMR (400 MHz, CDCl3) δ 7.14–7.08 (m, 1H), 7.05 (d, J = 6.4 Hz, 1H), 6.68 (t, J = 7.8 Hz, 
1H), 6.37 (d, J = 7.8 Hz, 1H), 5.07 (s, 1H), 3.95 (ddd, J = 8.7, 7.2, 1.6 Hz, 1H), 3.46 (ddd, J = 
11.0, 8.6, 5.3 Hz, 1H), 2.93 (s, 3H), 2.29–1.91 (m, 2H), 1.46 (s, 3H). Spectral data match 
those previously reported.
 15 
N
H
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OHO
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N
H
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Cl
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(57% yield)
Cl
N
NH2 +
OHO
Me
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(68% yield)
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Indoline 6.17 (Table 6.2, entry 4). Purification by flash chromatography afforded 
furoindoline 6.17 ((3aS,8aS)-7-fluoro-3a-methyl-3,3a,8,8a-tetrahydro-H-furo[2,3-b]indole) as a 
brown amorphous solid (34% yield, average of two experiments). Rf 0.4 (3:1 Hexanes:EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 6.88–6.81 (m, 2H), 6.69 (ddd, J = 8.2, 7.3, 4.6 Hz, 1H), 5.33 
(s, 1H), 3.97 (ddd, J = 8.8, 7.2, 1.7 Hz, 1H), 3.57 (ddd, J = 11.1, 8.7, 5.2 Hz, 1H), 2.18 (ddd, J = 
12.0, 5.2, 1.7 Hz, 1H), 2.09 (ddd, J = 12.0, 11.1, 7.2 Hz, 1H), 1.48 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 147.73 (JC-F = 2.39), 137.69 (JC-F = 0.05), 136.16 (JC-F = 0.13), 119.54 (JC-F = 
0.06), 118.55 (JC-F = 0.03), 114.63 (JC-F = 0.17), 100.23, 67.77, 54.83, 41.55, 24.69; 
19
F 
NMR (376 MHz, CDCl3) δ –136.09 (two minor peaks seen in 19F NMR spectrum could be 
inseperable isomers likely from impurities in the starting hydrazine). HRMS-ESI (m/z) [M + 
H]+ calcd for C11H13FNO+, 194.09757; found, 194.09755. 
 
 
Indoline 6.18 (Table 6.2, entry 5). Phenylhydrazine 6.11 (0.25 M in AcOH/H2O (1:1 v/v), 500 
uL, 1 equiv) was injected into Pump A. Lactol 6.5 (0.275 M in AcOH/H2O (1:1 v/v), 500 uL, 
1.1 equiv) was injected into Pump B. Chip reactor was preheated to 120 °C and pressure was 
set to 3 bar. Pumps A and B were both set to 100 µL/min flow rates to achieve a 5 min residence 
N
H
NH2 +
OHO
Me
(1:1) AcOH:H2O
N
H
O
H
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6.10 6.5 6.17
F
•HCl
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(34% yield)
F
N
H
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(1:1) AcOH:H2O
N
H
O
H
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6.11 6.5 6.18
•HCl
120 °C, 3 bar, 5 min
(55% yield)
Br Br
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time. The crude product was quenched with a solution of sat. aq. NaHCO3 (20 mL) and 
extracted with EtOAc (3 x 20 mL). Combined organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography afforded 
furoindoline 6 . 18 ((3aS,8aS)-5-bromo-3a-methyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indole) as 
a yellow oil (55% yield, average of two experiments). Rf 0.3 (3:1 Hexanes:EtOAc); 
1
H NMR 
(400 MHz, CDCl3) δ 7.16 (d, J = 1.7 Hz, 1H), 7.13 (dd, J = 8.2, 2.0 Hz, 1H), 6.45 (d, J = 8.4 
Hz, 1H), 5.26 (s, 1H), 3.96 (ddd, J = 8.8, 7.1, 1.7 Hz, 1H), 3.61–3.48 (m, 1H), 2.19–2.12 (m, 
1H), 2.11–2.03 (m, 1H), 1.46 (s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 148.08, 136.58, 130.78, 
126.31, 110.52, 109.72, 99.92, 67.57, 54.19, 41.56, 24.74; HRMS-ESI (m/z) [M + H]+ calcd for 
C11H13BrNO
+
, 254.01750; found, 254.01751. 
 
 
Indoline 6.19 (Table 6.2, entry 6). Purification by flash chromatography afforded 
furoindoline 6.19 ((3aS,8aS)-7-bromo-3a-methyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indole) as 
a yellow  solid (56% yield, average of two experiments). Melting point 39–43 °C; Rf 0.4 (3:1 
Hexanes:EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 7.19 (d, J = 8.0 Hz, 1H), 6.99 (d, J = 8.3 Hz, 
1H), 6.67–6.59 (m, 1H), 5.32 (s, 1H), 3.97 (ddd, J = 8.7, 7.1, 1.7 Hz, 1H), 3.62–3.53 (m, 1H), 
2.20–2.13 (m, 1H), 2.12– 2.04 (m, 1H), 1.48 (s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 
147.55, 135.38, 130.59, 121.92, 120.08, 101.79, 98.91, 67.62, 55.48, 41.73, 24.85; HRMS-ESI 
(m/z) [M+ H]+ calcd for C11H13BrNO
+
, 254.01750; found, 254.01755.
N
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Indoline 6 . 20 (Table 6 . 2, entry 7). Purification by flash chromatography afforded 
furoindoline 6 . 20 ((3aS,8aS)-5-methoxy-3a-methyl-3,3a,8,8a-tetrahydro-2H-
furo[3’,2’:4,5]pyrrolo[3,2-b]pyridine) as a yellow solid (40% yield, average of two 
experiments). Rf 0.3 (3:1 Hexanes:EtOAc); 1H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 8.4 
Hz, 1H), 6.43 (d, J = 8.4 Hz, 1H), 5.27 (s, 1H), 3.97 (ddd, J = 9.0, 7.5, 1.7 Hz, 1H), 3.87 (s, 
3H), 3.53 (ddd, J = 11.1, 8.7, 5.3 Hz, 1H), 2.40 (ddd, J = 12.1, 5.3, 1.5 Hz, 1H), 2.08–1.98 (m, 
1H), 1.47 (s, 3H). Spectral data match those previously reported.18  
 
 
Representative Procedure. Synthesis of Indoline 6.24 (Table 6.3, entry 1) is used as an 
example. Due to insolublity issues with the lactol, a more dilute solution of the starting materials 
were used (Table 6.3, entry 1-3). Phenylhydrazine 6.4 (0.4 M in AcOH/H2O (1:1 v/v), 500 uL, 1 
equiv) was injected into Pump A. Lactol 6.21 (0.44 M in AcOH/H2O (1:1 v/v), 500 uL, 1.1 
equiv) into Pump B. Chip reactor was preheated to 120 °C and pressure was set to 3 bar. Pumps 
A and B were both set to 100 µL/min flow rates to achieve a 5 min residence time. The crude 
product eluted and quenched with a solution of sat. aq. NaHCO3 (20 mL) and extracted with 
EtOAc (3 x 20 mL). Combined organic phases were dried over Na2SO4 and concentrated under 
N
N
H
NH2 +
OHO
Me
(1:1) AcOH:H2O
N
N
H
O
H
Me
6.13 6.5 6.20
•HCl
120 °C, 3 bar, 5 min
(40% yield)
MeO
MeO
N
H
NH2 +
OHO
Ph
(1:1) AcOH:H2O
N
H
O
H
Ph
6.4 6.21 6.24120 °C, 3 bar, 5 min
(49% yield)
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reduced pressure. Purification by flash chromatography a forded furoindoline 6.24 ((3aR,8aS)-
3a-phenyl-3,3a,8,8a-tetrahydro-2H-furo[2,3-b]indole) as a colorless oil (49% yield, average of 
two experiments). Rf  0.4 (3:1 Hexanes:EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 7.37–7.28 (m, 
4H), 7.25–7.20 (m, 1H), 7.12–7.07 (m, 1H), 7.05–7.01 (m, 1H), 6.76 (td, J = 7.4, 1.0 Hz, 1H), 
6.67 (d, J = 7.8 Hz, 1H), 5.62 (s, 1H), 4.19–4.13 (m, 1H), 3.75–3.62 (m, 1H), 2.83–2.68 (m, 1H), 
2.52 (dd, J = 11.9, 4.4 Hz, 1H). Spectral data match those previously reported. 15 
 
Any modifications of the conditions shown in this representative procedure are specified in the 
following schemes, which depict all of the reactions in Table 6.3. 
 
 
Indoline 6.25 (Table 6.3, entry 2). Phenylhydrazine 6.4 (0.1 M in AcOH/H2O (1:1 v/v), 500 uL, 
1 equiv) was injected into Pump A. Hemiaminal 6.22 (0.11 M in AcOH/H2O (1:1 v/v), 500 uL, 
1.1 equiv) was injected into Pump B. Chip reactor was preheated to 120 °C and pressure was set 
to 3 bar. Pumps A and B were both set to 100 µL/min flow rates to achieve a 5 min residence 
time. The crude product was quenched with a solution of sat. aq. NaHCO3 (20 mL) and 
extracted with EtOAc (3 x 20 mL). Combined organic phases were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography afforded 
pyrrolidinoindoline 6.25 ((3aS,8aS)-3a-methyl-1-tosyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-
b]indole) as a yellow solid (42% yield, average of two experiments). Rf 0.4 (3:1 
N
H
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N
TsHO
Me
(1:1) AcOH:H2O
N
H
NTs
H
Me
6.4 6.22 6.25120 °C, 3 bar, 5 min
(42% yield)
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Hexanes:EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.4 Hz, 
2H), 7.07 (td, J = 7.7, 1.3 Hz, 1H), 7.02–6.98 (m, 1H), 6.76 (td, J = 7.4, 0.9 Hz, 1H), 6.62 (d, J = 
7.8 Hz, 1H), 5.03 (s, 1H), 3.41 (ddd, J = 10.4, 7.9, 2.6 Hz, 1H), 3.13 (td, J = 10.2, 6.1 Hz, 1H), 
2.44 (s, 3H), 2.19–2.12 (m, 1H), 1.78 (ddd, J = 12.5, 10.1, 7.9 Hz, 1H), 1.27 (s, 3H). Spectral 
data match those previously reported.
 15 
 
 
Indoline 6.26 (Table 6.3, entry 3). Phenylhydrazine 6.4 (0.4 M in AcOH, 500 uL, 1 equiv) was 
injected into Pump A. Hemiaminal 6.23 (0.44 M in AcOH, 500 uL, 1.1 equiv) was injected into 
Pump B. Chip reactor was preheated to 120 °C and pressure was set to 3 bar. Pumps A and B 
were both set to 100 µL/min flow rates to achieve a 5 min residence time. The crude product was 
quenched with a solution of sat. aq. NaHCO3 (20 mL) and extracted with EtOAc (3 x 20 mL). 
Combined organic phases were dried over Na2SO4 and concentrated under reduced pressure. 
Purification by flash chromatography forded pyrrolidinoindoline 6.26 ((4aS,9aS)-4a-methyl-1- 
tosyl-2,3,4,4a,9,9a-hexahydro-1H-pyrido[2,3-b]indole) as a yellow amorphous solid (21% yield, 
average of two experiments). Rf  0.5 (3:1 Hexanes:EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 7.75 
(d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.06–7.00 (m, 1H), 6.96 (d, J = 7.3 Hz, 1H), 6.75 (t, 
J = 7.9 Hz, 1H), 6.59 (d, J = 7.7 Hz, 1H), 5.18 (s, 1H), 3.75–3.61 (m, 1H), 3.27–3.12 (m, 1H), 
2.45 (s, 3H), 1.72–1.41 (m, 4H), 1.26 (s, 3H). Spectral data match those previously reported.
 15 
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6.6 Spectra Relevant to Chapter Six: 
 
Synthesis of Fused Indolines by Interrupted Fischer Indolization in a Microfluidic Reactor 
Alexander Tuan-Huy Duong, Bryan J. Simmons, Mohammad Parvez Alam, Jesus Campagna, 
Neil K. Garg, Varghese John. 
Tetrahedron Lett. 2019, 60, 322–326. 
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Figure 6.3 1H NMR (400 MHz, CDCl3) of compound 6.6. 
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Figure 6.4 1H NMR (400 MHz, CDCl3) of compound 6.14. 
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Figure 6.5 1H NMR (400 MHz, CDCl3) of compound 6.15. 
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Figure 6.6 1H NMR (400 MHz, CDCl3) of compound 6.16. 
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Figure 6.7 1H NMR (400 MHz, CDCl3) of compound 6.17. 
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Figure 6.8 13C NMR (101 MHz, CDCl3) of compound 6.17. 
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Figure 6.9 19F NMR (376 MHz, CDCl3) of compound 6.17. 
 
Figure 6.10 1H NMR (400 MHz, CDCl3) of compound 6.18. 
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Figure 6.11 13C NMR (101 MHz, CDCl3) of compound 6.18. 
 
Figure 6.12 1H NMR (400 MHz, CDCl3) of compound 6.19. 
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Figure 6.13 13C NMR (101 MHz, CDCl3) of compound 6.19. 
 
Figure 6.14 1H NMR (400 MHz, CDCl3) of compound 6.20. 
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Figure 6.15 1H NMR (400 MHz, CDCl3) of compound 6.24. 
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Figure 6.16 1H NMR (400 MHz, CDCl3) of compound 6.25. 
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Figure 6.17 1H NMR (400 MHz, CDCl3) of compound 6.26. 
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